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ABSTRACT 
 
Background: Breast cancer is the most common cancer among Maltese women. No studies 
have explored factors related to mammography underutilisation in Malta. This thesis aimed to 
explore barriers and facilitators to mammography screening among Maltese women to inform 
future screening interventions. 
Methods: Seven studies were conducted through mixed methods research. First, a survey 
instrument to assess associations between health beliefs, illness perceptions and mammography 
was piloted-tested among Maltese women (Study 1). Four quantitative studies explored 
associations and predictors to mammography use: study 2 investigated factors associated with 
a first screening invitation; study 3 investigated reattendance; studies 4 and 5 examined lifetime 
mammography practices and timely adherence respectively. A systematic review of 
interventions, which employed the Health Belief Model and/or Common-Sense Model to 
improve mammography uptake, was conducted (Study 6). Experts helped to construct a logic 
model of the problem and change objectives, while members of the public interpreted the 
quantitative findings through the World Café method. Study 7 consisted of face-to-face 
interviews with non-attendees. Intervention Mapping was used to synthesise the findings and 
propose recommendations to increase uptake. 
Findings: The survey instrument was valid and reliable for use with Maltese women (Study 1). 
Health beliefs were strong predictors of mammography underutilisation and illness perceptions 
improved non-attendance predictions (Studies 2-5). First attendance is associated with 
reattendance (Study 3). Illness perceptions however are rarely included in mammography 
interventions (Study 6). Experts supported multiple interventions, including physician 
recommendations, education and counselling, while members of the public identified the 
involvement of partners and daughters in health decision-making. Qualitative findings found 
that health-related knowledge was low, and that socio-cultural factors impeded attendance, 
particularly support networks, household dynamics, traumatic histories and mental health 
approaches (Study 7). 
Conclusion: Multiple, theoretical strategies are considered more effective. Interventions, 
implemented within the community setting, should target women’s barriers, particularly fear, 
when first invited. Family members and practitioners can help to address screening barriers.  
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DEFINITIONS 
 
For the purpose of this study, the definitions of the key concepts used are listed below. Some of 
these definitions were sought from books and journals while others were drawn up for the 
purpose of this study. 
Barriers: Perceived negative aspects of undertaking health behaviours 
(Gözüm and Aydin 2004). These may also be physical or 
structural concerns or perceived emotions related to behaviours 
that might interfere with breast screening uptake. 
Benefits: Positive results of steps taken to avoid contracting the condition 
(Gözüm and Aydin 2004). 
Breast cancer: Cancer that originates from breast tissue, usually from the milk-
producing glands (lobules) and the tubules that carry milk from 
the lobules to the nipple during breastfeeding (ducts) (Sharma et 
al, 2010).  
Compliance:  The proportion who present for screening amongst those invited 
who remain eligible and are resident in the catchment population 
(Marshall 1995, p.112). 
Coverage:  The proportion of women resident and eligible for screening 
within a population invited for mammography screening in a 
specified time period (Jepson et al. 2000). 
Cues to action: Exposure to factors that prompt action i.e. anything that prompts 
an individual to think or act upon a specific health issue (i.e. TV 
commercials prompting to take a specific action or having a 
family member suffering from a specific condition) (Orji et al. 
2012). 
Determinants: Factors significantly influencing the screening uptake (e.g., 
individual’s characteristics, type of screening and methods 
involved, other) (Jepson et al. 2000).  
xxviii 
 
Incidence:  ‘The number of newly diagnosed cases of disease in a defined 
population within a defined time period. It is usual to present 
incidence as rates per 100 000 women’ (Marshall 1995, p.112). 
Internal consistency:  The degree to which all of the items on a test measure the same 
construct (Bowling 2009). 
Internal validity:  The extent to which the instrument is really measuring what it 
purports to measure (Bowling 2009).  
Mammography: ‘It consists of two mammographic views of each breast (Cranio-
Caudal and Medio Lateral Oblique projections). The CC view 
provides sagittal orientation of breast tissue and includes most of 
the breast with the exception of the far lateral portion’, while ‘the 
MLO view is a view of virtually all the breast’ (Eklund and 
Cardenosa 1992, p.22). 
Mammography screening:  ‘A suitable screening test that detects the great majority of breast 
cancers from those screened (high sensitivity) giving very few 
false negative results, while the majority of those not having 
breast cancer are eliminated from further diagnostic tests (high 
specificity) giving very few false positive results’ (Forrest 1990, 
p.13). 
Morbidity:  ‘The relative incidence of disability/disease, i.e. non-fatal illness’ 
(Marshall 1995, p.112). 
Mortality: ‘The number of people within a defined population who die within 
a defined period. As for incidence, it is usual to present mortality 
as rates per 100 000 women’ (Marshall 1995, p.112). 
Motivation: The beliefs and behaviours related to the state of general concern 
about health (Gözüm and Aydin 2004). 
Opportunistic screening: An individual seeks screening or is referred by a doctor or health 
care professional to non-dedicated mammography screening 
centers without active invitation neither control system 
(Anagnostopoulos et al. 2012).  
xxix 
 
Perception: ‘The process which determines the way we appraise the world 
around us and forms the basis of the actions we take to remain in 
control of what is going on in our lives’ (Payne and Walker 1996, 
pp.79-80). With respect to breast screening, perceptions may 
include: ‘value of health, risk factors and early warning signs of 
breast cancer, importance of and confidence in the test, 
confidence in own capabilities in breast cancer prevention, and 
expectations of pain in mammography’  (Aro et al. 1996, p.83). 
Perceived seriousness: Perceived severity of the consequences of contracting a disease 
(Gözüm and Aydin 2004). 
Perceived susceptibility: Perceived vulnerability to a disease or the risks of contracting it 
(Gözüm and Aydin 2004). 
Quality assurance: ‘The total overall management of actions taken to consistently 
provide high image quality, the primary objective being to 
enhance patient care. In general, quality assurance must be 
planned and systematic series of actions with key components 
being quality control’ (Peart 2005, p.2). 
Reliability:  ‘The extent to which the measure is consistent and minimizes 
random error (its repeatability) (Bowling 2009, p.468).  
Self efficacy: Confidence in one’s ability to perform the new health behaviour 
(Orji et al. 2012).  
Social inequalities: ‘Health disparities, within and between countries, that are judged 
to be unfair, unjust, avoidable, and unnecessary (meaning: are 
neither inevitable nor irremediable) and that systematically 
burden populations rendered vulnerable by underlying social 
structures and political, economic, and legal institutions’ 
(Krieger 2001, p.698). 
Test-retest reliability:  The degree to which the results are consistent over time 
(Bowling 2009). 
Uptake:  The proportion of women invited for screening for whom a 
screening test result is recorded (NHSBSP 2012).
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1.1 Introduction 
Chronic health diseases are a global public health concern (McKenzie et al. 2008) with cancer 
being among the most common and expensive health issues (Centers for Disease Control (CDC) 
2015). In particular, the burden of breast cancer (BC) on society, measured by incidence, 
mortality and economic cost (Legler et al. 2002), is estimated to increase substantially as people 
live longer and care and treatments become more complex and expensive (Knox 2009). 
Specifically, BC originates from breast tissue, usually from the milk-producing glands (lobules) 
and the tubules that carry milk from the lobules to the nipple during breastfeeding (ducts) 
(Sharma et al. 2010). BC is highly preventable and treatable if detected at the precancerous or 
local stage of development. Early BC detection through screening is associated with earlier-
stage disease and effective treatment (Dang et al. 2010). It has been shown to be effective in 
decreasing BC mortality by 25-35% in women over 50 (Tabár et al, 2011; Smith et al., 2004), 
thereby improving women’s survival (Galit et al. 2007). To achieve this goal, it is essential to 
have high participation rates in breast screening (BS) by mammography.  
 
This research has been informed by my previous work entitled ‘A study to evaluate women’s 
satisfaction of the Maltese Breast Screening Programme’ (Marmarà et al. 2015), which 
examined programme satisfaction among BS attendees. Apart from women’s high satisfaction 
with the programme, the findings showed a low attendance rate of 55.9% at the time of study 
(Marmarà et al. 2015). This gap in Malta needed to be urgently addressed. In Malta, there have 
been no evidence-based studies on BS barriers and facilitators, and no feasible and acceptable  
screening interventions for the Maltese population. Hence, Maltese women were selected as the 
target population in this research.  
 
This research lays the foundations to address barriers and facilitators associated with BS by 
exploring health beliefs and illness perceptions about BC and BS practices. Hence, the findings 
shall aid the design and development of a future intervention in Malta. This work is novel in 
Malta and may have a pivotal role in shedding light on the gap between practical strategies and 
any system level changes required to develop efficient and effective BS programmes in Malta. 
It is also hoped that this study will further contribute towards health services research knowledge 
and inform theoretical intervention development.  
3 
 
This chapter describes BC epidemiology, screening history and BS uptake in Europe and in 
Malta. It also introduces the Maltese context and justifies the focus of the thesis. The last section 
in this chapter contains a brief overview of each chapter. The terms BS and mammography 
screening are used interchangeably throughout this thesis. 
 
1.2 Background 
1.2.1 Malta and its healthcare system 
Malta is an archipelago in the centre of the Mediterranean Sea between Sicily and the North 
African coast (Chapman and Cassar 2004) with a total population of around 460,000 inhabitants, 
making it one of the smallest and most densely populated countries in the world (NSO 2018). 
Malta is known for its sunny weather and attractive beaches, but most of all for its historic sites 
(Rudolf and Berg 2010). Malta has two official languages - Maltese and English, though Maltese 
is regarded as the national language.  
 
Malta has had a reputable, long-standing medical history of healthcare provision, with its first 
hospital already functioning by 1372 (Savona-Ventura 2007), earning worldwide reputation for 
the nursing care offered to inpatients during World War 1. Malta ranked fifth in the World 
Health Organization’s (WHO) ranking of global health systems in 2000 (Coustsoukis 2016), 
superseding the United States, Sweden, United Kingdom and Spain. To date, the Maltese 
government provides comprehensive, publicly funded health care to all Maltese residents 
(through taxation and national insurance), covering a wide array of treatments, such as specialist 
treatment, hospitalisation, prescriptions, pregnancy, childbirth and rehabilitation. The public 
health care system operates through public hospitals and health care centres, and is overseen by 
the Ministry for Health with the Chief Medical Officer, Director General (Health Care Services) 
and Superintendent Public Health at the helm. Eight health centres provide primary care, 
offering preventive, curative and rehabilitative services, while secondary and tertiary care are 
provided through three public hospitals. Inaugurated in 2007, the largest public hospital in 
Malta, ‘Mater Dei’, is one of the largest medical buildings in Europe, receiving a number of 
awards for medical excellence and research. For those who opt for private health care insurance 
or out-of-pocket payments, the island offers a strong private health system (Ministry for Health 
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2017a). Pharmacies offer services by General Practitioners, specialized physicians and allied 
health care professionals.  
 
1.3 Breast cancer epidemiology 
BC is the most prevalent form of cancer among women (Ferlay et al. 2013); approximately 1.7 
million new cases were diagnosed worldwide in 2012 making it the second most common cancer 
overall (WHO 2013). BC is also the leading cause of female mortality worldwide (Stewart and 
Wild 2014). Despite substantial gains in mortality reductions over the past decade as well as the 
increase in public knowledge and the momentum gained for BS awareness, BC continues to 
pose a global health problem, representing a continuous threat to women’s health and well-
being.  
 
In Europe, BC accounted for around 29% of female cancer incidence in 2012 (an estimated 
incidence of 494,100 women) and around 17% of female cancer deaths, which translates into 
around 129,000 deaths caused by BC yearly (Ferlay et al. 2013). The estimated lifetime risk of 
developing BC before the age of 85 has risen from one in nine to one in eight women living in 
the European Union (EU-28) (Wise 2011). The annual European BC incidence is expected to 
rise to 466,000 cases by 2020 (OECD 2012). The exact cause of BC is still unclear (NHS Cancer 
Screening Programmes 2010). However, changes in lifestyle habits, increase in sedentary 
lifestyle, weight gain and obesity, as well as social changes, are known to contribute to the 
increasing number of BC cases, such as increasing age at first birth and decreasing number of 
children born to women (Stewart and Wild 2014).  
 
In Malta, BC is also the commonest type of female cancer (DHIR 2010); incident rates of 116 
per 100,000 females are among the highest rates in Europe (Ferlay et al. 2013). In 2012, the 
mortality rate for Malta was estimated to be 26 deaths per 100,000 females, compared to 23 
deaths in all Europe (Figure 1.1). Together with other southern European countries, the latter 
reflects a high mortality to incidence ratio, a proxy of unfavourable survival (Ferlay et al. 2013).  
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Figure 1.1 - Age-standardised incidence and mortality rates by area and country in Europe for 
breast cancer in 2012 (Ferlay et al. 2013, p.1397) 
 
1.4 Approaches to breast screening 
Breast self-examination (BSE), clinical breast examination (CBE) and mammography are the 
three major approaches to early BC detection (Perry et al. 2006; Kösters and Gøtzsche 2003). 
BSE and CBE involve feeling the breast for lumps or other abnormalities through physical 
breast examination. In BSE, women themselves systematically feel their breasts for changes, 
such as lumps. BSE is the preferred screening method for pre-menopausal women since 
mammography has a lower sensitivity to dense breast tissues (Vahabi 2003). Additionally, BSE 
plays an important role in interval cancer detection i.e. cancer appearing in between two 
successive mammograms (Lechner et al. 2004). However, medical evidence does not support 
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the sole use of BSE (Kösters and Gøtzsche 2003). A large number of studies have indicated that 
BSE was not effective in improving BC mortality rates and even increased the number of women 
having a biopsy (Kösters and Gøtzsche 2003; Thomas et al. 2002), resulting in increased anxiety 
and fear among women. 
 
On the other hand, CBE is a visual and manual breast examination conducted by health 
professionals to identify breast abnormalities. Other tests, such as mammography and 
ultrasound, are required alongside CBE when there are suspicious findings, or in women with 
increased risk for BC (Kösters and Gøtzsche 2003).  The reason for the inclusion of other tests 
may be due to the limited evidence on the effectiveness of CBE in reducing BC mortality (Pisani 
et al. 2006). Hence, the following breast awareness advice increases the chances of early BC 
detection: being familiar with one’s own breasts, knowing what is normal for one’s breasts, 
informing the GP once changes in the breasts are noticeable, and attending the BS programme 
at 50 years of age (NHS Cancer Screening Programmes 2010).  
 
1.4.1 Mammography screening 
Mammography screening examines asymptomatic women for BC through the use of an X-ray 
technique in an attempt to detect tumours before they are clinically palpable (Kimberly et al. 
2003), thereby minimising the probability of diagnosing advanced disease. The European Union 
(EU) Council recognises mammography screening as the sole screening method for women 
aged 50–69 on a two-year basis (Perry et al. 2006; Advisory Committee on Cancer Prevention 
2000), and supports its use as one of the most effective ways to detect cancer for women with 
an average risk (Kimberly et al. 2003). 
 
The efficacy of mammography screening was assessed through eight randomized control trials 
(RCTs) (Gøtzsche and Olsen 2000), the first being initiated in 1963 in New York (Shapiro 
1997). These RCTs compared BC mortality rates in women who had been screened 
(intervention) to those who had not (control). The combined results of these studies showed that 
mammography screening reduced BC mortality by 25-30% in women over 50 after 7-12 years 
from entry in the trials (Tabár et al. 2011; Smith et al. 2004). The RCTs also found that 
mammography screening did not significantly reduce BC mortality in younger 
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women. However, concerns have been raised about the validity of these RCTs because of 
supposed ‘flaws’ in randomisation and ascertainment of cause of death (Olsen and Gotzsche 
2001), insufficient power to show an effect and most sample populations included women below 
50 years (Sickles and Kopans 1993). More recent observational studies, reporting on the impact 
of population-based screening programmes have also been questioned due to similar 
inconsistencies (Jørgensen et al. 2011; Corder 2010). 
 
Mammography screening has thus been associated with controversy (Gøtzsche and Jørgensen 
2013) due to issues of overdiagnosis and its potential to cause harm to women through 
unnecessary treatments and medical procedures. These issues are related to the sensitivity of 
mammography in detecting slow-growing or non-aggressive lesions. These issues have 
provoked adverse criticism from many who believe that BS saves lives (Thornton 2001; 
Dilhuydy and Barreau 1997). However, since it is not possible to know which screen-detected 
cancers are potentially fatal, all screen-detected lesions are usually treated with the negative 
impact of overdiagnosis and associated treatment. 
 
Researchers from Norway also set out to evaluate the effectiveness of mammography screening 
by comparing the effects on BC mortality among screened and unscreened women. The study 
analysed data from all women in Norway aged 50 to 79 between 1986-2009, the period in which 
the BS programme was rolled out across the country. The researchers found that women invited 
to screening in the Norwegian mammography screening programme were at a 28% lower risk 
of death from BC than women who had not (yet) been invited (Weedon-Fekjær et al. 2014). The 
authors concluded that for every 368 women aged 50-69 invited to biennial mammography 
screening (95% confidence interval (CI) 266 to 508), one death from BC was prevented. 
According to another review of the European literature examining the impact of mammographic 
screening on BC mortality, a reduction of 38–48% was found among those who were actually 
screened (Broeders et al. 2012). Amidst controversies associated with mammography screening, 
these two studies add to prior evidence confirming that BS saves lives (Hendrick and Helvie 
2012; Mandelblatt et al. 2009).  
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1.5 Breast screening in Europe 
The eigth RCTs encouraged the implementation of free mammography screening services 
worldwide. Following the 2003 recommendations by the EU Council, 22 member states began 
to organise BS programmes (Altobelli and Lattanzi 2014) (Table 1.1).  
Table 1.1 - Timeliness of breast screening programmes with age covered in studied countries 
(Eurostat 2013) 
 
Country Implementation of screening programmes Age covered 
 
Austria 1974 40+ 
Belgium 2001 50-69 
Bulgaria 2012 45-69 
Czech Republic 2002 45-69 
Cyprus 2007 50-69 
Denmark 2007 50-69 
Estonia 2002 50-69 
France 2003 50-74 
Germany 2005 50-69 
Greece - 40+ 
Hungary 2001-2002 45-64 
Italy 2005 50-69 
Latvia 2009 50-69 
Malta 2009 50-60 
Poland 2006 50-69 
Slovenia 2008 50-69 
Spain 1990 45-69 
Slovak Republic - 40+ 
Romania - 50-69 
Sweden 1986 50-69 
Turkey 1999 50-69 
United Kingdom 1988 50-64 
 
EU countries implemented these recommendations as they deemed fit (Labrie et al. 2017). The 
first EU Member State to have ever implemented a BS programme was Austria in 1974. 
Mammography is offered to all women over 40 years old but screening remains opportunistic 
in most of the country (Vutuc et al. 2006). Opportunistic screening is also widespread across 
Belgium, with its organized screening programme offering mammograms at two-year intervals 
for women aged 50-69 (Altobelli and Lattanzi 2014). Norway adheres to the EU Council 
recommendations, while a biennial nationwide screening programme for women aged 50-75 is 
offered in the Netherlands (National Institute for Health and the Environment 2015). Regionally 
9 
 
organized screening programmes are offered in Switzerland for women over 50, with the age 
limit varying between 69-74 years (Swiss Cancer Screening 2015). Notable exception for the 
screening interval is by United Kingdom (UK) and Malta who opted for the introduction of a 
three-yearly screening frequency (Benson et al. 2013).  
 
Each country in the UK has a different BS programme. Following recommendations by the 
Forrest Committee in 1986, which sought to implement a BS Programme (NHSBSP) across 
England, the first national BS programme in the world was rolled out in 1988; it provided free 
mammograms to women aged 50-64 (Kinnear et al., 2010; Forrest, 1986). From 2010, a trial in 
England started phasing in an extension of the age range of invited women to those aged 47 – 
49 and 71 – 73 (Moser et al., 2011). Scotland’s first screening centre became operational in 
1988 with the target population aged 50-70. Wales activated its programme in 1989 for women 
aged 50–70. In Northern Ireland the screening programme, introduced in 1990, was initially 
aimed at 50–64-year-olds but was extended to women aged 70 in 2004. By the end of 2004, 
around 40% of NHSBSP units in the UK were inviting older women; full national coverage was 
accomplished by 2006.  
 
1.5.1 Breast screening in Malta  
By 2012, several high income countries had screening programmes that had been in place for 
20 years or more (Autier and Boniol 2012). However, it was only in October 2009 that a Maltese 
Breast Screening programme (MBSP) was launched in Malta for women aged 50 – 60 (Table 
1.1). The difficulties were due to the lack of acceptability and feasibility of pilot start-ups 
(Ministry for Health 2017b). The MBSP has been greatly influenced by the success of the 
NHSBSP in the UK. The MBSP calls eligible women for mammography screening by direct 
invitation and is free of charge (Government Portal 2008). The MBSP was the start of Malta’s 
cancer control strategy as recommended in Malta’s first National Cancer Plan 2011-2015 which 
covered prevention, screening and quality of care. Following the MBSP, a colorectal screening 
programme was implemented in 2012 and cervical screening in 2015. 
 
BS invitations commenced with the older client spectrum with each age group invited and 
completed over four-to-five monthly periods rather than through random invitations as in the 
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UK (European Commission 2014; Government Portal 2008). In 2015, this age cohort was in its 
second BS round and simultaneously expanded to include women up to 66 years (Ministry for 
Health 2017b) with the aim of gradually expanding the age range to 69 years over a five-year 
period. A woman receives a standard invitation letter from the MBSP to attend the sole static 
screening unit located in the heart of Valletta, Malta’s capital city, which is well-served by 
public transport; no mobile units exist. Unlike standard practice in the UK, the Maltese citizens 
are not registered with a GP or GP practices (Threlfall and Fazil 2009). The invitation letter 
describes the location and time of the screening appointment and provides contact details of the 
unit for women to change their appointment, if necessary. Initially, an information booklet 
accompanied the invitation letter, but the content was under review together with its cost 
effectiveness since the beginning of 2011 and has not been issued and mailed since. As is the 
current practice at the MBSP, two views (medio-lateral and cranio-caudal) are carried out by 
trained radiographers (mammographers) and the mammograms are reported by trained breast 
radiologists. Adjunct ultrasound is carried out at a subsequent (recall) appointment when 
deemed necessary, for cases such as dense breasts or for further evaluation of suspected 
mammographic abnormalities. 
 
1.6 Breast screening compliance 
1.6.1 Breast screening uptake in Europe 
The need to reduce BC mortality through early detection has become an increased recognized 
national priority worldwide (Ka’opua et al. 2011; Malta Breast Screening Programme 2011). 
Nonetheless, screening rates remain suboptimal across the EU with participation varying 
considerably across Europe (Schopper and de Wolf 2009). EU guidelines promote a 
recommended acceptable target rate of >70% (Perry et al. 2006) and a desirable benchmark of 
at least 75% of eligible women in EU countries (European Commission 2014). Nevertheless, in 
2010, only four countries had reached this target, with rates ranging from as low as 8% in 
Romania to over 80% in Finland, Slovenia and the Netherlands (Figure 1.2). Low screening 
rates may represent a system-level failure in care in some countries (Lester et al. 2009). 
However, the variation in participation may also, in part, be explained by programme longevity, 
with some countries having well-established programmes and others commencing programmes 
more recently, including Malta (OECD 2012).  
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Figure 1.2 - Mammography screening, percentage of women aged 50-69 screened, for the years 
2000 to 2010 (or nearest year) (OECD 2012) 
 
One of the countries that reached the EU benchmark was the UK, achieving an attendance rate 
of 73.4% for women aged 45-74 in 2010/11, or almost three-quarters of women (NHSBSP 
2012). This percentage resulted in the detection of more than 17,258 cancers in the UK – an 
increase of over 700 when compared to the previous year.  
 
1.6.2 Breast screening uptake in Malta 
By the end of the national roll-out of the MBSP’s first cycle, 193 women were diagnosed with 
BC (iNews Malta 2013). However, only 58.7% of those invited had accepted their invitation 
(iNews Malta 2013). This possibly reflects variations in the perceived costs, perceived beneﬁts 
to screening, as well as facilitators and barriers to screening (Carney et al. 2013). Hence, 
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identifying and addressing the barriers, facilitators and misconceptions affecting uptake and 
maximising coverage is crucial for a cancer screening programme’s success (Weller and 
Campbell 2009; Shen et al. 2005), as the percentage of non-attenders could well result in missed 
cancer detection (NHSBSP 2009). This further highlights the need for effective interventions to 
increase uptake and reduce any inequalities among the population (Weller and Campbell 2009). 
 
1.7 Aims and research questions 
The overall aim of this thesis is to explore the barriers and facilitators to mammography 
screening, to inform future development of an intervention to improve BS uptake in Malta. To 
fulfil this aim, this thesis aimed to address the following research questions (RQs) (Table 1.2). 
 
Table 1.2 – Research questions  
 
RQ 
number 
Research Questions Chapter Study 
RQ 1. Is the Maltese Breast Screening Questionnaire 
(MBSQ) valid and reliable?  
Chapter 4 Study 1 
RQ 2a-d. 
 
 
 
Which significant factors i.e. health beliefs, illness 
perceptions, knowledge, socio-demographic factors 
and health status of women are associated with: 
(2a) BS uptake to a first invitation at the MBSP,  
(2b) re-attendance,  
(2c) lifetime mammography use, and 
(2d) adherence to timely mammography practices in 
Malta? 
Chapter 4 Studies 2- 5 
respectively  
RQ 3. What types of interventions (which have employed the 
Health Belief Model and/or Common-Sense Model of 
illness self-regulation) are effective at increasing 
mammography uptake?  
Chapter 5 Study 6 
RQ 4. Which factors influence non-attendance among 
lifetime non-attendees and which interventions are 
considered appropriate to increase mammography 
screening uptake in Malta?  
Chapter 8 Study 7 
 
Each study had associated objectives as follows: 
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Study 1:  
1. To pilot test the reliability and validity of Champion’s Health Belief Model Scale for 
Mammography Screening (CHBMS-MS) and the Revised Illness Perception 
Questionnaire (IPQ-R) and their Maltese translated version (MBSQ).  
 
Study 2:  
1. To describe Maltese women’s knowledge, health beliefs and illness perceptions about 
BC and screening; 
2. To identify the main reasons related to non-attendance at the MBSP; 
3. To determine if health beliefs, illness perceptions, knowledge, socio-demographic 
factors and health status of women are associated with uptake to a first MBSP invitation; 
4. To determine significant predictors to a first BS invitation. 
 
Study 3: 
1. To explore whether sociodemographic factors, health status, knowledge, health beliefs 
and illness perceptions are significant predictors of uptake to a second MBSP invitation;  
2. To determine if uptake of first MBSP invitation is a significant predictor of uptake to 
the second invitation.  
 
Study 4: 
1. To determine the socio-demographics, health status, knowledge, health beliefs and 
illness perceptions of women who attend or do not attend for mammography screening 
during their lifetime;  
2. To examine the most significant predictors of lifetime mammography utilization and its 
non-use.  
 
Study 5: 
1. To determine mammography screening use within or exceeding the recommended three-
year frequency in Malta; 
2. To explore associations between socio-demographic factors, health status, knowledge, 
health beliefs and illness perception variables of adherent and non-adherent women. 
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Study 6: 
1. To describe study design and methods, report intervention effectiveness on BS 
behaviour, and to describe theories, procedures, functions and content of the 
interventions. 
 
Study 7: 
1. To gain a better understanding of beliefs, perceptions, attitudes, barriers and knowledge 
regarding BS among lifetime non-attendees; 
2. To determine which interventions and channels are appropriate for communicating with 
women about BC and BS. 
 
1.8 Thesis Overview 
To address the above aims and RQs, this project was divided into nine chapters. This thesis 
comprised 7 studies in total, which were conducted to gather and analyse new data. Two expert 
steering groups and members of the public provided feedback on the quantitative findings from 
these studies and to deepen my understanding of what future intervention(s) could improve BS 
uptake in Malta. These studies are listed in Table 1.2. 
 
Chapter 1 provided an introduction to this thesis and laid the policy contextual background about 
the Maltese healthcare system, BC and BS history, including the aims, objectives and RQs 
addressed in this thesis.  
 
Chapter 2 reviews the existing literature and empirical evidence regarding factors related to 
mammography screening behaviours and the application of relevant theoretical models to 
explain women’s behaviours. Chapter 2 therefore provides an in-depth description of key factors 
that influence BS behaviours and presents two main theoretical frameworks – the Health Belief 
Model (HBM) and the Common-Sense Model (CSM) of illness self-regulation. 
 
Chapter 3 describes the over-arching methodological approach and methods used in this 
research. Here, the Intervention Mapping (IM) approach is described, and how each study 
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influenced subsequent studies in a mixed methods approach to fulfil the RQs is also described 
in the context of using the IM approach.  
 
Chapter 4 presents a detailed overview of the quantitative findings of this thesis and is divided 
into five studies:  
 Study 1 describes the tool development used for the succeeding cross-sectional survey, 
and how it was translated and adapted for BS among Maltese women. Specifically, Study 
1 aimed to translate, adapt and pilot the adapted English version of CHBMS-MS and 
IPQ-R among Maltese women and the Maltese version of the latter scales (MBSQ).  
 Study 2 utilized the HBM and CSM to investigate factors associated with BS uptake in 
Malta and to identify the most important predictors to first BS uptake in a quantitative 
national study.  
 Study 3 investigated reattendance to the second MBSP round through a prospective 
study. Study 3 explored predictors and behaviour to re-attendance, and to determine if 
uptake of first invitation at the MBSP is a significant predictor of second BS uptake.  
 Studies 4 and 5 examine the predictors and/or associations for lifetime mammography 
practices and adherence to timely mammography use in Malta respectively.  
Each piece of quantitative analysis was labelled as a study for ease of reference, even though 
studies 2-5 all form part of one large national survey. 
 
Following the findings of the previous quantitative studies based on HBM and CSM, a 
systematic review of the literature was carried out in relation to effective interventions aimed at 
increasing mammography screening and which utilised the latter theoretical models (Chapter 5, 
Study 6).  
 
All the previous information was collated, presented and discussed with two expert steering 
groups (Chapter 6). These groups were set up to provide expert advice on the core elements of 
a future intervention. These groups reviewed the evidence from the quantitative data, literature 
review findings on BS determinants and the systematic review on interventions. The objectives 
were to develop a logic model of the problem and a logic model of change, and to judge basic 
fit of potential future intervention(s). 
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Chapter 7 presents findings gathered from a Patient and Public Involvement (PPI) event through 
the World Café method to engage members of the public to enhance the understanding of the 
quantitative and systematic review findings, and to inform the design of future interventions.  
 
In order to understand the perceptions of the previous findings in more depth, 20 face-to-face 
interviews were carried with Maltese women who never attended for mammography i.e. 
‘lifetime’ non-attendees (Chapter 8, Study 7).  
 
The above information and findings provided a wealth of knowledge and the opportunity to 
converge this insight into more tangible recommendations for health care providers and policy 
makers. Such recommendations, presented in Chapter 9, have the potential to be used as a guide 
for the development of future BS interventions in Malta through the use of a more targeted 
approach for Maltese women. 
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Chapter 2 
Literature Review 
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2.1 Introduction 
Chapter 1 provided an introduction to the thesis including breast cancer (BC) epidemiology, 
Malta and its healthcare system, and the history of breast screening (BS) services in Europe and 
in Malta. Chapter 1 therefore set the policy context for this thesis. Chapter 2 provides an in-
depth literature review of the factors influencing BS behaviour, namely psychosocial, 
knowledge, socio-demographic, medical and logistical factors. This is relevant to the overall 
aim of this thesis, which is to explore the barriers and facilitators of BS attendance in Malta. 
Health behaviour theories/models that may be used to explain BS behaviour are also described 
here. The two key models are the Health Belief Model (HBM) and the Common-Sense Model 
(CSM). A critique of the literature, and in particular, key gaps in evidence is also presented.  
 
2.2 Factors related to mammography screening  
Despite the known benefits of BS by mammography, a wide range of key screening 
determinants may influence a woman’s decision not to attend for screening (Vedel et al. 2011). 
Reasons for BS attendance include peace of mind, risk perception, positive prior screening 
experiences, anxiety, beliefs, intention to attend, socio-demographic factors and personal or 
family experiences of BC (Zackrisson et al. 2004; Isaacs et al. 2002; Lagerlund et al. 2002). 
 
Reasons for non-attendance are well documented and multifactorial (Whelehan et al. 2013; 
Anagnostopoulos et al. 2012). Substantial research has focused on identifying women’s, 
physicians’, and system-level barriers to mammography screening (Anagnostopoulos et al. 
2012; Arnold et al. 2009; Audrey et al. 2008). These factors are categorized into key groups: 
 Psychosocial factors (Petrak et al. 2015; Anagnostopoulos et al. 2012; Huaman et al. 
2011; Champion et al. 2008); 
 Knowledge (Liu et al. 2014; Dundar et al. 2006); 
 Socio-demographic factors (Liu et al. 2014; Walsh et al. 2011; Meissner et al. 2004); 
 Health status (medical factors) (Anagnostopoulos et al. 2012; Cohen and Azaiza 2010; 
Meissner et al. 2007); 
 Logistical factors (Elias et al. 2017; Carney et al. 2013). 
These factors are discussed in the following sections. 
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2.2.1 Psychosocial factors 
2.2.1.1 Understanding beliefs and perceptions 
Health behaviours can be shaped by our beliefs. Beliefs are influenced by perceptions (or 
cognitive characteristics) that can be acquired by: 
 internalising the beliefs of the people close to us during childhood (primary 
socialisation); 
 adopting beliefs of significant others in the individual’s surroundings (i.e. peers and 
leaders); 
 exposure to repetitive messages, such as informative campaigns and association of 
beliefs with strong positive or negative emotions such as images of love; 
 physical trauma (Day et al. 2010). 
There is an assumption that beliefs can be modified since they can differ among individuals 
from the same background (Parsa et al. 2006). However, modifying beliefs can be difficult as 
people often cling to beliefs and act on them, even against their own self‐interest (Day et al. 
2010). In a study by Yarbrough and Braden (2001), residents of a community with an increased 
cancer incidence were very resistant to health education interventions despite knowing about 
their increased risk. Yarbrough and Braden (2001) argued that health promotion activities might 
not be effective for reducing cancer risk because the cause of cancer is unclear. Numerous 
beliefs, perceptions and attitudinal factors have been linked with variance in the uptake of BS 
(Parsa et al. 2006) and these shall be discussed in the following sections. 
 
2.2.1.2 Beliefs and perceptions of Breast Cancer and Breast Screening  
Health beliefs and perceptions have long been reported to act as key facilitators or barriers to 
attending screening (Jahanlou et al. 2013; Champion 1999). Women may not perceive the 
importance of BS and this may result in low screening rates or late cancer detection, which may 
lead to less effective treatment. Studies have found that some women do not perceive the 
importance of detecting BC early as they lack adequate information (Im et al. 2004; Hisham and 
Yip 2003; Chong et al. 2002; Jarvandi et al. 2002). The findings revealed that women feared 
both cancer and death, and directly connected cancer to dying from the disease (Juon et al., 
2004; Nissan et al., 2004). In a Korean qualitative study (Im et al., 2004), women did not 
perceive the need for BS if they did not experience any recognizable symptoms, if they had no 
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family history of BC or because they had breastfed their children. This calls for educational 
interventions providing women with accurate information about BC risk factors and screening. 
 
2.2.1.3 Socio-cultural influences 
Individual BS behaviour is directly influenced by women’s wider social and cultural context 
(Moudatsou et al. 2014; Pasick et al. 2009). Socio-cultural influences include knowing someone 
with the disease or condition; having support of family, friends or significant others, such as a 
physician or other healthcare providers; being a member of a club, church or other organization; 
or knowing someone who has been screened (Jepson et al. 2000). The following are all 
associated with higher mammography attendance (Cabeza et al. 2007; Zackrisson et al. 2004; 
Lagerlund et al. 2002): being married or cohabitating and having social support from significant 
others (Farmer et al. 2007; Lechner et al. 1997), having a close friend (Calnan 1984), social 
participation and being a member of volunteer groups (Maxwell et al. 2001). Conversely, social 
isolation is associated with lower attendance (Lagerlund et al. 2014; Pasick and Burke 2008). It 
has been suggested that if socially isolated women are underscreened, they may have greater 
risks of undetected BC and dying from the disease (Lagerlund et al. 2014).  
 
A variety of barriers to BC awareness may include fatalism, inability to act without a husband’s 
permission, fear of casting stigma on one’s daughters, fear of being disliked or not accepted, 
fear of contagion, language barriers, and preference for traditional healers (Smith et al. 2006). 
For example, cancer fatalism stems from the belief that there is little an individual can do to 
alter one’s fate (Austin et al. 2002) and hence, death is inevitable when cancer is diagnosed 
(Powe and Finnie 2003). Fatalism is a prominent barrier to seek screening and is negatively 
associated with BS uptake (Schueler et al. 2008). Such socio-cultural barriers can be addressed 
with education or tailored approaches that take into account culture, religion and other factors. 
Tailored approaches will need to be directed towards women, health care workers, and relevant 
others in the community. 
 
Social support and network  
Social support is an interactive process in which particular behaviours or actions can have a 
positive effect on one’s physical or psychosocial well-being (O’Reilly 1988). Studies have 
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found that the presence of social support increased BS attendance (Jensen et al. 2016; Documet 
et al. 2015; Farmer et al. 2007; Courtney-Long et al. 2011; Lagerlund et al. 2014; McFall and 
Davila 2008). A few studies, however, did not find this association (Price et al. 2010; Aro et al. 
1999). These differences may be attributed to variances in the methods these studies used, e.g. 
measuring different attributes of social support or using different target populations (Jensen et 
al. 2016). Additionally, identified associations may be confounded by socioeconomic factors 
(Jensen et al. 2016).  
 
Social norms act as subjectivity norms in shaping an attitude such as a health behaviour (Tolma 
et al. 2003). There is evidence that participation in social networks influence social norms 
through a perceived sense of responsibility towards one’s social group by taking care of oneself 
and each other e.g., through social pressures to follow prevailing social norms around screening 
(Bankston and Zhou 2002). Social and family networks enable screening utilisation by 
providing the necessary structural, appraisal and emotional support (Moudatsou et al. 2014). 
The evidence for this is that being part of a social group/network brings about a sense of security, 
trust, belonging and reciprocity (Magai et al. 2007). In turn, these factors have been associated 
with increased BS rates (Burke et al. 2009; Pasick et al. 2009; Bankston and Zhou 2002). 
 
Moreover, women have the intention to adhere to screening guidelines when people who are 
important to them think that they should do so (Griva et al. 2009). Evidence suggests that 
recommendations and support from family and friends are associated with greater 
mammography intentions and compliance (Molina et al. 2013; Tejeda et al. 2009; Fowler 2007; 
Luquis and Cruz 2006). In particular, family recommendations may be potentially relevant due 
to particular cultural emphasis on maintaining family harmony (Molina et al. 2014). More 
specifically, the relationship between mother and daughter has an enabling role on mothers’ 
decisions to adhere to screening guidelines (Pasick et al. 2009). Another factor in close relations 
that could influence BS attendance is previous cancer or specifically BC (Manjer et al. 2015). 
If the social support network, including employers, colleagues, family and friends can be 
improved through appropriate health education campaigns, then it is likely that a more positive 
attitude towards preventive health care will prevail (Juon et al. 2004). 
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The role of physicians and other healthcare professionals in primary care 
Physicians, nurses and social workers can provide effective preventive interventions on cancer 
(Trigoni et al. 2008; Magai et al. 2007). Largely, there is strong evidence that recommedations 
by physicians predict mammography use among diverse populations (Roman et al. 2014; Sunil 
et al. 2014; Villani and Mortensen 2013; González  and Borrayo 2011; Nuno et al. 2011; 
Meissner et al. 2007). An exploratory study by Molina et al. (2014) found that physicians are 
effective in educating and promoting early detection behaviours among women with low levels 
of perceived seriousness regarding BC. Doctors may therefore be effective in disseminating 
information concerning mammography benefits and the perceived seriousness of BC (Juckett, 
2013).  
 
2.2.1.4 Fear of Breast Cancer and Breast Screening  
Fear of results, fear of treatment and fear of mammography itself are substantial deterrents to 
screening attendance and re-attendance (Brain et al. 2008). The word ‘cancer’ brings with it risk 
perceptions due to its associated potential mortality, disfigurement due to surgical treatment, 
sexuality threats, an impact on employment and the family, and late treatment effects (de Boer 
et al. 2009; Montazeri et al. 2008). Hence, a cancer diagnosis and fear of its associated treatment 
may take away one’s sense of security and control among multiple wellbeing domains 
(Coumans and Lee 2008), resulting in a negative psychological, physical and social impact on 
women and their way of life (Brett et al. 2005; Marshall 1995). It follows that the meaning of 
cancer will alter the meaning and perception of life, resulting in implications towards family 
life, social life and the ‘self’. Women’s fear of finding something wrong and the feeling that it 
is better not to know have been reported as barriers to BS among Iranian women (Lamyian et 
al. 2007). Such fears and anxieties often arise before, during or after screening (Brain et al. 2008; 
Van Dooren et al. 2005) and are consistent findings across countries, such as Malaysia (Hisham 
and Yip 2003), United Arab Emirates (Bener et al. 2002), Iran (Jarvandi et al. 2002) and Jordan 
(Petro-Nustus and Mikhail 2002).  
 
Besides the risks of BC, the general public’s perception of mammography has been reported as 
a painful experience (Myklebust et al. 2009; Davey 2007; Poulos and Llewellyn 2005; Asghari 
and Nicholas 2004). Women’s fears are associated with breast compression that is perceived to 
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‘damage the breasts’ (Poulos and Llewellyn 2005, p.20). Women continue to experience this 
fear during compression itself and after the test (Yilmaz and Kiymaz 2010; Myklebust et al. 
2009; Asghari and Nicholas 2004). Although perceptions of pain and discomfort in 
mammography have been extensively studied, both are still not easily quantified. The pain 
experience has shown great variability ranging from minimal to intense pain (Myklebust et al. 
2009; Asghari and Nicholas 2004). The reported prevalence of pain or discomfort ranges 
significantly from 1.3% to 92.3% in various studies (Asghari and Nicholas 2004; Bennett et al. 
1994); and specifically between 41% and 76% for discomfort (Papas and Klassen 2005; Dullum 
et al. 2000; Bruyninckx et al. 1999; Aro et al. 1996). Possibly, this reflects the methodological 
diversity of the publications on this subject, such as age-related anatomic breast differences 
between younger and older women (Almog et al. 2008). Much of that variability may also be 
due to the measures used to rate mammography pain.  
 
Poulos and Llewellyn (2005) confirmed that women’s experiences may be intertwined with 
prior experiences of mammography discomfort and pain. This supports the outcome of earlier 
studies which found that a significant proportion of women who experienced pain at a prior 
mammogram did not re-attend (Hamilton et al. 2003; Drossaert et al. 2002; Drossaert et al. 
2001). Nonetheless, pain experience is subjective and may be related to physiological and 
situational factors, for e.g. tense or worried women may experience greater pain than calmer 
women (Davey 2007; Aro et al. 1996). In fact, anxiety is perceived to influence pain experiences 
during screening (Poulos and Llewellyn 2005). Hafslund (2000) surveyed 170 women aged 40-
69 and found that there was a correlation between anxiety and pain (p<0.01). 
 
Given that mammography can be a painful experience, and that this pain should be amenable to 
minimisation, it was important to establish its related causes. Women often relate this bad 
experience to radiographers’ technique, incompetence and ineffective listening (Poulos and 
Llewellyn 2005; Van Goethem et al. 2003). The latter are among reasons cited by women for 
not adhering to recommended guidelines for screening (Mainiero et al. 2001). In a qualitative 
study of 12 women, Poulos and Llewellyn (2005) showed that beliefs about mammography 
influence women’s experiences on the day, which in turn influences their perceptions of the 
procedure. Therefore, it is possible that a change in any one of these three concepts will alter 
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the perception of mammography discomfort, possibly resulting in mammography service 
dissatisfaction and refusing re-attendance (Figure 2.1).  
 
Figure 2.1 - The conceptual framework of perception of mammography discomfort (Poulos and 
Llewellyn 2005, p.19) 
 
Currently, there are few interventions that have proven to reduce pain and discomfort in 
mammography (Miller et al. 2008). Effective communication is one recommendation to 
minimize discomfort (McNichol and Hamer 2006). Moreover, teaching the realistic risks of 
developing BC and the importance of BS can reduce these fears and would enable women to 
overcome barriers. 
 
2.2.1.5 Embarrassment 
Researchers have identified embarrassment as an emotional obstacle which could prevent 
women from attending screening (Schueler et al. 2008; Magai et al. 2007). BC is a very sensitive 
topic in various communities, not only because it is a private subject, but also because women 
feel embarrassed when talking about their breasts and may feel ashamed or embarrassed to 
expose them infront of others (Collins et al. 2010; Gany et al. 2006). It appears that besides pain, 
embarrassment is frequently reported and associated with mammography. The literature 
demonstrates that women of different nationalities, such as Chinese women (Gany et al. 2006), 
Korean American women (Lee 2015) as well as Maltese women (Marmarà et al. 2015), are 
reluctant to expose their breasts infront of others. However, some studies reported that there was 
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no significant association between embarrassment and breast screening (Lee et al. 2011; Lee et 
al. 2009). However, Zhang (2014) found that women did not view embarrassment as a major 
problem because they believed it was worth enduring due to detecting BC early. When female 
professionals carry out mammograms, embarrassment can be overcome (Kwok et al., 2005). It 
is therefore essential for BS educational materials and programmes to emphasise the fact that 
mammography is conducted by female professionals at national BS programmes to encourage 
BS participation. 
 
2.2.1.6 Stress and distress  
Stress has mostly been studied in association with mammography or in relation to waiting for 
or dealing with screening results (Brown and Pakenham 2004). Researchers agree that women 
often experience emotional and psychological distress, feelings of depression or anxiety before, 
during and/or after screening (Brown and Pakenham 2004; Gurevich et al., 2004). 
 
From a different perspective, Lagerlund and colleagues (2014) examined stress as a reflection 
of women’s general life situation and its impact on screening attendance. They found that 
women who experience higher levels of stress have less time or energy for attending screening 
tests. However, this result contradicts findings from other studies. For e.g. a Finnish study found 
that stress was unrelated to mammography attendance (Aro et al. 1999), and an American study 
found that women who experienced high stress in the past year were more likely to have had a 
mammogram compared with women who experienced low stress (Rakowski et al. 1993). Van 
Dooren et al. (2005) studied the association between psychological distress and BC in 351 
women and their relatives, and found that the impact of a BC diagnosis in a sister, particularly 
a recent diagnosis, increased screening participants’ psychological distress and may increase 
pain during mammography (Poulos and Llewellyn 2005; Drossaert et al. 2002). Differences 
across studies may result from differing definitions of stress and cultural experiences of stress.  
 
2.2.2 Knowledge factors 
2.2.2.1 Knowledge and attitudes toward breast cancer and mammography screening  
Knowledge of BS has been shown to be an important facilitator of mammography use (Secginli 
and Nahcivan 2006; Jarvandi et al. 2002). Unfortunately, the literature has consistently 
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identified that women have limited knowledge of BC and BS practices (Liu et al. 2014; Charkazi 
et al. 2013; Guvenc et al. 2012). For instance, Grunfeld et al. (2002) showed that only 38% of 
women were aware that nipple retraction was a sign of BC, and awareness of risk factors was 
even lower. Notably, several misconceptions of BC, BS and preventive behaviour such as hitting 
or bumping the breast, or that having one mammogram is sufficient, have been found 
consistently with women’s beliefs in diverse cultures, such as the Philippines, Korea, Saudi 
Arabia, Singapore and Australia (Dandash and Al-Mohaimeed 2007; Han et al. 2007; Im et al. 
2004; Goel et al. 2003; Chong et al. 2002; Grunfeld et al. 2002).   
 
Among women of Asian descent, lower screening rates were associated with their limited 
knowledge and misperceptions of preventive health measures (Chua 2005; Juon et al. 2004; 
Nissan 2004). Knowledge of BS guidelines was a major predictor of regular screening for 
women in studies carried out in Korea (Joun et al. 2004) and Turkey (Secginli and Nahcivan 
2006). Adequate knowledge about the recommended screening interval and higher values for 
BC worry were associated with an increased number of repeat lifetime mammograms in a study 
by Aro et al. (2001). Another study also found that women with knowledge of mammography 
guidelines were 10 times more likely to have regular mammography (Secginli and Nahcivan 
2006). These findings support the positive effects of screening knowledge on undertaking 
regular mammography.  
 
A number of demographic factors can affect level of BC/BS knowledge. Examples of these 
demographic factors include income status, age and educational attainment status. Dandash and 
Al-Mohaimeed (2007) found that higher income status was the strongest significant predictor 
of higher knowledge levels of BS/BC among female teachers in Buraidah, Saudi Arabia. On the 
other hand, many studies found a negative association of knowledge scores with age (Dandash 
and Al-Mohaimeed 2007; Chamot and Perneger 2002; Dolan et al. 1997), while data among 
Hispanic women revealed poor knowledge among the poorest and least educated women 
(Ramirez et al. 2000). Older women tend to lack knowledge of BC signs and symptoms 
(Grunfeld et al. 2002); 20% of older women never look at or feel their breasts (Linsell et al. 
2009) and present with more advanced disease resulting in poorer survival than younger women 
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(Moller et al. 2010). This may possibly be a result of lack of BC awareness, apathy, lack of 
concern, or low perceived need (Lagerlund 2002).  
 
To make an informed decision about BS, women need accurate and sufficient information about 
their risk and screening benefits. Women do receive a plethora of information from screening 
invitations, such as the benefits and risks of BS; the examination; waiting times; what should be 
avoided to avoid artefacts, e.g. deodorants or anti-perspirants (Young et al. 2002); parking 
facilities; who can accompany clients; further tests and professional teams involved (Perry et al. 
2008; Goldsmith et al. 2007; Lee et al. 2003). Thus, this information, as per screening 
guidelines, should be  presented in suitable format prior to attending screening through ‘written 
materials’, ‘web-site’ or ‘phone lines’ (Giordano et al. 2006, p.383). The use of media has been 
documented as an important source of BC and screening information for women that could 
improve their knowledge about BC risks and causes, and the mammography procedure (Secginli 
and Nahcivan 2006; Juon et al. 2004; Jarvandi et al. 2002).  
 
2.2.2.2 Previous mammography experience 
Women who are knowledgeable of the procedure and satisfied with the experience of the first 
screening episode often return for another mammogram (Almog et al. 2008; BreastScreen 
Australia 2008). In contrast, bad experiences may deter women from re-attendance, resulting in 
a reluctancy to recommend the examination to others (Yilmaz and Kiymaz 2010; Myklebust et 
al. 2009; Miller et al. 2008). There is some evidence that procedural pain may diminish feelings 
of self-efficacy and thus act as an indirect factor to non-reattendance (Drossaert et al. 2001). In 
a systematic review of three studies by Whelehan et al. (2013), the proportion of non-
reattendance accounted for by prior mammography pain ranged from 25% to 46% (Elwood et 
al. 1998; Rutter et al. 1997; Marshall 1994). However, the sample sizes were small in all three 
studies, with a combined sample size of 261. When transposing the two UK studies’ figures of 
25% and 41% (Rutter et al. 1997 and Marshall 1994 respectively) onto the English NHSBSP 
2010/11 figure for non-attendance, this would mean that between 47,000 and 77,000 clients had 
chosen not to re-attend in that year due to prior mammography pain (The Health and Social Care 
Information Centre 2012). This finding is further confirmed in prior literature showing the lack 
of compliance with follow-up appointments (Chiarelli et al. 2010; Myklebust et al. 2009). In the 
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context of cumulative participation rates, this is an important finding being increasingly 
recognised as an important performance indicator in screening (Jacobsen and Euler-Chelpin 
2012). 
 
2.2.3 Socio-demographic factors  
Population characteristics may influence the effectiveness and uptake of screening programmes 
(Damiani et al. 2012). Sociodemographic and economic characteristics such as age, gender, 
education, income, marital status and cohabitation, employment status, rural versus urban 
setting, health insurance coverage, ethnicity and religion, may be important variables associated 
with mammography use (Threlfall and Fazil 2009; Zackrisson et al. 2004; Jepson et al. 2000). 
For example, factors such as older age (>50), lower education, lower economic status (including 
higher level of deprivation), belonging to ethnic minority or living in a rural location, being 
single or divorced, have been widely discussed as having a positive association with lower BS 
uptake (Lofters et al. 2011; Thomas et al., 2005).  
 
2.2.3.1 Age  
Variances among different age groups have been noted in previous research about BS uptake. 
Some studies have demonstrated that increasing age is positively associated with mammography 
screening (Feldstein et al. 2011; Walsh et al. 2011) while others demonstrate that increasing age 
is associated with lower mammography uptake (Edwards and Jones 2000). For example, among 
ethnic groups residing in the US, younger Hispanic American women (<50 years) are more 
likely to have received a recent mammogram than older women (aged 50 and over) (Gorin and 
Heck 2005). Older Turkish women were more likely to have a mammogram in a study by 
Sadikoglu et al. (2010), while younger age was related to mammography adherence for South 
Korean women (Suh and Park 2009). In summary, younger age is generally associated with 
higher uptake while older age is mostly related to poorer adherence to cancer control measures 
in most studies (Petrak 2013). 
 
2.2.3.2 Education and occupation 
A positive association of education and occupation with BS uptake has been confirmed in many 
studies (Damiani et al. 2012; Duport et al. 2008; Hewitt et al. 2004). In the study by Damiani et 
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al. (2012) on socioeconomic disparities in cancer screening uptake in Italy, higher levels of 
educational attainment and being in employment were related to higher likelihood to undergo a 
mammogram than being less educated or unemployed (OR=1.77; 95% CI=1.55-2.03, OR=1.63; 
95% CI=1.40-1.91 respectively). A significant difference was found between women in the 
highest occupational class versus those in the lowest class (OR=1.81; 95% CI=1.63-2.01). The 
researchers also found that screening invitees with lower education or lower occupational levels 
were more likely to attend organised screening programmes than the more advantaged women 
who also attended those services from their own initiative (Damiani et al. 2012). Those having 
low educational attainment and manual occupation are associated with higher nonattendance 
rates (Aarts et al. 2011; Lagerlund et al. 2002; Abdullah and Leung 2001; Madan et al. 2000). 
However, Madan et al. (2000) and Abdullah and Leung (2001) studies have limitations such as 
women’s self reports of the screening test which may lead to an overestimation of BS. While 
cancer screening is critical to improving health outcomes, findings clearly indicate that those 
less educated and minority groups are among the most vulnerable (Zapka et al. 2011; Greiner et 
al. 2005), particularly since minority populations have been under-represented in national and 
community studies (Bazargan et al. 2009). Therefore, the reasons for disparities in screening 
behaviour are less clear among these populations than others and require particular attention.  
 
2.2.3.3 Income 
A powerful driver of BS uptake is known to be a woman’s socioeconomic status (Moser et al. 
2009). In a study by Maheswarab et al. (2006) on the association between BS uptake and socio-
economic deprivation, travel distance, urban-rural status, location and type of screening unit, 
the strongest association was socioeconomic deprivation with BS uptake especially with 
significantly lower uptake from deprived areas. In the UK, Blanks et al. (2002) found that 
women who attended BS were more likely to live in less deprived areas than those who did not 
attend it. In another study, Moser et al. (2009) investigated the inequalities in screening among 
3,185 women aged 40-74, and found a strong link between wealth and BS uptake, with car 
ownership and housing status as indicators of household wealth. This study showed no 
association between BS and other factors such as education and ethnicity. There is consistent 
evidence that lower household income demonstrates lower BS utilization (Paul 2012; Lagerlund 
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et al. 2002; Jepson et al. 2000), which seems to be associated with late stage BC presentation 
among Londoners (Cuthbertson et al. 2009). 
 
2.2.3.4 Marital status 
A husband’s social support has a positive influence on his wife’s health behaviours (Harley and 
Eskenazi 2006). In relation to mammography use, while some studies have not found an 
association between mammography attendance and being married (Aldridge et al. 2006; 
Coughlin et al. 2004), other studies have found that being married and having a partner’s support 
may act as a screening facilitator. Soni (2007) found that 62.8% of single women and 64.1% of 
separated women were less likely than married women (75.6%) to have mammography. 
Damiani et al. (2012) further confirmed these findings, reporting that married women were 1.83 
times more likely than single women to undertake regular BS practices (95% CI=1.56-2.15).  
 
2.2.3.5 Rural versus urban setting 
The evidence on the prevalence of BS uptake in rural regions is very limited in certain countries 
(Amelio 2013). However, it appears that there are lower levels of BS uptake in rural regions 
compared to urban ones (Day et al. 2010; Spaczynski et al. 2010). Prażmowska et al. (2010) 
found that in a sample of Polish women who attended free mammography, only 10% lived in a 
rural region. It is likely that women from rural areas will have limited access to health services, 
subsequently limiting BS access (Coughlin et al. 2002).  
 
2.2.3.6 Health Insurance 
Health insurance is a significant predictor of BS adherence (Vedel et al. 2011; Young et al. 
2011; Meissner et al. 2004). Women with health insurance are more likely than those without 
health insurance to undergo mammography (Secginli and Nahcivan 2006; Juon et al. 2004), and 
uninsured women are more likely to be overdue screeners (Elkin et al. 2010) or never screeners 
than insured women (Lopez et al. 2009). In seven out of twelve reviewed studies in the 
systematic review by Jepson et al. (2000), mammography rates were significantly higher 
amongst insured women. Women with private insurance are more likely to be those with higher 
educational levels and higher income (Esteva et al. 2008). However, recommendations and 
guidelines for mammography as a public health practice may vary between countries. For 
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instance, insurance coverage in Poland has been resolved since the last health care reform in 
2003, and currently every individual has the right to state funded health care (Golinowska and 
Kozierkiewicz 2008). Similarly, in Malta, healthcare is state funded. Nonetheless, a number of 
Maltese and foreign residents consider private healthcare on a regular basis due to a range of 
services offered and shorter waiting times.  
 
2.2.4 Health status 
Health status (medical factors) that influence uptake include having a family history of BC, 
experiencing BC symptoms, number of previous visits to a doctor and physician 
recommendation of BS, self-reported health status, able to perform activities of daily living and 
access to a regular source of health care (Cohen and Azaiza 2010; Meissner et al. 2007; Meissner 
et al. 2004). Women with poor health status are significantly less likely to undergo 
mammography than those having good health (Day et al. 2010; Sadler et al. 2007). These 
findings contrast those by Jepson et al. (2000), where the majority of reviewed studies did not 
find an association between health status and the uptake of mammograms. Personal or family 
experiences of BC (Isaacs et al. 2002; Meiser et al. 2000) are known motivators to attendance. 
Moreover, several studies suggest that a physician referral and having a gynaecologist as a 
regular physician are important predictors of BS uptake (Secginli and Nahcivan 2006; Juon et 
al. 2004; Im et al. 2004). The rate of referral by a physician was substantially higher among 
women who reported having mammography in the latter studies. In a cross-sectional study 
among Arab women in Qatar, only one quarter of the women interviewed said their doctors had 
discussed BC with them (Donnelly et al. 2013). Moreover, conflicting expert recommendations 
on BS may result in non-compliance over time (Han et al. 2007). Efforts to educate health care 
providers, particularly physicians, should emphasize the importance of recommending BS and 
informing women about screening guidelines.  
 
2.2.5 Logistical and health system factors 
2.2.5.1  Forgetfulness and competing priorities 
Having competing priorities, such as having concerns that are more important than screening 
may contribute to forgetfulness and lacking time to receive screening. The latter are reported as 
two of the most common barriers for BS among women in Asia (Hisham and Yip 2003; Jarvandi 
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et al. 2002) and other countries (Watson-Johnson et al. 2011; Tejeda et al. 2009; Clark and 
Natipagon-Shah 2008) and are known to be significant predictors of nonadherence (Carney et 
al. 2013; Gierisch et al. 2009; Lopez et al. 2009). These barriers could be due to the multiple 
responsibilities held by women at the workplace and at home, and time restrictions that urge 
working women to postpone their own health appointments or personal concerns for the sake of 
the family. Women may perceive cancer screening as less important than other health or 
personal concerns (Makuc et al. 2007; Ahmed et al. 2004) or as a low priority relative to other 
obligations they have, including work and childcare (Tejeda et al. 2009; Peek et al. 2008). 
Taking time off from work (Gany et al. 2006; Moy et al. 2006) and lacking a source of childcare 
during the appointment (Watson-Johnson et al. 2011), have been cited as screening barriers. In 
addition, amidst their busy schedules, women report forgetting to get a mammogram (Lee-Lin 
et al. 2007; Champion and Skinner 2003). 
 
2.2.5.2 Appointment barriers  
The BS pathway can be time consuming for some women. Six studies cited issues in navigating 
the healthcare system to make and attend screening appointments as screening barriers (Watson-
Johnson et al. 2011; Clark and Natipagon-Shah 2008; Documet et al. 2008; Davis et al. 2005; 
Fernandez et al. 2005; Ahmed et al. 2001). These issues included barriers at the point of making 
an appointment, barriers between making the appointment and attending it, and barriers when 
attending the appointment. Women complain of being unable to arrange an appointment in an 
efficient manner (Sarma 2015; Watson-Johnson et al. 2011; Ahmed et al. 2001). In a study of 
African-American women who had not had a mammogram in the previous year, 22% of 
interviewed women said that they were unable to get an appointment (Davis et al. 2005). Delays 
between making the appointment and the appointment date is also a perceived barrier to 
mammography use (Watson-Johnson et al. 2011). Women who reported long waiting times at 
the screening facility (Young et al. 2011; Wu et al. 2006; Liang et al. 2004) and long waits for 
receiving test results (Sarma 2015; Watson-Johnson et al. 2011) were less likely to be adherent 
to other screening appointments.  
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2.2.5.3 Lack of accessibility  
Lack of access to screening services, including lack of transportation and a lack of a nearby 
facility, can be a barrier to screening attendance (Carney et al. 2013) and a significant predictor 
of non-adherence (Young et al. 2011; Elkin et al. 2010; Documet et al. 2008; Levy-Storms et 
al. 2004). Furthermore, inconvenience in taking public transport, having to pay for parking or 
having to navigate to an inconvenient location may also be a screening barrier (Watson-Johnson 
et al. 2011; Liang et al. 2004). Depite the location of the screening service, women will often 
opt for that service that provides easy and free access and parking facilities (Hamilton et al. 
2003), which in turn have shown to enhance client satisfaction, attendance and re-attendance 
(Peipins et al. 2006; Hamilton et al. 2003). 
 
2.2.5.4 Medical mistrust 
Understanding why women do not make it through the clinic door is critical to having an 
effective health care system. Individuals often avoid seeking medical care when they suspect it 
may be necessary (Yousaf et al. 2013; Scott and Walter 2010) or when experiencing symptoms 
(Barbour et al. 2012; Ristvedt and Trinkaus 2005). A literature review by Sarma (2015) 
identified distrust of the medical system as a screening barrier in various studies (Documet et 
al. 2008; Peek et al. 2008; Fowler 2006; Moy et al. 2006). Most research among minority groups 
investigating trust in the medical system has focused on African Americans (Born et al. 2009; 
Corbie-Smith et al. 2002). In a study by Davis et al. (2012) based in New York, Maryland, and 
Puerto Rico, Hispanics lacked trust in medical professionals and feared being a “guinea pig”. It 
may be that individuals do not believe that medical personnel will act in their best interests. 
Fowler (2006) explored African-American women’s perceived barriers to mammography, and 
found that some women aged 60 and older indicated that the past discrimination and abuse of 
African-Americans by the healthcare system resulted in a distrust of health professionals. This 
resulted in less frequent attendance to medical appointments (Fowler 2006). In another study, 
African-American participants reported discriminatory treatment, including being patronised by 
staff, receiving insufficient medical explanations, being treated like experimental subjects and 
as second-class citizens because of their public health insurance, while Latina women 
complained about rude treatment and anti-immigrant attitudes in the same study (Documet et al. 
2008). Hence, discriminatory experiences in healthcare settings can act as BS barriers. 
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2.3 Applications of health psychology models to early breast 
cancer detection and prevention 
Health psychology aims at understanding how psychological, behavioural and cultural factors 
contribute to physical health and illness in an attempt to explain health behaviours (Parsa et al. 
2006). A theory is defined as “a set of interrelated constructs (concepts), definitions, and 
propositions that present a systematic view of phenomena by specifying relations among 
variables, with the purpose of explaining and predicting phenomena” (Kerlinger 1986, p.9). The 
use of health behaviour theory has been widely instrumental and used within research on health 
psychology in an attempt to predict behavioural outcomes including cancer screening (Glanz et 
al. 2008). Since many behaviour theories were developed for different settings and purposes, 
only few theories are relevant to BC and BS, particularly due to their construct validity (Glanz 
et al. 2008; Lauver et al. 2003). Moreover, there is little consensus regarding which theory is 
superior in explaining a health behaviour. Hence, understanding the relative merits and 
limitations of these theories might help to inform future research design on mammography 
participation, and facilitate the improvement of women’s compliance in mammography 
screening through the application of strategies supported by these theories. Mainly, there are 
two categories of theoretical models: social cognition models and stage-based models (Sutton 
2002). 
 
2.3.1  Social cognition models  
Social cognition models assume that behaviour change is determined by key cognitive variables, 
beliefs and attitudes, and socio-demographic variables (Sutton 2002; Stroebe 2000). Commonly 
used social cognition models on the prediction of women’s understanding of BC and BS 
compliance are evaluated and described in detail in the following sections. These models include 
the Health Belief Model (HBM) (Becker 1974), the Protection Motivation Theory (PMT) 
(Rogers 1983), the Theory of Planned Behaviour (TPB) (Ajzen 1991), and the Common-Sense 
Model of illness self-regulation or the Self-Regulation Model of Illness Behaviour (CSM or 
SRMI) (Leventhal et al. 1984).  
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2.3.1.1 The Health Belief Model 
The HBM was initially developed in the 1950s by social psychologists Hochbaum, Leventhal, 
Kegeles, and Rosenstock in the U.S. Public Health Service in response to the failure of a free 
tuberculosis health screening program (Rosenstock et al. 1988; Janz and Becker 1984). The 
HBM considers one’s overall perceived risk of an illness as a precursor to positive, preventive 
health behaviour (Wendt 2005). The fundamental premise of the HBM is that an individual’s 
desire to evade illness, coupled with a belief that a particular health action would avert onset of 
the illness, can be interpreted and explained in relation to a number of diseases.  
 
Prior to 1984, the HBM was not regularly used to explain screening behaviours. The year1984 
proved to be a major turning point for the HBM, where Victoria Champion conducted an array 
of research and developed an innovative research instrument i.e. Champion’s Health Belief 
Model Scale (CHBMS) and subsequent others, to measure HBM concepts in relation to Breast 
Self Examination (BSE) (Champion and Miller 1992) and later mammography (Champion 
1999). The HBM is now considered the most frequently used social cognition model for 
predicting BS behaviour (Orji et al. 2012).   
 
2.3.1.2 The main components of HBM 
The HBM’s core components are perceived susceptibility, perceived severity, perceived 
benefits and perceived barriers, which account for people's ‘readiness to act’. The constructs 
‘cues to action’ and ‘self-efficacy’ were later added to the model by Becker and Maiman (1975) 
and Rosenstock et al. (1988) respectively. The major HBM constructs are presented in Table 
2.1 for definition of each term, their widespread applications and examples as they relate to this 
study. 
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Table 2.1 - The Health Belief Model Constructs, their application to Breast Screening and HBM 
Construct Examples (adapted from Guilford 2011; Hayden 2009; Austin et al. 2002, p.124) 
CONSTRUCT DEFINITION Application Example as 
related to this 
study 
Perceived 
Susceptibility 
An individual’s assessment of 
his or her chances of getting 
the disease 
Define population(s) at 
risk, risk levels; 
personalize risk based on 
a person's features or 
behaviour; heighten 
perceived susceptibility if 
too low 
How likely am I to 
get BC? 
Perceived 
Severity 
Belief about the seriousness of 
the condition, or leaving it 
untreated and its consequences 
Specify consequences of 
the risk and the condition 
How serious will 
BC be? 
Perceived 
Benefits 
Belief as to whether the new 
behavior is better than what 
one is already doing 
Define action to take; 
how, where, when; clarify 
the positive effects to be 
expected 
What will I gain 
from participating 
in BS? 
Perceived 
Barriers 
Belief about the potential 
negative aspects of a particular 
health action 
Identify and reduce 
barriers through 
reassurance, incentives, 
assistance 
What is hindering 
me from 
participating in BS? 
Cues to Action Strategies/factors which 
activate “readiness”, triggering 
action 
Provide how-to 
information, promote 
awareness, reminders 
What will 
remind/cause me to 
perform screening? 
Self-Efficacy Personal belief (confidence) in 
one's own ability to take action 
Provide training, 
guidance in performing 
action 
Have I the 
skills/confidence to 
perform screening? 
 
Perceived Susceptibility 
The HBM predicts that in order for an individual to engage in a specific behaviour, he or she 
needs to believe that it is likely, or at least possible, that the behaviour is intended to prevent 
contracting that particular illness (Champion and Skinner 2008). However, perception of 
increased susceptibility does not always lead to behaviour change. In the context of BS 
behaviour, Hispanic women, for instance, have a very low perceived susceptibility to BC that 
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leads to poor compliance with screening (Fulton et al. 1995). This may lead to an increased risk 
for cancer because of their curative rather than preventive practices. 
 
Perceived Severity 
If an individual perceives that the condition would have a large impact on his or her life, 
including physical, practical, emotional and psychological issues (Harmer and Cruickshank 
2014), for example, whether it is life-threatening or may cause disability or pain, or reduced 
functioning at work or in social roles, that individual is more likely to engage in preventive 
behaviour (Carpenter 2010).  
 
The combination of perceived susceptibility and perceived severity is referred to as perceived 
threat (Glanz et al. 2008) and depend on knowledge about the condition (Rosenstock 1974). If 
the perception of threat is specific to a serious disease for which there is a real risk or is seen as 
fatal, this provides reason to combat the condition, and consequently, behaviour often changes. 
According to the HBM, women who believe that they are susceptible to BC and that BC is a 
serious condition are more likely to undergo mammography (Parsa et al. 2006). While perceived 
threat concentrates more on the perceptions of the disease, the remaining constructs emphasize 
the individual’s perceptions of the preventative behaviour (Champion and Skinner 2008). 
 
Perceived Benefits 
If an individual believes that engaging in a particular behaviour will result in positive outcomes 
such as reduced susceptibility or severity to a health problem and the prevention of negative 
outcomes of the disease, then he or she is more likely to adopt the healthier behaviour to 
experience these positive outcomes (Carpenter 2010; Champion and Skinner 2008). Hatefnia et 
al. (2010) and Eskandari-Torbagha et al. (2014) found a significant difference in women's 
perceived benefits after receiving an intervention involving BS training, compared to women 
who had not received the intervention.  
 
Perceived Barriers 
Of all the constructs, the final core construct of the HBM, perceived barriers, is the most 
significant to determine behaviour change (Janz and Becker 1984). This construct relates to the 
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perceived negative aspects of an action and the beliefs that would deter an individual from 
eliciting the behaviour. For example, barriers to mammography such as fear, pain or discomfort, 
embarrassment, inconvenience or competing priorities (Trigoni et al. 2008; Dandash et al. 2007; 
Jepson et al. 2000), exert a greater influence over the behaviour than does the threat of BC itself 
(Champion and Menon 1997). Hence, the perception of mammography pain, for instance, may 
act as a barrier to undergoing mammography (Myklebust et al. 2009). Women who perceive 
more benefits and fewer barriers from mammography are more likely to use BS behaviours 
(Jahanlou et al. 2013). 
 
Cues to action 
In addition to the four main constructs, cues to action is also included as a modifying factor to 
perceived threat. The HBM suggests that a cue, or trigger, is necessary for prompting 
engagement in health behaviours (Janz and Becker 1984). Cues to action suggests that internal 
(e.g. pain, symptoms) and/or external events (e.g. mass media campaigns, the media, advice 
from friends or health care providers, or reminders) would trigger a readiness to act and 
stimulate behaviour change (Carpenter 2010; Graham 2002; Rosenstock 1974). The cues to 
action for mammography adherence, especially physician support, have long been shown to be 
significant factors in various studies (Hartman 2002; Champion and Miller 1996; Aiken et al. 
1994). Individuals who believe they are at low risk for contracting a disease, and who do not 
have reliable health care access may require more external cues to get screened for BC.  
 
Self-efficacy 
The constructs of perceived benefits, barriers, and susceptibility have explained only around 
40% of the variance in mammography behaviour (Rosenstock et al. 1988). It is important to 
consider, evaluate and accurately measure additional constructs such as self-efficacy in an 
attempt to better explain individual differences in health behaviours (Champion and Miller 
1996). Regarding mammography behaviours, women who are more confident in their ability to 
detect abnormal lumps, more motivated to promote their health by overcoming potential 
barriers, for example, finding a mammography unit that provides the service, obtaining a 
referral, and paying for mammography (Champion and Skinner, 2008) are more likely to 
undergo mammography (Champion 1999). In several studies, perceived self-efficacy for 
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mammography has been predictive of mammography screening (Aymoori et al. 2015; Moodi et 
al. 2012). For example, it has been shown that women with a moderate level of fear from BC, 
in combination with a higher level of self-efficacy for mammography are more likely to adhere 
to mammography than women with a high level of BC fear in combination with lower self-
efficacy (Champion et al. 2008) and fewer perceived benefits of mammography (Fair et al. 
2012). Some women experiencing a low level of BC fear, regardless of self-efficacy and 
perceived benefits of mammography may not feel motivated to take action. This may be partly 
due to the lack of verbal persuasion and social influence (Hashemian et al. 2015). A persuasive 
caregiver, such as a doctor’s recommendations (Moshki et al. 2017), may be able to influence 
women’s decisions to attend for mammography. 
 
Figure 2.2 illustrates the most common conceptualization of the HBM and how behaviour 
change is a function of the perceived threat and behavioural evaluation, where external cues to 
action activate or moderate the perceived threat. Additionally, sociodemographic variables can 
influence an individual’s perceptions of the HBM’s four main constructs. 
 
 
Figure 2.2 - The Health Belief Model (Glanz et al. 2002, p. 52; Strecher et al. 1997) 
According to HBM, behaviour change is directly influenced by perceived threat and the net 
difference of benefits minus barriers. Perceived susceptibility to and perceived severity of the 
disease affect an individual’s perception of threat from that specific disease. Perceived benefits 
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and barriers of adopting a health action also influence an individual’s evaluation of the 
recommended action (Becker 1974). Research performed in Turkey (Secginli and Nahcivan 
2006), Korea (Han et al. 2000) and the US (Champion 1999) showed that perceived 
susceptibility, seriousness, benefits, and self-efficacy are positively associated with screening 
behaviours, while perceived barriers are negatively associated with them. Additionally, 
individual characteristics such as demographic variables (e.g. age, sex, education, ethnicity), 
psychological characteristics (e.g. personality, social class) and structural variables (e.g. 
knowledge about a given disease and prior contact with the disease) can affect perceptions on 
health behaviour (Rosenstock 1974). This is due to their effect on each of the HBM components 
(i.e. perceived seriousness, susceptibility, benefits and barriers) with the exception of cues to 
action (Glanz et al. 2008; Abraham and Sheeran 2005). 
 
2.3.1.3 Utility of the Health Belief Model 
A number of uses have been outlined for the HBM. Prior to the early 1970s, HBM was used to 
provide a useful framework for understanding individual differences in health behaviour, and 
for designing interventions to behavioural change (Abraham and Sheeran 2005). In later years, 
it has gained recognition in various health settings to address public health concerns and to 
evaluate health behaviours beyond prevention across diverse populations (Orji et al. 2012; Glanz 
et al. 2002). It has been applied to increase mammography screening (Michielutte et al. 2005), 
breast self-examination (Umeh and Rogan-Gibson 2001), to evaluate responses to symptoms 
and diagnoses as well as medical adherence (Champion and Skinner 2008) and in designing 
effective health interventions (Kharrazi et al. 2009).  
 
The HBM has been criticised for its limitations which make the different operationalisations of 
the theoretical constructs not strictly comparable across studies (Glanz et al. 2008). First, HBM 
does not provide a clear explanation of how its model components interact with each other or 
combine to affect behaviour (Morrison and Bennett 2006). Second, HBM does not account for 
sociocultural and economic factors, behavioural intentions and previous experiences (Soliday 
and Hoeksel 2000), resulting in its weak predictive validity of its core psychological 
components (Armitage and Conner 2000). Although self-efficacy has been added by Rosenstock 
et al. (1988), its mode of operation in relation to the other component variables has not been 
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defined and its use in HBM studies has been limited (Carpenter 2010). The models PMT and 
TPB, however, address this construct, and are discussed in sections 2.4.1.4 and 2.4.1.5. Since 
this construct has been recognised as a significant component of health behaviour change (Glanz 
et al. 2008; Seydel et al. 1990), self-efficacy has been included in the HBM model used for this 
study.  
 
Third, the six HBM components have been generally examined independently on the prediction 
of health behaviour in many studies (Abraham et al. 1996). Hence, there is a lack of consistency 
in the measurement of each HBM component (Abraham and Sheeran 2005); most attention has 
focused on the four factors contained in the threat and behavioural evaluation. Since cues are 
diverse and changeable, cues to action have not been examined in many studies on the HBM 
(Sheeran and Abraham 1996; Harrison et al. 1992) and is rarely included in HBM theoretical 
testing and meta-analyses (Kiviniemi et al. 2011; Carpenter 2010). For example, two meta‐
analyses (Harrison et al. 1992; Janz and Becker 1984) have calculated significance ratios and 
effect sizes for behavioural impact for the four main HBM constructs, but there does not appear 
to have been any such analysis for the other constructs (such as cues to action). In my research, 
cues to action was included in the evaluated model of HBM due to its potential importance.  
 
Fourth, the HBM does not provide detailed description on how the social/environmental factors 
such as social norms, family and friends may prevent engagement in desired behaviours (Janz 
and Becker 1984). Moreover, fear may be a key factor in predicting health-related behaviour 
(Glanz et al. 2008) but the HBM does not consider the impact of emotions on health-related 
behaviour. Based on the above methodological shortcomings of the model, the HBM has limited 
power to predict behaviours consistently (Yarbrough and Braden 2001) and can therefore only 
explain some variation in BS behaviour (Orji et al. 2012). This is why the Common-Sense 
Model (CSM) of self-regulation, has been used to consider the cognitive and emotional 
representations of an illness (Anagnostopoulos et al. 2012). 
 
2.3.1.4 Protection Motivation Theory  
Protection Motivation Theory (PMT) (Rogers 1975) differs from the HBM in that it specifically 
aims to predict intentions from cognitive responses of individuals to health interventions (Fry 
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and Prentice-Dunn 2006). Originally, PMT was proposed to provide conceptual clarity to the 
understanding of fear appeals and coping mechanisms to protect an individual from a health 
threat (Rogers 1975). A later revision of PMT (Rogers 1983) extended the theory to a more 
general theory of persuasive communication, such as health warning messages, with an 
emphasis on the cognitive processes mediating behavioural change (Morrison and Bennett 
2006).  
 
Several components are common between PMT and HBM. However, PMT emphasises the 
impact of fear on behaviour change, which HBM does not. Fear messages stimulate two parallel 
appraisal processes: threat appraisal, i.e. perceived sensitivity, perceived severity, and perceived 
rewards; and coping appraisal, i.e. perceived self-efficacy, perceived response efficacy, and 
perceived costs (Rogers 1983). Thus, the outcomes of these two stages i.e. fear, will direct 
protection motivation i.e. people’s intention to adopt adaptive responses and behaviour (Norman 
et al. 2005). Furthermore, according to PMT, protection motivation or maladaptive coping, i.e. 
avoidance, denial and the absence of behaviours, are functions of an individual’s threat 
appraisal, and the appraisal of coping responses (Prentice-Dunn and Rogers 1986). Individuals 
are considered likely to intend to adopt the recommended health behaviour when they perceive 
that the threat is high, i.e. high ‘perceived susceptibility,’ ‘perceived severity’ and ‘fear’; and if 
they believe that the recommended behaviour will be effective, i.e. high ‘response efficacy’; 
with little cost, i.e. low ‘response cost’; and easy to adopt, i.e. high ‘self-efficacy’ (Fry and 
Prentice-Dunn 2006). 
 
PMT has been a useful theoretical framework to predict cancer prevention and early detection 
behaviours (Inukai and Ninomiya 2010; Fry and Prentice-Dunn 2006). However, participation 
in mammography screening has not been specifically investigated using PMT, and therefore, 
few studies have applied this model to mammography screening (Naito et al. 2009). Inukai and 
Ninomiya (2010) have reported that self-efficacy and perceived consequences of behavioural 
responses, i.e. response costs, predict mammography screening attendance. However, evidence 
provides indirect support for the suggested relationships between PMT variables and intention 
and participation in mammography screening (Rutter 2000; Pearlman et al. 1999). In addition, 
popular health interventions include providing information and using persuasion (Hardeman et 
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al. 2002), where the PMT partially explains the mediating cognitive processes that link 
informational interventions to cognitive and behavioural changes (Fry and Prentice-Dunn 2006). 
Informational interventions based on the PMT framework have been shown to increase 
intentions for health behaviours in various studies (Fry and Prentice-Dunn 2006; Kaljee et al. 
2005; Milne et al. 2002). However, while findings support the anticipated relationships between 
BC information and mammography screening, screening knowledge and risk factors, PMT 
variables, and mammography intentions, the effects of PMT-based informational interventions 
on women’s mammography intentions have not been explicitly investigated. 
 
PMT has been criticised since the adoption of health behaviour is also influenced by other 
variables other than the threat appraisal and coping appraisal. For example, normative beliefs, 
which refer to an individual’s beliefs about the level of other people’s approval of their 
behaviour (Stroebe 2000), have been found to be an important variable influencing women’s 
BS participation. In a study examining the relationships between social network characteristics 
and BS practices, Allen et al. (2008) found that social norms significantly affected women’s 
regular screening attendance. Additionly, the normative beliefs in relation to the physician, 
family members and close friends have an important influence on women’s intention to attend 
the initial mammography screening (Tolma et al. 2003). Within social cognition models, only 
TPB explicitly addresses the subjective norm variable, a component of normative beliefs 
(Conner and Norman 2005).  
 
2.3.1.5 The Theory of Planned Behaviour / Reasoned Action 
In 1975, Fishbein and Ajzen developed the Theory of Reasoned Action (TRA) and proposed 
that a person’s intention to adopt a particular behaviour was influenced by a person’s attitudes 
(evaluation of taking the action), and subjective norms about the behaviour (the influence of 
others on the individual’s behaviour (social pressure) (Fishbein and Ajzen 1975).  Because TRA 
was criticised for limitations in dealing with behaviour over which people do not have complete 
voluntary control, the model was revised by Ajzen (1991) with the addition of a third component 
i.e. perceived behavioural control (Figure 2.3) and renamed the Theory of Planned Behaviour 
(TPB) (Godin and Kok 1996; Ajzen 1991) to predict deliberate behaviours (Ajzen 2011). The 
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TPB and PMT theories overlap in predicting intentions, each model providing unique 
contribution amounting only to 5% (Boer and Mashamba 2005). 
 
Figure 2.3 - Schematic representation of TPB (adapted from Amelio 2013, p.109; Armitage and 
Conner 2001, p.472; Ajzen 1991) 
 
Considerable support exists for TPB in the prediction of a range of intentions and health 
behaviours (Brickell et al. 2006; Myers and Horswill 2006; Boer and Mashamba 2005). 
Intention is the key predictor of actual behaviour in the TPB theory, and intentions are in turn 
predicted by attitudes (positive or negative beliefs about the consequences of the behaviour), 
perceived behavioural control (i.e. beliefs about the ease or difficulty to perform a given 
behaviour and is assumed to reflect past experience and anticipated barriers), and subjective 
norms (perceived social pressure to performing the behaviour (Ajzen 1998). Povey and 
colleagues concluded that perceived behavioural control is different from self-efficacy and it 
could be a better predictor of intentions (Povey et al. 2000).  
 
Women’s actual participation in mammography screening is determined by their intention to 
undergo mammography (intention leads to behaviour). The strong predictor of mammography 
screening was found to be intention in studies reporting actual attendance (Steadman and Rutter 
2004; Drossaert et al. 2003; Steadman et al. 2002; Rutter 2000) or self-reported attendance 
(Steele and Porche 2005), while the subjective norm is generally considered as the weakest 
predictor of intention (Godin and Kok 1996). As in PMT, although these two theories suggest 
that an individual’s intention can directly lead to the performance of behaviour, it has been found 
that woman’s intention to participate in mammography screening does not always lead to 
participation (Walker et al. 2012). This is because patients’ behaviours may be influenced by 
attitudes, perception of screening barriers and benefits, fear of cancer, illness perceptions, and 
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socio-demographic factors (Hay et al. 2005). The lack of provision of an explanation of the 
intention-behaviour gap is therefore a clear weakness of TPB.  
 
Since TPB focuses on individuals’ existing beliefs and attitudes (Ajzen 1998), behaviour is often 
predicted through the measurement of TPB variables and intentions at baseline or in studies that 
do not involve interventions (Hardeman et al. 2002). One area of weakness relates to 
inconsistencies in the predictive abilities of component variables. In their study to predict 
condom use through TPB, Bennett and Bozionelos (2000) found that the proportion of variance 
in behaviour explained by intentions reached significant levels in only just over a third (35%) 
of the studies they reviewed. TPB can account for moderate variance in intentions and 
behaviours in general but attitudes, subjective norms, and perceived behavioural control do not 
always allow the prediction of various health behaviours (Taylor et al. 2006). TPB does not 
explicitly include threat appraisal when compared with HBM and PMT and hence, TPB does 
not include affective variables in explaining health-related intention or behaviour (Oliver and 
Berger 1979).  
 
2.3.1.6 The Common-Sense Model (CSM) of Illness Self-Regulation or the Self-Regulation 
Model of Illness Behaviour (SRMI)  
Developed by Leventhal and colleagues in 1980s (Leventhal et al. 1980), the Common-Sense 
Model (CSM) of illness self-regulation (Leventhal et al. 1984) is also known by various terms, 
such as the Self-regulatory Model of illness behaviour (SRMI), the Illness Perception Model, 
the Illness Representations Model, the Parallel Process Model or Leventhal’s model (Hale et al. 
2007). This model provides a theoretical framework to understand the self-regulation process 
of illness and health (McAndrew et al. 2008), where individuals deal with the illness or 
symptoms through three hierarchical stages: representations, coping and appraisal (Leventhal et 
al. 1992). Representations refer to how one makes sense of his or her disease (Leventhal et al. 
1992) which then informs a coping response. This response is thought to be appropriate on the 
basis of an individual’s cognitive and emotional representations to cope with the illness (Rees 
et al. 2004). Two broad coping actions (approach coping and avoidance coping) are defined in 
this stage (Leventhal et al. 1992). When individuals suffer from an illness, coping strategies are 
developed to regain their healthy state. The success of a coping strategy is assessed which then 
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leads individuals to adjust their coping plan and/or representation of the illness or health threat 
according to their appraisal (Morrison and Bennett 2006). Hence, the model is conceptualized 
as a ‘parallel-processing’ model in that individuals actively produce both illness cognitions and 
emotional representations to a health threat when they receive an internal stimulus such as pain 
or external stimulus such as cancer diagnosis (Leventhal et al. 1980) (Figure 2.4). Such 
individual subjectivity and constructions, based on common sense about the health threat and 
personal experiences of a symptom or diagnosis, guides the understanding of the current 
situation and subsequently guides coping behaviour (de Castro et al. 2015).  
 
Figure 2.4 - Schematic representation of the Common-Sense Model of Illness Representations 
(adapted from Brandes and Mullan 2014, p.131; Hagger and Orbell 2003) 
 
Originally, illness representations comprised five domains: identity (possible related 
symptoms), causes (factors that give rise to the illness), timeline (course of the disease over 
time; e.g., acute/chronic – beliefs about the relative chronicity of the illness), consequences 
(severity of the disease and its anticipated impact on the physical, psychological and social 
functioning), and cure/control  (perception of if and how an illness can be cured or controlled) 
(Baines and Wittkowski 2013). A logical relationship exists between these five components 
(Morrison and Bennett 2006). A meta-analysis of the model reported consistent strong negative 
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relationships between cure/control and identity, timeline and consequences while there is 
positive relationships between identity, consequences and timeline (Hagger and Orbell 2003). 
Moreover, evidence indicates that when individuals considered that the illness outcomes can be 
influenced by coping strategies, illness perceptions had a more direct effect on the illness 
outcomes such as utilisation of medical treatment (Leventhal et al. 1992), treatment adherence 
(Horne and Weinman, 2002), and engagement in self-care activities (Hampson et al. 1990). The 
original five dimensions were further differentiated to include another four domains: timeline 
cyclical (beliefs about the fluctuation in symptoms and temporal illness changeability); personal 
and treatment control (perception of how an individual can control or cure the illness and 
treatment effectiveness); illness coherence (perception of how an individual understands the 
disease) and emotional representations (emotions involving the illness experience) (Moss-
Morris et al. 2002).  
 
The utility of the CSM 
The utility of the CSM has been extensively investigated quantitatively following the 
development of the Illness Perception Questionnaire (IPQ) (Weinman et al. 1996), which 
addresses the first five key dimensions. This was later revised and renamed as the Revised 
Illness Perception Questionnaire (IPQ-R) (Moss-Morris et al. 2002) with the inclusion of the 
new dimensions. The CSM has generally been employed in disease-affected populations to 
assess the cognitive (i.e. beliefs, thoughts, ideas) and emotional (i.e. feelings) representations of 
a health threat (Anagnostopoulos et al. 2012; Cameron 2008), derived from one’s own unique 
experience of an illness or illness-related symptoms (Leventhal et al. 1980). Healthy individuals 
can similarly develop illness perceptions to those affected by a disease through these cues. An 
individual’s behaviour can be affected by the assessment of symptoms and knowledge, beliefs 
and risk perceptions (de Castro et al. 2013) derived from various sources, including internal cues 
(e.g., existing understanding of an illness) (Cameron and Moss-Morris 2004) and external cues 
(e.g., information obtained from family, friends and/or media) (Morrison and Bennett 2006). In 
fact, healthy individuals who have lived with a relative with cancer hold stronger negative 
emotional representations (e.g., depressed, upset, fear) about cancer than healthy people without 
an affected relative (Del Castillo et al. 2011). Hence, CSM has also been used in a small number 
of studies to examine the illness perceptions of asymptomatic individuals (Anagnostopoulos et 
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al. 2012; Adams 2010; Moore 2008) including skin cancer (Cameron 2008; Figueiras and Alves 
2007), AIDS and tuberculosis (Figueiras and Alves 2007). In the study by Figuerias and Alves 
(2007), the cognitive dimensions (illness coherence, psychological attributions, chronic timeline 
and the perception of disease consequences) explained some variance in attitudes towards 
preventive behaviours and intention to adopt them. The evidence showed that those who endorse 
more acute/chronic timelines, fewer psychological causes (causal attributions), more severe 
consequences of the disease and its treatment, and have a better understanding of the illnesses 
(illness coherence), exhibit more positive attitudes towards health behaviours (Figuerias and 
Alves 2007). This suggests that illness representations may influence health-related behaviours 
in healthy individuals, independent of the illness experience. In relation to BC, healthy women 
have stronger beliefs about BC consequences (Buick and Petrie 2002), perceived susceptibility 
and treatment side-effects and duration (Buick 1997) than BC patients. One study found that 
older asymptomatic women perceived more negative consequences (physical disfigurement due 
to BC) and identified fewer risk factors (causal attributions) and symptoms (identity) of BC 
(Grunfeld et al. 2002). Moreover, the capacity to identify BC symptoms has been linked to one’s 
seeking intent (Hunter et al. 2003) and postponement of medical assistance (Grunfeld et al. 
2003).  
 
Illness perceptions also appear to be precursors of screening behaviour (de Castro et al. 2013), 
including mammography screening (Adachi et al. 2015; Petrak 2013; Anagnostopoulos et al. 
2012). In an effort to determine the factors that are associated with asymptomatic women’s 
mammography behaviours among 408 Greek women, aged 40 or older, Anagnostopoulos and 
colleagues (Anagnostopoulos et al. 2012) employed the validated IPQ-R to rate women’s 
perceptions of BC. The findings showed that women who participate in mammography 
screening are significantly more likely to perceive greater benefits and fewer barriers to BS, 
similar to previous findings (Lagerlund et al. 2000; Holm et al. 1999). Moreover, the higher 
level of negative emotional representations on BC (e.g. feeling afraid, getting depressed when 
thinking about BC) were associated with an increased likelihood of never having a 
mammogram. This is consistent with previous research on mammography utilization, which 
suggests that emotional responses and distress can influence mammography behaviour in a 
reverse fashion (Decruyenaere et al. 2000). Regarding repeat mammography screening, BC 
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worry was a significant predictor of repeat mammography use. This positive association has 
been previously reported in other studies (Adachi et al. 2013; Diefenbach et al. 1999), in a meta-
analysis (McCaul et al. 1996) and with a significant, albeit weak, positive association between 
these two variables in another study (Hay et al. 2006). Moreover, knowledge about 
recommended frequency of mammography screening also emerged as a significant predictor of 
repeat mammography screening. The latter result confers with the findings from Russell et al. 
(2006) who found that knowledge about recommended mammography screening interval was 
predictive of more repeat mammography use. However, the other illness representation 
dimensions (consequences, cyclical timeline, treatment control, personal control, and illness 
coherence) did not significantly predict mammography use in the Greek study 
(Anagnostopoulos et al. 2012). Key limitations of this study are that the causal (obtained low 
reliability) and identity subscales and the components of coping behaviours representations were 
excluded (Hagger and Orbell 2003). In a meta-analysis of 45 empirical studies to examine the 
intercorrelations between illness representations dimensions, coping strategies and health 
outcomes, Hagger and Orbell (2003) revealed that the correlations between illness 
representation dimensions and the coping behaviours are of low-to-moderate magnitude. 
Explanations for these findings may be that coping behaviours may only mediate the impact of 
illness representations on health outcomes or that illness representations focus on the beliefs of 
the illness rather than coping with the behaviour, which may, in turn, consist of a different set 
of dimensions (e.g. beliefs on the efficacy of mammography) (Hagger and Orbell 2003). 
 
Limitations of CSM 
Some criticisms about the use of this model in this context have been raised. Firstly, in terms of 
mammography use, CSM does not include perceived barriers and benefits to the performance 
of health-related behaviours (Zhang 2014) even though it is known that barriers and benefits 
significantly determine BS participation (Secginli and Nahcivan 2006; Han et al. 2000; 
Champion 1999). Secondly, the CSM excludes the role of significant others such as family, 
friends and healthcare providers (Hale et al. 2007). As mentioned in the literature review above, 
the support of family and recommendations by a physician are known facilitators to BS uptake 
(Trigoni et al. 2008; Magai et al. 2007; Jepson et al. 2000). In contrast to CSM, HBM addresses 
perceived benefits, perceived barriers and cues to action. 
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2.3.2 Stage models  
As discussed previously, social cognition models are a group of similar theories, each of which 
identifies various components (such as cognitive and affective factors, i.e. beliefs and attitudes) 
(Sutton 2002) which are combined to predict a continuum of behaviour likelihood (Weinstein 
et al. 1998). While stage models use similar concepts to social cognition models, they are 
fundamentally different in structure as they organize concepts in a different way (Weinstein et 
al. 1998). Stage models relevant to health behaviours include the Transtheoretical Model (TTM) 
(Prochaska and DiClemente 1984), the Precaution Adoption Process Model (PAPM) (Weinstein 
and Sandman 1992), and the Health Action Process Approach (HAPA) (Schwarzer and Fuchs 
1996). Since TTM is the dominant model in the field and has relatively more evidence in its 
application to health behaviours compared with the PAPM and HAPA (Schuz et al. 2009; 
Conner and Norman 2005), this section focuses on the TTM. 
 
2.3.2.1 The Transtheoretical Model  
Often referred to simply as the stages of change model, the TTM was initially developed by 
James Prochaska in 1977 to understand the processes of change in psychotherapy and smoking 
cessation (Prochaska 2013), but has been applied to a wide range of other health behaviours 
(Prochaska and Velicer 1997) including BS (Partin and Slater 2003; Chamot et al. 2001; 
Rakowski et al. 1996). The name ‘transtheoretical’ emerges from the fact that TTM attempts to 
integrate fifteen different constructs in a single comprehensive framework (Sutton 2002), which 
are drawn from different theories of behaviour change. These 15 constructs include the stages 
of change (the basic organizing principle of TTM), the 10 processes of change (i.e. the things 
that people think and do to help them move through the stages), the perceived pros and cons of 
changing (i.e. the perceived advantages and disadvantages of changing), self-efficacy (borrowed 
from Bandura's social cognitive theory) and temptation (the degree to which a person expects 
to feel tempted to lapse in different situations) (Figure 2.5). The pros and cons in the TTM are 
conceptually the same as HBM’s perceived benefits and barriers. For example, women are more 
likely to be in the later stage of mammography use if they perceive more pros than cons towards 
mammography. Moreover, the transitions between the successive stages are influenced by self-
efficacy and temptation in the TTM (Prochaska et al. 2002). Hence, stage models and social 
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cognition models share some concepts, though the former suggest the stages of behaviour 
change and the latter emphasize that behaviour change is a continuous process (Zhang 2014). 
 
Figure 2.5 - Schematic representation of the TTM constructs (Sarbandi et al. 2013, p.2) 
The version of the TTM used most widely in recent years includes five stages of behaviour 
change: precontemplation, contemplation, preparation, action and maintenance (DiClemente et 
al. 1991). The first three stages are defined in terms of current intentions and past behaviour: (1) 
precontemplation (where individuals lack awareness of health problems with no intention for 
behavioural change), (2) contemplation (where individuals begin to consider behaviour change 
possibly caused by the unhealthy behaviour and increased perceived susceptibility), and (3) 
preparation (where individuals plan to change behaviour). In spite of having a strong intention 
to change their behaviour in this stage, individuals may vary in their confidence in implementing 
behaviour change. Stages 4 and 5 of the TTM are purely defined in terms of behaviour: (4) 
action (individuals engage in behaviour change) and (5) maintenance (individuals enter into the 
stage of maintenance when they keep up the change over time, e.g. for more than 6 months). 
Although TTM assumes that individuals go through the five stages in order, it also assumes that 
individuals relapse to an earlier stage and can cycle and recycle from one stage to another before 
achieving successfully long-term behaviour change (Sutton 2002).  
 
The TTM was applied by researchers to explore mammography screening practices. Studies 
were reviewed by Spencer et al. (2005) who reported that findings support the construct validity 
of the TTM in mammography screening. Among immigrant Muslim women living in the US, 
the use of TTM yielded relevant information on how to improve this group of women’s 
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attendance (Hasnain et al. 2014). However, the HBM supported the theoretical framework to 
guide the latter study, since it was useful to explore the effectiveness of introducing an 
intervention rather than to directly explore Muslim women’s mammography screening 
behaviour (Lawal et al. 2017). 
 
Limitations of the Transtheoretical Model 
While there is a large body of evidence to support the model (Spencer et al. 2005), limitations 
of the TTM include: lack of standardization of measures, particularly of the central construct of 
stages of change; logical flaws in current staging algorithms; inadequate specification of the 
causal relationships among the different constructs; misinterpretation of cross-sectional data on 
stages of change; and confusion concerning the nature of stage models and their measurement 
(Sutton 2002; Sutton 2000). Further consideration should be given to the notion that behaviour 
change involves progression through a series of qualitative, sequential stages. 
 
2.4  Justification for using the Health Belief Model and the 
Common-Sense Model as the main theoretical framework  
The reviewed theories have similarities and differences on a theoretical level. As discussed 
earlier, social cognition models have been adopted to understand the determinants of 
mammography behaviour and behaviour change. Such models assume that personal choices and 
behaviour result from the analyses of benefits and costs of the possible consequences of courses 
of action (Conner and Norman 2005). Individuals generally prefer to choose the ideal behaviour 
with the combination of the highest probable outcome and the best expected value (Zhang 2014).  
 
Perceived benefits and barriers have been demonstrated to be significant predictors of 
mammography screening. Hence, understanding different beliefs and attitudes related to BS as 
well as the benefits and barriers related to the behaviour will partially explain why some women 
engage in positive behaviours and why others opt not to, particularly to target the barriers that 
inhibit individuals’ engagement in positive behaviours. Moreover, as mentioned in the literature 
review above, the support from family and physician’s recommendations predict mammography 
use among diverse populations (Sunil et al. 2014; Roman et al. 2014; Villani and Mortensen 
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2013). Such cues to action are included in the HBM but not in the other models, such as the 
CSM (Hale et al. 2007). In contrast to TPB and TTM, both the HBM and PMT explicitly 
emphasise the perceived health threat in terms of perceived susceptibility and perceived 
severity. However, Sheeran (2002) found that among those with positive intentions to perform 
cancer screening, 47% of participants did not implement the behaviour. It has been suggested 
that having the intention to go for BS may not be sufficient to initiate the behaviour due to a 
psychological ‘intention-behaviour gap’ (Sutton 2002), but rather forming a plan of action may 
bridge the gap between intention and behaviour, which can significantly improve 
mammography screening uptake (Zhang 2014). Therefore, it is essential for this study to explore 
the cues that would facilitate Maltese women converting intentions to attend mammography 
screening into tangible utilisation. Compared with TPB and PMT, HBM has ignored the link 
between intention and behaviour. 
 
The HBM, PMT and CSM are considered as content-specific models as they provide detailed 
information about factors that are related to health behaviour or illness perceptions. In contrast, 
the HBM, PMT and CSM provide a stricter guideline towards the understanding of health 
behaviours, compared with the TPB (a content-free model that has only three constructs) which 
does not define any specific content and the content of the included constructs is filled during 
the process of using this theory to understand a specific behaviour (Ajzen 1998). There is also 
evidence that TPB is infrequently used directly to inform behavioural change interventions, and 
when this has been the case, there has been relatively limited, additional health benefits gained 
(Hardeman et al. 2002). Moreover, systematic reviews and randomised controlled studies have 
not provided sufficient evidence for TTM’s effectiveness in interventions on health behaviour 
change or promoting the progression through the ‘stages of change’ mechanisms (Callaghan and 
Herzog 2006; Sutton 2005; West 2005). 
 
The application of HBM has received strong support by researchers to understand BS 
behaviours (Aflakseir and Abbasi 2012; Anagnostopoulos et al. 2012; Champion et al. 2008). It 
has been suggested that HBM is the best framework to understand infrequent health-related 
behaviour (e.g., mammography screening) while other models (e.g. PMT, TPB and TTM) are 
considered to be more predictive in frequent behaviour (e.g., smoking cessation) (Sanderson 
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2004). Because of its long record of use in several studies exploring health and cancer screening 
behaviours, the HBM was employed as one of two theoretical frameworks for this study to 
explore BC-related knowledge, beliefs, perceptions, and screening behaviours among Maltese 
women - a population not previously targeted. However, HBM only explains some variation in 
BS behaviour (Orji et al. 2012), and although the HBM may be used to derive information that 
may then prompt interventions designed to change health beliefs and behaviours, using the 
model alone cannot inform decision-making as to how such interventions might best be 
structured. HBM does not take into account the role of emotions in decision-making as well as 
the value of the ‘perceived threat’ element (Henshaw and Freedman-Doan 2009). Related to this 
is the increasing interest in models of self-regulation, whereby conscious personal management 
involves the process of guiding individual thoughts, behaviours and feelings to enact the 
behaviour. The CSM has made a great contribution to explain the effect of cognitive and 
emotional representations (such as fear) on behaviour change (Anagnostopoulos et al. 2012; 
Norman and Brain 2005). On the other hand, the CSM does not describe the perceived barriers 
and benefits to the performance of health-related behaviours (Zhang 2014) such as 
mammography use, and excludes the role of significant others such as family, friends and 
healthcare providers (Hale et al. 2007), nor does it accommodate social and environmental 
influences of past behaviour (Lunt et al. 2005). By contrast, the HBM addresses all of these, 
incorporating the components of perceived benefits, perceived barriers and cues to action. 
Therefore, both HBM and CSM have been chosen as the theoretical frameworks to guide the 
prediction of mammography screening uptake in Malta. 
 
2.5  Chapter summary 
There has been substantial interest worldwide in exploring BS determinants and how to address 
the factors influencing screening compliance, many of which are inter-related. In summary, this 
literature review related to mammography screening uptake has shown that risk perception, 
peace of mind, positive screening experiences, anxiety, beliefs in early detection, socio-
demographic factors, and personal or family experiences of BC are among the main reasons for 
BS attendance. On the other hand, psychosocial factors including fears and social influences, as 
well as the physical, socio-demographic, health status, logistical and knowledge variables may 
contribute to BS non-attendance. An understanding of these factors might contribute to the 
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development of BS interventions. This chapter also provides a context for Chapter 4 as it reviews 
the literature that forms the basis of the questionnaire and topic guides used in a study of 
women’s beliefs and perceptions about BS in Malta. 
 
The review of previous literature on the utility of behavioural theories highlights how models 
appear to have been widely used in attempting to understand behaviours in many different 
settings or more specifically, women’s BS behaviour. The theories discussed above could be 
used to inform studies on BS and underpin interventions to improve uptake. Although it was not 
possible to cover all theory combinations and applications, studies have acknowledged the 
strengths of individual theories by adding more or innovative constructs or embedding 
theoretical approaches within other broader frameworks. However, it is important to understand 
the limitations surrounding theories, for example, abstraction from context, focus on cognition 
rather than the progression by which behaviour might change or through which interventions 
can effect change. This is particularly important as the effect of such limitations and those 
factors not accounted for, could be significant to the understanding of women’s participation in 
mammography screening. While the HBM focuses on the individual, including one’s perceived 
barriers and benefits to health behaviours, and does not incorporate the role of emotions in 
decision-making behaviours, the CSM explains the effect of cognitive and emotional 
representations of a health threat on behaviour change. Due to the strengths of the HBM and 
CSM, both models were adopted in this thesis to explore the factors affecting women’s use of 
mammography in Malta. The following chapter provides the methodology, which guided the 
research questions in this thesis. 
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Chapter 3 
 
Methodology 
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3.1 Introduction 
This chapter discusses the overarching approach to this research by illustrating the application 
of Intervention Mapping (IM) to explore breast screening (BS) determinants, and plan a future 
tailored intervention that would have the potential to increase BS uptake among Maltese women. 
Subsequently, the mixed methods approach used throughout this research is explained in 
relation to each step of the IM framework. Since there are a number of studies, the entire thesis 
will be referred to as ‘the research’. While each study is briefly introduced, the detailed methods 
used for each study are presented in subsequent chapters. The purpose of this chapter is to 
describe the overarching framework to the entire research.  
 
3.2 Intervention mapping 
Interventions designed to address the needs of women attending BS may be complex and 
involve multi-level strategies to produce system and individual changes to improve attendance. 
Planning, developing and implementing such complex interventions may be guided by IM 
(Bartholomew et al. 2006). IM is a systematic approach that has been successfully used to adapt 
health promotion programmes (Leerlooijer et al. 2011) and to plan, implement and evaluate 
interventions that showed significant increase in uptake of disease prevention programmes 
(Garba and Gadanya 2017). Examples of these include colorectal cancer screening (Besharati et 
al. 2017), cervical cancer screening (Fernandez et al. 2005) and BS (Highfield et al. 2015; Zhang 
2014; Fernandez et al. 2005). Therefore, IM was employed as the overarching framework to 
guide the mixed methods approach to fulfil the aim and research questions (RQs) of this 
research. 
 
IM is an iterative process rather than a linear one (Bartholomew et al. 2006). It encompasses six 
steps (Bartholomew et al. 2016): 
 Step 1 is to conduct a needs assessment or problem analysis, identifying what needs to 
be changed and for whom; 
 Step 2 aims to create matrices of change objectives (COs) by combining (sub-) 
behaviours or performance objectives (POs) with behavioural determinants, and 
identifying which beliefs should be targeted by the intervention;  
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 Step 3 aims to select theory-based intervention methods that match the determinants with 
what the identified beliefs aggregate into, and translate these into practical applications 
that satisfy the parameters for effectiveness of the selected methods; 
 Step 4 aims to integrate methods and the practical applications into an organised 
intervention; 
 Step 5 considers and plans the adoption, implementation and sustainability of the 
intervention in real-life contexts; 
 Step 6 aims to formulate an evaluation plan, which not only assesses intervention 
effectiveness, but also examines the process and delivery of the intervention.  
 
The completion of the tasks within an IM step creates a product that guides the subsequent step, 
each of which link theory and evidence to practice to provide a systematic framework for 
planning, developing and implementating interventions (Kok et al. 2016) rather than providing 
another theoretical model (Kok et al. 2004). Effective decision-making at each step of the 
intervention development process is guided by the input from priority population members 
(Drum et al. 2009) and by operationalising the theoretical components to link POs with 
intervention methods and implementation strategies (Bartholomew et al. 2006). Therefore, IM 
is suitable for this research as the diverse component studies within this research adequately fit 
within IM’s various steps.  
 
IM steps 1-3 were adapted and utilized as the overarching framework for the purpose of this 
research, and were conducted with specific tasks (Table 3.1). Steps 4 – 6 were beyond the scope 
of the current research. In the future, the researcher may seek further funding to conduct a 
research study to carry out IM’s final steps through testing the feasibility of a potential 
intervention, and evaluating the potential effect of the proposed intervention on particular 
behaviours of screening non-attendees.  
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Table 3.1 - Steps of Intervention Mapping (IM) for this research 
Step Key Stages Research Questions (RQs) Tasks  Method Chapter / 
Study 
1 Logic Model of the problem 
 Needs 
assessment 
 
 
 
 
 
 
 
(1). Is the Maltese Breast Screening 
Questionnaire (MBSQ) valid and 
reliable? 
 
 
 
 
 
 
 
 
(2). Which significant factors are 
associated with: (a) BS uptake to a first 
invitation at the MBSP, (b) re-
attendance, (c) lifetime mammography 
use and (d) adherence to timely 
mammography practices in Malta? 
 
(1). To identify key factors that 
influence BS behaviours and 
relevant theoretical models that 
explain why these factors 
influence behaviours. 
 
 
(2). To translate, adapt and pilot-
test Champion’s Health Belief 
Model Scale for Mammography 
Screening (CHBMS-MS) and 
Revised Illness Perception 
Questionnaire (IPQ-R) and their 
Maltese translated version 
(MBSQ) among Maltese 
women. 
 
 
(3). To measure barriers, 
facilitators, associations and 
predictors to BS uptake in 
Malta. 
(1). A literature review  
 
 
 
 
 
 
(2). Translation 
pathway (n=4); expert 
panel (n=12); focus 
group with 
asymptomatic women 
(n=6); face-to-face 
interviews (n=15). 
 
 
 
 
(3). (a) National cross-
sectional survey on 
first invitation to the 
MBSP; 
(b) Prospective study 
on re-attendance; 
(c) Retrospective study 
on lifetime 
mammography use; 
(d) Retrospective 
study on timely 
screening adherence 
(1). Chapter 2 
 
 
 
 
 
 
(2). Chapter 4, 
Study 1 
 
 
 
 
 
 
 
 
 
(3). Chapter 4, 
(a) Study 2 
(b) Study 3 
(c) Study 4 
(d) Study 5 
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2 Logic Model of Change  
 
 
(a) Search for 
evidence-based 
interventions 
to address BS 
behaviour 
 
 
(b) Identify 
intervention 
outcomes and 
change 
objectives 
 
(3). What types of interventions are 
effective at increasing mammography 
uptake? 
 
 
 
 
 
 
(4). To determine the 
effectiveness of interventions to 
improve mammography uptake, 
which have employed the HBM 
and/or CSM as the theoretical 
basis. 
 
5(i). To specify performance 
objectives (POs) (i.e. 
preparatory behaviour); 
5(ii). To specify important, 
changeable determinants; 
5(iii). To differentiate the target 
population; 
5(iv). To construct matrices of 
change objectives; 
5(v). To identify essential 
elements of a potential 
intervention; 
5(vi). To discuss delivery, 
design, cultural fit, 
implementation fit and plan 
adaptations with field experts. 
(4). A systematic 
review of interventions 
 
 
 
 
 
(5). Two expert 
steering groups  
(4). Chapter 5, 
Study 6. 
 
 
 
 
 
(5). Chapter 6 
3 Intervention Design  
 Select theory-
based 
intervention 
methodologies, 
practical 
strategies and 
suggestions 
from targeted 
users. 
(4). Which factors influence non-
attendance among lifetime non-attendees 
and which interventions are considered 
appropriate to increase mammography 
screening uptake in Malta? 
(6). To brainstorm methods to 
achieve intervention objectives 
and to translate methods into 
strategies. 
 
 
 
 
 
(6). World café type 
focus groups with 
women and men – PPI 
event 
 
(7). Face-to-face in-
depth interviews with 
non-attendees 
(6). Chapter 7  
 
 
 
 
(7). Chapter 8, 
Study 7 
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3.3 Materials and Methods 
3.3.1 Mixed methods for Intervention Mapping  
Steps 1-3 of IM address all 4 RQs through a mixed methods approach (Table 3.1). A mixed 
methods approach was used in the design of this research to provide a basis for triangulation as 
the source of conceptualising a problem in different ways (Spratt et al. 2004). A mixed methods 
design was chosen to strengthen the reliability of data, validity of the findings and 
recommendations, and to deepen the understanding of the processes through which outcomes 
and impacts are achieved, and how these are affected by the context within which the 
intervention is implemented (Bamberger 2012). Mixed methodology goes beyond the 
limitations of a single approach as it can capitalise on the strengths of both quantitative and 
qualitative methods and offset their different weaknesses (Creswell and Garrett 2008).  
 
Distinct differences between qualitative and quantitative research approaches exist. Their 
primary differences are related to their research orientation and data analysis. Quantitative 
research is generally used to quantify a problem and seeks to test hypotheses by generating 
numerical values or data that can be analysed through statistical techniques (Carson et al. 2001). 
While quantitative data is more efficient to test hypotheses, it may miss contextual detail. On 
the other hand, qualitative research is exploratory in nature as it is provides deeper insights into 
research gaps and rich descriptive data on participants’ lives and social experiences (Smith 
2003) by uncovering trends in thoughts and perspectives through individual or group 
investigation (Smith 2006). Qualitative research occurs in participants’ natural settings, where 
conditions continuously develop and interact with each other to produce a process of ongoing 
change (Zhang 2014). This allows qualitative researchers to understand why and how people 
make decisions rather than just what, where and when. Naturalistic verbal reports are collated, 
such as from written accounts or interview transcripts, and data are analysed within textural 
contexts (Stuckey 2014). Therefore, quantitative research tends to focus on exploring what is 
measurable, while qualitative research tends to focus on the interpretation of the problem. 
 
Flexibility is another key difference between the two methods (Haq 2014). In comparison, 
qualitative research is more flexible than quantitative research. Quantitative methods use highly 
structured methods (e.g., survey questionnaires or experimental designs) to investigate 
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numerical data and to test the strength and significance of the relationships between variables 
(Bowling 2009). Responses do not affect or determine subsequent questions as scales are used 
to rate particular questions. In contrast, qualitative researchers utilise relatively unstructured 
methods, such as focus groups and in-depth interviews to capture individual’s perspective, their 
views and individuality (Smith 2006). In turn, questions can be adjusted according to 
participants’ responses and open-ended questions are used, thereby creating more spontaneity, 
interaction and a closer social relationship between the researcher and the participant/s when 
compared with the response of fixed answers in quantitative studies (Howitt 2010). Hence, 
researchers are considered to be insiders in qualitative research rather than outsiders as in 
quantitative research (Denzin and Lincoln 2000).  
 
Qualitative research is often criticised for lacking scientific rigour in terms of reliability, validity 
and generalizability (Noble and Smith 2015) with poor justification of the methods used, lack 
of transparency in the analytical procedures and the findings being merely a collection of 
personal opinions subject to researcher bias (Rolfe 2006). Nonetheless, the criteria of reliability 
and validity that apply to quantitative research are not suitable for qualitative methods (Yardley 
2008). On the other hand, qualitative methods explore individuals’ opinions, attitudes and 
experiences in different contexts and individuals’ differences (Yardley 2008). For example, 
women may give different descriptions of the severity of mammography pain when questioned 
by different people, such as family members or health professionals. This suggests that people 
may produce diverse replies to the same subject in different contexts. Hence, the criteria of 
reliability do not fit most of the qualitative studies. 
 
Some researchers argue that it is the pragmatic nature of mixed methods that enables this method 
to achieve multiple goals, such as explanation, confirmation and triangulation in explaining 
complex social constructs (Caruth 2013; Teddlie and Tashakkori 2012). Hence, a mixed 
methods design was employed in this research to obtain both breadth and depth about the topic 
under investigation, and to identify relationships between variables and the meanings of specific 
social phenomena, as these will be determined and explored for the first time. Therefore, a mixed 
methods approach would increase this research’s strength by enabling investigation of the 
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problem from various perspectives (Driscoll et al. 2007), thereby providing more 
comprehensive answers to the RQs. 
 
3.3.3.1 Step 1 of IM 
Primarily, the scoping review of the literature (Chapter 2) and the results of Studies 1-5 (Chapter 
4) in this thesis fulfilled the needs assessment (Step 1) of IM, and then fed into steps two and 
three (Chapters 5-8) of the IM process. These methods were considered sufficiently flexible to 
answer the RQs of each study in this research. The starting point for needs assessment was to 
review the literature to recognise BS determinants (Chapter 2). This literature review was used 
to design a quantitative instrument and qualitative topic guides that provided information to 
appraise factors that have an impact on BS behaviour in Malta. The quantitative instrument, a 
survey questionnaire, was translated by four expert translators and adapted by a panel of twelve 
experts to ascertain content validity and clinically meaningful content. The questionnaire was 
pilot-tested with six Maltese asymptomatic women and then tested for reliability through face-
to-face interviews with fifteen bilingual women, thus meeting RQ 1 (Study 1).  
 
Study 1 was followed by quantitative studies 2-5 (Chapter 4). The latter studies included a 
national, retrospective, cross-sectional survey among Maltese women to investigate first 
screening uptake at the MBSP (Study 2), a prospective study on re-attendance at the MBSP 
(Study 3), and retrospective studies on lifetime mammography use (Study 4) and timely 
screening adherence (Study 5), thus meeting RQ 2.  
 
A cross-sectional study is particularly suitable for estimating the prevalence of a behaviour or 
disease in a population (Sedgwick 2014) and can be used to capture information based on data 
obtained at a single point in time (Levin 2006). However, cross-sectional surveys cannot be used 
to analyse behaviour over a period of time. The data gathered are from a sample of participants 
with varied characteristics and demographics. Cross-sectional studies are generally quick, easy, 
and cheap to perform and are often based on a questionnaire survey. Participants are not lost to 
follow-up because they are interviewed only once. Therefore, a cross-sectional survey was 
considered as the most appropriate method to: 1) identify the main reasons for non-attendance 
to mammography; 2) gather data on women’s sociodemographic factors, health status, 
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knowledge, health beliefs and illness perceptions about BC and BS, and 3) to determine the 
associations and significant predictors to mammography practices.  
 
3.3.3.2 Step 2 of IM 
Step 2 aimed to address RQ 3 by determining the key components, techniques and the basic fit 
of a future intervention and its mechanisms. This step was supported by a systematic review 
(Chapter 5, Study 6) and two expert steering groups - one carried out in Scotland and one in 
Malta (Chapter 6).  
 
Systematic review 
The systematic review was conducted to gain an understanding of effective interventions to 
increase BS attendance. A systematic review involves a detailed and comprehensive plan and 
search strategy derived a priori to identify relevant research to specific RQs, and appraise and 
synthesize all relevant studies through systematic and explicit, accountable methods (Gough et 
al. 2012). This provides reliable research evidence for decision-makers (Centre for Reviews and 
Dissemination 2009). The data gathered from the systematic review informed this research on 
which interventions could be replicated for the Maltese population.  
 
Expert steering groups 
All intervention development should be based on broad participation of community members 
and through development of a working group, best composed of stakeholders who have an 
interest in the health problem, the intervention or its outcome (Bartholomew et al. 2006; Yoo et 
al. 2004). The development of this linkage system should begin early, optimally in project-
funding development and needs assessment (Bartholomew et al., 2006). The aim of the Scottish 
steering group (SSG) was to identify factors associated with BS behaviour, and formulate 
Performance Objectives (POs) i.e. statements of what a woman will do (preparatory behaviour) 
(Dalum et al. 2012) or how the BS behaviour will be modified, including who will create the 
change. Another aim was to formulate Change Objectives (COs) (i.e. specific intervention 
objectives or the specifications of what needs to change in the determinants of BS behaviour in 
order to accomplish the POs) (Bartholomew et al. 2006).  
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On the other hand, the purpose of the Maltese steering group (MSG) was to suggest practical 
and suitable strategies for the intervention population and its context. Basic fit is an initial 
assessment of how well an intervention tested in a specific setting might fit the needs and 
resources in another context (Highfield et al. 2015). The MSG helped to link COs to practical 
strategies i.e. specific techniques derived from theoretical methods for behaviour change to fit 
the intervention population and context in which the intervention will be conducted 
(Bartholomew et al. 2006). Ultimately, this helped to reveal the specific knowledge and actions 
that BS non-attendees need to learn and perform to change their screening behaviour. 
 
3.3.3.3 Step 3 of IM 
The third IM step was to identify suitable strategies in changing BS determinants and to translate 
these into practical applications (Suzuki et al. 2012), considering whether each strategy was 
appropriate in the Maltese context. In IM, it is advisable to involve the target group, as this is 
perceived as effective in increasing BS uptake and in developing interventions. Hence, Step 3 
of IM included patient and public involvement (PPI) through the World Café method (Chapter 
7) and face-to-face interviews with non-attendees (Chapter 8, Study 7). Qualitative research 
conducted in people’s natural social setting helped to provide a holistic picture of potential 
effective interventions and detailed participant views and enabled ‘deeper understanding of 
people, their perception and events’ (Bowling 2009, p.433), thus meeting RQ 4. A semi-
structured topic guide that was reviewed by other researchers and pilot-tested with two women, 
was used during face-to-face interviews (Chapter 8, Study 7).  
 
3.4 Chapter summary 
The aim of Chapter 3 was to describe and evaluate the methodology of this thesis. A description 
and outline of the IM approach was provided to identify and measure the determinants to BS 
uptake with the aim of developing a future intervention that has potential to increase BS uptake 
among Maltese women. A mixed methods approach was chosen for data collection, analysis 
and synthesis of results in this thesis. This involved a scoping review of the literature on barriers 
and facilitators to BS, tool translation, adaptation and pilot-testing, a national retrospective 
cross-sectional survey, a prospective quantitative study and retrospective studies on lifetime 
mammography use and timely screening adherence respectively. The quantitative studies were 
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followed by a systematic review of interventions, the involvement of expert steering groups and 
members of the public, and qualitative face-to-face interviews. All of these were based on the 
stepwise IM framework that describes an iterative path from the identification of gaps to 
problem solving. The following chapter presents the findings of the five quantitative studies. 
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Chapter 4 
 
Study 1: Maltese Translation and Adaptation of 
Champion’s Health Belief Model Scale and the 
Revised Illness Perception Questionnaire for Breast 
Screening among Maltese women1 
 
 
 
 
 
 
 
 
 
1 A version of this chapter has been published in the Journal of Nursing Measurement (Appendix 4.1.1) (Marmarà 
et al. 2017a).  
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4.1 Introduction 
As outlined in Chapter 2, breast screening (BS) uptake is influenced by a multitude of factors 
(Mamdouh et al. 2014). In particular, studies have demonstrated that beliefs about breast cancer 
(BC) and BS (Huaman et al. 2011) as well as illness perceptions (Anagnostopoulos et al. 2012) 
are important predictors of mammography compliance. However, little is known why Maltese 
women are less likely to have a screening mammogram than their European counterparts. This 
is because a gap exists in the understanding of factors impacting Maltese women’s decisions to 
undergo BS, partly due to the lack of instruments locally validated for this aim. The instruments 
chosen for translation and adaptation were selected from the extant literature, which shows that 
health beliefs and illness perceptions are key determinants of BS behaviour (Anagnostopoulos 
et al. 2012; Champion et al. 2008; Moss-Morris et al. 2002).  
 
4.1.1   Conceptual framework 
4.1.1.1 History and development of the Champion’s Health Belief Model Scale 
(CHBMS) 
The Health Belief Model (HBM), developed in the early 1950s, comprises its six fundamental 
constructs: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, 
cues to action, and self-efficacy (Jahanlou et al. 2013). Champion developed and validated a 
scale in 1984 (Champion’s Health Belief Model Scale - CHBMS), consisting of 36 items to 
measure perceived susceptibility to BC, perceived benefits and barriers to BS (Champion 1984). 
In 1999, Champion revised CHBMS for mammography screening (CHBMS-MS), excluding 
the breast self-examination used in the original studies, showing significant correlation between 
mammography compliance and high scores in the susceptibility and benefit subscales, whereas 
perceived barriers were associated with lower screening compliance (Huaman et al. 2011). This 
scale was originally validated in Indiana, US by Champion (Champion 1999) in a cohort of 804 
women aged 50 and over in a population of Caucasians (68%) and African-Americans (30%), 
accounting for 54% of the variance and showing adequate construct validity and reliability. 
Since then, Champion’s HBM scale has been tested for reliability and validity around the globe 
and translated for Iranian (Hashemian et al. 2013; Taymoori and Berry 2009), Lithuanian 
(Zelviene and Bogusevicius 2007), Malaysian (Parsa et al. 2008), Arabic (Mikhail and Petro-
Nustas 2001), Korean (Lee et al. 2002), Chinese-Australian (Kwok et al. 2010), Turkish 
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(Norman and Brain 2005; Lunt et al. 2005), African-American (Champion et al. 2008), and 
Spanish-speaking American women (Medina-Shepherd and Kleier 2010). Findings of these 
studies have provided support for the validity and reliability of these HBM-based scales. 
 
Since HBM is widely cited (Noar and Zimmerman 2005), I used Champion’s revised HBM 
scale for mammography screening (CHBMS-MS) (Champion 1999) to translate, adapt and test 
among Maltese women. HBM, however, only explains some of the variation in BS behaviour, 
such that it does not consider the impact of emotions (such as fear) (Norman and Brain 2005), 
nor does it accommodate social and environmental influences of past behaviour (Lunt et al. 
2005). This is why other models have been incorporated in studies to understand BS uptake 
(Cameron 2008). In response to HBM’s limitations, an instrument associated with the Common-
Sense Model (CSM) of self-regulation was also translated, adapted and tested.  
 
4.1.1.2 History and development of the Revised Illness Perception Questionnaire (IPQ-R)  
Leventhal and colleagues in the 1980s developed the CSM, which provides a framework for 
understanding how individual symptoms and emotions experienced during the health threat or 
diagnosis influence illness perceptions and guide subsequent coping behaviour (Diefenebach 
and Leventhal 1996). This model was later used to understand illness prevention and preventive 
behaviour intentions (Figueiras and Alves 2007).  
 
The Illness Perception Questionnaire (IPQ) (Weinman et al. 1996) was developed in light of 
self-regulation theory to provide a quantitative assessment of the five components of illness 
representations - identity, cause, timeline, consequences, and control/cure in Leventhal’s self-
regulation model (Moss-Morris et al. 2002). These five dimensions have been studied in BS 
(Anagnostopoulos et al. 2012) and colorectal screening (Orbell et al. 2008). Subsequent 
measures include the Brief Illness Perception Questionnaire (B-IPQ) (Broadbent et al. 2015), 
the Revised Illness Perception Questionnaire (IPQ-R) (Moss-Morris et al. 2002) which 
examines illness beliefs and behaviours within specific groups of patients, or groups at risk from 
an illness, and an adapted version of the Revised Illness Perception Questionnaire (IPQ-R) for 
“healthy” individuals (IPQ-RH) in recognition of the unique characteristics of asymptomatic 
populations (Figueiras and Alves 2007).  
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In order to remedy shortcomings in the original IPQ scale, the IPQ-R was developed by Moss-
Morris et al. (2002) as a more comprehensive, psychometrically acceptable, quantitative 
measure to include measures of perceptions of illness duration (‘acute/chronic timeline’), 
fluctuation in illness over time (‘cyclical timeline’), perceptions of ‘treatment control’ and 
‘personal control’ over illness, ‘illness coherence’ (how clear and comprehensive an individual 
feels her illness to be) and ‘emotional representations’ (feelings of depression, upset, anger, 
worry, and anxiety). The IPQ-R has been validated for use in diverse diseases or healthy 
populations (Chen et al. 2008) with language-specific validated measures, such as Italian 
(Giardini et al. 2007), Swedish (Brink et al. 2011), Greek (Giannousi et al. 2010), Croatian and 
Lebanese (Petrak et al. 2015) and Portuguese (Figueiras and Alves 2007) versions. However, it 
has not yet been adapted and validated for Maltese asymptomatic and/or symptomatic women. 
Hence, I adapted the IPQ-R in this study to make it appropriate for both healthy women and 
those with cancer. 
 
4.1.2 Aims and Objectives 
The aim of Study 1 was to translate and adapt existing scales i.e. Champion’s Health Belief 
Model Scale for mammography screening (CHBMS-MS) and the Illness Perception 
Questionnaire (IPQ-R) from English to Maltese (CHBMS-MS-M + IPQ-R-M = Maltese Breast 
Screening Questionnaire [MBSQ]) so that these could subsequently be used to examine why 
women in Malta attend/do not attend BS when invited. In reaching this aim and to address RQ 
1, Is the adapted tool i.e. MBSQ valid and reliable?, the analysis has targeted the following 
objective: 
(i) To pilot test the reliability and validity of the English version of CHBMS-MS and 
IPQ-R and their Maltese translated version (MBSQ). 
Since the English language is an official language for the Maltese but not the national and sole 
mother-tongue language, I aimed to pre-test not only the Maltese version but also the English 
version, since some Maltese women may opt to respond in the language they prefer. 
 
4.1.3 Methods 
4.1.3.1 Data sources and study design 
The study was conducted during June 2015, as part of a larger cross-sectional study about BS 
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in Malta. The parent study was approved by the School Research Ethics Committee at the School 
of Health Sciences, University of Stirling (SREC14/15-Paper No.18v4) (Appendix 4.1.2) and 
by the Maltese Health Ethics Committee (HEC 02/2015) (Appendix 4.1.3). Permission to use 
the scales (CHBMS-MS and IPQ-R) was sought from the respective authors (Appendix 4.1.4, 
4.1.5 respectively).  
 
4.1.3.2 Sample and procedures 
Four translators were recruited for the translation pathway as follows: two translators (i.e. an 
EU translator working in Brussels who was also a bilingual native speaker of both Maltese and 
English languages, and a Maltese expert translator) translated the instrument from English to 
Maltese (steps 2-3) and two different bilingual translators (i.e. a bilingual expert from the Health 
Ministry and an expert interpreter at the University of Malta) back-translated the instrument 
from Maltese to English (step 4). An expert panel (n=12) was set up to ascertain content validity 
and to verify that the content is clinically meaningful to experts in the clinical area 
(Anagnostopoulos et al. 2012). The twelve members comprised the lead researcher for this 
study, the four expert translators/interpreters, a statistician with ten years experience in statistical 
analysis, two mammographers (Maltese and Scottish radiographers), a BS client, a BC survivor, 
a Consultant, and a Clinician.  
 
A focus group was conducted with a convenience sample of asymptomatic women (n=6) to pilot 
test the adapted Maltese version of the instrument. Three of the women were housewives (53, 
55, 58 years respectively) who had attended BS, two were public employees (59, 60 years 
respectively) who had not attended BS and the other was a retired 62-year old midwife who had 
also not attended BS when invited.  
 
A convenience sample of fifteen women (n=15) participated in structured face-to-face 
interviews in order to assess comprehensibility and suitability of the research instrument and to 
ensure understanding of all scale items in both languages. Women were recruited from the 
MBSP and were BS attendees, aged 50-60. The convenience sample was recruited because it 
was felt that such women would be interested in engaging in such a topic (Creswell and Plano 
Clark 2011), thereby giving access to a range of women with different backgrounds (Kalsta et 
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al. 2013). Women with prior history of BC or breast surgery, those who sought BC treatment as 
well as non-bilingual women were excluded. Participants were assured that they had no 
obligation to participate, that their participation was voluntary and that they could withdraw 
from the study at any time without the need to give any reason. The cover letter provided 
information to the women on how the researcher would protect their anonymity and 
confidentiality through coding (Appendix 4.1.6a, b). Following explanation on the nature of 
the research, informed consent was obtained from the participants (Appendix 4.1.7a, b). 
  
4.1.3.3 Translation and adaptation 
Figure 4.1 illustrates the pathway in which the translation and adaptation of the above scales 
was undertaken, based on published methods (Yilmaz and Sayin 2014; Champion 1999, 1984). 
 Steps 1-2: Identification of scales and forward translation 
Following the identification of validated scales by the researcher, initial translation of the 
questionnaire from English (original) to Maltese (target) languages was performed by two 
translators. This bilingual team first prepared their own translated versions; they then exchanged 
versions and finally came up with collaborative decisions about the translation.  
 Step 3: Reconciliation session 
The two experts met up with the researcher in a 'reconciliation session' in Malta and reviewed 
the translation together for inconsistencies with the original English scale and to ensure that the 
language was kept simple to be understood by Maltese women. 
 Step 4: Back translation into English  
The adequacy of the Maltese translated instrument was evaluated using the back-translation 
technique. The Maltese version was back-translated into English (original language) by another 
team of experts (i.e. not the original translators in Steps 2-3).  
 Step 5: Adaptation process 
Both language versions were examined for conceptual equivalence by the expert panel (n=12) 
(Section 4.1.3.2). The back-translation and original English instrument version were compared 
with attention given to grammar and the meaning conveyed by the words. In this ‘adaptation’ 
process, cultural and social characteristics of the translation are protected as much as possible 
(Kulis et al. 2011). 
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Figure 4.1 - Translation, adaptation, face and content validity (MBSQ pathway) 
 
 
CHBMS-MS + IPQ-R 
Target document 1 
Step 1: Identification of English validated 
scales (Original versions: v1)  
Step 2: Forward translation from English to 
Maltese by 2 translators (v2) 
Forward translation  
(Translator 2) 
Forward translation 
(Translator 1) 
Step 3: Reconciliation meeting to decide on one 
translated version (v3) 
 
Reconciliation session (translators – researcher) 
Target document 3 
Step 4: Back translation of reconciled version 
from Maltese to English (2 translators) (v4) Back translation by Translators 3&4 
Step 5: Adaptation process: Both language 
versions examined for conceptual equivalence 
(v5) 
Comparison of versions by Expert panel  
Step 6: Face validity testing with target 
population to check that the translation of v5 
(Maltese version) and v1 (English version) are 
equivalent (v6) 
Pre-testing with target population (focus group 
of 6 women) 
Target document 6 
Step 7: Reconciliation session – Comparison of 
latest versions in a meeting between researcher 
and 2 professional translators (v7) 
Step 8: Proof reading and final Maltese version 
produced (Maltese Breast Screening 
Questionnaire: MBSQ v8) 
Final version 8 
(CHBMS-MS-M + IPQ-R-M = MBSQ) 
 
Reconciliation session (researcher + translators 1&4) 
Proof reading  
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 Step 6: Face validity testing  
A focus group was conducted with a convenience sample of asymptomatic women (n=6) to pilot 
test the adapted Maltese instrument version. This cognitive debriefing procedure (Wild et al. 
2005) was followed to ascertain face validity of the instrument, to ensure clarity and 
comprehensibility of the items, to highlight inappropriate items or response options, and to 
identify and test translation modifications. This ensures that conceptual equivalence and cultural 
appropriateness are achieved (Anagnostopoulos et al. 2012). This group of screened/non-
screened women tested the instrument’s face validity and determined its cultural appropriateness 
and the accuracy of the translation, similar to the undertaken Turkish process (Yilmaz and Sayin 
2014). The researcher read the translated text aloud to the participants, following which each 
item was scored on a five-point scale.  
 Step 7: Reconciliation session 
The scales were modified in a 'reconciliation session', where two translators met up with the 
researcher in Malta to review the final version so that it could be administered by an interviewer. 
 Step 8: Proof reading 
Following proof reading, the final Maltese version was produced (MBSQ). The following 
procedures were used to test the MBSQ. 
 
4.1.3.4 Test-retest reliability 
The final version (MBSQ) from step 8 was then tested for reliability (step 9). An estimation of 
stability is commonly assessed by a test-retest reliability analysis, where the questionnaire is 
given to the same person or set of respondents, in the same way, on two different occasions, 
usually with an interval of two to six weeks (Yilmaz and Sayin, 2014). In this study, a 
convenience sample of 15 bilingual women, aged 50-60, were recruited by the researcher from 
the MBSP to assess test-retest reliability of the Maltese and English subscales respectively. 
Participants responded to the questionnaire through face-to-face interviews on two occasions 
separated by a two-week interval, a test-retest period considered appropriate (Streiner et al. 
2008). These women were contacted by a research assistant and two convenient times were 
arranged with each participant. The interviews were conducted in the participants' homes. 
Participants were informed that they were free to choose only one language. However, all 
participants were willing to complete the survey in both languages and opted to respond to the 
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questionnaire first in Maltese followed by the English language at both time points (Day 1, Day 
14) to test and re-test for stability and reliability of responses in the same language. The scores 
were then correlated.  
 
4.1.3.5 Instrument scoring 
Items were answered on a five-point Likert scale ranging from 1 (strongly disagree) to 5 
(strongly agree), similarly used in other studies (Yilmaz and Sayin 2014; Anagnostopoulos et 
al. 2012; Huaman et al. 2011). Possible score ranges included: 3-15 for susceptibility, personal 
control, treatment control and emotional representations respectively; 6-30 for benefits; 13-65 
for barriers; 7-35 for cues to action and self-efficacy; 8-40 for BC identity and consequences; 
18-90 for the causal scale, 2-10 for acute/chronic timeline and illness coherence, and 1-5 for 
cyclical timeline. Higher scores indicated stronger agreement. 
 
4.1.3.6 Approaches to reliability and validity assessments 
Reliability was evaluated by Cronbach’s alpha (α) for internal consistency (reliability) and test-
retest correlation. In terms of reliability, lower values indicate no internal consistency of the 
tool (0.00 ≤ α ˂ 0.40 not reliable, 0.40 ≤ α ˂ 0.60 low reliability, 0.60 ≤ α < 0.80 high reliability, 
0.80 ≤ α ˂ 1 very high reliability) (Yilmaz and Sayin 2014; Buyukozturk 2012; Tekindal 2009). 
If Cronbach’s alpha score is low, then the corrected item-total correlations for values of <0.30 
are considered (minimum acceptable item-total correlation is 0.30) (Yilmaz and Sayin 2014). 
Such low values might be considered satisfactory if item deletion does not improve the overall 
alpha value (Buyukozturk 2012). Test-retest scores for each dimension were computed for the 
Maltese and English measures respectively using Pearson’s correlations at both time points 
(T1, T2) for an estimation of reliability over time. Test-retest reliability refers to the correlation 
coefficient which should be at least 0.6 (Buyukozturk 2012; Huaman et al. 2011). Construct 
validity, a measure that confirms the extent to which inferences can be made from scale scores 
in relation to the theoretical construct of interest (Pruitt et al. 2010), was supported through 
Pearson’s correlations to test the associations between subscales for each measure. Quantitative 
data analysis was performed using the Statistical Package for Social Sciences (SPSS® software) 
Version 21.0. 
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4.1.4 Results 
4.1.4.1 Translation and adaptation 
Four queries of subcultural word comprehension were raised by the bilingual translators, which 
required consensus. The term ‘breast lumps’ in the original instrument was translated to ‘boċoċ 
f’sidrek’. The second controversial term was ‘mammogram’, for which two panel members 
argued that some women in the target population may not be aware of early diagnostic breast 
examinations. Although ‘mammografija’ in the translated instrument was acceptable, the 
general known term was ‘mammogram’. Following this debate, the panel decided that both 
words were suitable and could be used interchangeably (i.e. mammogram, mammografija). A 
third controversial term was ‘thickening of the breast’. Following discussion, the panel decided 
on the phrase ‘ħxuna tat-tessuti tas-sider’. Another word discussed by all group members was 
‘nipple’. Several controversaries arose on whether to use the word ‘nipple’ as is, ‘nippla’ or the 
pure technical phrase ‘ras il-biżla’. Most members argued that some women in the target 
population are not aware of the technical phrase but are familiar with the English term. This was 
then literally translated to ‘nipil’.  
 
Since most women perceive BC as a serious threat (Lagerlund et al. 2000), it was decided that 
the construct ‘perceived severity’ would not be measured using HBM, similarly in 
Anagnostopoulos et al. (2012). Further removal of this item in the HBM scale would also avoid 
duplication since BC severity was addressed in the IPQ-R scale. Moreover, since the use of both 
HBM and CSM often fail to address contextual constraints such as low income and education 
level that may influence women’s screening behaviour, socio-demographic and socio-economic 
factors, as well as lifetime mammography use were added because of the acknowledgement of 
their contributions as BS determinants (Anagnostopoulos et al. 2012; Jepson et al. 2000). The 
panel further added cues to action (such as physician recommendations and family history) 
which are often omitted from empirical studies through HBM use (Anagnostopoulos et al. 
2012). Finally, based on these conclusions, the original instrument version consisted of 124 
items and was presented to the focus group (n=6) for testing. 
 
4.1.4.2 Face Validity 
From the original 50-item IPQ-R, two-items were removed from the cancer timeline domain 
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(‘BC will last for a long time’; ‘I expect to have BC for the rest of my life’) as they were found 
to confuse women and cause consistent heightened anxiety in responders, resulting in a 48-item 
Maltese (M) version (entitled IPQ-R-M). Participants were asked to report their personal views 
about BC rather than their perceptions of an illness personally affecting them. For example: ‘My 
illness has serious economic and financial consequences’ was replaced with ‘BC has serious 
economic and financial consequences’. The IPQ-R risk factors domain title were also amended 
to read ‘risk/lifestyle factors’, while the sections ‘personal’ and ‘treatment’ control were 
categorized under the heading ‘Curability/Controllability’. For the lifetime mammography use 
domain, 1 item was deleted to avoid overlap (‘a mammogram prior to BS invitation’ yes/no). 
Hence, the final Maltese instrument (MBSQ), comprising the Maltese (M) scales CHBMS-MS-
M and IPQ-R-M, consisted of 121-items that were clustered into: 
1) 11 subscales for socio-demographic and health status (20 items) related to age, residing 
district, education, employment, marital status, family income, car ownership/driving, 
illness/disability, having a GP, breast condition, family history of BC or other cancer. 
Response options were "yes", "no" or a series of tick boxes. Open questions were asked 
when it was believed to be important that women could provide further detail, e.g., type of 
illness, breast condition or cancer site.  
2) 4 subscales for lifetime BS practices (17 items), that were clustered into: lifetime 
mammography use (4 items), attendance/non-attendance to first round screening (8 items), 
re-attendance/intention (4 items), knowledge about recommended screening frequency (1 
item). Most of the response options were mostly designed to elicit "yes", "no" or "unsure" 
answers. Closed questions allowed women to respond to a series of tick boxes. 
3) 5 subscales (psychosocial constructs) for health beliefs (36 items) that were clustered into: 
perceived susceptibility (3 items), perceived benefits (6 items), perceived barriers (13 
items), cues to action (7 items) and self-efficacy (7 items). All items had 5 response options 
ranging from: 1 = ‘strongly disagree’ to 5 = ‘strongly agree’. Reverse scoring (r) was 
performed for only one item, ‘There is no possibility of getting BC’, so that higher values 
would indicate greater possibility. 
4) 7 subscales (psychosocial constructs) for illness perceptions (48 items) that were clustered 
into: BC identity (8 items), causal scale (18 items), cancer timeline: acute/chronic (2 items), 
cyclical (1 item), consequences (8 items), curability/controllability (personal control - 3 
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items; treatment control - 3 items), illness coherence (2 items), and emotional 
representations (3 items). All items had 5 response options ranging from: 1 = ‘strongly 
disagree’ to 5 = ‘strongly agree’.  
 
The above method found the instrument to be acceptable and ready for use in psychometric 
testing among the target population. Of the convenience sample of fifteen women (n=15), the 
mean age was 54.5 years ± 3.2 years (SD); 6 women were from below average income families 
(lower than €16,113), 11 women were housewives and 12 women had a secondary education 
level. 
 
4.1.4.3 Instrument Scoring 
For the scope of preliminary mean instrument scoring, the mean values at Time point 1 in 
Maltese were analysed (refer to mean Maltese T1, Table 4.1.2). Subscale scores were retrieved 
as the mean of items (following reverse scoring (r) for only one item ‘There is no possibility of 
getting BC’ in the perceived susceptibility subscale). Higher scores for health belief subscales, 
for instance, indicate more susceptibility, benefits, barriers, cues to action and self-efficacy 
(Champion 1999). Maltese women scored highest for perceived benefits and cyclical timeline, 
and lowest for perceived barriers and acute/chronic timeline.  
 
4.1.4.4 Internal consistency and correlation analysis: psychometric estimates of reliability 
Table 4.1.1 presents measures of central tendency (mean), variability (standard deviation) and 
alpha coefficients for the scales. In terms of reliability, Cronbach’s alpha value was 0.93 for 
CHBMS-MS and 0.92 for IPQ-R. Such a result in excess of 0.80 shows high internal consistency 
(reliability) (Huaman et al. 2011). Cronbach’s alpha estimations of each subscale were as 
follows: health beliefs - susceptibility (α=0.91), benefits (α=0.75), barriers (α = 0.88), cues to 
action (α=0.86), self-efficacy (α=0.90), while for illness perceptions - BC identity (α=0.92), BC 
causes (α=0.90), timeline acute/chronic (α=0.88), timeline cyclical (α=0.86), consequences 
(α=0.93), personal control (α=0.90), treatment control (α=0.90), illness coherence (α=0.86), and 
emotional representations (α=0.96). These values showed that the scale items measured similar 
features with high reliability since each dimension was expected to have an alpha of at least 0.7 
(Huaman et al. 2011). Hence, preliminary high Cronbach’s alpha values indicated internal 
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consistency for the Maltese instrument. 
 
Table 4.1.1 - Internal consistency of the subscales for the CHBMS-MS and IPQ-R scales 
 
  
Mean 
(Maltese)  SD 
Mean 
(English) SD 
Cronbach's 
alpha (Maltese 
vs English) 
Inter-item 
correlation 
(Pearson) 
Health Beliefs 3.15 1.33 3.16 1.29 0.93 0.87 
Perceived 
Susceptibility 3.04 1.24 2.88 1.22 0.91 0.83 
Perceived benefits 4.03 0.71 4.03 0.57 0.75 0.69 
Perceived barriers 1.99 1.01 2.06 1.02 0.88 0.78 
Cues to action 3.72 0.92 3.37 0.85 0.86 0.75 
Self-efficacy 4.00 1.02 4.00 1.02 0.90 0.81 
Illness Perceptions 3.20 1.19 3.20 1.19 0.92 0.85 
BC Identity 3.72 0.82 3.70 0.84 0.92 0.85 
BC Causes  2.78 1.18 2.76 1.20 0.90 0.82 
Timeline 
(Acute/Chronic) 2.58 1.09 2.70 1.12 0.88 0.79 
Timeline (Cyclical) 3.90 0.76 4.07 0.74 0.86 0.75 
Consequences 3.56 1.17 3.60 1.15 0.93 0.87 
Personal Control 3.68 0.91 3.66 0.95 0.90 0.82 
Treatment Control 3.31 1.29 3.19 1.18 0.90 0.81  
Illness Coherence 2.98 1.19 3.03 1.19 0.86 0.88 
Emotional 
Representations 3.09 1.28 3.08 1.21 0.96 0.93 
 
*The Pearson correlation test was tested against a p-value of 0.001. All Pearson correlation values were 
found to be statistically significant with a p-value ˂0.001. 
4.1.4.5 Reliability over time 
The CHBMS-MS and IPQ-R subscales demonstrated acceptable stability over a 2-week period 
for all measures. Responses were compared between time 1 (T1) and time 2 (T2) after two weeks 
for both Maltese and English versions respectively. Test-retest scores for all dimensions showed 
Pearson correlation coefficients higher than 0.6 for both languages. For test-retest reliability 
(Maltese) (Table 4.1.2), Pearson’s correlation coefficients for CHBMS-MS-M and IPQ-R-M 
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were 0.79 and 0.75 respectively. For test-retest reliability (English), Pearson’s correlation 
coefficients for CHBMS-MS and IPQ-R were 0.83 and 0.74 respectively (Table 4.1.3). Hence, 
all of the subscale items met the criteria of reliability and were retained. 
 
Table 4.1.2 - Test-retest correlations of the theoretical variables (Maltese) 
 
Mean      
(Maltese T1)  SD (T1) 
Mean 
  (Maltese T2)  SD (T2) 
Cronbach's 
alpha  
Test-retest 
correlation 
(Pearson) 
Health Beliefs 3.17 1.27 3.13 1.38 0.88 0.79 
Perceived Susceptibility 3.07 1.18 3.02 1.32 0.86 0.76 
Perceived benefits 4.06 0.73 4.00 0.70 0.71 0.62 
Perceived barriers 2.13 1.04 1.86 0.95 0.80 0.67 
Cues to action 3.69 0.96 3.76 0.87 0.77 0.63 
Self-efficacy 3.85 0.98 4.15 1.04 0.79 0.65 
Illness Perceptions 3.18 1.19 3.21 1.19 0.86 0.75  
BC Identity 3.74 0.92 3.70 0.71 0.76 0.63 
BC Causes  2.80 1.17 2.76 1.20 0.84 0.72 
Timeline 
(Acute/Chronic) 2.63 1.13 2.53 1.07 0.81 0.68 
Timeline (Cyclical) 3.93 0.70 3.87 0.83 0.83 0.71 
Consequences 3.45 1.17 3.66 1.17 0.88 0.78 
Personal Control 3.49 1.04 3.87 0.73 0.72 0.68 
Treatment Control 3.42 1.23 3.20 1.34 0.90 0.81 
Illness Coherence 2.87 1.25 3.10 1.13 0.80 0.67 
Emotional 
Representations 3.11 1.25 3.07 1.32 0.90 0.82 
 
*The Pearson correlation test was tested against a p-value of 0.001. All Pearson correlation values were 
found to be statistically significant with a p-value ˂0.001. 
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Table 4.1.3 - Test-retest correlations of the theoretical variables (English) 
 
Mean 
(English T1) SD (T1) 
Mean 
(English T2) SD (T2) 
Cronbach's 
alpha  
Test-retest 
correlation 
(Pearson) 
Health Beliefs 3.19 1.23 3.126 1.341 0.905 0.83 
Perceived Susceptibility 2.84 1.09 2.91 1.35 0.85 0.75 
Perceived benefits 4.06 0.53 4.00 0.62 0.78 0.71 
Perceived barriers 2.21 1.03 1.91 0.98 0.82 0.70 
Cues to action 3.71 0.93 3.75 0.77 0.71 0.61 
Self-efficacy 3.92 0.99 4.09 1.05 0.91 0.84 
Illness Perceptions 3.21 1.16 3.18 1.22 0.85 0.74 
BC Identity 3.73 0.90 3.68 0.78 0.87 0.78 
BC Causes  2.83 1.20 2.70 1.21 0.76 0.61 
Timeline 
(Acute/Chronic) 2.73 1.08 2.67 1.18 0.85 0.74 
Timeline (Cyclical) 4.00 0.76 4.13 0.74 0.78 0.64 
Consequences 3.58 1.06 3.62 1.23 0.83 0.72 
Personal Control 3.49 0.97 3.82 0.91 0.80 0.67 
Treatment Control 3.18 1.17 3.20 1.20 0.95 0.91 
Illness Coherence 2.97 1.13 3.10 1.27 0.90 0.82 
Emotional 
Representations 3.09 1.15 3.07 1.29 0.92 0.86 
 
*The Pearson correlation test was tested against a p-value of 0.001. All Pearson correlation values were 
found to be statistically significant with a p-value ˂0.001. 
 
4.1.4.6 Construct validity 
When applying Correlation analysis between the English and the Maltese versions (Table 4.1.1), 
the Pearson correlation values for CHBMS-MS and IPQ-R were 0.87 and 0.85 respectively. All 
correlation values exceeded 0.6, and showed a significant correlation between the items of both 
versions (p<0.001). The Pearson correlation values were tested at the 0.05 level of significance. 
 
When applying a Pearson Correlation between the two time points, the Pearson Correlation 
value was 0.778, showing a strong positive correlation between both time points. Such an 
association was found to be significantly different (p<0.001).  
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4.1.5 Discussion 
The current study focused on translating, adapting and pilot-testing the validity and reliability 
of two existing scales for use among Maltese women. It was feasible to translate and adapt these 
scales, and the translated instrument showed promise of acceptable validity and reliability. The 
high correlation values obtained are suggestive of strong validity of scale items (Heale and 
Twycross 2015). Moreover, completeness was high (100% of participants answered all 
questions), thereby indicating that the instrument was easy and simple to administer.  
 
Results of the translation and adaptation pathway and focus group analysis provided useful 
information on the understanding of items. Evidence suggests that although measures may be 
valid and reliable across diverse cultures, researchers are encouraged to modify and reword 
subscale items, taking into account cultural settings and any linguistic origins of their 
populations under exploration (Abubakari et al. 2012). This led to some items being omitted 
from the original scales because they either duplicated other items or failed to convey a clear 
expression of the intended objectives.  
   
Overall positive and high correlation of the total inter-item correlation (Pearson) was obtained 
in this study for health beliefs (0.87) and illness perceptions (0.85), and high Cronbach's alpha 
(CHBMS-MS: 0.93, IPQ-R: 0.92) denoting overall acceptable internal consistency. Moreover, 
internal consistency ranged from 0.69 to 0.83 for health beliefs. Similarly, internal consistency 
reliability ranged from 0.69 to 0.83 in Gozum and Aydin’s study (Gozum and Aydin 2004), 
from 0.64 to 0.79 in Hashemian and colleagues’ study (Hashemian et al. 2013), and was above 
0.73 for all scales in Champion’s study (Champion et al. 2008) among African-American 
women. A high consistency was observed in my study between the three perceived susceptibility 
scale items. Champion similarly reported high internal consistency of items for this subscale 
and observed a proper fit (0.82) using confirmatory factor analysis (Champion 1999). However, 
I could not confirm the subscales through confirmatory factor analysis as my reported findings 
were limited to a small sample in comparison, though the aim of Study 1 was not to elicit the 
most important factors that explain health beliefs and illness perceptions. Therefore, the findings 
can only be considered as preliminary values for the instrument’s internal consistency.  
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In this study, test-retest reliability correlations were from 0.62 to 0.76 for CHBMS-MS-M 
(Maltese) and ranged from 0.61 to 0.84 for CHBMS-MS (English). In Hashemian and 
colleagues’ study, test-retest reliability correlation ranged from 0.67 to 0.92 for health belief 
subscales, and ranged from 0.67 to 0.92 for the Persian scale version among Iranian women 
(Hashemian et al. 2013). The test-retest data for the health beliefs dimensions shows that 
perceived susceptibility and perceived benefits appear to remain the most consistent over the 
two-week period. This may suggest that women will take action to screen for, or control illness 
if they believe they are susceptible to it, especially if the illness is viewed to potentially have 
serious personal consequences, and if they believe that screening benefits outweigh the barriers 
for doing so. 
 
In Medina-Shepherd and Kleier’s study (Medina-Shepherd and Kleier 2010), test–retest 
correlations for control group women (n=20) were perceived susceptibility (Spearman’s rho: 
r=0.57), perceived benefits (r=0.63) and perceived barriers (r=0.83). In Champion’s original 
validation study in an American city (Champion 1999), test–retest scores were 0.62 
(susceptibility), 0.61 (benefits) and 0.71 (barriers). The findings of Study 1 were similarly 
significant for test-retest correlation (0.76, 0.62, 0.67 respectively for Maltese version; 0.75, 
0.71, 0.70 respectively for English version), while all five CHBMS-MS subscales showed 
similar psychometric properties to more recent findings (Yilmaz and Sayin 2014; Medina-
Shepherd and Kleier 2010). A test-retest score ˂0.80 indicates that women did not reply in the 
same way at the second time point (Yilmaz and Sayin 2014), which could mean that women did 
not read the scale items in the same way at both time points. However, according to the test-
retest results, women answered scale items similarly in both sessions, indicating that the scale 
has strong stability over time. The test-retest results in Study 1 were generally higher than those 
reported in the Medina-Shepherd and Kleier’s study (Medina-Shepherd and Kleier 2010) and 
Champion’s study (Champion 1999). This difference may be attributed to the small sample in 
this study. 
 
My preliminary findings for Cronbach's alpha coefficients were 0.91 (susceptibility), 0.88 
(barriers), 0.75 (benefits), 0.86 (cues to action) and 0.90 (self-efficacy). Similarly, Cronbach’s 
alpha coefficient for Champion’s subscales were also reported between 0.77 to 0.90 among 
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Chinese American women (Wu and Yu 2003), and were found to be equal to 0.88 (barriers) and 
0.93 (benefits) in a Malaysian study (Parsa et al. 2008), 0.89 and 0.73 respectively among 
African-American women (Champion et al. 2008) but lower (0.63 for benefits) in Medina-
Shepherd and Kleier’s study (Medina-Shepherd and Kleier 2010). Among Iranian women with 
family history of BC, Cronbach’s alpha coefficients were 0.72 (susceptibility), 0.75 
(seriousness), 0.82 (benefits) and 0.76 (barriers), though a limitation in the Iranian study is that 
all participants had a family history of BC which can be considered to guide further prevention 
and increase women’s susceptibility for this disease (Hashemian et al. 2013). A controversial 
HBM subscale is perceived barriers (ibid) because of the diverse individual and environmental 
barriers present in different communities (Park et al. 2011). However, none of the items of this 
subscale in the original version of the questionnaire were omitted because women considered 
all items to be equally important.  
 
The original IPQ-R demonstrates higher internal consistency (Cronbach’s alpha range from 0.75 
to 0.89) than the original IPQ and good test-retest reliability ranging from 0.46 to 0.88 over 
three weeks (Moss-Morris et al. 2002). In this study, the IPQ-R scale similarly demonstrated a 
relatively high degree of internal consistency (Cronbach’s alpha = 0.75–0.93), with overall 
Cronbach’s alpha ˃0.70 (α = 0.86 {Maltese} and 0.85 {English}). My test–retest data of the 
IPQ-R dimensions is homogeneous with the original IPQ and IPQ-R versions (Moss-Morris et 
al. 2002; Weinman et al. 1996) and show that the IPQ-R has acceptable stability levels over two 
weeks. Test-retest reliability (Pearson’s) correlations were computed between the IPQ-R 
completed at the two time points with correlations above 0.6 i.e. 0.63-0.82 (Maltese) and 0.61-
0.91 (English). ‘BC identity’, ‘causes’ and ‘emotional representations’ appear to remain the 
most consistent over this time period for the Maltese language. This suggests that patients 
possibly attribute a relatively high or low number of symptoms to their illness and experience a 
wide range of emotional issues. As for the English version, treatment control and emotional 
representations remain most consistent. These findings provide evidence towards the validity 
and reliability of the IPQ-R as a suitable measure of illness perceptions in the BS context. IPQ-
R dimensions prove to be useful measures on how illness 'makes sense' holistically to 
symptomatic or asymptomatic women and may play an important role in longer term adjustment 
and symptom response. The IPQ-R also allows researchers to investigate how emotional 
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representations affect coping behaviours and illness outcomes (Moss-Morris et al. 2002). 
Moreover, cognitive beliefs that the illness has severe consequences, is cyclical in nature and 
out of one’s personal control, seem to strongly affect women’s emotional responses.  
 
4.1.6 Implications 
The Maltese and English versions of the CHBMS-MS and IPQ-R can be used by nurses and 
other health care professionals as measures to assess Maltese women’s health beliefs and illness 
perceptions concerning BC and BS. Nurses have frequent patient contact in a variety of health 
care settings and are known to be valuable change agents and patient advocates (Arabi et al. 
2014). An important breast health promotion opportunity for public health nurses as well as 
physicians is raising public awareness on BC by educating women about the importance of 
screening. Likewise, health professionals can structure patient education and counselling 
sessions guided by the conceptual theoretical framework proposed in this study to ensure 
comprehensiveness of approach and content. For instance, information on BC risks, BC 
susceptibility, signs and symptoms and its consequences, as operationalised by different HBM 
and CSM constructs, can increase patients’ knowledge to improve screening use (Noar and 
Zimmerman 2005). Moreover, health providers can use the HBM and CSM to understand 
patients' needs, employing constructs of the models to guide patient interviewing. For instance, 
a BS invitation may be based on factors that influence BS behaviour such as existing perceptions 
of benefits and barriers and on psychological and social factors (Kalsta et al. 2013). Health care 
providers can therefore assess women’s level of perceived risk and target their teaching about 
health-promoting behaviours to reduce risk perception by educating women about BC risk 
factors. If women are aware they may be at risk of developing BC, they may perceive themselves 
at risk and participate in screening. Counseling may be required to increase the likelihood that 
a woman attends for screening by increasing women’s confidence. Particular focus on the BS 
appointment could provide an opportunity for targeted interventions to increase uptake, such as 
assisting women with scheduling an appointment, ensuring that guidelines and information is 
provided about the recommended intervals between mammograms and addressing the 
importance of regular screening. This will ultimately affect the quality of an individual’s life 
and reduce the allocation of resources needed to treat those who develop BC.  
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Since individuals possess multifaceted cognitive representations of various diseases (Lykins et 
al. 2008), nurses can support patients across their care pathway to explore beliefs and 
perceptions by helping them to relate personal accounts about their families, culture and their 
illness perceptions, including causal attributions for the disease (Richer and Ezer 2000). 
Achieving this may be more attainable if health care providers are knowledgeable, competent 
and feel supported in providing education and counselling in the clinical setting. This presents 
a challenge for all health care disciplines considering that health implications span the entire 
health care continuum. Furthermore, the gap in competency among health professionals includes 
lack of recognition of screening relevancy which may impact the uptake of continuing education 
in this area.  
 
To overcome these challenges, robust interventions are needed with reliable measures that can 
adequately assess the outcomes of these strategies. Validated instruments for health care 
professionals and patient assessment should be made available in clinical settings as a priority. 
With reliable measures to inform the required interventions and outcomes associated with their 
implementation, nurse-led and physician-led interventions make it possible to design cost-
effective strategies focused upon reducing disparities across diverse populations and increasing 
quality within health care systems. 
 
4.1.7 Limitations 
Although our preliminary internal consistency and test-retest reliability correlation scores were 
relatively similar or higher to those reported in prior validation studies of the CHBMS and IPQ-
R research, this study has its limitations. Firstly, the findings cannot be generalized as these are 
limited to a convenience sample. The aim was not to obtain a representative sample, but rather 
to obtain an indication of the instrument’s reliability and validity among women with varied 
backgrounds and diverse perspectives. For greater applicability, it is recommended that this 
instrument be tested among a larger sample. Secondly, recruitment of these women may have 
led to a biased sample of women with no socio-economic inequalities. It is acknowledged that 
those who participated may have been more interested in and knowledgeable about screening 
as compared with those who do not attend for screening. Thirdly, for those who participated in 
this study, the formal consent to participate sets them apart from those who would refuse such 
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an invitation. Moreover, although women were asked to express their true feelings, they may 
have responded in a way that is considered socially acceptable. Despite these limitations, the 
rigorous approach undertaken to translating and adapting the instrument provides confidence in 
the instrument’s acceptability and readiness for use to collect data from the target population.  
 
4.1.8 Conclusion 
The novel part of this study is the translation and adaptation of two scales as one instrument. 
Preliminary evidence of the psychometric properties assessment of the MBSQ shows promise 
of being a valid and reliable instrument that can be used among Maltese women to assess their 
health beliefs and illness perceptions towards BC and screening practices, and provides insights 
for the planning of effective interventions. Hence, these translated instruments were used for 
studies 2 to 5 that are described throughout chapter 4. Nonetheless, these are preliminary 
findings; further psychometric testing of these scales is recommended to include diverse 
socioeconomic strata, educational levels and geographic location. Future studies should include 
factor analyses on the current scale items using a larger sample size. Further research to measure 
women’s health beliefs and illness perceptions on BC and BS is also warranted.  
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Chapter 4 
 
Study 2: Health Beliefs, Illness Perceptions and 
Determinants of Breast Screening Uptake in Malta: 
A Cross-Sectional Survey2 
 
 
 
 
 
 
 
 
 
 
 
2A version of this chapter has been published in the BMC Public Health Journal (Appendix 4.2.1) (Marmarà et al. 
2017b).   
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4.2 Introduction 
Study 1 found preliminary evidence that the Maltese questionnaire (MBSQ) is a valid and 
reliable tool that can be utilised among Maltese women. It did not, however, explore women’s 
health beliefs and illness perceptions towards BC and BS from a national perspective. 
Understanding women’s beliefs and perceptions of BC and BS in Malta may help highlight the 
salient predictor for BS practices among Maltese women and provide potential opportunities for 
interventions to help women increase their attendance to screening. For the first time, this cross-
sectional study utilized the HBM and CSM to explore factors associated with BS uptake in 
Malta and subsequently, to identify the most important predictors to first BS uptake. 
 
4.2.1 Aims and Objectives 
The aim of Study 2 was to gain an understanding of determinants associated with uptake to first 
invitation at the MBSP, thus meeting RQ 2a: 
RQ 2a. Which significant factors (i.e. health beliefs, illness perceptions, knowledge, socio-
demographic factors and health status) are associated with BS uptake to a first invitation at the 
MBSP? 
 
In reaching this RQ, this analysis has targeted the following objectives:  
1. To describe Maltese women’s knowledge, health beliefs and illness perceptions about 
BC and screening; 
2. To identify the main reasons related to non-attendance at the MBSP; 
3. To determine if health beliefs, illness perceptions, knowledge, socio-demographic 
factors and health status are associated with uptake to a first MBSP invitation; 
4. To determine significant predictors to a first BS invitation. 
 
‘Strengthening the Reporting of Observational Studies in Epidemiology’ (STROBE) guidelines 
(von Elm et al. 2007) (Appendix 4.2.2), have been used to present the findings in this study. It 
was hypothesized that there would be significant associations between health beliefs and illness 
perceptions, knowledge, socio-demographic factors, health status, and BS uptake. 
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4.2.2 Methods 
4.2.2.1 Study design 
A cross-sectional survey of women’s uptake of first MBSP invitation was undertaken by 
telephone through the use of validated tools (Study 1) to measure women’s health beliefs, illness 
perceptions, knowledge of BC and BS, socio-demographic factors and health status. 
 
4.2.2.2 Setting 
The study was carried out in Malta between June 2015 and September 2015. Since there is only 
one public screening centre (no mobile units), located in Malta’s capital city, Valletta, all data 
was generated from one computerized screening database and women were contacted from the 
centre. 
 
4.2.2.3 Participants 
The inclusion criteria were: women aged 50-60 at the time of their first screening invitation, 
residents in Malta or Gozo with a valid identity card number, able to communicate in English 
or Maltese, and with no severe co-morbidities. Women were excluded if they had been 
diagnosed with BC (n=200), if they were invited to the second screening cycle (n=12,210), if 
registered as deceased at the time of the sample selection (n=71) and if incorrect information 
existed at the MBSP (n=209) (Figure 4.2).  
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Figure 4.2 - Participant pathway and sampling flowchart (based on STROBE guidelines) 
 
Unreachable 1st attempt = 53 
 
Reachable on 1st attempt = 351 
     Introduction - 3 min 
     Obtain Verbal consent - 2 min 
     Completion time – 20 min 
Step 4: 
Analysis 
Day 120 
Data Cleaning 
Analysed (n=404) 
Assessed for eligibility  
(n = 36,151) 
Drop-out (n=48) due to: 
 Withdrawal from survey (n=4) 
 Ineligibility - due to BC (n=18) 
 Ineligibility - due to 2nd invite (n=16) 
 
n=48 replaced by RA through stratification 
 
Responded to full 
questionnaire (n=404) 
Agreed to consent and 
commenced survey (n=404) 
Step 1:  
Data provided  
(MBSP) 
Stratified Random Sampling 
by age, district, 
attendance/non-attendance  
(Target sample: 404 women) 
 
Information 
Letter sent by post 
 (RA)  
Day 0 – Day 7 
 
Step 2: 
Recruitment  
Via telephone 
Day 0 – Day 7 
(by Research 
Assistant, RA) 
Replaced (n=45) by stratification 
TOTAL: n = 449 contacts by RA  (404 + 45) 
 
 
Agreed to participate  in 
survey (n=359) 
Refused to participate (n=45) 
TOTAL: n = 404 
 
 
 
Client is at home 
(n=220) 
Client is not home 
(n=23) 
2 or more attempts on different 
times (n=53) 
Reachable on 2nd or 3rd attempt 
(n=33) 
Unreachable and replaced (n=20) 
Client is at home 
(n=131) 
Client is not 
home (n=30) 
 
Randomly selected non-
attendees (n=161) 
Randomly selected 
attendees (n=243) 
Step 3:  
Data Collection 
Telephone Survey 
(Researcher)  
Minimum Day 7 – 
Maximum Day 21 
Not meeting inclusion criteria (n=12,690):  
 Had BC in 1st cycle (n=200) 
 Other reasons  
 Died (n=71) 
 Incorrect contact information (n=209) 
 Invited for 2nd cycle at the time of sample 
selection (n = 12,210) 
Target population (n = 48,841) 
Random Number Generator 
in excel sheet by MBSP staff 
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4.2.2.4 Sample size and sampling technique 
According to the MBSP, the target population was estimated to be 48,841 women who were 
invited during the first screening cycle (Maltatoday 2013). Following the exclusion of subjects 
(numbers in parentheses) in the sampling flowchart (Figure 4.2), the eligible population was 
calculated to be equal to 36,151 women. A sample size of 404 women was determined using a 
95% confidence level and a 5% confidence interval through the sample size equations. This 
level of confidence is the typical estimation of the level of precision used in similar surveys 
(Taherdoost 2017). In order to ensure that the sample was nationally representative of the 
screening population and to decrease the margin of error in the estimation, women were selected 
by a stratified random sampling technique, employed by strata i.e. district (geographical 
distribution), age and attendance/non-attendance to the first BS invitation (Step 1). In order to 
obtain the target sample size (n=404), the following number of attendees and non-attendees were 
randomly selected through a random number generator as follows: n = 243 attendees (women’s 
reasons for attendance may provide a better insight to why people do not turn up for BS), and n 
= 161 non-attendees (this is representative of the actual population as 58.7% of those invited 
accepted their first invitation) (Marmarà et al. 2015). Three hundred and fifty one women from 
the target sample of 404 women were reached by the research assistant (RA) on her first 
telephone contact attempt (Step 2). Those who were unreachable were recontacted for two or 
more attempts on different times. If they remained unreachable, women were replaced by the 
RA, based on the random sampling technique adopted for this study via stratification. Three 
hundred and fifty nine women agreed to participate in the survey, while forty five women 
refused participation in this study. These 45 women were free to provide their own reason for 
non-participation in the study, following which content analysis of their open-ended comments 
on reasons for refusal was employed and later categorised and classified as being one of two 
reported reasons (i.e. lack of time due to work and family; fearful to speak about the topic under 
investigation). Women’s comments were typical reasons for refusals in similar studies (Menold 
and Zuell 2010). Hence, all 45 women were replaced by RA, once again based on the random 
sampling technique adopted through stratification so that all replacements were carried out in a 
way so as not to lose any of the sample representativeness of the population. Due to women’s 
refused participation, 449 women were eventually contacted by RA in order to reach the 
necessary quota for each strata (404/449 = 90% response rate). Hence, the required total sample 
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of 404 women was collected and passed on to the researcher to commence data collection (Step 
3). Upon contact by the researcher, 48 women from the target sample of 404 women dropped 
out since they either withdrew from the study or were found to be ineligible during the telephone 
survey. These 48 women were therefore replaced by RA by resorting to the original sample to 
be stratified with the same demographics of the non-respondent (i.e. according to age, district 
and attendance/non-attendance to the MBSP). Step 4 included an analysis of the replies of the 
404 women. 
 
4.2.2.5 Data collection 
The participant recruitment pathway is presented in Figure 4.2. Participants were recruited by 
telephone, by a trained research assistant who requested initial verbal consent. If the client 
agreed to participate, a brief explanation of the study was provided by telephone. Thereafter, a 
written information letter was posted to women on that same day. Hence, women received pre-
notification letters to further inform the participant about the study’s aims and objectives, thus 
allowing participants adequate time to read the information letter before further contact 
(Appendix 4.1.6a, b). Those who refused participation were deemed to have refused consent 
and were not contacted further. Scheduled appointments were set at women’s most convenient 
date and time (in around 7 days from first call) so that participants would not to be caught ‘off-
guard’ when contacted, and also so that the researcher could conduct a telephone survey which 
was the chosen, feasible method for this study. Telephone surveys have also been utilised 
successfully in the extant literature (Chambers et al. 2014; Hersch et al. 2014). In cases of non-
response, three call-backs were performed on different occasions, following which the 
researcher moved on to contact other women.  
 
Respondents were assured that all the collected information would be processed anonymously 
and confidentially. They were also informed that they could refuse to answer any question or 
decline participation at any point. For those participants who affirmed they were willing to 
respond, verbal informed consent was obtained by telephone through the use of standard 
procedures and guidelines (Sturges and Hanrahan 2004). Verbal consent is common practice 
when conducting survey interviews or interventions by telephone (Chambers et al. 2014; Hersch 
et al. 2014; Fair et al. 2012) and was chosen because it facilitates comprehension of study 
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objectives and questionnaire items, and reduces the unnecessary burden entailed in a written 
consent form (Hersch et al. 2014). Participant recruitment by the research assistant was done 
manually, using paper format to record verbal consent by ticking Yes/No and to schedule 
appointments for the participants and the primary investigator (DM) (Appendix 4.2.3a, b). The 
telephone survey was carried out by a single researcher (DM) and data entry was carried out 
(DM) through the use of computer-assisted technology through an online tool (the 
SurveyMonkey program). Subsequently, the data were downloaded by the primary investigator 
(DM) from the same program. Minor formatting adjustments were made to the raw aggregate 
data in Microsoft Excel, and then the data were exported into SPSS®. This method of handling 
data significantly decreased human error in the data entry process. This procedure of data 
storage and handling was secure, ensuring confidentiality of information provided by 
participants.  
 
4.2.2.6 Measures 
The MBSQ was used in this cross-sectional study. Further details on the 121-item questionnaire 
can be found in section 4.1.4.2. 
 
4.2.2.7 Ethical considerations 
As discussed in Study 1, ethics approval was obtained from SREC (Appendix 4.1.2) and HEC 
(Appendix 4.1.3). Following approvals, data were obtained from the MBSP and was computer 
generated from the screening register.  
 
4.2.2.8 Variable definitions 
A first invitation was defined as the first (initial) time a woman is invited to the MBSP and 
either attends or does not attend for the screening mammogram. Modifying factors include 
socio-demographic and health status variables (some of which were confirmed from women’s 
health records from the screening database), and structural variables such as knowledge of 
screening frequency and of the disease. These variables were collected from the survey 
administered retrospectively from the time of the first screening invitation.  
 
 
95 
 
4.2.2.9 Data analysis 
Data entry and statistical analysis were performed using SPSS® version 21.0 under direct 
guidance of an expert statistician. Descriptive and inferential statistics, such as percentages, 
frequencies, means, standard deviations and confidence intervals, were used to present basic 
statistics in relation to socio-demographics, knowledge, health beliefs and illness perception 
variables. Tests for associations (Chi-square test: to determine significant associations between 
one categorical variable and another) were applied to investigate the associations of health 
beliefs, illness representations, knowledge, socio-demographic factors and health status with 
uptake to MBSP. Binary logistic regression modelling, using the “Backward-elimination” 
method, was performed to identify the significant predictors for BS uptake. The unstandardized 
coefficients, standard error, the Wald value, p-values, Odds Ratios (ORs) and 95% confidence 
intervals (95% CIs) were calculated for each logistic regression model. The level of accuracy 
was included in the final outcome of the model. Missing data was minimal and reported in Table 
4.2.1. Statistical significance was established at p < 0.05 for all analyses. 
 
4.2.2.10 Piloting the data collection method 
A pilot study was conducted with a random sample of 15 women of different age groups to 
assess the practicalities of conducting the tool by telephone. In order to reduce bias, a random 
selection of participants was computer generated from the computerized MBSP database; hence, 
attendance for first round screening was ascertained from programme records. A similar 
approach to the larger study for ‘selection’ and ‘recruitment’ was undertaken as in the participant 
pathway (Figure 4.2). These women were contacted by a research assistant and those who 
agreed to participate were introduced to the researcher. A convenient time was arranged with 
each participant in order for the researcher to conduct the pilot survey by telephone. Verbal 
informed consent was sought from all 15 participants. The results from the pilot study showed 
that the tool was practical and feasible to conduct by telephone and that no methodological 
changes were required. Women participating in the pilot study were not included in the larger 
study. The time for scale completion had a median of 25 minutes (range, 15 – 45 minutes). 
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4.2.3 Results 
4.2.3.1 Sample characteristics  
The sample characteristics (n=404) are presented in Table 4.2.1. Women were aged between 50 
to 60 years at the time of the programme’s first screening round, with a mean age of 54.6 years 
± 2.8 years (SD). The majority were married (86.9%, n=351), housewives (77%, n=311), had 
up to a secondary education level (75.7%, n=306) and more than half (60.3%, n=244) were from 
below average income families (lower than €16,113). Although the majority owned a family car 
(83.7%, n=338), only 43.8% (n=177) could drive. An illness, disability or condition was 
reported by 45.8% of women (n=185) and 2.5% (n=10) had cancer (other than BC).  
 
Furthermore, 81.7% (n=330) had relatives or close friends with cancer (6.7% (mother with BC) 
and 21.3% (close friend with BC)). The majority (93.3%, n=377) reported having a named 
family physician (GP); however, 88.6% (n=358) of the total sample visited a GP only when they 
had a problem. Furthermore, nearly 70% of women in this study reported that they were not 
encouraged by their GP to attend to BS. 
 
Table 4.2.1 - Sample Characteristics (n = 404) 
Characteristics Mean SD N % 
Age (year)         
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60     
20 
45 
42 
48 
56 
44 
29 
44 
27 
37 
12 
5.0 
11.1 
10.4 
11.9 
13.9 
10.9 
7.2 
10.9 
6.7 
9.2 
3.0 
 54.62 2.79     
Education level         
No schooling     1 0.3 
Primary level     67 16.6 
Secondary level     306 75.7 
Tertiary level     30 7.4 
Occupation         
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Pensioner     5 1.2 
Housewife     311 77.0 
Employee     88 21.8 
Status         
Single     16 4.0 
Married     351 86.9 
Separated/Divorced     13 3.2 
Widowed     24 5.9 
Family income         
Less than €10,737     102 25.3 
€10,737 – €16,113     142 35.2 
€16,114 – €23,563     20 5.0 
€23,564 – €33,966     14 3.5 
Greater than €33,966     1 0.3 
Prefer not to say     125 30.9 
Own a car         
Yes     338 83.7 
No     66 16.3 
Drive         
Yes     177 43.8 
No     227 56.2 
Any illness, disability or condition         
Yes     185 45.8 
No     219 54.2 
Family physician (GP)         
Yes     377 93.3 
No     27 6.7 
Frequency of GP visit         
Only when I have a problem     358 88.6 
Once a month     6 1.5 
More than once a year     16 4.0 
Once a year     1 0.2 
Missing     23 5.7 
Lumpy breasts         
Yes     30 7.4 
No     374 92.6 
Relatives or close friends had cancer         
Yes     330 81.7 
No     68 16.8 
Prefer not to say     6 1.5 
4.2.3.2 Knowledge of breast screening frequency and breast cancer 
The majority of women were knowledgeable of the recommended screening frequency to 
varying degrees (Table 4.2.2): 46.3% (n=187) indicated yearly mammograms; 3.7% (n=15): 
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every 1.5 years; 43.3% (n=175): every 2-3 years; 6.2% (n=25) were unsure. BC identity scores 
were reported by above 80% of women for the majority of the sub-scale items (7 out of 8 items) 
(Table 4.2.3). However, there was wide variation for knowledge of BC causes and risk factors 
among Maltese women (Table 4.2.3). Hereditary predisposition to the disease was the most 
commonly reported risk factor, followed by smoking, altered immunity and pollution. 
Misconceptions concerning risk factors of BC were found (e.g. a germ or virus (38.6% ‘agree’, 
30.7% ‘disagree’; accident or injury (47.5% ‘agree’; 39.1% ‘disagree’)).  
 
Table 4.2.2 - Women’s Knowledge of breast screening frequency (n = 404) 
      n % 
Knowledge about recommended BS 
frequency 
    
Every year     187 46.3 
Every year and a half     15 3.7 
Every 2-3 years     175 43.3 
Every 4-5 years     2 0.5 
Unsure     25 6.2 
 
Table 4.2.3 - Women’s Knowledge on breast cancer identity and causes (n = 404) 
Breast cancer identity scores, n (%) 
  
  
Disagree/Strongly 
Disagree 
Undecided 
Agree/Strongly 
Agree 
The presence of a lump or 
thickening in the breast   
5 (1.2) 26 (6.4) 373 (92.3) 
Nipple discharge   3 (0.7) 54 (13.4) 347 (85.9) 
Sudden nipple retraction   2 (0.5) 64 (15.8) 338 (83.7) 
Change in shape or appearance 
of the nipple   
2 (0.5) 29 (7.2) 373 (92.3) 
Breast swelling, dimpling, 
redness or soreness of the skin   
3 (0.7) 66 (16.3) 335 (82.9) 
Skin changes of the breast   3 (0.7) 67 (16.6) 334 (82.7) 
A sudden change in breast size   5 (1.2) 52 (12.9) 347 (85.9) 
Aching breasts   40 (9.9) 114 (28.2) 250 (61.9) 
Causes of breast cancer scores, n (%) 
  
  
Disagree/Strongly 
Disagree 
Undecided 
Agree/Strongly 
Agree 
Stress or worry   152 (37.6) 95 (23.5) 157 (38.9) 
Your mental attitude   262 (64.9) 94 (23.3) 48 (11.8) 
Family problems or worries   171 (42.3) 82 (20.3) 151 (37.4) 
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Overwork   281 (69.6) 59 (14.6) 64 (15.8) 
Your emotional state   257 (63.6) 76 (18.8) 71 (17.6) 
Your personality   262 (64.9) 94 (23.3) 48 (11.8) 
Hereditary - it runs in the 
family   
5 (1.2) 10 (2.5) 389 (96.3) 
Diet or eating habits   121 (30.0) 61 (15.1) 222 (55.0) 
Poor medical care in the past   98 (24.3) 90 (22.3) 216 (53.4) 
Your own behaviour   174 (43.1) 172 (42.6) 58 (14.3) 
Ageing   142 (35.1) 63 (15.6) 199 (49.3) 
Smoking   47 (11.6) 39 (9.7) 318 (78.7) 
Alcohol   80 (19.8) 60 (14.9) 264 (65.3) 
A germ or virus   124 (30.7) 124 (30.7) 156 (38.6) 
Pollution in the environment   65 (16.1) 49 (12.1) 290 (71.8) 
Altered immunity   43 (10.6) 69 (17.1) 292 (72.3) 
Chance or bad luck   205 (50.7) 37 (9.2) 162 (40.1) 
Accident or injury   158 (39.1) 54 (13.4) 192 (47.5) 
 
4.2.3.3 Health beliefs and Illness perceptions 
Women’s health beliefs and illness perceptions are presented in Table 4.2.4. Subscale scores 
were retrieved as the mean of items (i.e. those items with which respondents are most in 
agreement, though a disagreement answer for barrier items represents a more positive result). 
In general, higher percentage scores indicate higher agreement among participants for perceived 
mammography benefits (79.7%), self-efficacy (77.7%) and cues to action (76.6%), while lower 
scores indicate lower agreement among women for perceived barriers (45.1%). There was also 
higher agreement with emotional representations (82.0%), personal control items (78.7%), BC 
identity (76.5%) and cyclical cancer timeline (72.0%), while lower agreement for BC causes 
(62.4%) and cancer timeline (acute/chronic) (61.0%). 
Table 4.2.4 - Instrument scoring:  the percentage and mean scores for Health Beliefs and 
Illness Perceptions  
 
Health Beliefs 
*Subscale Minimum Maximum Mean Score Percentage Score 
Perceived Susceptibility 3 15 9.6 64.0% 
Perceived Benefits 6 30 23.9 79.7% 
Perceived Barriers 13 65 29.3 45.1% 
Cues to action 7 35 26.8 76.6% 
Self-Efficacy 7 35 27.2 77.7% 
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                           Illness Perceptions 
*Subscale Minimum Maximum Mean Score Percentage Score 
BC Identity 8 40 30.6 76.5% 
BC Causes  18 90 56.2 62.4% 
Cancer Timeline: 
Acute/Chronic 
2 10 6.1 61.0% 
Cancer Timeline: Cyclical 1 5 3.6 72.0% 
Consequences 8 40 28.3 70.8% 
Personal Control 3 15 11.8 78.7% 
Treatment Control 3 15 9.9 66.0% 
Illness Coherence 2 10 7 70.0% 
Emotional 
Representations 
5 15 12.3 82.0% 
*All subscale items were grouped according to their respective subscale. Each subscale item had 5 
response options ranging from 1 = ‘strongly disagree’ to 5 = ‘strongly agree’. 
 
When comparing health beliefs and illness perceptions among attendees and non-attendees 
(Tables 4.2.5 - 4.2.6), the majority agree that the possibility of developing BC in their lifetime 
is high (M=4.0, SD=0.3) and believe in early detection through screening (M=4.2, SD=0.5). 
Each item in the ‘perceived barrier’ subscale was scored by respondents with the highest level 
of uncertainty, such that 6 out of 13 items had a mean score of 2.5 - 3.5 (Table 4.2.5).  
 
This study found that a large number of participants had higher emotional representations when 
they think about BC, such that they get anxious (M=3.6, SD=1.1), feel afraid (M=4.3, SD=0.7) 
and worried (M=4.4, SD=0.7), they believe that BC has major consequences on a patient’s life 
(M=4.3, SD=0.6), and more specifically, their whole life would change (M=4.2, SD=0.6). The 
course of the BC pathway is believed to be dependent on their actions (M=3.9, SD=0.4). 
 
Table 4.2.5 - Comparison of Health Beliefs between attendees and non-attendees 
When you received your invite to the 
MBSP, did you attend? Yes No Total 
Chi-Square 
testa 
Health Beliefs Mean SD Mean SD Mean SD χ2 
p-
value 
There is no possibility of getting BC (r) 1.9 0.7 2.0 0.7 2.0 0.7 4.3 0.367 
Your chances of getting BC are high 3.7 0.7 3.6 0.8 3.6 0.8 7.1 0.130 
There may be the possibility of 
developing BC in your lifetime 
4.0 0.3 4.0 0.4 4.0 0.3 1.7 0.645 
When you get a mammogram, you feel 
good about yourself 
4.0 0.4 3.9 0.5 4.0 0.5 16.7 0.001* 
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When you get a mammogram, you do 
not worry as much about BC 
3.8 0.8 3.6 0.8 3.7 0.8 2.8 0.423 
Having a mammogram will help you find 
lumps early in your breasts 
4.2 0.4 4.1 0.5 4.2 0.5 7.8 0.051 
If you find a lump through a 
mammogram, the treatment for BC may 
not be as bad 
4.0 0.4 4.0 0.3 4.0 0.4 3.3 0.349 
Having a mammogram will decrease 
your chances of dying from BC 
4.0 0.4 4.0 0.3 4.0 0.3 6.2 0.103 
Having a mammogram will help you find 
a lump before it can be felt by yourself 
or a health professional 
4.0 0.5 4.0 0.4 4.0 0.5 0.6 0.899 
Having a routine mammogram would 
make you anxious about BC 
2.7 1.0 2.9 1.0 2.8 1.0 7.1 0.070 
Having a routine mammogram would 
make you worry 
2.7 1.0 2.9 1.0 2.8 1.0 3.9 0.416 
You fear having a mammogram because 
you might find out that something is 
wrong 
2.9 1.0 3.2 1.0 3.0 1.1 12.0 0.017* 
You fear having a mammogram because 
you do not know the procedure or what 
to expect 
2.2 0.6 2.5 0.9 2.3 0.8 31.9 0.000* 
You fear having a mammogram because 
you know someone (family or friend) 
with BC 
2.6 1.1 2.9 1.1 2.7 1.1 7.1 0.132 
It is embarrassing for you to have a 
mammogram 
2.4 0.8 2.7 1.0 2.5 0.9 13.6 0.009* 
Undergoing mammography will be 
painful or uncomfortable 
3.4 1.0 3.3 0.9 3.3 1.0 39.0 0.000* 
Having a mammogram is time 
consuming 
1.2 0.4 1.3 0.6 1.3 0.5 7.2 0.067 
You are discontent with BS personnel as 
they have been rude to you 
1.2 0.5 n/a n/a 1.2 0.5 n/a n/a 
You have fear or distrust in the medical 
team 
1.7 0.7 2.2 0.9 1.9 0.8 38.3 0.000* 
Having a mammogram would expose 
you to unnecessary radiation 
2.2 0.6 2.5 0.8 2.3 0.7 16.6 0.001* 
You have too many other problems in 
your life than to get a mammogram 
done 
1.6 0.6 2.0 0.8 1.7 0.7 38.8 0.000* 
You are not old enough to have a 
mammogram periodically 
1.7 0.5 1.9 0.4 1.8 0.5 22.6 0.000* 
If your GP advises you to attend for a 
mammogram, you will attend 
4.3 0.6 4.0 0.7 4.2 0.7 13.6 0.004* 
If your relatives or friends advise you to 
attend for a mammogram, you will 
attend 
3.4 1.0 3.4 1.0 3.4 1.0 2.0 0.576 
If someone close to you has been 
diagnosed with BC, you will attend for a 
mammogram 
4.2 1.0 3.9 1.0 4.1 1.0 13.8 0.008* 
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*Significant at α=0.05; (r) = reverse scored 
aChi-square test was applied for all health beliefs; hence the categorical answers were used to apply this test for 
association. For each question, respondents were asked to select a number between 1-5, where 1 = strongly 
disagree and 5 = strongly agree. 
 
Table 4.2.6 - Comparison of Illness Perceptions between attendees and non-attendees 
When you received your invite to the 
MBSP, did you attend? Yes No Total 
Chi-Square 
testa 
Illness Perception Mean SD Mean SD Mean SD χ2 
p-
value 
The presence of a lump of thickening in 
the breast 3.9 0.4 3.9 0.3 3.9 0.3 5.5 0.141 
Nipple discharge 3.9 0.4 3.8 0.4 3.9 0.4 3.8 0.286 
Sudden nipple retraction 3.9 0.4 3.8 0.4 3.8 0.4 5.8 0.121 
Change in shape or appearance of the 
nipple 3.9 0.3 3.9 0.3 3.9 0.3 1.7 0.630 
Breast swelling, dimpling, redness or 
soreness of the skin 3.8 0.4 3.8 0.4 3.8 0.4 2.6 0.463 
Skin changes of the breast 3.8 0.4 3.8 0.4 3.8 0.4 2.1 0.555 
A sudden change in breast size 3.8 0.4 3.9 0.4 3.9 0.4 0.4 0.950 
Aching breasts 3.5 0.7 3.5 0.7 3.5 0.7 2.9 0.578 
Stress or worry 3.0 0.9 3.0 0.8 3.0 0.9 3.9 0.140 
Your mental attitude (e.g. thinking about 
life negatively) 2.5 0.7 2.5 0.7 2.5 0.7 6.0 0.111 
Family problems or worries 3.0 0.9 2.9 0.9 3.0 0.9 3.5 0.178 
Overwork 2.5 0.8 2.4 0.7 2.5 0.8 4.1 0.249 
Hearing about BC and BS in the media or 
news makes you think about getting a 
mammogram 
3.8 0.7 3.5 0.9 3.6 0.8 15.7 0.000* 
Reminder letters would help you to get a 
mammogram 
4.0 0.4 3.8 0.7 3.9 0.5 15.4 0.001* 
Reminder phone calls or text messages 
would help you to get a mammogram 
4.0 0.4 3.8 0.7 3.9 0.5 15.4 0.001* 
Routine educational talks regarding BC 
awareness would help you to get a 
mammogram 
3.8 0.7 3.5 0.9 3.6 0.8 16.9 0.001* 
You feel confident that if you had a 
mammogram done, any abnormalities in 
your breasts will be detected 
3.7 0.6 3.6 0.7 3.7 0.6 2.2 0.697 
You can arrange other things in your life 
to get a mammogram 
4.2 0.6 4.0 0.7 4.1 0.7 13.1 0.011* 
In case you need a mammogram, you 
will find a place to get it done 
4.2 0.5 4.1 0.5 4.2 0.5 10.9 0.028* 
You can make an appointment for a 
mammogram 
4.2 0.5 4.1 0.6 4.2 0.5 12.1 0.016* 
You can arrange transportation to get a 
mammogram 
4.2 0.5 4.1 0.6 4.2 0.6 13.1 0.011* 
You can talk to people at the BS centre 
about your concerns 
4.1 0.7 n/a n/a 4.1 0.7 n/a n/a 
You can find a way to pay for a 
mammogram if you need to 
4.2 0.5 4.1 0.5 4.2 0.5 10.3 0.036* 
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Your emotional state (e.g. feeling down, 
lonely, anxious, empty) 2.5 0.8 2.6 0.8 2.5 0.8 19.0 0.000* 
Your personality 2.4 0.7 2.5 0.7 2.5 0.7 6.6 0.087 
Hereditary - it runs in the family 4.6 0.6 4.4 0.6 4.5 0.6 13.4 0.004* 
Diet or eating habits 3.3 0.9 3.2 0.9 3.3 0.9 5.6 0.131 
Poor medical care in the past 3.3 0.8 3.3 0.8 3.3 0.8 2.4 0.489 
Your own behaviour 2.7 0.7 2.8 0.7 2.7 0.7 10.0 0.018* 
Ageing 3.1 0.9 3.1 0.9 3.1 0.9 4.9 0.087 
Smoking 3.7 0.7 3.6 0.7 3.7 0.7 3.0 0.399 
Alcohol 3.5 0.8 3.4 0.8 3.5 0.8 0.1 0.948 
A germ or virus 3.0 0.8 3.1 0.8 3.1 0.8 3.7 0.160 
Pollution in the environment 3.7 0.8 3.5 0.8 3.6 0.8 6.1 0.108 
Altered immunity 3.6 0.7 3.6 0.7 3.6 0.7 1.5 0.683 
Chance or bad luck 3.0 1.0 2.8 0.9 2.9 1.0 5.8 0.214 
Accident or injury 3.1 0.9 3.1 0.9 3.1 0.9 1.7 0.782 
BC will last a short time 2.8 0.7 2.9 0.7 2.8 0.7 4.2 0.241 
BC is likely to be permanent rather than 
temporary 3.3 0.8 3.2 0.8 3.3 0.8 1.5 0.481 
A patient with BC goes through cycles in 
which her illness gets better and worse 3.7 0.7 3.4 0.7 3.6 0.7 11.1 0.026* 
BC has major consequences on a 
patient's life 4.3 0.6 4.2 0.5 4.3 0.6 14.2 0.003* 
BC will not have much effect on your life 1.5 0.7 1.6 0.7 1.5 0.7 11.8 0.019* 
BC would strongly affect the way others 
see you 3.3 1.0 3.3 0.9 3.3 0.9 14.9 0.005* 
BC has serious economic and financial 
consequences 3.9 0.6 3.7 0.7 3.8 0.6 13.3 0.004* 
BC would strongly affect the way you 
see yourself as a person 4.1 0.5 4.0 0.6 4.1 0.6 0.7 0.875 
BC would threaten a relationship with 
your husband or partner 3.1 0.9 3.0 0.9 3.1 0.9 2.2 0.699 
If you had BC, your whole life would 
change 4.3 0.7 4.1 0.6 4.2 0.6 18.0 0.000* 
If you developed BC, the chances of 
living a long life would decrease 4.0 0.5 4.0 0.3 4.0 0.4 9.4 0.024* 
There is a lot which you can do to 
control the symptoms if BC occurs 3.9 0.4 3.9 0.4 3.9 0.4 2.6 0.629 
The course of BC will depend on your 
actions 4.0 0.4 3.9 0.3 3.9 0.4 5.9 0.118 
Your actions will have an effect on the 
outcome of BC 4.0 0.3 4.0 0.2 4.0 0.3 5.9 0.118 
There is no treatment that will help to 
improve BC 2.0 0.6 2.0 0.5 2.0 0.5 5.8 0.211 
The treatment provided will be effective 
in controlling or curing BC 4.0 0.3 3.9 0.3 4.0 0.3 1.8 0.615 
The negative effects of BC can be 
prevented or avoided by the treatment 
given 4.0 0.3 3.9 0.3 3.9 0.3 5.5 0.241 
You have a clear picture and 
understanding of BC 3.8 0.6 3.8 0.6 3.8 0.6 0.7 0.873 
BC is a mystery to you 3.2 1.0 3.2 1.0 3.2 1.0 3.7 0.455 
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You get anxious when you think about 
BC 3.6 1.1 3.7 1.1 3.6 1.1 2.6 0.464 
BC makes you feel afraid 4.3 0.7 4.3 0.6 4.3 0.7 1.7 0.645 
You get worried when you think about 
BC  4.4 0.7 4.4 0.6 4.4 0.7 1.4 0.502 
*Significant at α=0.05 
aChi-square test was applied for all illness perceptions; hence the categorical answers were used to apply this test 
for association. For each question, respondents were asked to select a number between 1-5, where 1 = strongly 
disagree and 5 = strongly agree. 
 
4.2.3.4 Reasons for non-attendance to first screening invitation 
When non-attendees were asked to further identify reasons for non-attendance to first MBSP 
invitation (i.e. respondents were allowed to mention more than one reason), the main reported 
reason was fear (41.0%, n=66), of which sub-categories included ‘fear of result’ (20.5%; n=33), 
‘fear of pain’ (10.6%; n=17), ‘fear of an unknown procedure’ (depicting knowledge gap) (6.2%; 
n=10), ‘fear of radiation’ (3.7%, n=6) and ‘embarrassment’ (8.1%; n=13). Some women had 
also opted for the service elsewhere (38.5%, n=62) or had never received an invitation (13.7%; 
n=22). Practical reasons were mentioned by 8.7% (n=14) of non-attendees, which included 
‘busy at work’ or ‘home’, ‘transport issues’, ‘on vacation’ and ‘being ill’. 
 
4.2.3.5 Associations between health beliefs and uptake to first screening invitation 
The variables related to HBM constructs were compared with attendance and non-attendance to 
the first MBSP invitation (Table 4.2.5). In general, the majority of the HBM constructs showed 
statistical significance as follows: 
 
Perceived Benefits 
Women who feel good about themselves when getting a mammogram (χ2 = 16.7, p = 0.001) 
were more likely to attend their first screening invitation. On the other hand, non-attendees 
believe less than attendees that BS will help to detect a lump early before it can be felt (χ2 = 7.8, 
p = 0.051). 
 
Perceived Barriers 
Although there was no significant association between anxiety and initial screening uptake, fear 
was found to be statistically significant across all subscale items (p<0.05). Non-attendees 
expressed fear of a cancer diagnosis (χ2 = 12.0, p = 0.017), fear of the unknown procedure (χ2 
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= 31.9, p = 0.000), fear of radiation (χ2 = 16.6, p = 0.001), consider mammography to be 
embarrassing (χ2 = 13.6, p = 0.009), other problems in life are considered greater than getting a 
mammogram (χ2 = 38.8, p = 0.000), and women were more undecided on whether 
mammography is painful (χ2 = 39.0, p = 0.000). On the other hand, attendees are more in 
disagreement with the statement: ‘they are not old enough to have a mammogram periodically’ 
(χ2 = 22.6, p = 0.000) and have less fear or distrust in the medical team (χ2 = 38.3, p = 0.000). 
 
Cues to action 
Women attend more if advised by their GP (χ2 = 13.6, p = 0.004) and if someone close to them 
had BC (χ2 = 13.8, p = 0.008), but do not attend more if advised by their relatives or friends (χ2 
= 2.0, p = 0.576). Attendees are more in agreement that hearing about BC and BS in the media 
or news makes them think about getting a mammogram (χ2 = 15.7, p = 0.000), and similarly 
reminder letters (χ2 = 15.4), phone calls or text messages (χ2 = 15.4), and educational talks (χ2 
= 16.9) help them to get a mammogram done (p = 0.001 respectively).  
 
Self-Efficacy 
Attendees also tend to agree more that they can arrange other things in life to get a mammogram 
(χ2 = 13.1, p = 0.011), such as finding a place to get it done (χ2 = 10.9, p = 0.028), arranging an 
appointment (χ2 = 12.1, p = 0.016) and transportation (χ2 = 13.1, p = 0.011), and also paying 
for it if they need to (χ2 = 10.3, p = 0.036). 
 
4.2.3.6 Associations between illness perceptions and uptake to first screening invitation 
Illness perception constructs were compared with attendance and non-attendance to the first 
MBSP invitation (Table 4.2.6). In general, Chi-square tests showed no statistical significance 
for BC identity, acute/chronic cancer timeline, personal and treatment control, illness coherence 
and emotional representation items with first screening uptake. 
 
Causes of Breast Cancer 
In general, no significant association was found for most causal variables. However, attendees 
were more in agreement that BC could be hereditary (χ2 = 13.4, p = 0.004) and considered one’s 
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own behaviour to cause BC (χ2 = 10.0, p = 0.018), while non-attendees were more undecided 
whether one’s emotional state or personality cause BC (χ2 = 19.0, p = 0.000). 
 
Cancer Timeline (Cyclical) 
Attendees agree more than non-attendees that a BC patient gets better and worse along the 
treatment pathway (χ2 = 11.1, p = 0.026).  
 
Consequences 
Attendees consider more that BC has major consequences on a patient’s life (χ2 = 14.2, p = 
0.003), has serious economic and financial consequences (χ2 = 13.3, p = 0.004) and is life-
changing (χ2 = 18.0, p = 0.000). On the other hand, non-attendees are more undecided whether 
BC would strongly affect the way others see them (χ2 = 14.9, p = 0.005) and consider the 
chances of living a long life to decrease (χ2 = 9.4, p = 0.024).  
 
4.2.3.7 Associations between sociodemographic and health status, knowledge of breast 
screening frequency and uptake to first screening invitation 
There were no significant associations for demographic factors or health status variables with 
first screening uptake, except for family income (χ2 = 9.7, p = 0.047). Non-attendees were the 
most unsure of the recommended screening frequency (χ2 = 13.9, p = 0.003). 
 
4.2.3.8 Predictors of uptake to first screening invitation 
Different groups of variables and constructs were incorporated into seven logistic regression 
models and ‘backward-elimination’ method was applied to every model to identify significant 
BS predictors (Table 4.2.7).  
 Model 1 (Demographics) and Model 2 (Health Status) 
All items related to demographic variables were incorporated in a logistic regression model 
(Model 1) and health status items were incorporated into Model 2. Both demographics and 
health status variables were found to be non-important BS predictors, such that for both models, 
non-attendance was not predicted and none of the variables were significantly different.  
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 Model 3 (Health Belief items) 
All HBM items were incorporated in a logistic regression model (Model 3). Five variables were 
found to be good BS predictors: 'distrust in medical team', 'fear of unknown procedure', 'other 
life problems', 'relatives and friends̕ advice' and 'reminder letters' (Table 7). For this model, 
attendance was predicted with an accuracy of 88.5% and non-attendance with 38.8%.  
 Model 4 (Illness Perception items) 
All IPQ-R variables were incorporated into one logistic regression model (Model 4). Seven 
variables were found to be good BS predictors: 'hereditary', 'pollution', 'a patient with BC goes 
through cycles in which her illness gets better and worse', 'BC has major consequences on a 
patient’s life', 'if you had BC, your whole life would change', 'if you developed BC, the chances 
of living a long life would decrease' and 'BC makes you feel afraid' (Table 4.2.7). The accuracy 
for this model was found to be 83.5% for attendance and 37.3% for non-attendance.  
 Model 5 (Significant predictors from Models 3 and 4) 
The above significant predictors from both models 3 and 4 were incorporated into a new single 
model (Model 5) and backward-elimination was applied on these 12 variables (five Health 
Beliefs and seven Illness Perception variables). The final model retained nine significant 
predictors, without excluding any of the Health Belief variables, hence showing that Health 
Beliefs are more significant predictors than Illness Perceptions. When combining both scores, 
the model accuracy improved to 53.8% for non-attendance and 84.8% for attendance.  
 Model 6 (All individual Health Belief and Illness Perception items) 
When all items related to Health Beliefs and Illness Perceptions were incorporated into one 
model (Model 6), 21 variables were found to be significantly different. The model accuracy 
improved again to 85.2% for attendees and 65% for non-attendees.  
 Model 7 (All 14 constructs) 
When the 14 constructs (not individual items) related to Health Beliefs and Illness Perceptions 
were used to construct a logistic regression model (Model 7), ‘perceived barriers’, ‘cancer 
timeline (cyclical)’ and ‘illness coherence’ were found to be significant predictors, of which the 
‘perceived barriers’ construct was the strongest predictor. However, the accuracy for predicting 
the non-attendees was found to be 42.2%, which is inferior when compared to Model 5. 
Moreover, when removing the ‘perceived barriers’ variable from the latter model, the accuracy 
to predict non-attendance decreased sharply from 42.2% to 14.9%.  
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Our findings reveal that ‘perceived barriers’ is the most important construct to describe the 
variance between attendees and non-attendees. This result is further echoed in Model 5, where 
three predictors (from all the other predictors) are all related to perceived barriers. The above 
logistic regression analyses show that, although Health Beliefs are the most important BS 
predictors, the inclusion of Illness Perception items into one logistic regression model is 
important to improve model accuracy (Model 5 vs Model 3). 
 
Table 4.2.7 - Logistic Regression Models on breast screening uptake against different variables 
and different constructs  
  
B SE Wald 
P-
value 
OR 95% CI 
Model 
Accuracy 
YES 
Model 
Accuracy 
NO 
Model 1: Demographics  100% 0% 
Drive -0.361 0.207 3.047 0.081 0.697 0.465, 1.045     
Constant 0.979 0.342 8.172 0.004 2.661       
Model 2: Health Status             100% 0% 
Breast condition 0.174 0.265 0.430 0.512 1.190 0.708, 1.998     
Constant 0.081 0.492 0.027 0.869 1.085       
Model 3: Health Beliefs             88.5% 38.8% 
Distrust in medical 
team 
-0.573 0.153 14.051 0.000 0.564 0.418, 0.761     
Fear of unknown 
procedure 
-0.409 0.153 7.120 0.008 0.664 0.492, 0.897 
  
  
Other life problems -0.693 0.195 12.630 0.000 0.500 0.341, 0.733     
Relatives or friends' 
advice 
-0.363 0.130 7.745 0.005 0.696 0.539, 0.898     
Reminder letters 0.660 0.238 7.678 0.006 1.934 1.213, 3.083     
Constant 2.336 1.091 4.585 0.032 10.335       
Model 4: Illness 
Perceptions             
83.5% 37.3% 
Hereditary 0.456 0.185 6.072 0.014 1.578 1.098, 2.268     
Pollution 0.290 0.134 4.682 0.030 1.336 1.028, 1.738     
Illness gets better 
and worse 
0.312 0.153 4.154 0.042 1.366 1.012, 1.844     
Major consequences 
in life 
0.420 0.195 4.640 0.031 1.522 1.039, 2.231 
    
Whole life would 
change 
0.509 0.201 6.442 0.011 1.664 1.123, 2.466     
Living long 
decreases 
-0.685 0.298 5.290 0.021 0.504 0.281, 0.904     
Fear of BC -0.363 0.176 4.264 0.039 0.695 0.492, 0.983     
Constant -3.375 1.494 5.106 0.024 0.034       
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Model 5: Health Beliefs 
and Illness Perceptions 
            84.8% 53.8% 
Distrust in medical 
team -0.676 0.162 17.468 0.000 
0.509 0.371, 0.699     
Fear of unknown 
procedure 
-0.612 0.166 13.629 0.000 0.542 0.392, 0.751     
Other life problems -0.669 0.206 10.544 0.001 0.512 0.342, 0.767     
Relatives or friends' 
advice 
-0.476 0.140 11.610 0.001 0.621 0.473, 0.817     
Reminder letters 0.687 0.251 7.470 0.006 1.987 1.214, 3.251     
Pollution 0.479 0.151 10.060 0.002 1.615 1.201, 2.172     
Illness gets better 
and worse 
0.396 0.167 5.656 0.017 1.486 1.072, 2.061     
Whole life would 
change 
0.855 0.221 14.924 0.000 2.351 1.524, 3.626     
Living long 
decreases 
-0.890 0.336 7.016 0.008 0.411 0.212, 0.793     
Constant 0.113 1.742 0.004 0.948 1.120       
Model 6: Health Beliefs 
and Illness Perceptions 
            85.2% 65.0% 
Fear of unknown 
procedure -0.742 0.194 14.633 
0.000 0.476 0.325, 0.696     
Embarrassing -0.320 0.149 4.600 0.032 0.726 0.542, 0.973     
Distrust in medical 
team 
-0.808 0.176 21.149 0.000 0.446 0.316, 0.629     
Other life problems -0.735 0.234 9.843 0.002 0.479 0.303, 0.759     
Relatives or friends' 
advice 
-0.529 0.153 11.965 0.001 0.589 0.437, 0.795 
    
Reminder letters 0.795 0.290 7.536 0.006 2.215 1.255, 3.907     
Arrange 
appointment 
1.133 0.506 5.020 0.025 3.106 1.153, 8.372     
Pay for 
mammography 
-1.669 0.580 8.286 0.004 0.188 0.06, 0.587     
Stress or worry -0.940 0.419 5.044 0.025 0.39 0.172, 0.887     
Family problems 0.839 0.405 4.292 0.038 2.314 1.046, 5.118     
Overwork 0.539 0.216 6.262 0.012 1.715 1.124, 2.616     
Personality -0.548 0.240 5.235 0.022 0.578 0.361, 0.924     
Hereditary 0.533 0.231 5.342 0.021 1.704 1.084, 2.677     
Pollution 0.500 0.170 8.698 0.003 1.649 1.183, 2.299     
Change or bad luck 0.432 0.140 9.568 0.002 1.54 1.171, 2.024     
Illness gets better 
and worse 
0.398 0.185 4.629 0.031 1.489 1.036, 2.141 
    
Economic 
consequences 
0.647 0.223 8.438 0.004 1.91 1.234, 2.955     
Whole life would 
change 
0.755 0.245 9.493 0.002 2.128 1.316, 3.441     
Living long 
decreases 
-1.177 0.373 9.956 0.002 0.308 0.148, 0.64     
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Depends on your 
actions 
0.856 0.409 4.381 0.036 2.354 1.056, 5.246     
Your actions effects 
outcome 
-1.094 0.552 3.933 0.047 0.335 0.114, 0.987     
Constant 0.384 3.083 0.016 0.901 1.468       
Model 7: The 14 
constructs             
84.4% 42.2% 
Perceived barriers -0.121 0.022 31.731 0.000 0.886 0.849, 0.924     
Cancer timeline 
cyclical 
0.432 0.154 7.893 0.005 1.54 1.139, 2.081     
Illness coherence 0.249 0.100 6.179 0.013 1.283 1.054, 1.561     
Constant 0.623 0.895 0.484 0.487 1.864       
B unstandardized coefficients; SE standard error; OR odds ratio; CI confidence interval 
 
4.2.4 Discussion 
For the first time, this study aimed to explore factors related to Maltese women’s BS behaviours, 
their knowledge, health beliefs and illness perceptions related to BC and BS, providing answers 
as to why more than 40% of eligible women did not attend their first MBSP invitation. 
 
4.2.4.1 Knowledge 
Study findings confirm the wide variation in knowledge level of Maltese women about BC 
causes and its related risk factors, though good awareness of BC signs and symptoms were 
reported, such as nipple discharge and sudden nipple retraction. Women’s limited knowledge 
about BC and BS practices has been identified in a consistent body of literature (Liu et al. 2014; 
Charkazi et al. 2013; Guvenc et al. 2012; Dandash and Al-Mohaimeed 2007). For instance, 
Grunfeld et al. (2007) showed that only 38% of people were aware that nipple retraction was a 
sign of BC, and awareness of risk factors was even lower. Notably, local misconceptions (e.g., 
one’s own behaviour, personality, emotional state, germ or virus, accident or injury could cause 
BC) also corroborate findings in older studies (e.g., hitting or bumping the breast), which is 
consistent with women’s beliefs in other societies with different cultures such as the Philippines, 
Korea, Saudi Arabia and Australia (Dandash and Al-Mohaimeed 2007; Han et al. 2007; 
Grunfeld et al. 2002).  
 
Since relevant knowledge has been emphasized as a screening compliance predictor (Ritvo et 
al. 2012; Lagerlund 2002) or a screening barrier (Guilford 2011), it was hypothesized that there 
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would be significant association between knowledge and BS uptake in Malta. The findings 
support this hypothesis since Maltese women who have a lack of awareness regarding screening 
recommendations, guidelines and BC risk factors are more likely not to attend and this may 
prove difficult for women to perceive their risk (Liu et al. 2014). Communicating risk 
information to the general public makes knowledge an essential element of health promotion, 
disease prevention and screening interventions (Vahabi 2005). Despite the vast array of 
worldwide initiatives, an overlap exists between knowledge, health beliefs and illness 
perceptions; the knowledge construct operationalized in BS studies does not often include 
identifications of specific beliefs (Ritvo et al. 2012). Hence, in order for a woman to attend for 
her BS appointment, she must perceive the actual BC threat, believe that cancer can be avoided 
by BS, and that she is capable of accessing the unit, which may include remembering her 
appointment, driving to or be driven to the unit, and not be afraid of the test (Gozum et al. 2010).  
 
4.2.4.2 Reasons to non-attendance 
Fears, negative expectation of the screening experience, and embarrassment were among the 
main BS barriers in this study, similarly reported as barriers to attendance and re-attendance 
worldwide (Whelehan et al. 2013; Paul 2012; Esteva et al. 2008). Minor practical barriers to 
non-attendance reported in this study (such as lack of time, transportation issues) are also 
reiterated in previous studies (Carney et al. 2013; Trigoni et al. 2008; Aro et al. 2001), justifying 
local transportation accessibility improvements and reduction of logistical barriers (Charkazi et 
al. 2013).  
 
4.2.4.3 Health beliefs and illness perceptions 
Significant associations were mainly found for health beliefs about BS and BC i.e. the 
perceptions of the behaviour (barriers, self-efficacy, cues to action), while weaker associations 
were found for the perceptions of the illness i.e. significant associations for certain illness 
perception items (causes, cyclical cancer timeline, consequences) with uptake. BS non-
attendance was related to more perceived barriers, less perceived benefits, lower self-efficacy 
and cues to action, and to the representations of the causes, consequences and timeline of BC. 
In contrast to HBM, perceived susceptibility was not significantly associated with first screening 
attendance in this study; a finding which corroborates results in previous studies (Moodi et al. 
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2012; Hatefnia et al. 2010; Farmer et al. 2007) and contrasts others (Champion et al. 2008; 
Dundar et al. 2006; Secginli and Nahcivan 2006). One explanation for this finding may be due 
to women’s lack of knowledge about BC and BS (Moodi et al. 2012), such that improving 
women’s risk assessment of developing BC may increase uptake rates. Our findings are in 
agreement with previous studies where positive association with perceived self-efficacy and 
having BS was found (Farmer et al. 2007; Secginli and Nahcivan 2006). This implies that 
attendees feel confident that they can arrange other things in their life to get a mammogram. 
However, self-efficacy was not the most important predictor for the decision to undergo 
screening in Malta. This result complies with a study in Cyprus (Tolma et al. 2006) and contrasts 
the findings by others (Orji et al. 2012).  
 
It has also been reported that if a woman perceives mammography benefits to be higher than 
perceived barriers, she is more likely to attend (Carney et al. 2013; Avci and Kurt, 2008; Dundar 
et al. 2006). However, the benefits subscale was not the most significant component associated 
with BS in Malta unlike in other studies (Dundar et al. 2012; Soskolne et al. 2007). It was the 
strong negative association between perceived barriers and screening uptake which was mainly 
identified in this study, similar to findings among American asymptomatic women (Aiken et al. 
1994), Israeli women (Cohen 2006) and other populations (Hatefnia et al. 2010; Farmer et al. 
2007; Parsa et al. 2006; Secginli and Nahcivan 2006). It was predominantly fear that was found 
to be statistically significant across all subscale items. This is evidenced by women who do not 
attend for mammography in other countries because they perceive greater fear of BC (Fayanju 
et al. 2014; Baron-Epel et al. 2009; Consedine et al. 2004). A cancer diagnosis seems to be 
associated with a negative physical, psychological and social impact on Maltese women’s ability 
to cope with BC outcomes, which can have a profound effect on their way of life: an economical 
and financial impact, altered perception of others and oneself, altered relationship with their 
husband/partner, and that diagnosis may lead to mortality. This is noticeable in other findings 
(Baron-Epel et al. 2009; Consedine et al. 2004; Austin et al. 2002). It is also likely that the fear 
of knowing someone with cancer is related to the cultural impact it would have on a woman’s 
life or social local networks (Baron-Epel et al. 2009). This consistent fear across populations 
stems from the belief that there is little an individual can do to alter fate (fatalism) or prevent 
cancer (Austin et al. 2002). Therefore, non-attendees may be more pessimistic of early BC 
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detection and the effectiveness of subsequent treatment, and may perceive BC as being 
uncontrollable, chronic and highly symptomatic with avoidance and denial coping strategies 
(Hagger and Orbell 2003). 
 
Helping to manage barriers associated with cancer and screening could be one of the main tasks 
addressed by interventions to increase uptake, for example through the use of patient navigators 
alongside access to care (Pascal et al. 2011) and the identified recommendations from a 
physician, health care providers, family members and personal communication with other 
women which have been proven to be of greater importance than external cues (Cohen and 
Azaiza 2010; Trigoni et al. 2008; Meissner et al. 2007; Sohl and Moyer 2007). However, our 
findings show that many women are not encouraged by their GP to attend to BS and would 
attend more if advised. This is in agreement with a previous study where screening tests are 
advised at suboptimal rates (Trigoni et al. 2008). Similarly, in a cross-sectional study among 
Arab women in Qatar, only one quarter of the women interviewed said their doctors had 
discussed BC with them (Donnelly et al. 2013). It is important to provide a local context for the 
lack of GP recommendation and to take into account unique aspects of the Maltese health care 
service. Although the state health system and private GPs provide primary health care in Malta, 
patients are not affiliated with a regular primary care general practitioner or group practice 
(Parliamentary Secretariat for Health 2014). Besides, there exists an extent of private purchase 
of screening outside public health services (Parliamentary Secretariat for Health 2014). 
However, little is known in Malta regarding the true supporting network of women’s care 
pathway to date (Government of Malta 2016). These issues, coupled with negative women’s 
representations of BC and perceived BS barriers may have resulted in non-attendance to the  
first MBSP invitation.  
 
4.2.4.4 Sociodemographic factors and health status 
The findings also demonstrate that women with a lower family income tend to attend less to 
screening. There is consistent evidence that lower household income demonstrates lower 
utilization of BS in various countries (Paul 2012; Cuthbertson et al. 2009; Lagerlund et al. 2002). 
However, in regression analyses, the results revealed that the demographic and health status 
variables were poor and insignificant predictors of screening uptake and hence, do not provide 
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strong prediction of non-attendees. Similarly, sociodemographic factors do not appear to 
constitute strong predictions of non-attendance in various studies (Lagerlund et al. 2000), which 
is why other determinants, such as health beliefs and illness perceptions, need to be explored 
within populations because of their importance in stimulating positive health behaviours 
(Dundar et al. 2012).  
 
4.2.4.5 Predictors to first breast screening uptake 
Previous studies have demonstrated that beliefs about BC and BS are important predictors of 
uptake (Anagnostopoulos et al. 2012; Huaman et al. 2011; Dundar et al. 2012). In regression 
analysis, health belief constructs emerged as the strongest and most significant predictors of 
attendance and non-attendance, and that perceived barriers were the strongest predictors to 
describe the variance between attendees and non-attendees (p<0.05). This fits well with previous 
literature, where interventions tailored after the HBM were more effective in increasing BS 
uptake than those that were not (6 studies OR = 2.51, OR = 1.27, p<0.001) (Sohl and Moyer 
2007). Limited evidence for the effectiveness of interventions based on other models was found 
(Bridle et al. 2005).  
 
Only one Greek study similarly incorporated both HBM and CSM to explore health beliefs and 
illness perceptions (Anagnostopoulos et al. 2012), though this theoretical framework was related 
to lifetime mammography use as opposed to this study regarding BS uptake in an organised 
programme. However, their results similarly showed that illness perception dimensions did not 
prove to be significant predictors of mammography lifetime use. There may be a number of 
alternative explanations for the non-significant associations and the less significant predictions 
exhibited by illness representation dimensions and screening uptake in Study 2. Hagger and 
Orbell (2003) hypothesized that coping may just mediate the effect of illness cognitions on the 
outcomes of an illness (e.g., psychological well-being, social, and role functioning). This may 
be due to women’s focus on illness perceptions ('mental representation') as such, rather than on 
coping strategies (such as obtaining a screening mammogram or visiting a doctor) which, in 
turn, may possess a different set of diverse and multiple characteristics which IPQ-R does not 
tackle (e.g., specific beliefs about mammography risks). Therefore, it seems that it is the HBM 
constructs related to response efficacy (expecting that a particular health action will result in an 
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outcome, such as undertaking mammography screening), self-efficacy, and utility beliefs 
(believing that taking a certain action would be worthwhile to reduce BC susceptibility or 
severity, if the disease did occur, while perceived benefits would outweigh perceived barriers to 
undertaking health actions) that are significant BS predictors, rather than the IPQ-R dimensions. 
However, the CSM is the only model which seriously considers the role of emotions in response 
to illness (Lunt et al. 2005), although even here ‘emotions’ are often inadequately 
operationalised as ‘anxiety’, worry about, or ‘fear’ of symptoms. On the other hand, the HBM 
is considered a weak predictor of behaviour change as it does not include the formation of an 
intention to change behaviour as a precursor to behavioural change, does not accommodate 
social and environmental influences or past behaviour, and assumes that human decision-
making are rational (Lunt et al. 2005). In response to each model’s limitations, a combination 
of the two may determine behaviour likelihood (Kalsta et al. 2013; Lunt et al. 2005) and as 
shown in this study, their combination provided improved prediction of non-attendance (i.e. 
from 38.8% to 65.0% when combining all significant predictors). This suggests that 
interventions could be aimed to incorporate various dimensions of both models. 
 
4.2.5 Limitations 
Although these data can be generalizable to other screening programmes with a similar 
population, such as Mediterranean populations, this study has some limitations. First, a temporal 
relationship between exposure and outcome cannot be established because the study was cross-
sectional thus excluding causal associations. Second, the study’s retrospective design may have 
had an impact on the recall of events. Third, it was not possible to capture data of repeat 
mammograms at another facility as this was not recorded on the screening database at the time 
of study. Such data would show more accurately women’s adherence to screening guidelines 
(Rutter et al. 1997) by using multiple points of service. Hence, future research should take into 
account the type of screening programme and a clear distinction of the type of mammography 
(screening or diagnostic mammography), since women’s accuracy and consistency in reporting 
mammography experiences sharply declines with an increased number of lifetime 
mammograms (Rauscher et al. 2002). Fourth, data collected might be affected by recall or 
social-desirability response bias i.e. having performed mammography, whether in the organized 
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screening programme or as opportunistic screening due to its well-publicized recommendation 
by media and clinicians (Anagnostopoulos et al. 2012), thus amplifying the recall bias effects.  
Additional research is required to test the interactions of HBM and CSM components in 
multivariate models to test threat representations and coping mechanisms. Further research to 
measure health beliefs and illness perceptions before and after screening could help to clarify 
the HBM and CSM’s value in explaining the beliefs and perceptions of BC risks. Additionally, 
a longitudinal study design could provide better understanding of the psychological and 
emotional pathways and processes involved in how individuals form beliefs and risk perceptions 
of a particular health threat to better understand the factors underpinning health behaviours and 
reduce BC risk. Further research is warranted to determine whether uptake to first screening 
invitation is a significant predictor of subsequent screening in Malta. 
 
4.2.6 Conclusions 
Study 2 showed that there is high awareness of BC signs and symptoms among Maltese women, 
but wide variation in knowledge about causes of BC and its related risk factors. Non-attendees 
were the most unsure of BS recommended practices and had higher emotional barriers. 
Interventions to increase BC screening uptake in Malta should address health beliefs, in 
particular perceived barriers such as fear, since these emerged as the strongest predictors of 
uptake throughout the analyses. However, those interventions that also address illness 
representations, such as causes, consequences and cyclical timeline of BC, may increase their 
effectiveness since these were also associated with BS uptake. The CHBMS-MS and IPQ-R 
variables that contributed most to the regression model were perceived barriers, cues to action 
and self-efficacy, BC causes, cancer cyclical timeline, consequences and personal control. The 
findings of Study 2 indicate that it was the combination of HBM and CSM constructs which 
provides improved prediction of non-attendance. To the best of my knowledge, this is an 
innovative finding in BS research which can aid researchers, screening leads and public health 
educators to design culturally sensitive interventions to improve BS behaviours. 
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Chapter 4 
 
Study 3: Predicting reattendance to the second 
round of the Maltese National Breast Screening 
Programme3 
 
 
 
 
 
 
 
 
 
 
3A version of this chapter has been submitted for publication in the BMC Public Health Journal (Marmarà et al. 
2019).   
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4.3 Introduction 
Detecting BC early is not ensured by a one-off BS attendance (Marshall 1994), but on the 
consistency of attendance (‘adherence’) in line with recommended time intervals (Coyle et al. 
2014) i.e. biennial screening mammography in average-risk women aged 50-69 as 
recommended by the EU Council (Perry et al. 2006). Thus, an important factor that merits 
exploration includes screening adherence in Malta, because of its significant impact on 
morbidity and mortality reductions (Anagnostopoulos et al. 2012; Ritvo et al. 2012). In 2009, 
the MBSP was set up similar to the UK, to screen women aged 50-60 through mammography 
every three years (Marmarà et al. 2017b), aiming gradual expansion to reach women until the 
age of 69 years while reducing the screening time interval as in other countries. In 2015, this 
age cohort (50-60 years) was in its second BS round. 
 
The literature suggests that previous mammography use is highly associated with future use 
(Allen et al. 2008) because when women believe in the effectiveness of screening, it in turn, 
increases their intentions to go for screening, resulting in their adherence to subsequent screens 
(Abbaszadeh et al. 2007). An earlier study by Cockburn et al. (1997) found that those having 
weakest intentions to attend for their first screening are less likely to attend for their second 
screening (OR = 0.44, CI 0.23, 0.85). Therefore, it has been suggested that programs should 
focus on reaching those who have underutilized mammography in their past (Allen et al. 2008) 
as this would feed into attendance in subsequent BS rounds. Nonetheless, many studies have 
focused on the reasons for one-time screening rather than subsequent use (Ritvo et al. 2012; 
Halabi et al. 2000) and limited studies have sought to specifically explore predictors of uptake 
for second round BS invitations (O’Byrne et al. 2000; Cockburn et al. 1997; Rutter et al. 1997). 
In a comparative study of 200 re-attenders and 200 non-reattenders for second triennial National 
BS appointments in Nottingham (Marshall 1994), the 200 women who failed to accept their 
invitation implicated their negative initial screening experience in their decision, with 41% 
implicating pain, 6% stress and 3% embarrassment.  
 
Study 2 found that a number of barriers influence women’s uptake to a first BS invitation. Health 
beliefs, in particular perceived barriers, were the strongest predictors of uptake of first MBSP 
invitation, though the inclusion of illness representation dimensions improved the predictive 
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accuracy for non-attendance. Prior to this research, no studies had explored women’s 
reattendance at the MBSP or screening predictors to the second BS cycle. This analytical 
descriptive study follows Maltese women to explore predictors and behaviour to re-attendance, 
and to determine if uptake of first MBSP invitation is a significant predictor of second screening 
uptake, thus meeting research question 2b: 
RQ 2b. Which significant factors (i.e. health beliefs, illness perceptions, knowledge, socio-
demographic factors and health status) are associated with re-attendance at the MBSP? 
 
4.3.1 Aims and Objectives 
The aim of Study 3 was to gain an understanding of women’s re-attendance at the second BS 
invitation round. In reaching this aim, the analysis has targeted the following objectives: 
(1) To explore whether sociodemographic factors, health status, knowledge, health beliefs and 
illness perceptions are significant predictors of uptake to a second MBSP invitation; and  
(2) To determine if uptake of first invitation to attend the MBSP is a significant predictor of 
uptake to the second invitation.  
 
4.3.2 Methods 
4.3.2.1 Design and setting 
Full details of the methods are described in Study 2 (Section 4.2.2). This prospective study was 
conducted in Malta in January 2016 to determine factors associated with the second BS cycle. 
 
4.3.2.2 Participants  
The MBSP database was used to identify the 404 women who participated in the previous study 
on the first MBSP invitation (Marmarà et al. 2017b) for their attendance and non-attendance to 
the second invitation. Characteristics of the larger sample (n = 404) are found in Study 2. Of the 
404 women surveyed between June and September 2015 about their first MBSP attendance, 100 
women were identified in January 2016 to have subsequently been invited to the second round. 
These 100 women were a sub-sample of the larger study who had received an invitation to attend 
both the first and second MBSP rounds.  
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4.3.2.3 Measures 
To predict reattendance, the previously constructed 121-item questionnaire was used. Refer to 
section 4.1.3 for its translation, adaptation and pilot-testing and section 4.1.4.2 for full details 
on its composition. 
 
4.3.2.4 Ethical considerations 
As discussed in Study 1, ethics approval was obtained from SREC (Appendix 4.1.2) and HEC 
(Appendix 4.1.3). In Study 2, participants were informed that their data could be used for further 
analysis of subsequent BS cycles, if required, for which they provided verbal consent. Data was 
computer generated from the MBSP register.  
 
4.3.2.5 Variable definitions 
A second invitation was defined as the second (subsequent) time a woman is invited to the 
MBSP and either attends or does not attend for the mammogram. Women were considered 
eligible in this study if their scheduled appointment date had elapsed for their second BS 
invitation and they had not informed the unit to reschedule their mammography invitation. A 
screening invitation is posted to the client approximately one month before the scheduled 
mammography date. Hence, those women invited to the second round and awaiting their 
scheduled day for mammography screening were not considered in this study. 
 
4.3.2.6 Data analysis 
Primarily, the Chi-square test was used to assess the association between attendance or non-
attendance to the second MBSP invitation and women’s knowledge, health beliefs and illness 
perceptions. When one of the assumptions of the Chi-Square test was violated, Fisher’s exact 
test was used. Secondly, the Shapiro-Wilk test was applied on all constructs to verify whether 
the data was normally distributed. The Independent Samples t-test was used to compare if there 
were significant differences between attendees versus non-attendees against all the constructs. 
However, the non-parametric Mann-Whitney test was used for cases where the test variable was 
found to be not normally distributed. Thirdly, significant predictors for re-attendance were 
determined through binary logistic regression. The logistic regression model produced the 
unstandardized coefficients, standard error, the Wald value, p-values, Odds Ratios (ORs) and 
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95% confidence intervals (CIs). Seven logistic regression models were developed through 
different groups of variables and constructs, with the ‘backward-elimination’ method applied to 
every model. The reason for providing these models in this format was to understand the level 
of accuracy in predicting the dependent variable, based on different categories of variables. 
Hence, it was possible to identify the most important category of variables (i.e. health beliefs 
and illness perceptions) to predict attendance and non-attendance to the second MBSP cycle. In 
order to explore if the uptake of first MBSP invitation is a significant predictor of uptake to 
second invitation, a logistic regression model was applied to predict second (subsequent) BS 
uptake using the first BS uptake as the predictor. The data was analysed using SPSS version 21 
under the guidance of an expert statistician. A P-value of < 0.05 was considered statistically 
significant and missing data was minimal (Table 4.3.1). 
 
4.3.3 Results 
4.3.3.1 Sample characteristics 
Table 4.3.1 presents the sample characteristics (n = 100). Women were aged between 53-63 
years at the time of the second screening cycle, with a mean of 58.63 years (±2.63 standard 
deviation (SD)). The majority of women were housewives (n = 78), married (n = 85), had a 
secondary education level (n = 68) and were from below average income families (n = 60).  
 
Table 4.3.1 - Sample Characteristics (n = 100) 
 
Characteristics Mean SD N % 
Age (year)         
 58.63    2.63     
Education level         
Primary level     26 26.0 
         Secondary level     68 68.0 
Tertiary level     6 6.0 
Occupation         
 Pensioner     4 4.0 
          Housewife     78 78.0 
          Employee     18 18.0 
Status         
Single     4 4.0 
         Married     85 85.0 
         Separated/Divorced     5 5.0 
Widowed     6 6.0 
Family income         
Less than €10,737     28 28.0 
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         €10,737 – €16,113     32 32.0 
         €16,114 – €23,563     8 8.0 
€23,564 – €33,966     2 2.0 
Greater than €33,966     2 2.0 
Prefer not to say     30 30.0 
Own a car         
Yes     78 78.0 
         No     22 22.0 
Drive         
Yes     46 46.0 
         No     54 54.0 
Any illness, disability or condition         
Yes     58 58.0 
         No     42 42.0 
Family physician (GP)         
Yes     92 92.0 
         No     8 8.0 
Frequency of GP visit         
Only when I have a problem     80 80.0 
         Once a month     5 5.0 
         More than once a year     7 7.0 
Missing     8 8.0 
Lumpy breasts         
Yes     9 9.0 
         No     91 91.0 
Relatives or close friends had cancer         
         Yes     89 89.0 
         No     9 9.0 
         Prefer not to say     2 2.0 
     
From the 100 women invited to the second screening round (Figure 4.3), nearly three-quarters 
of this sample (74%; n = 74) attended the second round; of these, 83.8% (n = 62) had responded 
to their first invitation while 16.2% (n = 12) had not attended the first round. Over a quarter of 
our sample (26%; n = 26) did not attend the second round; of these, 34.6% (n = 9) had attended 
the first screening cycle while 65.4% (n = 17) had not responded to their first invitation. Women 
who attended their first invitation were more likely to sustain mammography screening than 
non-attendees (χ2 = 22.6, p < 0.001).  
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Figure 4.3 - First and second breast screening invitation pathway 
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4.3.3.2 Associations between psychosocial factors, and attendance and non-attendance 
to a second breast screening invitation 
Sociodemographic factors and health status 
There was a significant association between breast condition (lumps or cysts but not BC) 
and second screening uptake (Fisher’s exact test applied: p = 0.046), whereby from those 
who attended their second invitation, 15.1% had a breast condition, whereas from among 
non-attendees, 34.6% had a breast condition. There were no significant associations for other 
sociodemographic or health status variables (p > 0.05). 
  
Knowledge of the recommended screening frequency  
There was a significant association between knowledge about recommended frequency for 
attend BS; women who did not attend the second invitation were most unsure of the 
recommended frequency (χ2 = 9.580, p = 0.048). 
 
Health beliefs  
In general, the majority of the HBM constructs showed no statistical significance, except for 
5 items as follows (Table 4.3.2): 25.7% of women who attended the second round strongly 
disagreed with the statement: ‘there is no is possibility of getting BC’ as opposed to 11.5% 
of non-attendees (p = 0.041), while 23.1% of non-attendees were undecided. Attendees 
considered more strongly than non-attendees (41.9% vs 19.2%) that they would sustain 
mammography adherence if their GP advised them to attend (p = 0.028).  
 
On the other hand, non-attendees were in stronger agreement than attendees (11.5% vs 0.0%) 
that mammography is painful or uncomfortable (p = 0.008). Non-attendance to the second 
round was more likely for women who considered reminder letters, reminder phone calls 
and text messages not to be helpful (15.4% non-attendees vs 1.4% attendees) (p = 0.017 
respectively). 
 
4.3.3.2.4 Illness perceptions  
Chi-square tests showed no statistical significance for all illness perception items except for 
one variable (Table 4.3.3): those who attended the second round agreed more strongly than 
non-attendees (39.2% vs 7.7%) that their whole life would change if BC occurred (p = 
0.011).  
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Table 4.3.2 - Comparison of Health Beliefs between attendees and non-attendees 
Attendance to the second BS invitation Yes No Total 
Chi-Square 
testa 
Health Beliefs Mean SD Mean SD Mean SD χ2 
p-
value 
There is no possibility of getting BC (r) 1.8 0.6 2.2 0.7 1.9 0.6 0.3 0.041* 
Your chances of getting BC are high 3.6 0.7 3.5 0.7 3.6 0.7 1.1 0.789 
There may be the possibility of 
developing BC in your lifetime 
4.0 0.3 3.9 0.4 4.0 0.3 3.8 0.147 
When you get a mammogram, you feel 
good about yourself 
4.0 0.3 3.9 0.5 4.0 0.4 6.5 0.088 
When you get a mammogram, you do 
not worry as much about BC 
3.8 0.7 3.7 0.7 3.8 0.7 1.2 0.759 
Having a mammogram will help you find 
lumps early in your breasts 
4.2 0.5 4.1 0.5 4.2 0.5 3.3 0.355 
If you find a lump through a 
mammogram, the treatment for BC may 
not be as bad 
4.0 0.4 4.0 0.2 4.0 0.3 1.2 0.750 
Having a mammogram will decrease 
your chances of dying from BC 
4.0 0.4 3.9 0.4 4.0 0.4 4.3 0.227 
Having a mammogram will help you find 
a lump before it can be felt by yourself 
or a health professional 
4.0 0.4 3.9 0.4 4.0 0.4 3.3 0.344 
Having a routine mammogram would 
make you anxious about BC 
2.7 1.0 3.0 1.1 2.8 1.0 1.6 0.449 
Having a routine mammogram would 
make you worry 
2.7 1.0 2.9 1.1 2.7 1.0 1.5 0.685 
You fear having a mammogram because 
you might find out that something is 
wrong 
2.8 1.1 3.2 1.2 2.9 1.1 6.2 0.103 
You fear having a mammogram because 
you do not know the procedure or what 
to expect 
2.1 0.5 2.4 0.8 2.2 0.6 4.8 0.092 
You fear having a mammogram because 
you know someone (family or friend) 
with BC 
2.6 1.1 2.7 1.2 2.6 1.1 0.6 0.907 
It is embarrassing for you to have a 
mammogram 
2.3 0.8 2.4 0.9 2.4 0.8 0.5 0.779 
Undergoing mammography will be 
painful or uncomfortable 
3.2 1.0 3.3 1.1 3.2 1.0 11.9 0.008* 
Having a mammogram is time 
consuming 
1.3 0.5 1.3 0.7 1.3 0.5 3.8 0.153 
You are discontent with BS personnel as 
they have been rude to you 
1.1 0.4 n/a n/a 1.1 0.4 n/a n/a 
You have fear or distrust in the medical 
team 
1.7 0.8 2.0 0.8 1.8 0.8 4.7 0.094 
Having a mammogram would expose 
you to unnecessary radiation 
2.2 0.6 2.4 0.8 2.3 0.7 1.6 0.652 
You have too many other problems in 
your life than to get a mammogram 
done 
1.7 0.6 1.8 0.7 1.7 0.6 0.7 0.699 
You are not old enough to have a 
mammogram periodically 
1.8 0.4 1.8 0.4 1.8 0.4 0.9 0.344 
If your GP advises you to attend for a 
mammogram, you will attend 
4.4 0.5 4.1 0.6 4.3 0.6 9.1 0.028* 
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*Significant at α=0.05 
(r) = reverse scored 
aChi-square test was applied for all health beliefs; hence the categorical answers were used to apply this test 
for association. For each question, respondents were asked to select a number between 1-5, where 1 = 
strongly disagree and 5 = strongly agree. 
Table 4.3.3 - Comparison of Illness Perceptions between attendees and non-attendees 
Attendance to the second BS invitation Yes No Total 
Chi-Square 
testa 
Illness Perception Mean SD Mean SD Mean SD χ2 
p-
value 
The presence of a lump or thickening in 
the breast 3.9 0.3 3.9 0.4 3.9 0.4 4.8 0.186 
Nipple discharge 3.9 0.4 3.8 0.4 3.9 0.4 0.8 0.666 
Sudden nipple retraction 3.8 0.4 3.7 0.5 3.8 0.4 1.3 0.509 
Change in shape or appearance of the 
nipple 3.9 0.3 3.8 0.4 3.9 0.3 1.0 0.603 
Breast swelling, dimpling, redness or 
soreness of the skin 3.9 0.3 3.7 0.5 3.9 0.4 4.2 0.124 
Skin changes of the breast 3.8 0.4 3.7 0.5 3.8 0.4 1.3 0.509 
A sudden change in breast size 3.9 0.4 3.8 0.4 3.9 0.4 3.4 0.180 
Aching breasts 3.6 0.6 3.4 0.6 3.6 0.6 4.1 0.132 
Stress or worry 2.9 0.9 2.8 0.8 2.9 0.9 0.8 0.673 
Your mental attitude (e.g. thinking about 
life negatively) 2.4 0.6 2.2 0.5 2.4 0.6 1.9 0.379 
If your relatives or friends advise you to 
attend for a mammogram, you will 
attend 
3.6 0.9 3.3 1.0 3.5 0.9 1.9 0.586 
If someone close to you has been 
diagnosed with BC, you will attend for a 
mammogram 
4.3 0.9 4.2 0.9 4.3 0.9 0.9 0.826 
Hearing about BC and BS in the media or 
news makes you think about getting a 
mammogram 
3.6 0.8 3.4 1.0 3.6 0.9 1.7 0.418 
Reminder letters would help you to get a 
mammogram 
4.0 0.3 3.7 0.8 3.9 0.5 8.1 0.017* 
Reminder phone calls or text messages 
would help you to get a mammogram 
4.0 0.3 3.7 0.8 3.9 0.5 8.1 0.017* 
Routine educational talks regarding BC 
awareness would help you to get a 
mammogram 
3.6 0.8 3.4 1.0 3.6 0.9 1.7 0.418 
You feel confident that if you had a 
mammogram done, any abnormalities in 
your breasts will be detected 
3.7 0.6 3.5 0.7 3.7 0.6 3.1 0.378 
You can arrange other things in your life 
to get a mammogram 
4.2 0.6 4.0 0.9 4.1 0.7 6.2 0.103 
In case you need a mammogram, you 
will find a place to get it done 
4.2 0.5 4.1 0.5 4.2 0.5 3.3 0.355 
You can make an appointment for a 
mammogram 
4.2 0.5 4.2 0.5 4.2 0.5 3.3 0.355 
You can arrange transportation to get a 
mammogram 
4.2 0.5 4.2 0.5 4.2 0.5 3.3 0.355 
You can talk to people at the BS centre 
about your concerns 
4.1 1.0 n/a n/a 4.1 1.0 n/a n/a 
You can find a way to pay for a 
mammogram if you need to 
4.3 0.4 4.2 0.5 4.2 0.5 2.9 0.234 
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Family problems or worries 2.9 0.9 2.7 0.8 2.8 0.9 1.5 0.477 
Overwork 2.4 0.7 2.2 0.6 2.4 0.7 1.5 0.483 
Your emotional state (e.g. feeling down, 
lonely, anxious, empty) 2.5 0.8 2.3 0.5 2.5 0.7 3.6 0.167 
Your personality 2.5 0.8 2.3 0.5 2.4 0.7 1.9 0.597 
Hereditary - it runs in the family 4.6 0.5 4.4 0.7 4.6 0.6 5.1 0.080 
Diet or eating habits 3.3 0.9 2.8 0.9 3.2 0.9 7.1 0.069 
Poor medical care in the past 3.3 0.9 3.3 0.8 3.3 0.9 0.9 0.818 
Your own behaviour 2.6 0.7 2.7 0.6 2.6 0.7 3.6 0.164 
Ageing 3.0 0.9 3.2 0.9 3.1 0.9 1.2 0.562 
Smoking 3.7 0.6 3.5 0.8 3.7 0.7 3.5 0.174 
Alcohol 3.5 0.8 3.2 0.9 3.4 0.8 2.6 0.272 
A germ or virus 3.1 0.8 3.0 0.8 3.1 0.8 0.8 0.686 
Pollution in the environment 3.7 0.7 3.3 1.0 3.6 0.8 6.2 0.104 
Altered immunity 3.6 0.7 3.8 0.5 3.7 0.6 5.7 0.129 
Chance or bad luck 2.9 1.0 3.1 1.0 2.9 1.0 4.1 0.386 
Accident or injury 3.0 1.0 3.0 0.9 3.0 0.9 0.9 0.831 
BC will last a short time 2.7 0.7 2.7 0.5 2.7 0.7 3.8 0.286 
BC is likely to be permanent rather than 
temporary 3.4 0.7 3.2 0.8 3.3 0.7 3.4 0.178 
A patient with BC goes through cycles in 
which her illness gets better and worse 3.6 0.7 3.4 0.7 3.5 0.7 3.0 0.394 
BC has major consequences on a 
patient's life 4.4 0.6 4.1 0.6 4.3 0.6 6.3 0.096 
BC will not have much effect on your life 1.5 0.7 1.5 0.8 1.5 0.7 3.7 0.297 
BC would strongly affect the way others 
see you 3.4 0.9 3.6 0.8 3.5 0.8 1.4 0.506 
BC has serious economic and financial 
consequences 3.9 0.5 3.8 0.5 3.9 0.5 1.9 0.587 
BC would strongly affect the way you 
see yourself as a person 4.1 0.5 4.1 0.6 4.1 0.5 0.6 0.736 
BC would threaten a relationship with 
your husband or partner 3.1 1.0 2.9 0.9 3.1 0.9 1.4 0.714 
If you had BC, your whole life would 
change 4.4 0.6 4.0 0.4 4.3 0.6 11.2 0.011* 
If you developed BC, the chances of 
living a long life would decrease 4.1 0.4 4.0 0.0 4.0 0.3 3.9 0.142 
There is a lot which you can do to 
control the symptoms if BC occurs 3.9 0.5 4.0 0.0 3.9 0.4 1.8 0.604 
The course of BC will depend on your 
actions 4.0 0.4 4.0 0.0 4.0 0.3 1.5 0.691 
Your actions will have an effect on the 
outcome of BC 4.0 0.4 4.0 0.0 4.0 0.3 2.2 0.524 
There is no treatment that will help to 
improve BC 2.1 0.6 2.0 0.6 2.0 0.6 0.5 0.930 
The treatment provided will be effective 
in controlling or curing BC 4.0 0.2 4.0 0.2 4.0 0.2 0.4 0.804 
The negative effects of BC can be 
prevented or avoided by the treatment 
given 4.0 0.2 4.0 0.2 4.0 0.2 1.0 0.621 
You have a clear picture and 
understanding of BC 3.6 0.7 3.7 0.7 3.7 0.7 0.7 0.722 
BC is a mystery to you 3.2 1.0 3.2 1.0 3.2 1.0 1.3 0.860 
You get anxious when you think about 
BC 3.6 1.1 3.7 1.0 3.6 1.1 3.2 0.359 
BC makes you feel afraid 4.2 0.7 4.3 0.5 4.2 0.7 2.2 0.523 
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You get worried when you think about 
BC  4.3 0.8 4.4 0.5 4.3 0.7 2.3 0.504 
*Significant at α=0.05 
aChi-square test was applied for all illness perceptions; hence the categorical answers were used to apply this 
test for association. For each question, respondents were asked to select a number between 1-5, where 1 = 
strongly disagree and 5 = strongly agree. 
4.3.3.3 Differences between attendees and non-attendees 
We further explored health beliefs and illness perceptions as ‘constructs’ and which of these 
constructs were statistically significant with BS uptake. Table 4.3.4 shows the relationship 
of all 14 constructs respectively (perceived susceptibility, perceived benefits, perceived 
barriers, cues to action, self-efficacy, BC identity, BC causes, cancer timeline: 
acute/chronic, cancer timeline: cyclical, consequences, personal control, treatment control, 
illness coherence, emotional representations) when compared to attendance and non-
attendance to second BS round. 
Table 4.3.4 - Comparisons between health beliefs/illness perception constructs and second 
breast screening uptake 
  
Range 
    Attendees  
  (n = 74) 
  Non-attendees  
(n = 26) 
Test            
Statistic 
p-
value 
Perceived Susceptibility 3 – 15  M=9.5, SD=0.8 M=9.6, SD=0.9 1019.5b 0.626 
Perceived Benefits 
 
6  - 30 M=24.0, SD=1.7 M=23.6, SD=1.6 864.0b 0.384 
Perceived Barriers 
 
13 – 65 M=27.0, SD=4.5 M=29.2, SD=6.1 -2.0a 0.049* 
 
Cues to action 
 
7 – 35 
 
M=27.6, SD=2.8 
 
M=25.9, SD=4.4 
 
726.5b 
 
0.061 
Self-Efficacy 
 
7 – 35 M=24.9, SD=2.7 M=24.2, SD=2.7 783.0b 0.129 
BC Identity 
 
8 – 40 M=30.8, SD=1.9 M=29.9, SD=2.5 776.0b 0.124 
BC Causes  
 
18 – 90 M=55.8, SD=7.2 M=53.9, SD=5.9 1.2a 0.238 
 
Cancer Timeline: 
Acute/Chronic 
 
 
2 – 10 M=6.1, SD=0.8 M=5.9, SD=0.8 839.0b 0.295 
Cancer Timeline: Cyclical 
 
1 – 5 M=3.6, SD=0.7 M=3.4, SD=0.7 829.5b 0.221 
Consequences 
 
8 – 40 M=28.8, SD=2.3 M=28.1, SD=1.9 744.0b 0.083 
Personal Control 
 
3 - 15 M=11.9, SD=0.7 M=12.0, SD=0.0 1014.0b 0.432 
Treatment Control 
 
3 - 15 M=10.0, SD=0.6 M=9.9, SD=0.6 865.0b 0.265 
Illness Coherence 
 
2 - 10 M=6.8, SD=1.2 M=6.9, SD=1.1 991.5b 0.802 
Emotional Representations 
 
3 - 15 M=12.1, SD=2.3 M=12.4, SD=1.8 991.5b 0.811 
*Significant at α=0.05, a Independent Samples t-test, b Mann Whitney  
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The ‘perceived barrier’ construct was the only statistically significant variable that described 
the variance between attendees and non-attendees.  
 
4.3.3.4 Predictors of attendance and non-attendance to the second screening round  
For all logistic regression models, the most significant variables were identified and 
presented in Table 4.3.5. Logistic regression models 1 and 2 incorporated all items related 
to socio-demographic and health status variables respectively, though none were found to 
be significant predictors of second BS uptake. 
 
Models 3 to 7 include the psychosocial variables. Model 3 focused on health belief variables 
only; hence, all HBM items were incorporated in logistic regression model 3, of which three 
variables were found to be good BS predictors: 'there is no possibility of getting BC', 'fear 
of the unknown procedure', and 'GP advice to attend' (Table 4.3.5). For this model, 
attendance was predicted with an accuracy of 93.2% and non-attendance with 30.8% 
accuracy. When removing ‘fear of the unknown procedure’ from the model, the accuracy 
decreased from 30.8% to 19.2% and hence was retained even though p > 0.05. 
 
Model 4 focused on the illness perception variables only; hence, Model 4 included all IPQ-
R variables, of which four variables were found to be good predictors: 'breast swelling, 
dimpling, redness or soreness of the skin', 'diet', 'altered immunity', and 'if you had BC, your 
whole life would change' (Table 4.3.5). The model accuracy was 89.2% for attendance and 
69.2% for non-attendance.  
 
Model 5 focused on the significant variables found in model 3 and 4 altogether, i.e. on 7 
variables (3 Health Beliefs and 4 Illness Perception variables). The final model (Model 5) 
retained the same significant predictors as in Model 4, excluding the Health Belief variables, 
hence showing that Illness Perceptions are important predictors for second BS uptake. The 
model accuracy, when combining both scores, was identical to that of Model 4, predicting 
attendance by 89.2% and non-attendance by 69.2%.  
 
Model 6 incorporated all individual Health Beliefs and Illness Perception items, of which 14 
variables were significantly different. However, the latter variables made this model more 
complex due to the large number of predictors. The model accuracy improved substantially 
to 95.9% for attendees and 84.6% accuracy for non-attendees. The model accuracy 
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decreased from 84.6% to 76.9% when the following variables were removed from the model: 
‘if you find a lump through a mammogram, BC treatment may not be as bad’ and ‘having a 
mammogram will decrease your chances of dying from BC’. Hence, the latter variables were 
retained even though p > 0.05. 
 
When Health Beliefs and Illness Perceptions were used to construct a logistic regression 
model (Model 7) with all 14 constructs (not individual items), ‘perceived barriers’, ‘BC 
identity’, ‘BC causes’ and ‘consequences’ were found to be the most significant predictors, 
with ‘perceived barriers’ being the strongest predictor. However, non-attendance was 
predicted with an accuracy of 30.0%, which is inferior when compared to Models 5 and 6 
(69.2%). Moreover, when removing the constructs ‘BC causes’ and ‘consequences’ from the 
model (p-value slightly greater than 0.05), the accuracy to predict non-attendance would 
decrease from 30.0% to 15.4% even though p > 0.05. 
 
Although ‘perceived barriers’ remains the most important construct to describe the variance 
between attendees and non-attendees, illness perception constructs (BC identity, its causes 
and consequences) can also be considered as strong predictors of second BS uptake; a result 
further echoed in Model 5, where the predictors are all related to illness perceptions (BC 
identity, causes and consequences). Hence, although Health Beliefs are important BS 
predictors, the model accuracy improved with the inclusion of illness perception items into 
one logistic regression model (Model 6 vs Model 3). 
 
Table 4.3.5 - Logistic Regression Models on second breast screening uptake against different 
variables and different constructs  
 
  
B SE Wald 
P-
value 
OR 95% CI 
Model 
Accuracy 
YES 
Model 
Accuracy 
NO 
Model 1: 
Demographics 
 100% 0% 
Age -0.154 0.084 3.329 0.068 0.858 0.727, 1.011     
Constant 7.926 4.905 2.611 0.106 2769.527       
Model 2: Health 
Status             
100% 0% 
Breast condition -1.093 0.526 4.315 0.038 0.335 0.119, 0.940     
Constant 0.893 0.940 0.902 0.342 2.441       
Model 3: Health 
Beliefs             
93.2% 30.8% 
No possibility of 
getting BC 
1.064 0.474 5.030 0.025 2.897 1.144, 7.338     
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Fear of unknown 
procedure* 
0.563 0.388 2.102 0.147 1.755 0.820, 3.756 
  
  
GP advice -1.145 0.562 4.158 0.041 0.318 0.106, 0.956     
Constant 0.480 2.717 0.031 0.860 1.617       
Model 4: Illness 
Perceptions             
89.2% 69.2% 
Breast swelling, 
dimpling, redness 
or soreness of the 
skin  
-1.796 0.720 6.215 0.013 0.166 0.040, 0.681 
    
Diet -1.029 0.312 10.873 0.001 0.357 0.194, 0.659     
Altered immunity 1.462 0.568 6.610 0.010 4.313  1.415, 3.141     
Whole life would 
change 
-1.334 0.533 6.257 0.012 0.263 0.093, 0.749     
Constant 9.082 3.931 5.337 0.021 8796.855       
Model 5: Health 
Beliefs and Illness 
Perceptions 
          
  
89.2% 69.2% 
Breast swelling, 
dimpling, redness 
or soreness of the 
skin  
-1.796 0.720 6.215 0.013 0.166 0.040, 0.681 
    
Diet -1.029 0.312 10.873 0.001 0.357 0.194, 0.659 
    
Altered immunity 1.462 0.568 6.610 0.010 4.313  1.415, 3.141     
Whole life would 
change 
-1.334 0.533 6.257 0.012 0.263 0.093, 0.749     
Constant 9.082 3.931 5.337 0.021 8796.855       
Model 6: Health 
Beliefs and Illness 
Perceptions 
          
  
95.9% 84.6% 
Early detection 5.699 2.097 7.390 0.007 298.646 
4.904, 
18187.040     
If early detection, 
treatment not as 
bad** 
12.267 7.293 2.830 0.093 2.126x105 
0.132, 
3.427x1011     
Having 
mammography 
decreases chances 
of dying** 
-8.890 6.724 1.748 0.186 0.000 
0.000, 
72.821 
  
Fear of unknown 
procedure 
5.210 1.842 8.003 0.005 183.103 
4.955, 
6765.914     
Unnecessary 
radiation 
4.471 1.655 7.301 0.007 87.419 
3.414, 
2238.732     
Breast swelling, 
dimpling, redness 
or soreness of the 
skin 
-8.961 3.119 8.252 0.004 0.000 0.000, 0.058 
    
Personality -5.566 2.295 5.885 0.015 0.004 0.000, 0.343     
Diet -5.558 1.946 8.160 0.004 0.004 0.000, 0.175     
Germ or virus -5.721 2.168 6.967 0.008 0.003 0.000, 0.229     
Altered immunity 8.217 2.860 8.254 0.004 3705.048 
13.620, 
1.008x106     
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BC lasts a short 
time 
-2.623 1.042 6.340 0.012 0.073 0.009, 0.559     
Affects the way 
others see you 
3.105 1.286 5.831 0.016 22.305 
1.795, 
277.210     
Whole life would 
change 
-9.738 3.266 8.888 0.003 0.000 0.000, 0.036     
You get worried if 
BC occurs 
2.444 1.199 4.159 0.041 11.521 
1.100, 
120.694     
Constant 14.947 26.502 0.318 0.573 3.102x106       
Model 7: The 14 
constructs             94.6% 30.0% 
Perceived barriers 0.155 0.054 8.305 0.004 0.167 1.051, 1.296     
BC identity -0.231 0.120 3.691 0.055 0.794 0.627, 1.005     
BC Causes*** -0.070 0.040 3.022 0.082 0.932 0.861, 1.009     
Consequences*** -0.204 0.116 3.082 0.079 0.815 0.649, 1.024   
Constant 11.286 4.983 5.129 0.024 79721.454       
B unstandardized coefficients; SE standard error; OR odds ratio; CI confidence interval 
 *’Fear of unknown procedure’ was retained due to better accuracy in the logistic regression model. Without 
this variable, the accuracy would decrease from 30.8% to 19.2%. 
**’If early detection, treatment not bad’ and ‘Having mammography decreases death’ were retained due to 
better accuracy in the logistic regression model. Without these variables, the accuracy would decrease from 
84.6% to 76.9%. 
***’BC Causes’ and ‘Consequences’ were retained due to better accuracy in the logistic regression model. 
Without these variables, the accuracy would decrease from 30.0% to 15.4%. 
 
4.3.3.5 Predicting attendance to second screening using first screening uptake 
When a logistic regression model was applied to predict second BS uptake using the first BS 
uptake as the predictor (Table 4.3.6, Model 8), non-attendance was predicted with an 
accuracy of 65.4% and attendance with an accuracy of 83.8%.  
 
Another model (Table 4.3.6, Model 9) incorporated the Health Beliefs and Illness 
Perception constructs as covariates, together with the first BS uptake variable as the main 
dependent variable. Model 9 shows that, following the inclusion of all constructs, ‘perceived 
barriers’ and ‘BC identity’ were found to be important covariates to improve the accuracy 
of predicting attendance to the second cycle i.e. 83.8% (Model 8) to 91.9% (Model 9). On 
the other hand, model accuracy dropped from 65.4% (Model 8) to 61.5% (Model 9) when 
predicting non-attendance to the second MBSP invitation. 
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Table 4.3.6 - Logistic regression analysis on the prediction of second breast screening uptake 
 
  
B SE Wald 
P-
value 
OR 95% CI 
Model 
Accuracy 
YES 
Model 
Accuracy 
NO 
Model 8: 2nd 
Screening 
Uptake 
  83.8% 65.4% 
1st Screening 
Uptake 
-2.278 0.519 19.266 0.000 0.102 0.037, 0.283     
Constant 0.348 0.377 0.853 0.356 1.417       
Model 9: 2nd 
Screening 
Uptake 
      91.9% 61.5% 
1st Screening 
Uptake 
2.462 0.571 18.591 0.000 11.728 3.830, 35.914     
Perceived 
barriers 
0.129 0.057 5.102 0.024 1.138 1.017, 1.273   
BC identity -0.272 0.123 4.917 0.027 0.762 0.599,0.969   
Constant 0.157 3.730 0.002 0.966 1.170    
B unstandardized coefficients; SE standard error; OR odds ratio; CI confidence interval 
 
4.3.4 Discussion 
It is not enough to getting women to initiate BS, but it is essential to encourage them to 
maintain use over time. Previous studies have examined re-attendance rates (Jack et al. 2014; 
Gierisch et al. 2010; O’Byrne et al. 2000). However, BS statistics are not available 
specifically for a second BS invitation. The available routine BS statistics largely provide 
cross-sectional estimates of coverage rather than information on women’s ongoing BS 
attendance (Moser et al. 2009). Moreover, data has long relied on self-reports (Meissner et 
al. 1998), are measured by area deprivation (using either residential postcodes or general 
practice postcodes) rather than individual characteristics (Maheswaran et al. 2006) and can 
be affected by inflation based on registered general practice lists (Moser et al. 2009).  
 
The preliminary rates for Maltese women invited to their second call seem to be lower than 
those in other countries (Figure 4.3.2: from the total data (n = 100), 62% of Maltese women 
attended the first and second round, 9% had attended the first but not the second round, 17% 
attended neither call). In a recent study in London among different ethnic groups (Jack et al. 
2014), white British women were most likely to attend their first call (67%) and routine 
recall (78%). Mixed White and Asian women had the next highest uptake of routine recall 
invitations (75%), followed by Indian women (first call (61%) or routine recall (74%) 
appointments), Pakistani (52% and 67%, respectively) and Bangladeshi women (43% and 
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61%, respectively). The lower subsequent uptake rates in Malta could be due to the 
programme being relatively new. This study therefore sought to explore the associations and 
predictive psychosocial factors to second screening based on HBM and CSM.  
 
All sociodemographic characteristics were not significantly associated with second 
screening uptake and the latter were also found to be non-significant predictors of second 
screening at the MBSP. These findings are substantiated by similar predictors of returning 
to a second screen in Australia (O’Byrne et al. 2000). 
 
More specifically, earlier studies found that women with a breast problem were more likely 
to undergo clinical breast examination (CBE) and mammography than those who had none 
(Parsa and Kandiah 2010; Juon et al. 2002), while poor self-rated general health status was 
not associated with ever having had a mammogram in another study (Achat et al. 2005). 
This relationship is likely driven by higher knowledge levels on BS benefits (Juon et al. 
2002). In contrast, significant differences were not observed between attendees and non-
attendees for self-reported health status in this study, except for those who claimed they had 
a breast condition. The latter women were more likely not to attend for second screening 
when compared with those who said they had no breast problems. It is acknowledged that 
self-reports may not be as accurate as clinically documented mammographic reports. 
Nonetheless, in view of the nature and organization of the cognitive and emotional 
representations of such a health threat, as proposed by CSM (Anagnostopoulos et al. 2012; 
Baines and Wittkowski 2013), women may have opted to attend for private mammography, 
possibly as my earlier studies suggests, to obtain an earlier result (Marmarà et al. 2017b; 
Marmarà et al. 2015). Such reasons for non-attendance to second screening merit further 
investigation in the local context.  
 
This study also provides evidence that women who were less knowledgeable of the 
recommended screening frequency were less likely to reattend at the MBSP. There is a 
similar widespread lack of knowledge of recommended screening guidelines for a first BS 
invitation in Malta (Marmarà et al. 2017b) and in other countries (Charkazi et al. 2013; 
Sadler et al. 2007). The impact of the physician-patient relationship may play an important 
role in the latter finding. In this respect, it is important to note the variation in the order of 
invitation from service to service as highlighted in section 1.5.1. For example, in the UK, 
women are invited to BS through GP practices (Zelenyanszki 2009) whereas in Malta, 
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women are invited to BS according to age cohorts. Possibly, this infrequent encounter 
between GPs and Maltese women (Table 4.3.1) may be the reason for physicians’ lack of 
opportunity to address knowledge gaps and to recommend regular BS.  
 
Factors associated with BS behaviours in other populations (Kim et al. 2014; Secginli and 
Nahcivan 2006) were similar to the second MBSP round. Namely, Maltese women who 
believed that they were susceptible to BC, considered personal consequences of the disease, 
believed that mammography was not painful, and considered cues to action to motivate them 
to attend, were more likely than others to reattend. Similarly, items for BC consequences 
and cues to action as well as mammography pain were also significantly associated with first 
BS uptake. Evidence has shown that women’s responsibilities within the family may conflict 
with self-care and limit screening attendance and re-attendance (Haley et al. 2011). Efforts 
to educate health care providers, particularly physicians, should emphasize the importance 
of mammography and regular physical check-ups (Secginli and Nahcivan 2006).  
 
Of the remaining cognitive variables, perceived BC susceptibility and attitude towards BS 
use predicted attendance to the second round, echoing predictors of repeat use in other 
studies (Rauscher et al. 2005) while contrasting others (Gierisch et al. 2010). Attitudes 
towards BS behaviour and risk perceptions may be necessary components of why Maltese 
women contemplate maintaining a behaviour, but may not be prime motivators to influence 
the initiation of that behaviour. 
 
Self-efficacy was not significantly associated with maintaining BS practices in Study 3 but 
played a key role in explaining why some women were unable to initiate BS at the MBSP 
(Marmarà et al. 2017b). Although previous research has shown that self-efficacy may be 
particularly central in moving women from contemplating about undergoing mammography 
to actually obtaining it (Menon et al. 2007), in the context of a second invitation, the rising 
challenges or barriers women experience when trying to maintain that behaviour may buffer 
the intentions that prompt planning for that behaviour (Gierisch et al. 2010). 
 
Although several variables differentiated those women who returned for second screening 
from those who did not, the ‘perceived barrier’ construct was found to consistently explain 
the differences between attendees and non-attendees and to improve the accuracy of 
predicting attendance to the second screening cycle; a concurrent finding for first invitation. 
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A trial by Farhadifar and colleagues (Farhadifar et al. 2016) also suggests that regular BS 
practices are related to fewer barriers. The fact that some women did not return to their 
second invitation implies that based on their first contact with the screening service, they 
were less likely to return for routine calls. In the extant literature, this is attributable to a 
previous negative experience (Parkington et al. 2009), possibly due to pain or discomfort 
(Marmarà et al. 2015; Carney et al. 2002), embarrassment, distress, unhelpful staff and/or 
lower reassurance during the first screen (Myklebust et al. 2009). Study 2 also provides 
evidence that fear of pain was a major factor for not attending the first BS invitation 
(Marmarà et al. 2017b) and similarly, this study found pain to be a significant determinant 
to non-adherence. Preparing women through the invitation letter or in screening campaigns 
(Aro et al. 2001) and improving the mammography experience so that it matches women’s 
expectations could help to increase and maintain BS uptake (Jack et al. 2014).  
 
The inclusion of both Health Beliefs and Illness Perception items in Study 3 improved the 
accuracy of predicting non-attendance to the second cycle (Model 6, 84.6%). This finding 
coincides with findings for first invitation (Marmarà et al. 2017b). Given the importance of 
both theories and the higher predictive accuracy for both BS cycles, it is likely that 
psychosocial variables, women’s BC perception and its related risk, and the enactment of 
cancer control measures predict regular BS behaviours (Petrak et al. 2015) in an attempt to 
gain control over the disease (Katapodi et al. 2004). This sense of internal control has been 
proven among disease-effected individuals across diverse health contexts (Cabassa et al. 
2008; Hill et al. 2007; Moss-Morris et al. 2002) and healthy individuals (Petrak et al. 2015; 
Anagnostopoulos et al. 2012).  
 
Finally, when considering that only one variable was utilised to predict second BS uptake, 
Model 8 can be considered as an extreme improvement over all the previous logistic 
regression models (Table 4.3.5). Furthermore, the fact that Model 8 utilised only one 
predictor to predict second uptake makes the model more efficient and easy to use. 
Moreover, first screening uptake is a very important and significant predictor to predict 
future uptake as this variable does not require any health beliefs and/or illness perception 
variables or any other information to predict second BS uptake. These results further support 
the evidence that women who obtain at least one mammogram are more likely to obtain 
subsequent screening (Anagnostopoulos et al. 2012; Moodi et al. 2012; Allen et al. 2008). 
Attendees may be more aware of the possibility for BC to occur, possibly because a BC 
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threat (BC identity, causes and consequences found as CSM predictors for a second BS 
invitation in this study), coupled by BS benefits, may have helped the individual to ascertain 
what factors pose barriers to BS attendance and adjust these in the first place. Therefore, 
what matters most is the social and psychological characteristics, health behaviours and 
attitudes which women bring to screening the first time, such as a positive attitude towards 
BS, its value, health behaviours and the belief that an individual would be able to overcome 
any obstacles to attendance (Anagnostopoulos et al. 2012; Moodi et al. 2012). The most 
important implication is that if women can be recruited successfully on the first occasion, 
they will probably stay in the programme. Hence, efforts could be focused on identifying 
and encouraging attendance among women who have never participated in BS and who are 
reluctant or unsure to participate initially (Cockburn et al. 1997) because if women are 
persuaded to change their beliefs, attendance rates will increase and reattendance will 
become a routine (Rutter et al. 1997). 
 
4.3.5 Strengths and limitations 
Study 3 was not subject to response bias because figures for re-attendance were extracted 
from screening records. This study is one of a few to assess sociodemographic and attitudinal 
variables as predictors of adherence, but we found none that used initial predictors including 
HBM and CSM to explore factors to second screening. There are some limitations in our 
research. The limited sample size to examine women’s attendance to a second BS invitation 
may have reduced sample representativeness. The characteristics of some women may have 
changed from first to second screening; this may have introduced misclassification and an 
underestimation of the relationships presented. Notwithstanding, the study design was 
necessary for the feasibility to conduct a prospective study to clarify and strengthen our 
findings, based on an understanding of the culture and attitudes among Maltese womenn. 
Additional research would help to identify barriers and reasons influencing decisions about 
BS adherence at the MBSP. 
 
4.3.6 Conclusions 
Researchers have focused more often on promoting behaviour change than on sustaining 
change. For the first time, the psychosocial associations and predictors to the second 
screening invitation were explored based on demographic factors, health status, knowledge, 
health beliefs, illness perceptions, and actual previous health behaviours. The combination 
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of HBM and CSM variables provided improved prediction of attendance and non-attendance 
to the second screening call. Perceived barriers, BC identity, causes of BC, and 
consequences contributed most to the regression model, though perceived barriers was 
consistently significant across the analyses. Interventions should particularly target non-
attendance to first screening. If non-attendees can be persuaded to attend once, they are likely 
to re-attend, unless their screening experience has been a negative one. The implications of 
these results are considered for theory, policy and practice to improve the limited 
understanding of second round screening and to aid the design of culturally sensitive 
interventions to improve BS uptake in Malta. 
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Chapter 4 
 
Study 4: Lifetime utilization of mammography 
among Maltese women4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4A version of this chapter has been published in the BMC Public Health Journal (Appendix 4.3.1) (Marmarà 
et al. 2018a).    
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4.4 Introduction 
Study 3 concluded that BS interventions to increase uptake should target first invitees since 
attending for the first time is a strong predictor of uptake to the second cycle. Furthermore, 
Study 2 identified that screening non-attendees consisted clearly of two distinct subgroups: 
(i) women, who had obtained a mammogram outside the MBSP, possibly as a self-initiated 
action or routine check-up (Aro et al. 2001) or as part of private breast awareness campaigns, 
which may have been based on their recognition of BC susceptibility and high self-efficacy 
in preventing BC (Jahanlou et al. 2013), and  
(ii) ‘lifetime non-attendees’ i.e. women who have never attended anywhere for 
mammography during their lifetime. It is unknown which determinants are predictive of 
lifetime attendance ‘anywhere’ and lifetime non-attendance.  
 
Most of the literature does not take into account the context of mammography provision, 
such as countries with dual health systems (organized and private screening). Considering 
the fact that the Maltese NHS comprises both the public and private sectors, and that the 
MBSP was introduced at the end of 2009 for women aged 50-60 at the time (European 
Commission 2014), some women chose to go privately for a mammogram before the year 
2009 and still do so to date rather than taking up the invitation to be screened at the MBSP. 
It is the diversity of ‘lifetime non-attendees’ that needs to be better understood, in order to 
develop culturally sensitive interventions (Aro et al. 2001).  
 
This study is a continuation of Study 2 such that data from that 2015 national survey were 
used to examine the relationship between ever-using mammography i.e. attendance 
‘anywhere’ (LIFETIME attendance) or never using mammography (LIFETIME non-
attendance) with socio-demographics, health status, knowledge, health beliefs and illness 
perception variables. Study 4 was guided by STROBE guidelines (Appendix 4.3.2). 
 
4.4.1 Aims and Objectives 
The aim of Study 4 was to gain an understanding of the determinants of lifetime 
mammography use among Maltese women who attend for mammography ‘anywhere’ and 
those who ‘never’ attend for mammography during their lifetime, thus meeting research 
question 2c: 
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RQ 2c: Which significant factors (i.e. health beliefs, illness perceptions, knowledge, socio-
demographic factors and health status) are associated with lifetime mammography use? 
In reaching this RQ, the analysis has targeted the following objectives: 
(1) To determine the socio-demographics, health status, knowledge, health beliefs and illness 
perceptions of women who attend or do not attend for mammography screening during their 
lifetime;  
(2) To examine the most significant predictors of lifetime mammography utilization and its 
non-use.  
 
4.4.2 Methods 
4.4.2.1 Design and setting 
Since Study 4 uses the same dataset of Study 2, the full details of the methods and sample 
are described in Section 4.2.3. For those invited to the MBSP, attendance or non-attendance 
was verified through screening records but further mammography performed in private 
practices was self-reported.  
 
4.4.2.2 Survey development 
The composition of the survey questionnaire is described elsewhere (Section 4.1.4.2). 
Lifetime mammography practices and knowledge on mammography time intervals were 
incorporated into 4 subscales (17 items).  
 
4.4.2.3 Classification of variables  
Women were asked if they ever had a mammogram in their lifetime with a yes/no response.  
Women were categorized as LIFETIME ATTENDEES if they had ever had a mammogram 
in their lifetime or LIFETIME NON-ATTENDEES if they had never attended for a 
mammogram during their lifetime.  
 
4.4.2.4  Statistical Analysis 
The chi-square test was used for comparison of proportions between two categorical 
variables. The Shapiro Wilk test was applied on the 14 constructs in order to determine 
whether these variables are normally distributed. It was found that only the variable Causes 
of BC was normally distributed. Hence, parametric tests were used for this latter construct. 
All the other 13 constructs were found to be not normally distributed (p-value <0.001) and 
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hence, non-parametric tests were used for all the 13 constructs. When comparing two 
independent samples, the Independent Samples t-test was used for normally distributed data 
(parametric test) and Mann-Whitney test was used for the non-normal distributed dataset 
(non-parametric test). Similarly, for analysis including two of more independent samples, 
ANOVA was used for normally distributed data and Kruskal-Wallis test was used for the 
non-normal distributed datasets. Different variables and constructs were incorporated into 
six logistic regression models and the ‘backward-elimination’ method was applied to each 
model to identify the significant predictors of lifetime mammography use. The results of the 
regression are reported with 95% confidence intervals, Beta (unstandardized) coefficients, 
Standard Errors (SE), Walds, Odds Ratios (OR) and p-values. All tests were analysed with 
an α = 0.05 level of significance; hence, any statistical test obtaining a p-value of < 0.05 was 
considered as statistically significant. Missing data was minimal (n=23 for frequency of GP 
visit) and this missing data was reported in Study 2 (Table 4.2.1). Missing data was reported 
as is; hence this data was not excluded. The data was analyzed using SPSS® version 21.0 
 
4.4.3 Results 
4.4.3.1 Sample characteristics 
Descriptive statistics are presented in Study 2 (Section 4.2.3.1). 
 
4.4.3.2 Mammography screening practices 
Mammography screening practices are presented in Figure 4.4. BS use (LIFETIME 
ATTENDEES) was reported by 86.1% of women (n = 348), of which 243 women underwent 
a mammogram at the MBSP. From those who did not undergo a mammogram at the MBSP 
(n = 161), 105 women underwent mammography elsewhere. No mammography was 
reported by 13.9% (n = 56) (LIFETIME NON-ATTENDEES).  
 
4.4.3.3 Lifetime attendees versus lifetime non-attendees subgroup analyses  
Chi-square tests were performed to explore associations between lifetime attendees and non-
attendees, and the following variables: sociodemographic factors, health status, knowledge, 
health beliefs and illness perceptions. 
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Figure 4.4 - Mammography use in Malta  
 
4.4.3.4 Sociodemographic factors and health status  
There was significant association between marital status and lifetime mammography (χ2 = 
9.0, p = 0.030) such that a lower number of widowers attended for mammography (66.7%) 
when compared to women of other statuses (single, married, separated/divorced) (≥87%). 
The higher their family income, the more likely it is for a woman to undergo mammography 
in her lifetime (χ2 = 13.1, p = 0.011). In fact, all women who had a family annual income 
greater than €23 564 claimed that they acquired mammography during their lifetime while 
from those with a family annual income lower than €10 737, around one in every four women 
did not undergo mammography. In addition, those who do not drive are more likely not to 
attend for a mammogram (χ2 = 7.7, p = 0.006). Our data showed that 91.5% of drivers 
attended for a mammogram in their lifetime as compared to 81.9% of non-drivers. All 
women in our sample who said they had a breast condition attended for mammography in 
their lifetime when compared to 82.9% of women without a breast condition (χ2 = 14.2, p < 
0.001). Moreover, those who had relatives or close friends with cancer were more likely to 
attend for mammography (χ2 = 8.3, p = 0.016). 
 
No significant association was found between lifetime mammography and age (Independent 
samples t-test: p = 0.133), district (χ2 = 7.8, p = 0.802), owning a car (χ2 = 1.2, p = 0.267) 
or having an illness (χ2 = 0.1, p = 0.709). Although there was no significant association for 
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education level (χ2 = 5.4, p = 0.067) and occupation (χ2 = 5.7, p = 0.057), women with a 
higher education level and who were employed were more likely to undergo mammography 
in their lifetime (e.g. 93.2% {employed} versus 83.9% {housewives}). There was no 
significant association between having a family physician and lifetime mammography (χ2 = 
3.5, p = 0.060). However, women who were not encouraged by their GP were more likely 
not to attend for a mammogram during their lifetime (χ2 = 4.9, p = 0.027).  
 
4.4.3.5 Knowledge of the recommended mammography frequency  
Knowledge of mammography frequency was significantly associated with whether women 
had undergone a mammogram in their lifetime (χ2 = 28.5, p < 0.001). The main difference 
arises with those who said they were ‘unsure’ about the recommended mammography 
frequency (48% of the latter group did not undergo a mammogram in their lifetime), whereas 
for women who mentioned other mammography frequency options (i.e. ‘every year’; ‘every 
1.5 years’; ‘every 2-3 years’), more than 86% of women from each individual latter groups 
had acquired a mammogram.  
 
4.4.3.6 Health beliefs  
All sub-scale items for perceived barriers and cues to action for mammography use were 
found to be statistically significant (p < 0.05) (Table 4.4.1). Women tend to attend less for 
mammography if they are in agreement with or are undecided on the following: having a 
mammogram ‘would make you more anxious’, ‘more worried’, ‘more fearful about BC’ and 
‘the procedure itself’, is ‘embarrassing’ and ‘time-consuming’ and ‘causes unnecessary 
radiation’, have ‘fear or distrust the medical team’, ‘consider other problems in life to be 
greater’ and feel they are ‘not old enough to have a mammogram periodically’ (p < 0.001 
respectively). Significant association is mirrored for the statement ‘you fear having a 
mammogram because you know someone (family or friend) with BC’ (p < 0.001). When 
comparing pain and discomfort with mammography use, statistical significance is mirrored 
(p < 0.001), whereby the absolute majority of the undecided group (95.8%) do not attend for 
a mammogram in their lifetime whereas those who are in disagreement or in agreement 
(≥88%) attend for mammography.  
 
Those who underwent mammography tend to attend more for mammography if advised by 
their GP (χ2 = 54.4, p < 0.001) or by relatives or friends (χ2 = 16.9, p = 0.001). Those who 
are in disagreement that hearing about BC and BS in the media would trigger thoughts to 
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get a mammogram tend to attend less. The absolute majority of those who are in 
disagreement that cues to action (such as ‘reminder letters’, ‘reminder phone calls’ or ‘text 
messages’) are effective, are more likely not to attend for mammography. There is also 
similar significant association for the vast majority of self-efficacy sub-scale items (p < 
0.001) i.e. for attendees, the stronger is women’s confidence in arranging other things in 
their life to get a mammogram, while for the undecided group and those who are in 
disagreement with self-efficacy items are more likely not to attend for mammography 
screening. 
 
Table 4.4.1 - Health Belief items 
 
LIFETIME SCREENERS 
versus 
NON-SCREENERS 
Health Beliefs χ2 p-value 
There is no possibility of getting BC (r) 8.4 0.077 
Your chances of getting BC are high 8.2 0.085 
There may be the possibility of developing 
BC in your lifetime 
3.0 0.390 
When you get a mammogram, you feel 
good about yourself 
45.5 < 0.001* 
When you get a mammogram, you do not 
worry as much about BC 
6.4 0.093 
Having a mammogram will help you find 
lumps early in your breasts 
19.1 < 0.001* 
If you find a lump through a mammogram, 
the treatment for BC may not be as bad 
5.2 0.160 
Having a mammogram will decrease your 
chances of dying from BC 
7.5 0.580 
Having a mammogram will help you find a 
lump before it can be felt by yourself or a 
health professional 
7.2 0.065 
Having a routine mammogram would make 
you anxious about BC 
27.7 < 0.001* 
Having a routine mammogram would make 
you worry 
22.8 < 0.001* 
You fear having a mammogram because you 
might find out that something is wrong 
39.7 < 0.001* 
You fear having a mammogram because you 
do not know the procedure or what to 
expect 
145.8 < 0.001* 
You fear having a mammogram because you 
know someone (family or friend) with BC 
20.0 < 0.001* 
It is embarrassing for you to have a 
mammogram 
40.4 < 0.001* 
Undergoing mammography will be painful 
or uncomfortable 
147.5 < 0.001* 
Having a mammogram is time consuming 31.1 < 0.001* 
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*Statistically significant 
(r) = reverse scored 
aChi-square test was applied for all health beliefs; hence the categorical answers were used to apply this test 
for association. For each question, respondents were asked to select a number between 1-5, where 1 = 
strongly disagree and 5 = strongly agree. For certain items, responses were re-grouped to ensure the 
feasibility of the Chi-square test. 
 
 
 
 
 
 
 
 
 
You are discontent with personnel at the 
MBSP as they have been rude to you 
n/a n/a 
You have fear or distrust in the medical 
team 
32.9 < 0.001* 
Having a mammogram would expose you to 
unnecessary radiation 
27.9 < 0.001* 
You have too many other problems in your 
life than to get a mammogram done 
83.1 < 0.001* 
You are not old enough to have a 
mammogram periodically 
35.4 < 0.001* 
If your GP advises you to attend for a 
mammogram, you will attend 
54.4 < 0.001* 
If your relatives or friends advise you to 
attend for a mammogram, you will attend 
16.9 0.001* 
If someone close to you has been diagnosed 
with BC, you will attend for a mammogram 
39.4 < 0.001* 
Hearing about BC and BS in the media or 
news makes you think about getting a 
mammogram 
34.2 < 0.001* 
Reminder letters would help you to get a 
mammogram 
38.9 < 0.001* 
Reminder phone calls or text messages 
would help you to get a mammogram 
38.9 < 0.001* 
Routine educational talks regarding BC 
awareness would help you to get a 
mammogram 
37.1 < 0.001* 
You feel confident that if you had a 
mammogram done, any abnormalities in 
your breasts will be detected 
0.6 0.960 
You can arrange other things in your life to 
get a mammogram 
49.2 < 0.001* 
In case you need a mammogram, you will 
find a place to get it done 
32.8 < 0.001* 
You can make an appointment for a 
mammogram 
36.0 < 0.001* 
You can arrange transportation to get a 
mammogram 
41.1 < 0.001* 
You can talk to people at the BS centre 
about your concerns 
n/a n/a 
You can find a way to pay for a 
mammogram if you need to 
32.3 < 0.001* 
147 
 
4.4.3.7 Illness perceptions  
There is significant association for emotional representation subscale items (p < 0.05) (Table 
4.4.2). For lifetime non-attendees, the higher is their anxiety (χ2 = 8.3, p = 0.040) and fear 
(χ2 = 8.3, p = 0.039) of BC. The undecided group attend less for mammography when taking 
into account that their emotional state (χ2 = 12.9, p = 0.002) and their own behaviour (χ2 = 
12.7, p = 0.002) is perceived to possibly cause BC. Those who agree that BC can be caused 
by their own behaviour (χ2 = 12.7, p = 0.002) or by a germ/virus (χ2 = 9.4, p = 0.009) attend 
less for mammography, while those who consider BC to have major consequences in life 
(χ2 = 9.9, p = 0.019) attend more. 
 
Table 4.4.2 -  Illness Perception items  
 
LIFETIME SCREENERS 
 versus  
NON-SCREENERS 
Illness Perceptions χ2 p-value 
The presence of a lump or thickening in the breast 1.8 0.611 
Nipple discharge 2.3 0.509 
Sudden nipple retraction 1.1 0.769 
Change in shape or appearance of the nipple 1.2 0.743 
Breast swelling, dimpling, redness or soreness of the 
skin 0.9 0.826 
Skin changes of the breast 1.7 0.641 
A sudden change in breast size 1.5 0.688 
Aching breasts 1.5 0.820 
Stress or worry 3.0 0.223 
Your mental attitude (e.g. thinking about life 
negatively) 2.0 0.580 
Family problems or worries 2.9 0.233 
Overwork 7.9 0.052 
Your emotional state (e.g. feeling down, lonely, 
anxious, empty) 12.9   0.002* 
Your personality 3.0 0.391 
Hereditary - it runs in the family 9.7   0.021* 
Diet or eating habits 1.5 0.679 
Poor medical care in the past 0.8 0.847 
Your own behaviour 12.7   0.002* 
Ageing 1.9 0.395 
Smoking 1.8 0.601 
Alcohol 1.2 0.538 
A germ or virus 9.4   0.009* 
Pollution in the environment 1.4 0.709 
Altered immunity 2.5 0.469 
Chance or bad luck 3.0 0.562 
Accident or injury 3.6 0.460 
BC will last a short time 5.8 0.120 
BC is likely to be permanent rather than temporary 0.9 0.650 
A patient with BC goes through cycles in which her 
illness gets better and worse 5.8 0.215 
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BC has major consequences on a patient's life 9.9   0.019* 
BC will not have much effect on your life 6.1 0.189 
BC would strongly affect the way others see you 7.8 0.100 
BC has serious economic and financial consequences 5.0 0.174 
BC would strongly affect the way you see yourself as 
a person 0.9 0.826 
BC would threaten a relationship with your husband 
or partner 2.5 0.641 
If you had BC, your whole life would change 5.6 0.133 
If you developed BC, the chances of living a long life 
would decrease 4.9 0.179 
There is a lot which you can do to control the 
symptoms if BC occurs 0.7 0.948 
The course of BC will depend on your actions 2.9 0.400 
Your actions will have an effect on the outcome of 
BC 4.0 0.261 
There is no treatment that will help to improve BC 4.0 0.400 
The treatment provided will be effective in 
controlling or curing BC 3.1 0.371 
The negative effects of BC can be prevented or 
avoided by the treatment given 1.5 0.822 
You have a clear picture and understanding of BC 4.5 0.211 
BC is a mystery to you 2.1 0.720 
You get anxious when you think about BC 8.3   0.040* 
BC makes you feel afraid 8.3   0.039* 
You get worried when you think about BC  4.3 0.231 
*Statistically significant 
aChi-square test was applied for all illness perceptions; hence the categorical answers were used to apply this 
test for association. For each question, respondents were asked to select a number between 1-5, where 1 = 
strongly disagree and 5 = strongly agree. For certain items, responses were re-grouped to ensure the 
feasibility of the Chi-square test. 
 
4.4.3.8 Health beliefs and illness perception constructs  
The following 4 HBM and 1 CSM constructs were found to be significantly different when 
comparing lifetime mammography attendees and non-attendees: perceived benefits, 
perceived barriers, cues to action, self-efficacy (p < 0.001 respectively) and emotional 
representations (p = 0.033) (Table 4.4.3). 
Table 4.4.3 - Comparisons between mammography screening use and health beliefs/illness 
perception constructs. For all constructs, Mann Whitney test and Independent Samples t-test 
were applied to compare ‘LIFETIME ATTENDEES’ and ‘LIFETIME NON-ATTENDEES’ 
  
LIFETIME 
ATTENDEES 
(n = 348) 
LIFETIME NON-
ATTENDEES 
(n = 56) 
 
Test 
Statistic 
p-value 
Perceived Susceptibility M=9.6, SD=1.0 M=9.6, SD=1.0  10,065.5a    0.669 
Perceived Benefits M=24.0, SD=1.8 M=23.1, SD=1.5  6816.5a < 0.001* 
Perceived Barriers M=27.5, SD=4.9 M=34.8, SD=4.9  16569.5a < 0.001* 
Cues to action M=27.3, SD=3.2 M=23.1, SD=4.8  4306.0a < 0.001* 
Self-Efficacy M=24.8, SD=2.7 M=22.7, SD=2.8  6114.5a < 0.001* 
BC Identity M=30.6, SD=2.3 M=30.7, SD=2.0  10,344.0a 0.434 
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BC Causes  M=56.0, SD=7.2 M=57.4, SD=6.9  -1.3b 0.186 
Cancer Timeline: 
Acute/Chronic M=6.1, SD=0.9 M=6.2, SD=0.9 
 
10,213.5a 0.534 
Cancer Timeline: Cyclical M=3.6, SD=0.7 M=3.4, SD=0.7  8513.0a 0.069 
Consequences M=28.2, SD=2.5 M=28.5, SD=2.0  9909.0a 0.837 
Personal Control M=11.8, SD=0.8 M=11.9, SD=0.5  9890.0a 0.757 
Treatment Control M=9.9, SD=0.7 M=10.0, SD=0.5  10,592.0a 0.119 
Illness Coherence M=7.0, SD=1.1 M=7.0, SD=1.1  9857.5a 0.880 
Emotional 
Representations M=12.2, SD=2.1 M=12.7, SD=2.5 
 
11,431.5a   0.033* 
*Statistically significant, a Mann Whitney test, b Independent Samples t-test 
The findings show that for women who acquire mammography during their lifetime, the 
higher is their agreement on perceived mammography benefits, while more cues to action 
and greater self-efficacy help women to undergo mammography. Higher perceived barriers 
to mammography screening and stronger emotional representations of BC are associated 
with no mammography use during a woman’s lifetime.  
 
4.4.3.9 Predictors of mammography screening practices  
We further explored which variables and constructs were most significant to women’s 
attendance (LIFETIME ATTENDEES versus LIFETIME NON-ATTENDEES). A number 
of logistic regression models were applied (Table 4.4.4) in order to examine the 
variables/constructs (independent variables) which are key to identifying differences 
between women who attended mammography during lifetime and non-attendees (dependent 
variables).  
 
Model 1 represents the demographics against attendance/non-attendance. Although ‘drive’ 
and ‘status’ variables were found to be significant (p < 0.05), this model was not found to 
provide any accuracy to predict non-attendance. Hence, demographics did not provide any 
useful prediction for the scope of this analysis. Model 2 focused on Health Belief variables 
only, which served as the independent variables for this model. This model predicted 
attendance with an accuracy of 98.3% and non-attendance with an accuracy of 48.2%. Five 
variables were found to be significant (p < 0.05) with an Odds Ratio (OR) that varies between 
0.213 (fear of unknown procedure) and 3.327 (arrange transportation) for all the five 
variables. Model 3 focused on Illness Perception variables only, which served as the 
independent variables for this model. This model predicted attendance with an accuracy of 
99.4% and non-attendance with an accuracy of 5.4%. Six variables were found to be 
significant (p < 0.05) with OR varying between 0.432 (fear of BC) and 1.926 (major 
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consequences in life). The above significant predictors from both models 2 and 3 were 
incorporated into a new single model (Model 4), both health beliefs and illness perception 
variables serving as the independent variables for this model. The model accuracy, when 
combining both scores, improved to 98.0% for attendance and 53.6% for non-attendance. 
The model retained six significant predictors (p < 0.05) with OR varying between 0.212 (fear 
of unknown procedure) and 3.202 (arrange transportation). When all individual Health 
Belief and Illness Perception items were incorporated into one model (Model 5), eight 
variables were found to be significantly different (p < 0.05) with OR varying between 0.149 
(fear of unknown procedure) and 3.716 (arrange transportation). The accuracy of the model 
improved again to 97.1% for attendees and 58.9% accuracy for non-attendees. When the 14 
constructs (not individual items) related to Health Beliefs and Illness Perceptions were used 
to construct a logistic regression model (Model 6), ‘perceived barriers’ (OR 0.776) and ‘cues 
to action’ (OR 1.196) were found to be the strongest and most significant predictors (p < 
0.05) to describe the variance between the subgroups. However, the accuracy for predicting 
non-attendees was found to be 37.5% and 96.6% for predicting attendance, which is inferior 
when compared to Model 4. No health status variables were found to be significant and were 
therefore not included in Table 4.4.4.  
 
4.4.4 Discussion 
The extant research identifies multifactorial reasons why women choose not to attend for BS 
(Kinnear et al. 2011; McDonald and Sherman 2010; Doescher and Jackson 2009; Staniscia 
et al. 2003), particularly psychological, socio-economic and practical factors (Moser et al. 
2009; Steadman and Rutter 2004; Aro et al. 2001). Hence, this study was carried out to 
provide an understanding of the determinants of lifetime mammography use among Maltese 
women who attend ‘anywhere’ and those who ‘never’ attend for mammography. 
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Table 4.4.4 - Logistic Regression Models on lifetime mammography use (LIFETIME ATTENDEES versus LIFETIME NON-ATTENDEES) against 
different variables and different constructs  
  
B SE Wald P-value OR 95% CI 
Model Accuracy 
Attendance 
Model Accuracy  
Non-attendance 
Model 1: Demographics  100% 0% 
Drive 0.912 0.325 7.891 0.005 2.488 1.317, 4.700     
Status 0.591 0.224 6.987 0.008 1.807 1.165, 2.801   
Constant -4.605 0.792 33.773 0.000 0.010      
Model 2: Health Beliefs             98.3% 48.2% 
Fear of unknown procedure -1.548 0.219 50.028 0.000 0.213 0.138, 0.327     
Other life problems -1.213 0.302 16.130 0.000 0.297 0.165, 0.537     
Relative or close       
friend with breast  
cancer 
0.383 0.187 4.218 0.040 1.467 1.018, 2.114 
    
Reminder letters 1.099 0.307 12.826 0.000 3.001 1.645, 5.475     
Arrange  
Transportation 
1.202   0.410 8.605 0.003 3.327 1.490, 7.427 
    
Constant -1.993 2.109 0.893 0.345 0.136       
Model 3: Illness Perceptions             99.4% 5.4% 
Hereditary 0.579 0.233 6.179 0.013 1.784 1.130, 2.816     
Own behaviour -0.554 0.213 6.774 0.009 0.575 0.379, 0.872     
Major consequences in life 0.655 0.255 6.627 0.010 1.926 1.169, 3.172     
Economic  consequences 0.520 0.238 4.777 0.029 1.683 1.055, 2.683     
Threatens your relationship  -0.396 0.178 4.973 0.026 0.673 0.475, 0.953     
Fear of BC -0.840 0.280 9.038 0.003 0.432 0.250, 0.746     
Constant 1.060 1.828 0.337 0.562 2.888       
Model 4: Health Beliefs and Illness 
Perceptions 
          
  
98.0% 53.6% 
Fear of unknown procedure -1.553 0.224 48.123 0.000 0.212 0.136, 0.328     
Other life problems -1.239 0.310 15.973 0.000 0.290 0.158, 0.532     
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Relative or close       
friend with breast  
cancer 
0.407 0.189 4.618 0.032 1.502 1.036, 2.178 
    
Reminder letters 1.123 0.316 12.638 0.000 3.074 1.655, 5.710     
Arrange transportation 1.164 0.411 8.028 0.005 3.202 1.432, 7.163     
Own behaviour -0.612 0.288 4.536 0.033 0.542 0.309, 0.952     
Constant -0.240 2.306 0.011 0.917 0.787       
Model 5: Health Beliefs and Illness 
Perceptions 
          
  
97.1% 58.9% 
Poor medical care 0.878 0.360 5.970 0.015 2.407 1.190, 4.870     
Own behaviour -1.195 0.380 9.893 0.002 0.303 0.144, 0.637     
Pollution 0.603 0.283 4.543 0.033 1.829 1.050, 3.185     
Possibility of  
developing breast  
cancer 
-1.295 0.658 3.876 0.049 0.274 0.075, 0.994 
    
Fear of unknown procedure -1.907 0.268 50.587 0.000 0.149 0.088, 0.251     
Other life problems -1.478 0.331 19.976 0.000 0.228 0.119, 0.436     
Reminder letters 1.256 0.321 15.352 0.000 3.512 1.874, 6.584     
Arrange transportation 1.313 0.442 8.832 0.003 3.716 1.564, 8.831     
Constant 3.476 3.406 1.041 0.308 32.328       
Model 6: The 14 constructs             96.6% 37.5% 
Perceived barriers -0.253 0.039 43.157 0.000 0.776 0.720, 0.837     
Cues to action 0.179 0.041 19.169 0.000 1.196 1.104, 1.295     
Constant 5.192 1.688 9.460 0.002 179.859       
B unstandardized coefficients; SE standard error; OR odds ratio; CI confidence interval 
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Study 4 found that four health belief constructs (perceived benefits, perceived barriers, cues 
to action, self-efficacy) and one illness perception construct (emotional representations) 
influence lifetime BS practices among Maltese women. In particular, the findings show that 
women who perceive more barriers to mammography attendance (e.g. fear of pain, fear of 
the result), fewer benefits (e.g. lower belief in early detection), lower cues to action (e.g. no 
advice by a GP) and lower self-efficacy (e.g. lower confidence in one’s ability to arrange 
other things in life), and who have higher emotional representations of BC (e.g. greater fear, 
worry, anxiety and who consider other problems in life to be greater) were less likely to 
attend for mammography during their lifetime. This is consistent with Champion’s HBM 
and Leventhal’s CSM. This also implies that women who have previously experienced BS 
may already have established health-related behaviours (Moodi et al. 2012) and have 
therefore already recognized the benefits of undergoing regular mammography, have already 
overcome personal barriers to undergo mammography, have increased their self-confidence 
in getting screened throughout their lifetime and have higher levels of health motivation 
(Anagnostopoulos et al. 2012; Moodi et al. 2012; Allen et al. 2008). Therefore, efforts should 
be focused on identifying and encouraging attendance among women who have never 
participated in screening (Jepson et al. 2000).  
 
The findings emphasize the importance of adapting interventions for women with lower 
socio-economic backgrounds. This is so since widowers, those having lower family incomes 
and non-drivers were found to be significantly associated with lifetime non-attendance in 
this study. These women are less likely to attend for screening anywhere. Women with socio-
economic disadvantages in life are less likely to take part in BS. This relationship has been 
shown in previous literature (Lagerlund 2002). This socioeconomic difference is re-
emphasized in Study 2 whereby household income has solely emerged as significantly 
associated with attendance to first MBSP invitation (Marmarà et al. 2017b). Although not 
statistically significant in Study 4, women with a higher level of education and in 
employment were found to be more likely to attend than non-employed women and those 
with a lower education level. These socio-economic characteristics may serve as a proxy for 
interaction with other people, and in the degree of social integration during women’s lifetime. 
These findings may indirectly reflect social differences and the degree of equality regarding 
BC detection and treatment received, and may help to identify prognostic factors amenable 
to intervention. 
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There were significant associations in this study between lifetime attendees and non-
attendees regarding having a breast condition or having BC in the family and the close 
relations, such that women with a breast condition or who had relatives or close friends with 
cancer were more likely to attend for mammography during their lifetime. Similarly, having 
a family member or close friends with BC was associated with mammography attendance in 
other studies (Tejeda et al. 2009; Willis 2008) but contrast others (Manjer et al. 2015; Dundar 
et al. 2012; Luengo et al. 1999). Women most often play key roles as health managers and 
family caregivers (Marton and Choo 2012; Yoo and Robbins 2008; Young 1996) and this is 
not only reflected in that women more regularly than men are searching for health-related 
information on the internet (Bidmon and Terlutter 2015) but in women seeking a preventive 
action when faced with a prior personal or close relation experience that subsequently 
triggers them to engage in health-related behaviours (Fleming et al. 2013; Zackrisson et al. 
2004; Luengo et al. 1999). This corresponds with other research in other fields, particularly 
on mothers and children (Jansen et al. 2012). 
 
It has been acknowledged that lifetime non-attendees are an extremely difficult group to 
target and are a real challenge for screening management and public health officials 
(Australian Government 2014). For instance, structural and socio-economic factors such as 
age, income and marital status cannot be directly or easily modified (Consedine et al. 2004). 
Hence, although the exploration of such variables can help identify those at risk for a poor 
screening profile, such research offers little direction in terms of viable 
interventions. Therefore, in order to better understand which constructs are most significant 
to lifetime mammography non-attendees in Malta, logistic regression analyses confirmed 
that health beliefs were the strongest and most important predictors to lifetime non-
attendance and this result has been consistent across my studies on first MBSP invitation 
(Marmarà et al. 2017b) and re-attendance (Marmarà et al. 2018a). This implies that lifetime 
non-attendees are women who were not motivated in health behaviour, have strong 
emotional representations of BS and BC, who highlight more screening barriers, lower 
benefits and less cues to action because this is a new skill for them. This is evidenced by 
women who do not attend for mammography in other countries (Fayanju et al. 2014; 
Consedine et al. 2004) because they perceive greater BS barriers.  
 
The data shows evidence that lifetime non-attendees were less encouraged by their GP to 
attend for a mammogram during their lifetime. However, it is also true that Maltese women 
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tend to visit their GPs when they have a problem rather than routinely (Marmarà et al. 
2017b). While it is known that GPs are significantly more influential than relatives or friends 
at supporting mammography uptake (Fleming et al. 2013), women obtain information more 
often from friends and relatives than from official sources (Kee et al. 1992). This reinforces 
the influence of word of mouth from friends and relatives as a means of screening promotion 
(Fleming et al. 2013), supporting related promotional schemes worldwide (Passanisi et al. 
2001; Bencivenga et al. 2008; Kiger 2003). However, while word of mouth is important, 
such initiatives are aimed at ensuring that information passed through word of mouth is 
based on factual information, rather than emotional reasons (Fleming et al. 2013). Although 
physician recommendation is critical for the provision of factual information about BS, BC 
and adherence recommendations, many women still do not screen frequently enough 
(Consedine et al. 2004). Hence, it seems increasingly clear that interventions should be 
developed to target variables that are both amenable to change and for which there is scope 
for improvement, if BS rates are to be improved. 
 
The undecided group of women in this study tend to attend less for BS, particularly those 
who are unsure about: (i) self-efficacy items such as whether they can arrange other things 
in life to get a mammogram, (ii) screening barriers such as whether mammography is painful 
or uncomfortable, (iii) illness perception items such as whether one’s emotional state or own 
behaviour causes BC, and (iv) mammography frequency recommendations. In all of my 
findings, limited knowledge was found to be significantly associated with attendance to the 
first screening invitation, re-attendance and lifetime mammography use. This calls for urgent 
renewed health education and tailored information on the importance of screening while 
addressing misunderstandings, debunking screening myths and improving knowledge gaps. 
All of the findings in Study 4, and when considered in the light of previous results, can be 
used to lead the development of current non-existent, evidence-based interventions in Malta. 
 
4.4.5 Strengths and limitations 
The group of lifetime non-attendees came from the same target screening group, which 
further strengthens the value of this data. Additionally, the rich dataset allowed for diverse 
subgroup analyses, which facilitated an overview of lifetime screening practices. An 
additional strength is that the 121-item tool (MBSQ) contains information that makes it 
possible to adjust the analyses for potential confounders. Some aspects of study limitations 
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should be considered. One limitation of this study is its cross-sectional design, which does 
not allow for the associations of non-attendance with socio-demographic factors such as age 
to be studied over time. Future research is needed to evaluate a potential cause effect relation. 
A problem in some of the analyses is the low number of lifetime non-attendees, hence a 
lower level of confidence in the results for this particular group. This may have led to a type 
I and/or type II error in relation to some of the analysed factors. Another limitation of this 
study is that self-reports for private mammography was used to measure lifetime 
mammography rather than objective data from private mammographic screening clinics. 
However, no national data records from private practices are currently available to date in 
Malta. Hence, self-reports for lifetime mammography use was the only possible method of 
data collection. The findings are likely to be generalizable and broadly applicable to other 
populations.  
 
4.4.6 Conclusions 
In general, the results are in line with differences reported in the literature between screening 
attendees and non-attendees, such that non-attendees were less knowledgeable of the 
recommended mammography frequency, had attitudinal, emotional and motivational 
barriers, less socio-economic support and were less confident in themselves. Additionally, 
Study 4 showed that health beliefs were the most significant predictors to lifetime 
mammography screening behaviour. Hence, screening organisers and public health officials 
should target women’s perceived barriers, particularly fear, and enhance cues to action when 
reaching out to non-attendees. Further qualitative research is required to clarify the 
determinants and consequences of emotional barriers, particularly fear among lifetime non-
attendees, and also to evaluate the need for a more targeted approach among this hardest-to-
reach group in order to understand the complexity of their behavioural barriers. 
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Chapter 4 
 
Study 5: Adherence to Timely Mammography 
Use in Malta5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5A version of this chapter has been published in the BMC Cancer Journal (Appendix 4.4.1) (Marmarà et al. 
2018b).      
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4.5 Introduction 
To improve chances of survival from breast cancer (BC), women must attend breast 
screening (BS) regularly at recommended time intervals (Greif 2010). Maltese women are 
routinely invited to undergo mammography at three-year intervals at an organized screening 
programme (MBSP) or can opt to attend a private clinic. Prior to the MBSP, women in Malta 
could only use private mammography for routine screening (there are currently seven private 
practices offering mammography in Malta). Despite the current availability of the MBSP, a 
number of women still do not attend for mammography or may not attend at the 
recommended frequency. This is evidenced by data from Study 2 showing that the uptake 
rate for the first MBSP round was lower than the European target rate of 70% (Perry et al. 
2006), and similarly for re-attendance, evidenced in Study 3 on the second MBSP round. 
Screening programmes can only be effective and indeed cost-effective (Feig 2006) if the 
attendance of the target screening population is consistent with recommended intervals 
(Coyle et al. 2014; Achat et al. 2005; Banks et al. 2002) in order to achieve health benefits 
(Ritvo et al. 2012). Moreover, Study 2 showed that health beliefs were significant predictors 
of uptake of the first MBSP invitation. Similarly, the findings of Study 4 concluded that it is 
the health beliefs of women who never attend for mammography during their lifetime that 
should be targeted. Whether health beliefs are predictive of women’s adherence to 
recommended time intervals for mammography at organized or private screening in Malta 
is unknown. 
 
Organized BS programmes are offered for free to asymptomatic women by many countries 
in Western Europe and North America (Labrie et al. 2017), with time intervals between 
mammograms depending on the varying recommendations of different countries (Eichholzer 
et al. 2016). In Europe, the EU Council recommends a two-year time interval for women 
aged 50-69 (Perry et al. 2006; Advisory Committee on Cancer Prevention 2000). However, 
countries implement these recommendations as they consider fit (Labrie et al. 2017). For 
instance, Norway adheres to the recommended EU thresholds, while a biennial nationwide 
screening programme for women aged 50-75 is offered in the Netherlands (National Institute 
for Health and the Environment 2015) and regionally organized screening programmes are 
offered in Switzerland for women over 50, with the age limit varying between 69-74 years 
(Swiss Cancer Screening 2015). Notable exceptions for the screening time interval is by the 
UK and Malta who opted for a three-year time interval (Benson et al. 2013). 
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Substantial disparity remains to date across countries on attendance at regular time intervals 
(Anagnostopoulos et al. 2012) with recent and regular attendance being studied less often 
than initial attendance (Whelehan et al. 2013; Achat et al. 2005; Aro et al. 2001). For 
instance, the more privatized system in the United States may enable less access to 
mammography than the social health care system found in the UK (Leung et al. 2015), 
suggesting that national context is important and worth exploring.  
 
The Maltese NHS adopts a mixed model approach comprising elements from both the public 
(organized) and private sectors and this is one possible reason for non-participation in the 
organized screening programme (MBSP) or non-attendance at recommended three-year time 
intervals. Prior to the MBSP rollout across Malta, asymptomatic women could self-refer 
privately for mammography and symptomatic women were referred by a general practitioner 
(GP), breast surgeon or gynaecologist, either to the public symptomatic breast unit or to the 
private sector for mammography. Despite having the availability and efficiency of 
nationally-organised screening programmes, some women may still opt for the service 
privately (Francois et al. 2012; Bihrmann et al. 2008) but will be counted as non-compliant 
in the context of invitation-based BS (Aro et al. 2001). Similarly, screening mammograms 
taken and read in private clinics (Bihrmann et al. 2008) remain widely used in America and 
in European countries such as France, Luxembourg and Switzerland (Ferrat et al. 2013; 
Bihrmann et al. 2008; Chamot et al. 2007; Autier et al. 2002).  
 
In order to understand if Maltese women are adherent with recommendations for BS, data 
were analysed in an effort to describe adherence to the recommended three-year time interval 
between mammograms at a private/government organised BS programme in Malta. Study 5 
built on the findings of Study 2 (Marmarà et al. 2017b), which suggests that health beliefs 
and illness perceptions vary between women who accept or refuse a BS invitation to the 
organized BS programme in Malta. STROBE guidelines (Appendix 4.4.2) have guided the 
presentation of the study findings.  
 
4.5.1 Aims and Objectives 
The aim of Study 5 was to explore if health beliefs, illness perceptions, knowledge, 
sociodemographic factors and heath status are associated with adherence to recommended 
three-year time intervals, thus meeting RQ 2d: 
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RQ 2d: Which significant factors (i.e. health beliefs, illness perceptions, knowledge, socio-
demographic factors and health status) are associated with adherence to timely 
mammography practices in Malta? 
In reaching this RQ, the analysis has targeted the following objectives: 
(1) To determine mammography screening use within or exceeding the recommended three-
year frequency in Malta; 
(2) To explore associations between socio-demographic factors, health status, knowledge, 
health beliefs and illness perception variables of adherent and non-adherent women. 
 
4.5.2 Methods 
The full details of the methods used in this study are described in Chapter 4, Study 2 (Section 
4.2.3). As discussed in Study 1, ethics approval was obtained from SREC (Appendix 4.1.2) 
and HEC (Appendix 4.1.3). 
 
4.5.2.1 Measures 
The measures have been described in detail in Chapter 4, Study 1 (Section 4.1.4.2). The key 
variable of interest in this study was adherence to the recommended three-year time interval 
between mammograms. Screening mammography uptake in the past three years was self-
reported for women who opted to go to a private clinic for a mammography. For those who 
had attended the MBSP, attendance or non-attendance was verified objectively using 
screening records. Women were asked with a yes/no response if they had a mammogram 
within the past three years (ADHERENT) or whether they had exceeded the three-year 
frequency (NON-ADHERENT). Furthermore, they were asked to identify the location of 
their mammogram if they had undergone the screening test recently.  
 
4.5.2.2 Statistical analysis 
Throughout the analyses, basic statistics were presented through the use of mean values or 
percentages. A Chi-square test was used to test for any significant associations between two 
categorical variables. The Shapiro-Wilk test was applied to determine whether variables 
were normally distributed. Since only the variable (causes of BC) was normally distributed, 
the Independent Samples t-test (parametic test) was used for the latter construct to compare 
two independent samples, while the Mann-Whitney test was used for the non-normal 
distributed variables (non-parametric test) i.e. for all the other 13 constructs which were not 
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normally distributed (p < 0.001). Missing data was minimal and reported in Study 2 (Table 
4.2.1). Statistical significance was established at p < 0.05 for all analyses. Since those who 
never attended for mammography anywhere (n=56) were already analysed in further detail 
in Study 4, the following analysis focused on those who underwent at least one mammogram 
in their lifetime. 
 
4.5.3 Results 
4.5.3.1 Sample characteristics 
The sample characteristics are available in Section 4.2.3.1 
 
4.5.3.2 Mammography screening practices 
Figure 4.4 presented the mammography screening practices by Maltese women. From the 
total sample of 404 women, 80.2% (n = 324) had undergone a mammogram in the previous 
three years (ADHERENT), 5.9% (n = 24) had exceeded the three-year time interval (NON-
ADHERENT) and 13.9% (n = 56) had never had a mammogram. Out of the 404 women, 
60.1% (n = 243) had attended the MBSP and 39.9% (n = 161) had never attended the MBSP. 
Out of the 39.9% (n = 161) of women who had not attended the MBSP, 65.2% (n = 105) had 
undergone mammography elsewhere (at a private practice); 82.9% (n = 87) of these women 
had undergone a mammogram within three years (ADHERENT) while 17.1% (n = 18) had 
undergone a mammogram that exceeded the recommended regular three-year time interval 
(NON-ADHERENT). Out of the 60.1% (n = 243) of women who underwent a mammogram 
at the MBSP, 97.5% (n = 237) had undergone a mammogram within the three-year time 
interval (ADHERENT), while 2.5% (n = 6) exceeded the three-year time interval (NON-
ADHERENT). When applying a Chi-square test to compare NON-ADHERENCE to private 
practice versus NON-ADHERENCE to MBSP (17.1% versus 2.5%), this result was found 
to be significantly associated (χ2 = 24.6, p = 0.000), implying that MBSP users are 
significantly more adherent than those attending privately. 
 
4.5.3.3 ADHERENT versus NON-ADHERENT subgroup analyses 
Sociodemographic characteristics and health status 
There was no significant association between sociodemographic variables (e.g. age) or 
health status (e.g. breast condition or disease) and adherence to three-year time intervals for 
BS. 
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Knowledge of breast screening frequency 
Knowledge of recommended time interval was significantly associated with women’s 
adherence to the three-year time interval for mammography (χ2 = 5.5, p = 0.020). 12.5% of 
the non-adherent group were unsure about the recommended frequency while only 3.1% of 
the adherent group were unsure of the recommended time interval. 
 
Health beliefs  
The following health beliefs were significantly associated with adherence to the 
recommended three-year time interval for mammography (Table 4.5.1): ‘having a routine 
mammogram would make you anxious about BC’ (p = 0.040), ‘if your GP advises you to 
attend, you will attend’ (p = 0.038), ‘hearing about BC and BS in the media or news makes 
you think about getting a mammogram’ (p = 0.030), or ‘reminder letters’, ‘reminder phone 
calls or text messages’ would help you to get a mammogram’ (p = 0.000 respectively). 
Women who fear or distrust the medical team (p = 0.003) or who feel they have too many 
other problems in life (p = 0.001) was significantly associated with non-adherence to the 
recommended three-year time interval. Women who do not agree that reminder letters, 
reminder phone calls or text messages would help them get a mammogram (p = 0.000 
respectively) was significantly associated with non-adherence to the recommended three-
year time interval. 
Table 4.5.1 -  Health Belief items 
 
ADHERENT 
versus  
NON-ADHERENT 
Health Beliefs χ2 p-value 
There is no possibility of getting BC (r) 5.5 0.239 
Your chances of getting BC are high 0.3 0.960 
There may be the possibility of developing BC in your 
lifetime 
7.8 0.055 
When you get a mammogram, you feel good about 
yourself 
5.9 0.115 
When you get a mammogram, you do not worry as 
much about BC 
3.6 0.302 
Having a mammogram will help you find lumps early in 
your breasts 
0.9 0.819 
If you find a lump through a mammogram, the 
treatment for BC may not be as bad 
0.7 0.863 
Having a mammogram will decrease your chances of 
dying from BC 
1.2 0.744 
Having a mammogram will help you find a lump before 
it can be felt by yourself or a health professional 
1.5 0.676 
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*Significant at α=0.05; (r) = reverse scored.  
Chi-square test was applied for all health beliefs; hence the categorical answers were used to apply this test 
for association. For each question, respondents were asked to select a number between 1-5, where 1 = 
strongly disagree and 5 = strongly agree. For certain items, responses were re-grouped to ensure the 
feasibility of the Chi-square test. 
 
 
 
Having a routine mammogram would make you anxious 
about BC 
8.3 0.040* 
Having a routine mammogram would make you worry 3.2 0.522 
You fear having a mammogram because you might find 
out that something is wrong 
5.3 0.257 
You fear having a mammogram because you do not 
know the procedure or what to expect 
2.8 0.418 
You fear having a mammogram because you know 
someone (family or friend) with BC 
7.0 0.136 
It is embarrassing for you to have a mammogram 6.0 0.055 
Undergoing mammography will be painful or 
uncomfortable 
3.8 0.284 
Having a mammogram is time consuming 2.7 0.258 
You are discontent with BS personnel as they have been 
rude to you 
n/a n/a 
You have fear or distrust in the medical team 13.9 0.003* 
Having a mammogram would expose you to 
unnecessary radiation 
4.7 0.197 
You have too many other problems in your life than to 
get a mammogram done 
14.9 0.001* 
You are not old enough to have a mammogram 
periodically 
0.4 0.823 
If your GP advises you to attend for a mammogram, you 
will attend 
8.4 0.038* 
If your relatives or friends advise you to attend for a 
mammogram, you will attend 
1.3 0.741 
If someone close to you has been diagnosed with BC, 
you will attend for a mammogram 
3.2 0.362 
Hearing about BC and BS in the media or news makes 
you think about getting a mammogram 
8.9 0.030* 
Reminder letters would help you to get a mammogram 20.9 0.000* 
Reminder phone calls or text messages would help you 
to get a mammogram 
20.9 0.000* 
Routine educational talks regarding BC awareness 
would help you to get a mammogram 
6.7 0.820 
You feel confident that if you had a mammogram done, 
any abnormalities in your breasts will be detected 
4.7 0.318 
You can arrange other things in your life to get a 
mammogram 
1.5 0.821 
In case you need a mammogram, you will find a place to 
get it done 
1.8 0.752 
You can make an appointment for a mammogram 1.7 0.800 
You can arrange transportation to get a mammogram 1.6 0.812 
You can talk to people at the BS centre about your 
concerns 
n/a n/a 
You can find a way to pay for a mammogram if you need 
to 
2.3 0.511 
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Illness perceptions  
The following illness perceptions were significantly associated with adherence to the 
recommended three-year time interval for mammography (Table 4.5.2): ‘your mental 
attitude’ (p = 0.008), ‘family problems or worries’ (p = 0.035), your emotional state’ (p = 
0.000), ‘your personality’ (p = 0.006), and ‘you get anxious when you think about BC’ (p = 
0.044).   
Table 4.5.2 -  Illness Perception items  
 
 
        ADHERENT 
      versus   
             NON-ADHERENT 
Illness Perceptions χ2 p-value 
The presence of a lump or thickening in the 
breast 3.2 0.361 
Nipple discharge 4.1 0.254 
Sudden nipple retraction 7.0 0.072 
Change in shape or appearance of the nipple 7.9 0.052 
Breast swelling, dimpling, redness or 
soreness of the skin 3.6 0.305 
Skin changes of the breast 4.7 0.193 
A sudden change in breast size 1.5 0.682 
Aching breasts 6.2 0.185 
Stress or worry 2.8 0.250 
Your mental attitude (e.g. thinking about life 
negatively) 12.0   0.008* 
Family problems or worries 6.7   0.035* 
Overwork 7.5 0.057 
Your emotional state (e.g. feeling down, 
lonely, anxious, empty) 22.0   0.000* 
Your personality 12.3   0.006* 
Hereditary - it runs in the family 3.2 0.360 
Diet or eating habits 1.9 0.590 
Poor medical care in the past 1.4 0.699 
Your own behaviour 3.8 0.282 
Ageing 0.8 0.663 
Smoking 0.5 0.927 
Alcohol 0.0 0.979 
A germ or virus 2.9 0.234 
Pollution in the environment 2.8 0.428 
Altered immunity 0.4 0.933 
Chance or bad luck 1.0 0.908 
Accident or injury 1.2 0.875 
BC will last a short time 0.6 0.904 
BC is likely to be permanent rather than 
temporary 4.8 0.089 
A patient with BC goes through cycles in 
which her illness gets better and worse 1.6 0.800 
BC has major consequences on a patient's life 2.1 0.559 
BC will not have much effect on your life 2.4 0.662 
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BC would strongly affect the way others see 
you 4.4 0.351 
BC has serious economic and financial 
consequences 0.8 0.840 
BC would strongly affect the way you see 
yourself as a person 2.7 0.446 
BC would threaten a relationship with your 
husband or partner 3.6 0.461 
If you had BC, your whole life would change 0.6 0.902 
If you developed BC, the chances of living a 
long life would decrease 0.8 0.844 
There is a lot which you can do to control the 
symptoms if BC occurs 1.3 0.869 
The course of BC will depend on your actions 1.7 0.646 
Your actions will have an effect on the 
outcome of BC 1.1 0.787 
There is no treatment that will help to 
improve BC 4.0 0.406 
The treatment provided will be effective in 
controlling or curing BC 0.5 0.926 
The negative effects of BC can be prevented 
or avoided by the treatment given 1.0 0.914 
You have a clear picture and understanding 
of BC 2.6 0.455 
BC is a mystery to you 1.7 0.786 
You get anxious when you think about BC 8.1   0.044* 
BC makes you feel afraid 0.7 0.875 
You get worried when you think about BC  0.7 0.871 
*Significant at α=0.05 
Chi-square test was applied for all illness perceptions; hence the categorical answers were used to apply this 
test for association. For each question, respondents were asked to select a number between 1-5, where 1 = 
strongly disagree and 5 = strongly agree. For certain items, responses were re-grouped to ensure the 
feasibility of the Chi-square test. 
 
 
Comparisons of constructs between Adherent and Non-Adherent women 
Mann Whitney test and Independent Samples t-test were applied to compare ‘ADHERENT’ 
and ‘NON-ADHERENT’ groups against all 14 health belief/illness perception constructs. 
There were statistically significant differences in perceived barriers and cues to action (p = 
0.000, p = 0.039 respectively) between adherent and non-adherent women (Table 4.5.3). 
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Table 4.5.3 - Comparisons between the frequency of mammography use and health 
beliefs/illness perception constructs 
 
  
ADHERENT 
(n = 324) 
NON-
ADHERENT 
(n = 24) 
Test 
Statistic 
p-value 
Perceived 
Susceptibility M=9.6, SD=1.0 M=9.4, SD=0.9 3,641.0a       0.577 
Perceived Benefits M=24.0, SD=1.8 M=23.9, SD=1.3 3515.0a 0.387 
Perceived 
Barriers M=27.2, SD=4.7 M=31.1, SD=5.0 5540.5a   0.000* 
Cues to action M=27.4, SD=3.2 M=26.0, SD=3.5 2919.0a   0.039* 
Self-Efficacy M=24.8, SD=2.7 M=24.5, SD=2.1 3666.5a 0.615 
BC Identity 
 M=30.6, SD=2.1 M=30.3, SD=3.4 4136.5a 0.582 
BC Causes  M=55.9, SD=7.2 M=57.0, SD=6.9 -0.7b 0.467 
Cancer Timeline: 
Acute/Chronic M=6.1, SD=0.9 M=5.9, SD=1.0 3515.5a 0.402 
Cancer Timeline: 
Cyclical M=3.6, SD=0.7 M=3.7, SD=0.6 4271.0a 0.327 
Consequences M=28.2, SD=2.5 M=28.5, SD=2.7 4247.5a 0.446 
Personal Control M=11.8, SD=0.8 M=11.9, SD=0.6 3905.5a 0.951 
Treatment 
Control M=9.9, SD=0.7 M=10.0, SD=0.5 4166.5a 0.397 
Illness Coherence M=6.9, SD=1.2 M=7.3, SD=0.9 4538.0a 0.139 
Emotional 
Representations M=12.2, SD=2.1 M=12.7, SD=1.8 4348.0a 0.320 
*Significant at α=0.05, a Mann Whitney test, b Independent Samples t-test 
The findings show that women who were NON-ADHERENT to the three-year time 
frequency for mammography use perceive higher barriers and lower cues to action than 
ADHERENT women. 
 
4.5.4 Discussion 
This study facilitates understanding of the determinants of adherence to the recommended 
three-year interval for mammography use in Malta, which aid to the design of evidence-
based and culturally-sensitive BS interventions for the Maltese population. Those who attend 
for mammography at the recommended time intervals may already understand screening 
benefits, have come to terms with screening barriers, and have confidence in their abilities 
to get screened (Anagnostopoulos et al. 2012). Similarly, findings by Moodi et al. (2012) 
suggest that women who previously had at least one mammogram in their lifetime had higher 
levels of health motivation, perceived benefits, and perceived self-efficacy to BS and fewer 
perceived screening barriers. This further proves that previous mammography use strongly 
predicts subsequent screening (Anagnostopoulos et al. 2012; Moodi et al. 2012).  
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Study 5 showed that there were some Maltese women who did not attend for mammography 
in a timely manner. Consistent with Champion’s HBM and Leventhal’s CSM, in this study 
it was the ‘perceived barriers’ and ‘cues to action’ constructs that explain the variance 
between the ADHERENT and NON-ADHERENT groups. Hence, women may need to 
overcome barriers to seeking mammography and follow tailored cues to action in order to 
attend BS at recommended time intervals.  
 
A plausible explanation for the disappearance of an effect of socio-demographic factors in 
subgroup analyses on adherence in this study is that they represent ‘carriers’, as described 
by Lagerlund (2002), of already established health-related behaviours. This is evidenced in 
all my studies on attendance to first invitation to MBSP (Marmarà et al. 2017b), re-
attendance (Marmarà et al. 2019, in press) and lifetime mammography use (Marmarà et al. 
2018a), where different socio-demographic and health status variables were non-significant 
predictors of BS uptake.  
 
Knowledge of BS frequency was found to be significantly associated with adherence to 
recommended three-year time intervals as in Study 2 (Marmarà et al. 2017b), Study 3 
(Marmarà et al. 2019, in press) and Study 4 (Marmarà et al. 2018a). This shows that women 
who were unsure of screening recommendations were less likely to attend for mammography 
at recommended three-year intervals. This study’s findings are consistent with studies that 
examined the relationship in average risk women over 50 years where women who reported 
screening according to the respective national guidelines were significantly more likely to 
adhere than women who reported less frequent time intervals (Ritvo et al. 2012; Edwards et 
al. 2009; Rakowski et al. 2006). Ritvo and colleagues expanded on such data, showing that 
it becomes more consequential with findings that the belief about recommended screening 
intervals predicts screening adherence in women with a family history of BC (Ritvo et al. 
2012). The results of Study 5 underscore the significance of communicating and reiterating 
a screening interval recommendation to women such that they develop strong beliefs about 
the need to screen at that recommended three-year time interval. 
 
The findings also suggest that those attending an organised screening programme such as, 
the MBSP, are more likely to adhere to screening recommended time intervals when 
compared with those attending the private sector. In order to reach greater adherence to 
recommended time intervals, women should receive further information on the 
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recommended screening frequency and the benefits of being part of an organised programme 
(WHO 2014; Ferrat et al. 2013). For example, in Malta, private screening does not have the 
same quality controls as the MBSP such as higher quality of mammographic interpretation 
through special training of the readers and mammographers, double-reading and consensus 
reads (Heywang-Köbrunner et al. 2011). For instance, a mammogram in organised screening 
is read by two radiologists, who interpret at least 5,000 screening mammograms a year. This 
is the recommended volume set by the European Guidelines for Quality Assurance in BS 
(WHO 2014; De Gelder et al. 2009; Bihrmann et al. 2008; Frede 2005; Gabe and Duffy 
2005) and the desirable individual level of experience set in the UK (National Accreditation 
Committee 1994). Moreover, based on a similar screening context as our local system, other 
studies raise awareness that organized screening leads to inequality reductions, higher 
quality assurance, and more timely screens than opportunistic screening (Heywang-
Köbrunner et al. 2011; Ouedraogo et al., 2011; Palència et al. 2010).  
 
While private screening remains unregulated, quality cannot be guaranteed which is why 
national screening programmes are recommended (Borg et al. 2013; Heywang-Köbrunner 
et al. 2011). Therefore, a key benefit of a national screening programme is that women can 
be individually monitored to ensure that they are conformant with screening guidelines and 
that they are adequately monitored in terms of robust quality assurance measures. 
 
4.5.5 Strengths and limitations 
Although Study 5 was limited to the Maltese setting, much of the developed world has 
organised screening programmes and access to the same body of scientific evidence, and 
thus the findings are likely to be broadly applicable across such countries. However, no study 
could be found that had similarly and simultaneously assessed sociodemographic and 
psychological variables as predictors of timely attendance and specifically attendance at 
organized or opportunistic screening. Moreover, none were found which utilised HBM and 
CSM as the theoretical framework. The major strength of this study is the rich dataset, which 
allowed the analyses of diverse subgroups. Since this study was cross-sectional, it precluded 
looking at cause-and-effect relationships over time. While a Chi-square test showed that 
women who attend private screening were less likely to be regulated in their attendance when 
compared to MBSP attendees, it cannot be ruled out that women attending private screening 
would be less likely to attend screening regularly even if they attended MBSP. This could 
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be due to the characteristics of women attending private screening. Although screening 
attendance was confirmed through screening records, records of private mammography were 
self-reported and hence, subject to bias. Self-reported data could also have affected the 
observed difference between women attending private screening and the MBSP. Objective 
measurement would require data from private clinics, which was not possible to obtain, since 
no data records from private screening in Malta are nationally available to date. As a first 
step, it would be necessary to identify reliable and validated measures for regular 
mammography use that can be used simultaneously in government organised and private 
screening programmes. While limited studies to date have been of sufficient dimension to 
provide results on irregular attendance (Coyle et al., 2014), qualitative studies would 
contribute towards understanding why beliefs and perceptions influence timely adherence. 
 
4.5.6 Conclusions 
In conclusion, women’s knowledge, health beliefs and illness perceptions were found to be 
significantly associated with timely mammography adherence. The results also suggest that 
attendance at an organised BS programme improves adherence to recommended time 
intervals when compared with those attending the private sector for screening. In order to 
reach greater adherence to recommended time intervals, women should be made more aware 
of the recommended screening time intervals and on the benefits of being part of an 
organised programme. Women can be individually monitored through the national BS 
programme to ensure that they are conformant with screening guidelines. Screening 
programmes should target women’s health beliefs, in particular perceived barriers and cues 
to action, which have emerged as the most important factors to distinguish between adherent 
and non-adherent women to improve adherence to recommended time intervals. Further 
qualitative research is required to understand in more depth why women choose 
opportunistic screening over an organised programme. 
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5.1 Introduction 
This chapter presents a systematic review of quantitative literature to explore interventions 
to improve breast screening (BS) uptake among women. Studies 2-5 (Chapter 4) suggest that 
HBM and CSM constructs are associated with BS behaviours in Malta. Therefore, as part of 
the process of intervention development, it was important to find out if interventions that 
address HBM / CSM constructs existed and what was their effect, thus meeting RQ 3: What 
types of interventions (which have employed the HBM and/or CSM) are effective at 
increasing mammography uptake? The objectives of Study 6 and thereby this chapter was 
to describe study design and methods, report intervention effectiveness on BS behaviour, 
and to describe theories, procedures, functions and content of the interventions. 
 
5.2 Background 
Health promotion interventions have a large contribution to early breast cancer (BC) 
detection and improved survival (Agide et al. 2018). Numerous interventions such as 
telephone or postal reminders, text messaging, education, individual counselling, and 
physician interventions have been conducted to increase BS participation and tested to 
evaluate their effectiveness (Kerrison et al. 2015; Camilloni et al. 2013; Gardner 2013; 
Guy et al. 2012; Jensen et al. 2012; Lakkis et al. 2011).  
 
In the year 2000, Jepson and colleagues conducted a monumental systematic review to 
evaluate the determinants of screening and interventions that increase screening uptake 
(Jepson et al. 2000). This review found 65% of intervention studies and 82% of determinant 
studies were undertaken in the US or Canada. Both countries differ from the UK and Malta 
in the recommended ages and screening intervals and in the organisation of screening 
programmes. Since Jepson’s review, some systematic reviews have concentrated on a 
specific type of screening, such as increasing BS uptake (Bonfill et al. 2001), or on specific 
types of interventions concerning ‘personalized risk communication’ (Edwards et al. 2006) 
or ‘patient decision aids’ (O’Connor et al. 2009), or on specific populations (Lu et al. 2012), 
or outcomes related to participation, like the impact of female screening on future attendance 
and women’s health beliefs (Bankhead et al. 2003), or the impact of interventions among 
lower socioeconomic groups (Spadea et al. 2010). Although a recommended approach is to 
provide patient education or advice, this is often insufficient for generating and maintaining 
behaviour change as patients’ health decision-making is not typically driven by the lack of 
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knowledge alone but by multiple influencing factors (Heath et al. 2015), such as health 
beliefs and illness perceptions.  
 
Theories aid the understanding of complex phenomena by providing tentative explanations 
for why and under what circumstances behaviours occur as well as an understanding of an 
intervention’s effectiveness, or lack thereof (Heath et al. 2015). Theoretically-informed 
interventions can then target these factors, leading to better outcomes (Michie and Prestwich 
2010). For example, a meta-analysis of tailored interventions to promote mammography 
screening (Sohl and Moyer 2007) found that tailored interventions that used the Health 
Belief Model (HBM) and included a physician recommendation produced the strongest 
effects in promoting screening compliance. Hence, evidence places an emphasis on the use 
of theory in developing and evaluating complex (i.e., multi-component) interventions (Craig 
et al. 2008).  
 
Several reviews have documented the HBM and CSM’s performance in predicting health 
behaviours (Hagger et al. 2017; Jones et al. 2014), but to the best of my knowledge, no 
systematic reviews have addressed their utility in the design or efficacy of these 
interventions in relation to mammography screening uptake. It is believed that the results of 
this systematic review could be used as a guideline for the future design and implementation 
of BS interventions targeted at Maltese women. 
 
5.3 Methods 
5.3.1 Contributors 
The team who contributed to this systematic review were as follows. DM (Danika Marmarà), 
the principal investigator, conceived the study and design, conducted the searches, selected 
and screened articles for inclusion, conducted the systematic review and drafted its written 
content. GH (Gill Hubbard), the researcher’s primary supervisor, independently screened 
and reviewed 10% of articles, as suggested by Trivedi et al. (2013) and discussed any 
discrepancies with DM. RP (Robert Polson), an information specialist at the University of 
Stiring, aided the researcher to conduct the searches in electronic databases. AM (Andrea 
Mohan), a doctoral researcher at the University of Stirling, discussed data extraction with 
DM and checked full text articles to resolve disagreements by consensus. The risk of bias 
assessment of each study was independently conducted by two reviewers (DM, AM).  
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5.3.2 Search strategy  
The search strategy was guided by the PRISMA guidelines (Moher et al. 2009) to identify 
all relevant articles. The researcher elicited support from RP to conduct the searches. A 
comprehensive primary search of the literature from January 2000 to September 2015 was 
conducted. The review was limited to start from 2000 since Jepson’s review (Jepson et al. 
2000) included the articles up to 2000. Thirteen electronic databases were searched, namely: 
CINAHL, PsycINFO, MEDLINE via OVID, EMBASE, Pubmed, Scopus, Cochrane, Web 
of Science, Prospero, University of York, Centre for Reviews and Dissemination database 
suite and Joanna Briggs (Appendix 5.1). The searches primarily used relevant keywords 
referring to mammography screening (e.g., BS, mammogram) combined with terms 
describing intervention types (e.g., campaign, outreach, navigation) to identify articles (An 
example of a search using CINAHL is given in Table 5.1).  
 
A further supplementary search was conducted through eight electronic databases to search 
specifically for interventions up to August 2016 that used the HBM and CSM. The electronic 
databases for the supplementary search included: CINAHL, EMBASE, MEDLINE via 
OVID, Scopus, Cochrane, Web of Science, Prospero and University of York, Centre for 
Reviews and Dissemination database suite. The keywords referring to mammography 
screening (e.g., BS, mammogram) were combined with terms describing the theoretical 
models (e.g., HBM, CSM) (Appendix 5.2).  
 
Table 5.1 - Example of search terms used in CINAHL 
 
Search 
ID#  Search Terms Search Options Actions 
S15 S6 AND S14  Limiters - Published Date: 20000101-
20151231; English Language 
Search modes - Boolean/Phrase 
(293) 
 
S14 S7 OR S8 OR S9 OR S10 OR S11 OR 
S12 OR S13  
Search modes - Boolean/Phrase (299,456) 
 
S13 (MH "Patient Navigation")  Search modes - Boolean/Phrase (52) 
 
S12 (MH "Health Promotion+")  Search modes - Boolean/Phrase (32,040) 
 
S11 (MH "Health Education+")  Search modes - Boolean/Phrase (75,340) 
S10 (MH "Audiovisuals+")  Search modes - Boolean/Phrase (64,739) 
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S9 audiovisual* or audio-visual* or 
"audio-visual aid*" or "audiovisual 
use*" or "audio-visual use*"  
Search modes - Boolean/Phrase (2,052) 
S8 "patient education" or "patient 
educat*" or "health educat*"  
Search modes - Boolean/Phrase (65,877) 
 
S7 "attitud* to health" or "attitude to 
health" or attitud*  
Search modes - Boolean/Phrase (155,755) 
S6 S4 AND S5  Search modes - Boolean/Phrase (896) 
 
S5 campaign* or educat* or interven* or 
program* or promot* or outreach* or 
navigat*  
Search modes - Boolean/Phrase (721,791) 
 
S4 S1 AND S2 AND S3  Search modes - Boolean/Phrase (1,906) 
 
S3 (MH "Mammography") OR "breast 
screen*"  
Search modes - Boolean/Phrase (5,997) 
 
S2 (MH "Health Screening+") OR "mass 
screen*"  
Search modes - Boolean/Phrase (43,101) 
 
S1 (MH "Breast Neoplasms+") OR 
"breast cancer*" OR "breast tum?r*"  
Search modes - Boolean/Phrase (38,954) 
 
 
 
5.3.3 Eligibility criteria and selection process 
Randomised controlled trials (RCTs) have been labelled as the gold standard of medical 
knowledge and therapeutic evidence since the 1980s (Jones and Podolsky 2015). They have 
improved the quality of health care by clarifying benefits and setbacks of health 
interventions (Bothwell et al. 2016). However, certain challenges and limitations of RCTs 
arise from establishing appropriate inclusion criteria to standardizing interventions and 
determining the most relevant outcomes (Bothwell et al. 2016). To overcome these 
challenges, RCTs, which aimed to increase mammography use in asymptomatic populations, 
which had mammography use as an outcome, and which utilised the theoretical frameworks 
for this study i.e. the HBM and/or CSM, were eligible for inclusion. The primary outcome 
of interest to evaluate the success of interventions was the post-intervention difference in the 
proportion of women who underwent mammography screening in the intervention and 
control groups (screening rates). Electronic search results were downloaded into Refworks 
bibliographic software for screening and later retrieval. Two reviewers (DM, GH) were 
involved in selecting articles for inclusion. A full list of articles was obtained and screened 
for duplicates by the main reviewer (DM). Titles and abstracts of articles were independently 
reviewed (DM) to identify articles against predefined inclusion criteria, based on language, 
date, type of study, participants, type of intervention, theory and outcomes (Table 5.2).  
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Table 5.2 - Inclusion and exclusion criteria 
Language and 
Date 
All papers not in the English language were excluded because of the lack of 
translation services.  
 
Primary studies dated 2000 – 2016 (including the supplementary model 
searches) were included. Jepson (2000) included all primary studies of 
interventions prior to this date. 
 
Type of study Only RCTs were included because this is the most robust and ‘gold’ standard 
for measuring the effect of interventions on BS uptake. Comparison groups can 
include usual care, no intervention or other interventions. Therefore, controlled 
non-randomized studies, controlled before-and-after studies and experimental 
studies were excluded.   
 
Excluded studies: pilot studies, opinion pieces, newspaper reporting, policy 
documents, guidelines or studies of interventions that did not report the effect 
of the intervention on BS uptake.  
 
Type of 
intervention 
All interventions aimed at increasing mammography rates were included e.g., 
community-based (such as group education in the workplace, schools or a 
particular geographical region), mass media, small media or those targeting 
individuals (such as client reminders i.e. text messages, reminder phone calls, 
one-on-one education, client incentives among others) or targeting economic 
barriers (such as reducing structural barriers or reducing client out-of-pocket 
costs).  
Interventions to alter the screening test or process were excluded (such as new 
screening tests that are less invasive, decrease pain, and are more accurate and 
timely) because no change in the screening test or process is envisaged in Malta.  
Studies that included BS together with other screening programmes (e.g. 
cervical screening) were included as long as the BS interventions were reported 
separately. 
 
Intervention 
theory 
Interventions designed to address all/some of the constructs derived from the 
HBM and/or CSM were included. 
HBM constructs: perceived susceptibility, perceived severity, perceived 
benefits, perceived barriers, cues to action, and self-efficacy. 
CSM constructs: BC identity, causes, timeline (acute/chronic and cyclical), 
consequences, personal control, treatment control, illness coherence and 
emotional representations. 
No other additional established psychological model informed the intervention. 
 
Intervention 
populations 
Since the recommendation of cancer screening tests varies in developing and 
developed countries (Agide et al. 2018), the study population included women 
of all age groups. 
 
Outcomes Primary outcome measure was a change in BS uptake rates of individuals who 
were screened by mammography.  
 
Studies were excluded if: 
- they only reported secondary outcome measures such as women’s knowledge 
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of, and attitudes and intentions towards BS; 
- the primary outcomes reported repeat mammography screening; 
- they solely evaluated breast self-examination (BSE) or clinical breast 
examination (CBE); 
- they focused on patients with existing BC or survivors. 
 
 
All potentially relevant articles were obtained in full. Reference lists of relevant articles were 
hand-searched to identify any appropriate studies that could potentially be included in the 
review. The search strategy is summarized in Figure 5.1. 
 
5.3.4 Narrative synthesis  
Narrative synthesis was used to organize the evidence from the studies – an approach used 
when studies are too methodologically diverse to be combined to produce a statistical data 
summary i.e. meta-analysis (Higgins and Green 2011; Centre for Reviews and 
Dissemination 2009). The narrative synthesis was conducted in four stages.  
 
First, data extraction was conducted by one reviewer (DM) using a data extraction template 
designed for use in this review. For all studies, data were extracted on study design, sample 
size, sample characteristics, theory, type of intervention, intervention duration, and study 
outcomes. Second, data extraction forms were used to produce a narrative descriptive 
summary of all RCTs, methods and bias, rationale, theories, procedures, functions and 
content. Third, data were discussed and checked by another reviewer (AM), with reference 
to the full text article. Both reviewers (DM, AM) collectively identified and discussed 
patterns between intervention characteristics (e.g., rationale, theories, procedures, functions 
and content), the effect of the intervention on BS uptake and the extent to which these 
characteristics might explain variation in the size/direction of effect. Fourth, the strengths 
and limitations of the evidence-based approaches to increase BS uptake were discussed by 
both reviewers and summarised. Disagreements were resolved by consensus among the two 
reviewers. 
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Figure 5.1 – Search strategy for the identification of intervention studies based on the  
Prisma flow diagram using the HBM and/or CSM to improve mammography uptake 
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5.3.5 Quality assessment 
The quality of the studies was assessed using five data extraction forms used for data 
collection: the FBI Consort 2010 checklist (Schulz et al. 2010), FBI TIDieR checklist 
(Hoffmann et al. 2014), FBI Function checklist (Michie et al. 2011), FBI Theory checklist 
(Michie and Prestwich 2010), and the Cochrane risk of bias tool (Higgins and Green 2011). 
These data extraction forms are described below. 
 
5.3.5.1 Methods 
The CONSORT checklist (Consolidated Standards of Reporting Trials) (Begg et al. 1996) 
was used to describe the reporting of each trial through a 25-item checklist (Moher et al. 
2010), including the study’s aims and objectives, methods (e.g., design, participants, 
interventions, outcomes, sample size), randomization and statistical techniques, participants 
and numbers analysed, results and discussion, and other information such as trial 
registration, protocol accessibility and source of funding. 
 
5.3.5.2 Intervention description 
A Template for Intervention Description and Replication (TIDieR) checklist and guide 
(Hoffmann et al. 2014) was used for each study to assess the completeness of intervention 
description, and ultimately the replicability of interventions. This 12-item TIDieR checklist 
includes the following: brief name, why, what (materials), what (procedure), who provided, 
how, where, when and how much, tailoring, modifications, how well (planned) and how well 
(actual). If studies provided a rationale, theory or goal of the elements essential to the 
intervention to increase uptake, this was reported under the section ‘Why’; the materials and 
procedures used were reported under the section ‘What’; the professional delivering the 
intervention was reported under the section ‘Who provided’ and any training provided for 
the deliverer was also recorded; where, when and how long the intervention was delivered 
were reported under the sections ‘Where’ and ‘How much,’ respectively; any ‘tailoring’ or 
‘modifications’ to the intervention were reported under these sections; mammography 
adherence was reported under the section ‘How well.’ If the intervention included other 
screening behaviours (e.g., cervical screening), these were not described. 
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5.3.5.3 Intervention function 
A function checklist was used to categorise intervention functions (Michie et al. 2011). Nine 
functions are designated in the checklist, namely education, persuasion, incentivisation, 
training, restriction, environmental restructuring, modelling and enablement. Four of these 
functions (coercion, restriction, environmental restructuring, and modeling) place more 
emphasis on external influences and less on personal agency (Michie et al. 2011). Only the 
intervention functions for women were reported. If the intervention had more than one 
function, these were selected accordingly. 
 
5.3.5.4 Theory coding scheme 
The 19-item Theory Coding Scheme (Michie and Prestwich 2010) was used to describe the 
theoretical basis of interventions by providing a clear description of how to code each item. 
Each item required a yes/no/don’t know response and the coder to identify the supporting 
evidence (location) in the study. All 19 items are presented within the following six 
categories, which can be used to assess the explicit application of theory:  
(1) Is theory/model mentioned? (items 1 to 3); 
(2) Are the relevant theoretical constructs targeted? (items 2, 5, 7-11); 
(3) Is theory used to select recipients or tailored interventions? (items 4 and 6); 
(4) Are the relevant theoretical constructs measured? (items 12 and 13); 
(5) Is theory tested? (items 14-18); 
(6) Is theory refined? (item 19).   
This coding scheme provided a method for the systematic appraisal of theoretical 
components of interventions as well as more general behaviour change theories and models 
(Hubbard et al. 2016). 
 
5.3.5.5 Risk of bias 
For the risk of bias assessment, the Cochrane Risk of Bias tool (a domain-based evaluation 
tool) was used (Higgins and Green 2011) to assess risk for selection, performance, detection, 
attrition, reporting, sampling or any other source of bias, respectively. For each study, the 
six risk of bias domains were addressed through a pre-specified question about the adequacy 
of that RCT in relation to each domain, and judgement made on the risk of bias (high, low 
or unclear) for that domain. Risk of bias was undertaken by two reviewers (DM, AM), with 
disagreements resolved by consensus. 
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5.4 Results 
The primary search identified 6951 potentially relevant articles (CINAHL (293), PsycINFO 
(221), MEDLINE (1556), EMBASE (1829), Pubmed (1832), Scopus (78), Cochrane (224), 
Web of Science (548), Prospero (1), University of York, Centre for Reviews and 
Dissemination database suite (356), Joanna Briggs Institute (13)), which were reduced to 
3294 articles after removing duplicates. An additional 7 articles were identified through 
reference lists of included articles. Following review of titles and abstracts, 117 full text 
articles were retrieved. Of the 117 articles assessed to determine eligibility, six met the 
selection criteria.  
 
The second literature search identified 91 potentially relevant articles (CINAHL (6), 
EMBASE (13), MEDLINE (16), Scopus (17), Cochrane (16), Web of Science (23), Prospero 
(0) and University of York, Centre for Reviews and Dissemination database suite (0)), which 
were reduced to 40 articles after removing 51 duplicates. No articles were found to be 
eligible and none included the CSM. In total, six articles were included in the final narrative 
synthesis (Figure 5.1).  
 
5.4.1 Study characteristics and target group  
Five out of the six studies were conducted in the US (Wu and Lin 2015; Wang et al. 2012; 
Sadler et al. 2011; Bodurtha et al. 2009; Duan et al. 2000) and one in Turkey (Secginli and 
Nahcivan 2011). The primary target group for mammography uptake varied across studies 
(Table 5.3). The majority of studies were carried out in America, whereby two studies 
targeted women (mainly African Americans) ≥40 years in US (Sadler 2011; Bodurtha et al. 
2009), another American study targeted mainly White, African American and Hispanic 
women aged 50-80 (Duan 2000) and two studies targeted Chinese-American women in US 
over the age of 40 (Wu and Lin 2015; Wang et al. 2012). One study targeted Turkish women 
aged ≥ 41 years in Turkey (Secginli and Nahcivan 2011).  
 
5.4.2 Outcome measures 
Mammography attendance in all studies was self-reported (Table 5.3). One study (Secginli 
and Nahcivan 2011) also included self-reported CBE and BSE frequency as primary 
outcomes, one study reported screening intentions (Bodurtha et al., 2009) and three studies 
included knowledge of BC and screening to assess programme effectiveness (Wang et al. 
181 
 
2012; Sadler et al. 2011; Secginli and Nahcivan 2011). Common variables reported at 
baseline included: 
 Age (n = 6) (Wu and Lin 2015; Wang et al. 2012; Sadler et al. 2011; Secginli and 
Nahcivan 2011; Bodurtha et al. 2009; Duan et al. 2000); 
 Educational level (n = 6) (Wu and Lin 2015; Wang et al. 2012; Sadler et al. 2011; 
Secginli and Nahcivan 2011; Bodurtha et al. 2009; Duan et al. 2000); 
 Household income (n = 5) (Wu and Lin 2015; Wang et al. 2012; Secginli and 
Nahcivan 2011; Bodurtha et al. 2009; Duan et al. 2000);  
 Health insurance (n = 4) (Wu and Lin 2015; Wang et al. 2012; Secginli and Nahcivan 
2011; Bodurtha et al. 2009).  
 
Four studies reported that they had adjusted the covariance during analysis (Wu and Lin 
2015; Wang et al. 2012; Sadler et al. 2011; Bodurtha et al. 2009). While older age, insurance 
coverage, and low acculturation were associated with greater screening intention and uptake 
in the intervention group for two studies (Wu and Lin 2015; Wang et al. 2012), none of the 
potential moderators (age, race, family history, perceived risk) were significant in Bodurtha 
et al. (2009). Similarly, in Sadler et al. (2011), there were no significant differences in age, 
education level, or any of the baseline measures used to assess outcomes (CBE and 
mammography use). Two studies reported secondary outcome measures: Bodurtha et al. 
(2009) reported CBE, BSE and mammography intentions; Sadler et al. (2011) reported 
adherence to recommendations for CBE. Follow-up varied from 1 month to 18 months; this 
represents a weakness of the shorter durations being unable to report comparable duration 
of mammography uptake for comparison.
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Table 5.3 - Methods and results of included studies 
Study and 
Country 
Age 
group 
(years) 
Sample* Eligibility criteria Outcome measures / 
Length Follow-up 
Comparison groups 
(Interventions 
described fully 
in Table 5.4) 
Findings  
 
Wu and Lin 
2015;  
US 
≥ 41 193 women: 
96 (I),  97 
(C);   
power 
calculation. 
Self-identified 
Chinese or 
Taiwanese 
American; 
≥ 41years;  
No mammogram 
within past 15 
months; 
No BC diagnosis; 
Can read and speak 
English or Chinese. 
Self-reported 
mammography 
(screening or 
diagnostic). 
4-month F/U 
telephone interviews. 
2 arm:  
I = Tailored individual 
telephone counselling;  
C = NCI Brochure 
(mammography 
pamphlet on breast 
health). 
 
Greater intervention effect among 
participants who resided in US 10 
years or less in I (more participants 
obtained mammogram) than C. 
For older women (≥ 65 years) and 
recent immigrants, 51% of I and 
25% of C had obtained 
mammography at 4 months F/U. 
40% of women (n=34) (I) and 33% 
of women (n=27) (C) obtained 
mammogram after intervention; no 
significant difference. 
Wang et al. 
2012;  
US -
Washington 
and New 
York 
>40  664 Chinese-
American 
women: 
225/664 
(Cultural 
video I), 
217/664 
(Generic 
Video I), 
222/664 (C);  
power 
calculation. 
 
Self-identified 
Chinese-American;  
>40 years;  
Lived in the 
Washington, DC or 
New York City 
metropolitan areas;  
Had no personal 
BC history;  
Non-adherent to 
ACS annual 
mammography 
screening 
guideline; 
Self-reported receipt of 
mammography 
screening. 
6 months F/U 
telephone interviews.  
 
3-arm:  
I = Two theoretically 
guided DVDs: 1) a 
culturally-targeted 
video; 2) a 
linguistically-
appropriate but non-
targeted video 
(referred to as the 
cultural video and the 
generic video); 
C = Chinese BC fact 
sheet. 
No significant increase in 
mammography uptake in cultural 
and generic video group compared 
to C at 6-months post-intervention. 
 
Significant effect observed only in 
one subgroup (low-acculturated 
women in cultural video group had 
a significant greater increase in 
self-reported mammography than 
fact sheet (C) at 6-months post-
intervention). 
Women having obtained 
mammography had a significantly 
lower score on perceived barriers 
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No medical 
appointment for a 
mammogram 
within the six 
months following 
the enrollment 
period.  
(p<0.0001) than those who had not 
obtained mammography 6-months 
post-intervention. 
Both cultural and generic video 
groups had fewer perceived barriers 
at F/U than C (p<0.05).  
Sadler et al. 
2011;  
US - San 
Diego, 
California 
20-81 
years; 
40+ in 
BC (I) 
group. 
984 African 
American 
women: 
219/428 (I), 
209/428 (C)  
power 
calculation. 
Self-identified 
African American 
women; 
20-81 years; 
Receiving services 
at a participating 
salon with any of 
the salons’ 
cosmetologists.  
Self-reported 
adherence to 
mammography 
screening.  
Secondary outcomes: 
adherence to 
recommendations for 
CBE, participants’ 
awareness and 
perceptions of their 
vulnerability for BC. 
6 months F/U 
telephone surveys. 
2 arm:  
I = Salon-based BC 
education program; 
C = training program 
about diabetes 
Significantly higher rates of 
mammography compared to women 
in diabetes group. 
 
 
Secginli and 
Nahcivan 
2011;  
Turkey 
≥ 41 190 women:  
97 (I),  
93 (C); 
power 
calculation. 
≥ 41 years;  
No mammography 
or CBE within the 
previous 12 
months;  
Not practicing 
regular BSE;  
No BC history. 
Self-reported 
mammography, CBE 
and BSE frequency 
(primary outcomes).  
Secondary outcomes: 
BSE proficiency, 
breast health 
knowledge, and health 
beliefs (perceived 
susceptibility, 
benefits/barriers to 
2 arm:  
I = 120-min BHP 
program based on 
HBM including a 
breast health 
education, film, BSE 
instruction, booklet,  
calendar and a card 
designed specifically 
for the study.  
Significant improvement in BSE 
rates, proficiency and breast health 
knowledge among Turkish women.  
No anticipated effect on CBE and 
mammography rates. 
 
BHP program effective in 
increasing perceived BC 
susceptibility, perceived 
mammography benefits and BSE, 
and confidence of BSE.  
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mammography and 
BSE, confidence in 
performing BSE). 
3-6 months F/U 
surveys. 
C = general 
information except 
breast health. 
No significant difference between 
the 2 groups for perceived 
mammography barriers. 
Bodurtha et 
al. 2009; US 
(Virginia) 
≥40 899 women: 
449 (I),  
450 (C); 
power 
calculation. 
 
≥ 40 years; 
Not pregnant; 
Nonparticipants in 
the trial’s pilot 
study; 
No history of BC or 
CIS. 
 
Self-reported 
mammography 
behaviour (primary 
outcome). Secondary 
outcomes: CBE, BSE, 
and mammography 
intentions. 
1, 6, or 18-months F/U 
surveys.  
2 arm:  
I = Risk-tailored 
information messages 
(education and risk 
assessment (WISER)  
C = general 
information about BC 
prevention practices.  
 
No significant effect overall on 
mammography screening at 18 
months.  
 
No significant differences in CBE, 
BSE, or mammography intentions. 
Duan et al. 
2000;  
US - Los 
Angeles 
50-80 1443 
women:  
397 (I),  
416 (C);  
no power 
calculation. 
 
Black, Hispanic, 
and White women; 
50-80;  
Residing in Los 
Angeles 
County. 
Self-reported annual 
mammography 
screening. 
1-year telephone F/U 
surveys. 
2 arm:  
I = One session 
telephone counselling 
individualized to 
address barriers, 
education, persuasion, 
conducted annually for 
2 years  
C = Survey only 
 
Mammography adherence 
maintained among baseline 
adherent-participants and reduction 
of non-adherence rate from 23.5% 
to 15.8% (p < 0.05).  
* Studies vary in how sample size is reported.  
BHP - Breast health promotion; VCUHS - Virginia Commonwealth University Health System ; I  - Intervention; C – Control; F/U – Follow-up; BC – Breast 
cancer;  CIS - carcinoma in situ; ACS - American Cancer Society; BSE – Breast Self-Examination; NCI - National Cancer Institute .
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5.4.3 Intervention characteristics  
Table 5.4 describes key intervention components, with a particular focus on health 
belief components. Three were mammography behaviour only interventions (Wu et al. 
2015; Wang et al. 2012; Duan et al. 2000); two included mammography, CBE and BSE 
(Secginli and Nahcivan 2011; Bodurtha et al. 2009), and one included mammography 
and CBE (Sadler et al. 2011). Two studies involved a breast health education program 
(Sadler et al. 2011; Secginli and Nahcivan 2011); two delivered individualized 
telephone counselling (Wu et al. 2015; Duan et al. 2000); one study provided face-to-
face risk tailored information messages (Bodurtha et al. 2009), and one study mailed 
dvd materials (2 videos) (Wang et al. 2012).  
 
Health professionals (nurse, consultants in psychology, oncology nursing and statistics) 
or behaviour change counsellors, delivered the interventions in three studies 
respectively (Wu et al. 2015; Secginli and Nahcivan 2011; Duan et al. 2000); one 
involved trained bilingual interviewers (Wang et al. 2012); one did not make reference 
to who delivered the intervention (Bodurtha et al. 2009). One study mentioned that 
training was provided to the intervention deliverers i.e. cosmetologists (Sadler et al. 
2011) and that training a single educator proved sufficient to permeate the entire salon 
with the health message. English language classes were offered to two Chinese 
community coordinators to recruit potential participants in another study (Wu et al. 
2015), while trained peer counsellors were supervised to conduct the brief year 1 
telephone follow-up in the study by Duan et al. (2000).  
 
Intervention duration mostly included one session for all studies, except for one study 
that mailed intervention material (Wang et al. 2012), following which participants were 
called two-to-four weeks after materials were mailed to confirm receipt and review of 
the materials. Four studies specified where the intervention was delivered; only one was 
in a healthcare (academic) practice (Bodurtha et al. 2009). Four studies reported 
tailoring or modifying the intervention (Wu et al. 2015; Wang et al. 2012; Secginli and 
Nahcivan 2011; Bodurtha et al. 2009).  
 
In addition, most programmes were carried out in a community setting (n=5) (Wu et al. 
2015; Wang et al. 2012; Sadler et al. 2011; Secginli and Nahcivan 2011; Duan et al. 
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2000) and two of these studies used multiple intervention strategies to meet participants' 
multi-dimensional needs (Wang et al. 2012; Secginli and Nahcivan 2011), e.g., a 
combination of access-enhancing strategies and involvement in participants' social 
networks (Wang et al. 2012). Moreover, cultural and social values were integrated in 
three studies such that programme design and delivery addressed participants’ 
culturally determined fatalistic views and attitudes towards BC and BS (Wang et al. 
2012) and respecting culturally or religiously constructed norms in conveying relevant 
information (Wu and Lin 2015; Sadler et al. 2011). 
 
5.4.4 Intervention function 
Table 5.4 describes the intervention function for the mammography behaviour 
component of the intervention. Interventions could be categorised as having more than 
one function. An intervention function in all studies was categorised as ‘education’ 
beause the interventions aimed to increase knowledge or understanding of, for instance, 
lifetime risks, lifestyle recommendations and instructions for scheduling 
mammogram/genetic counselling visits (Bodurtha et al. 2009). Only one study was 
categorised as ‘enablement’ because the counseling was individualized to address 
barriers to increase mammography uptake (Duan et al. 2000). An intervention function 
in two studies was categorised as ‘training’ i.e., individual training was received to 
enhance their ability to build confidence in their understanding of the BSE technique 
(Secginli and Nahcivan 2011) or to enhance their ability to pass on health promotion 
messages (Sadler et al. 2011). An intervention function in five studies was categorised 
as ‘persuasion’ because the intervention emphasised communication or tailored 
messages to proactively engage participants in discussions anticipated to encourage 
them to adhere to recommended BS guidelines (Wu et al. 2015; Wang et al. 2012; 
Sadler et al. 2011; Bodurtha et al. 2009; Duan et al. 2000). 
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Table 5.4 - Intervention description 
 
Author Behaviours Materials and procedures  Intervention 
function(s) 
Deliverers Setting / 
Duration 
Tailoring 
Wu and 
Lin 2015 
Mammography Individual telephone interviews conducted 
in Mandarin, Cantonese, or English.  
 
I: A Web-based, individually tailored 
program (tailored messages) for the 
telephone counseling component. 
 
C: mammography pamphlet on breast 
health developed by the NCI (explaining 
the procedure of mammography and the 
importance of early detection through 
mammography). Not stated whether these 
pamphlets were mailed to participants’ 
homes or given during face-to-face contact. 
Education; 
persuasion; 
incentivisation 
Research staff 
conducted baseline 
surveys using CATI 
system. Two senior 
investigators were 
consultants in 
psychology, oncology 
nursing, and statistics. 
Staff conducting 
interviews had at least 
a bachelor’s degree in 
health-related field and 
completed a 2-day 
intensive training. 
Community 
setting.  
20-30 minutes 
interview; 
Intervention 
telephone calls  
up to 1 hour.  
 
Yes. 
 
The counselling content 
provided individualized 
messages pertinent to 
the individual 
participant based on her 
responses at baseline 
assessment.  
Wang et 
al. 2012 
Mammography 
 
I: Two theoretically guided videos: 1) a 
culturally-targeted video (cultural video) 
and 2) a linguistically-appropriate but non-
targeted video (generic video). DVD 
format, 18 minutes duration, and included 
two segments: 1) a soap-opera style 
production and 2) a female physician’s 
recommendations. Intervention materials 
mailed to participants’ homes within 1-
week after randomization.  
 
C: Chinese BC fact sheet. The mailed two-
sided color-printed sheet included concise 
information about the development of BC, 
Education; 
persuasion; 
incentivisation 
Trained bilingual 
interviewers conducted 
baseline and 2 F/U 
assessments. 
 
 
Community 
setting. 
First F/U 
survey held 2-
4 weeks after 
materials were 
mailed. 
Second F/U 
assessment 
administered 6 
months post 
intervention to 
measure 
Yes. 
 
Group tailoring rather 
than individual tailoring: 
Only the cultural video 
incorporated Chinese 
cultural beliefs. 
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Asian women’s risk for BC, BC symptoms, 
and ACS BS guidelines. 
screening 
behaviour. 
Sadler et 
al. 2011 
Mammography, 
CBE 
Face-to-face contact (cosmetologists and 
clients) at 20 beauty salons. Verbally 
delivered health messages were reinforced 
by posters, pamphlets, booklets and 
brochures in plexiglass stands throughout 
salons. Cosmetologists received 4 hours of 
one-on-one training and an additional 4 
hours of reading materials. 
Cosmetologists in BC training arm were 
given soft plastic BC model and string of 
clay beads.  
Education; 
persuasion; 
training 
20 Cosmetologists. 
 
Twenty of the 24 
stylists consented to 
participate in the 
study.  
Community 
setting. One 
session at 
client’s salon 
visit. 
ITT analysis 
No 
Secginli 
and 
Nahcivan 
2011 
Mammography, 
CBE, 
BSE  
Program delivered face-to-face in small 
groups of 5-8 women. 
Breast health education (teaching session 
and film), BSE instruction, a booklet, a 
calendar, and a card: 
Health education: 35-min teaching session 
using a flip chart. 
Film (15-min): providing BSE instructions 
BSE instruction (15 min): in a separate 
room, building confidence to complete all 
BSE steps, silicon breast model exercises 
(standard size five lumps). 
27-page booklet given as BSE reminder. 
Educational calendar: key points about BSE, 
CBE and mammography and remembering 
the right days to perform BSE. 
Card: one page, colour card providing an 
example of correct BSE method. 
Education; 
training; 
modelling 
The first author  
presented the program 
(Nurse-delivered). 
 
Community  
setting. One 
intervention 
session. 
 
Yes. 
 
The educational calendar 
designed to address key 
points about BSE, CBE, 
and mammography.  
 
The BSE card was based 
on the card obtained 
from Susan G. Komen 
BC Foundation (2007). 
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Bodurtha 
et al. 
2009 
Mammography, 
CBE, 
BSE 
Face-to-face intervention. 
 
Information sheets containing personal 5-
year and lifetime risks, HBM (barriers, 
seriousness and benefits) factors, lifestyle 
recommendations and instructions for 
scheduling mammogram/genetic 
counselling visits. 
 
Access not specified. 
 
 
Education; 
persuasion 
Not described.  
 
 
Clinical 
practice 
setting.  
Duration not 
described 
Yes.  
 
Risk-tailored 
information messages 
(education and risk 
assessment).  
I: Handouts addressed 
traditional HBM 
constructs (barriers, BC 
seriousness, 
individual BC risk, 
benefits of  
yearly mammogram). 
Nutrition and physical 
activity 
recommendations 
included.  
No specific tailoring of 
invitation script. 
Duan et 
al. 2000 
Mammography  Part-time peer counselors, hired from 
participating churches assigned to 
telephone counseling, called participants 
from churches to provide individualized 
mammography counseling over the phone. 
 
Unclear materials: Counseling 
individualized to address barriers. Women 
were informed about their risk status and 
BC rates. Encouraged to ask their 
physicians for referral and information 
about convenient screening facilities. 
Education; 
persuasion;  
enablement 
A survey firm 
collected the baseline 
telephone data. 
Trained and 
supervised peer 
counsellors conducted 
the brief year 1 
telephone F/U.  
Community 
setting.  
One 
individualized 
telephone 
counselling 
session 
conducted 
annually for 2 
years. 
Not described. 
  
It is only mentioned that 
individualized 
mammography 
counseling was provided 
by telephone. 
 
ITT - Intention-to-treat analysis; I – Intervention group; C – Control group; CATI - Computer Assisted Telephone Interview  
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5.4.5 Theoretical framework and constructs 
The underpinning theoretical approaches adopted in each study are summarised in 
Table 5.5. All six studies utilised the HBM, but this was often not in depth. No RCT 
was found adopting the CSM as the conceptual framework to increase mammography 
uptake.  
 
Only one study targeted all constructs found within the HBM (Bodurtha et al. 2009), 
followed by five constructs in Sadler et al. (2011). Interventions targeted perceived 
mammography barriers in all studies, followed by perceived mammography benefits in 
5 studies (Wu and Lin 2015; Wang et al. 2012; Sadler et al. 2011; Secginli and Nahcivan 
2011; Bodurtha et al. 2009), perceived susceptibility of BC in 4 studies (Wang et al. 
2012; Sadler et al. 2011; Secginli and Nahcivan 2011; Bodurtha et al. 2009), self-
efficacy in 3 studies (Wu and Lin 2015; Secginli and Nahcivan 2011; Bodurtha et al. 
2009), perceived severity of BC in 3 studies (Wang et al. 2012; Sadler et al. 2011; 
Bodurtha et al. 2009) and cues-to-action in 2 studies (Sadler et al. 2011; Bodurtha et al. 
2009). The knowledge variable was less likely to be addressed in the interventions 
(three studies) (Wang et al. 2012; Sadler et al. 2011; Secginli and Nahcivan 2011).  
 
Three studies reported which scale was used to measure health beliefs i.e., Champion’s 
Health Belief Model Scale (CHBMS) in Secginli and Nahcivan (2011) and Wu and Lin 
(2015) and the Chinese Mammography Screening Beliefs Questionnaire in Wang et al. 
(2012). No studies reported if or how theory was used to select recipients or tailored 
interventions of whether theory was adapted. Three studies reported when the targeted 
constructs were measured. Health beliefs were assessed at baseline and 6-months post 
intervention in Secginli and Nahcivan (2011). Health beliefs were administered before 
and after the intervention in Wang et al. (2012). Baseline and six month follow-up 
surveys were carried out in Sadler et al. (2011). Although one study reported that 
perceived benefits, barriers, self-efficacy, and knowledge related to BS were measured, 
it did not report the results of the constructs at 4-month follow-up telephone survey 
(Wu and Lin 2015).  
 
Justification for HBM use and the reasons why certain HBM constructs were the target 
in interventions was provided in only three studies (Wu and Lin 2015; Sadler et al. 
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2011; Secginli and Nahcivan 2011). These justifications were based on earlier research, 
which had identified the important and modifiable constructs related to improved 
mammography adherence.  
 
5.4.6 Effects of programmes on outcome measures and tools used in 
measuring outcomes  
 
5.4.6.1 Effect on mammography uptake  
Mammography uptake was self-reported in all studies, with inconsistent results (Table 
5.4). Wu and Lin (2015), Secginli and Nahcivan (2011) and Bodurtha et al. (2009) did 
not find any significant difference between the intervention and control groups. Wu and 
Lin (2015) further performed a sub-group analyses of insurance status, age and length 
of residence in US in assessing the intervention effect on mammogram uptake. A 
significant difference between groups was noted in women having insurance coverage 
to undergo mammography (56% I versus 34% C). Wang et al. (2012) revealed that only 
low-acculturated women in the intervention group had significantly increased 
mammography uptake six months post-intervention (p < 0.05). In Duan et al. (2000), 
the telephone counselling intervention maintained mammography adherence among 
baseline adherent-participants and reduced the non-adherence rate at one-year follow-
up from 23.5% to 15.8% (p < 0.05). Similarly, in Sadler et al. (2011), women in the BC 
intervention group (BC education sessions offered in beauty salons) reported 
significantly higher mammography rates compared to women in the control group who 
had received information about diabetes during the same six-month timeframe. At 
baseline, there were no significant differences in reported mammography adherence 
and CBE. Given the high attrition rate by follow-up, the intention-to-treat (ITT) 
analysis did not produce significant differences between groups at follow-up. However, 
the ITT analysis showed similar trends to the completers analysis, such that women in 
both treatment arms reported significantly (p < 0.05) higher mammography rates at 
follow-up compared to baseline. 
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Table 5.5 - Theoretical models 
Study Is theory/ 
model 
mentioned? 
Are the relevant theoretical 
constructs targeted? 
Is theory used 
to select 
recipients or 
tailored 
interventions? 
Are the relevant 
theoretical constructs 
measured? 
Is mammography behaviour-
related theory tested? 
Is theory 
adapted? 
Wu and 
Lin 2015 
HBM with 
justification 
Yes. 
Three HBM constructs 
(perceived benefits, barriers, 
self-efficacy). 
 
Knowledge variable related to 
BC screening  
 
 
Not reported Perceived benefits (5 
items), barriers (15 items) 
and self-efficacy 
(Champion’s 10-item 
measure) measured (4-
point Likert-type scale). 
Knowledge (13-item scale 
developed by principal 
investigator. 
Self-reported data on demographic 
variables, knowledge, beliefs, and 
screening behaviours at baseline and 
4 months. 
I: mammography screening increased 
to 40% (n=34) compared with 33% 
(n=27) for C at 4 months; not 
statistically significant.  
Not 
reported 
Wang et 
al. 2012 
HBM – no 
justification  
Yes. 
Four HBM components 
(perceived susceptibility, 
perceived severity, perceived 
benefits, perceived barriers). 
 
Knowledge variable.  
 
Not reported Four validated subscales: 
perceived susceptibility, 
severity, benefits, and 
barriers from the Chinese 
Mammogram Screening 
Beliefs Questionnaire 
(Wu and Yu, 2003).  
 
 
 
 
The cultural video, generic video, 
and fact sheet increased 
mammography use by 40.3%, 38.5%, 
and 31.1% from baseline, 
respectively. A significant 
intervention effect observed only in 
one subgroup: The cultural video 
significantly increased 
mammography screening among 
low-acculturated women over the 
fact sheet (OR=1.70, 95% CI=1.04, 
2.78). Both video groups reported 
fewer barriers after I than C group. 
Not 
reported 
Sadler et 
al. 2011 
HBM with 
justification 
Yes. Not reported  Yes. 
Measure not reported, 
except for baseline and 
Yes.  
Women in I engaged in 
mammography screening with 
Not 
reported  
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Five constructs: susceptibility, 
severity, benefits, barriers, and 
cues to action.  
 
 
F/U surveys (assessed BC 
awareness, personal 
exposure to BC, personal 
vulnerability, steps to 
reduce personal risk of 
BC mortality, and 
adherence to guidelines). 
significantly greater frequency than 
women in C who had received 
information about diabetes during the 
same six months.  
 
Secginli 
and 
Nahcivan 
2011 
HBM with 
justification 
Yes.  
Four constructs: perceived 
susceptibility, benefits to 
mammography and BSE, 
barriers of mammography and 
BSE, confidence in performing 
BSE). 
 
 
Not reported Yes.  
Champion’s Health Belief 
Model Scale (CHBMS)  
was used to measure 
health beliefs of 
susceptibility (5 items), 
benefits of BSE (6 items), 
benefits of mammography 
(6 items), barriers to 
BSE (6 items), barriers to 
mammography (5 items), 
and confidence (11 items) 
by using five-point Likert 
responses. Health 
beliefs were assessed at 
baseline and 6-month 
post-intervention. 
 
Yes.  
I: significant changes pre- to post-test 
in perceived susceptibility, benefits 
of BSE and mammography, and 
confidence (all increased), perceived 
barriers to mammography 
(decreased). No significant changes 
in I for perceived barriers to BSE.  
C: significant changes pre- to post test 
in confidence, and barriers to 
mammography (all increased), and 
perceived susceptibility, barriers to 
BSE, and benefits of mammography 
(all decreased).  
At 6-months, mean scores were 
significantly higher in I for all health 
belief scales (p < 0.05) except for 
barriers to mammography (p = 0.116). 
Yes  
Bodurtha 
et al. 
2009 
HBM – no 
justification  
 
Yes  
All 6 HBM constructs.  
 
Not reported Not reported Not reported Not 
reported 
Duan et 
al. 2000 
HBM – no 
justification  
Yes.  
One construct: Barriers.  
 
Not reported  Not reported Not reported Not 
reported 
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5.4.6.2 Effect on mammography intentions 
One study reported women’s screening intentions to obtain a mammogram (Bodurtha 
et al. 2009). The former asked participants to report their intention by rating how likely 
they were to get a mammogram in the coming year. Responses were dichotomized as 
‘Definitely or Very likely’ vs. ‘Unlikely’, ‘Somewhat likely’ or ‘Not sure’. No 
statistical difference was found in mammography intentions by intervention condition 
overall. 
 
5.4.6.3 Health beliefs about breast cancer and screening 
Studies show contradictory results for changes in beliefs about BC and screening 
(Table 5.5). Three studies (Wu and Lin 2015; Wang et al. 2012; Secginli and Nahcivan 
2011) used the sub-scales of a standard, validated scale in different languages i.e., 
Champion’s Health Belief Model Scale (CHBMS) (Wu and Yu 2003; Champion et al. 
1997; Champion 1993) to evaluate changes in health beliefs about BC and 
mammography screening, in the areas of perceived susceptibility (Wang et al. 2012; 
Secginli and Nahcivan 2011), perceived benefits and barriers (Wu and Lin 2015; Wang 
et al. 2012; Secginli and Nahcivan 2011), perceived severity (Wang et al. 2012), and 
self-efficacy (Wu and Lin 2015; Secginli and Nahcivan 2011). Secginli and Nahcivan 
(2011) found that at 6-months post-intervention, the mean scores were significantly 
higher in the intervention group for benefits, self-efficacy and susceptibility (p < 0.05) 
except for barriers to mammography (p = 0.116). Wang et al. (2012) found that 
participants in the intervention group who obtained a mammogram during the follow-
up period reported significantly lower perceived barriers to screening six months post-
intervention (p < 0.05) and significantly greater risk perception than that of the control 
group. Wu and Lin (2015) found no statistically significant differences in perceived 
barriers, benefits or self-efficacy between groups at 4-months post-intervention. The 
other three studies did not report the scales used to measure health beliefs (Sadler et al. 
2011; Bodurtha et al. 2009; Duan et al., 2000). 
 
5.4.6.4 Effect of knowledge of breast cancer and screening  
The content of the intervention played an important role in increasing breast health 
knowledge and changing participants’ screening behaviour. Key BS messages were 
targeted in three studies (Wang et al. 2012; Sadler et al. 2011; Secginli and Nahcivan 
2011), such as facts on BC, information on the effectiveness and importance of 
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screening, screening recommendations, myths or misconceptions, and health beliefs 
about cancer and screening. However, the changes in BC knowledge levels before and 
after the intervention produced inconsistent results.  
 
The knowledge scores in Secginli and Nahcivan (2011) showed a significant increase 
in the intervention group over time (p < 0.001), but the knowledge scores in Wang et 
al. (2012) and Sadler et al. (2011) showed no statistical significant difference in 
knowledge scores between groups. This could be due to the diversity of instruments 
used to assess knowledge. Two studies used two different but validated knowledge tests 
to assess knowledge of BC and screening, with higher scores meaning greater 
knowledge (Wang et al. 2012; Secginli and Nahcivan 2011). The latter used a 22-item 
breast health knowledge (BHK) form to assess knowledge at baseline, immediate post, 
and 3- and 6-month follow-up period. Wang et al. (2012) used a previously validated 
10-item instrument to measure knowledge at baseline and 2-4 weeks follow-up. The 
instrument used in Sadler et al. (2011) to assess knowledge at baseline and six-month 
follow-up was unreported, and hence considered of unknown validity.  
 
5.4.7 Risk of bias 
The results of the ‘risk of bias assessment’ are presented in Table 5.6. All trials were 
judged as unclear or at high risk of bias in at least some domains. In the majority of 
studies, the risk of bias from not blinding trial personnel were identified as high risk or 
unclear, while for blinding outcome assessors, the majority of articles (five studies) 
were unclear. One study was assessed as having a high risk of bias in the random 
sequence generation (Bodurtha et al. 2009), while another study was considered to have 
a high risk of bias for allocation concealment (Secginli and Nahcivan 2011). Three 
studies were assessed as having a high risk of bias for addressing incomplete outcome 
data (Wang et al. 2012; Sadler et al. 2011; Bodurtha et al. 2009). Three studies (Wu 
and Lin 2015; Secginli and Nahcivan 2011; Duan et al. 2000) did not use ITT analysis. 
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Table 5.6 - Risk of bias 
 Design Selection bias Performance 
bias 
Detection 
Bias 
Attrition 
bias 
Reporting 
bias 
 
Authors  Random 
sequence 
generation 
Allocation 
concealment 
Blinding 
participants/ 
personnel 
Blinding 
outcome 
assessment 
Incomplete 
outcome 
data 
Selective 
reporting 
Other 
bias 
Wu and 
Lin 2015 
Prospective RCT (2-arm) single-blind 
study - the efficacy of an individually 
tailored telephone counselling vs. NCI 
mammography brochure (control) 
Unclear Unclear High  Unclear Low;  
No ITT 
analysis. 
Low  High  
Wang et 
al. 2012 
RCT (cluster) (3-arm) – a culturally-
targeted video and a generic video vs. 
BC fact sheet (control) 
Low  Unclear Unclear Unclear High;  
ITT 
analysis. 
Low  Low  
Sadler et 
al. 2011 
RCT (cluster) -  
BC education sessions offered in 
beauty salons vs. a comparable 
diabetes education program (control) 
Low  Low  High  Low  High;  
ITT 
analysis. 
High  Unclear 
Secginli 
and 
Nahcivan 
2011 
RCT – nurse-delivered breast health 
promotion vs control (general 
information except breast health). 
Low  High  Unclear Unclear Low;  
No ITT 
analysis. 
Low  Unclear 
Bodurtha 
et al. 
2009 
RCT - Risk-tailored information 
messages (education and risk 
assessment) vs. control (general 
information about BC practices, 
including mammography, not tailored 
to women’s risk level and did not 
address HBM factors). 
High  Unclear Unclear  Unclear High;  
ITT 
analysis. 
Low  Unclear 
Duan et 
al. 2000 
RCT (cluster) - Telephone counseling 
vs. control 
Unclear Unclear High  Unclear Low;  
No   ITT 
analysis. 
Unclear Unclear 
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5.5 Discussion 
This is the first systematic review of interventions to explore the effectiveness of intervention 
strategies to increase mammography uptake based on two key theoretical models – HBM and 
CSM. This review sought to provide information on the programme characteristics that could 
potentially inform the development of future interventions for the Maltese population. Six RCTs 
were found to have used the HBM as the theoretical basis to guide the development of 
intervention strategies in promoting mammography compliance. There is a clear gap in the 
literature regarding interventions to improve mammography uptake through theoretical frameworks 
such as the HBM and CSM, evidenced by the identified small number of studies. This is an important 
finding considering the high prevalence of BC and female mortality worldwide (Ferlay et al. 2013).  
 
Apart from one study carried out in Turkey (Secginli and Nahcivan 2011), the other five studies 
were carried out in US, limiting the generalisability of the findings to other settings. The US 
healthcare system is based on private insurance, supplemented by Medicare for over 65s 
(Gardner 2013). In contrast, healthcare services in Malta as well as in the UK are free at the 
point of delivery. It is therefore likely that cost is more of a barrier for low-income women to 
attend mammography in the US compared to other countries. Nevertheless, it is also important 
to consider opportunity costs, even in the Maltese health setting. Women who are paid a wage 
(e.g. by the hour) incur a higher personal cost due to loss of income than salaried women 
(Gardner 2013). 
 
5.5.1 HBM and theoretical constructs 
Application of the HBM has frequently been confirmed in BS interventions (Ceber et al. 2009), 
indicating the importance of the model and its impact on BS behaviours. While the model 
constructs include perceived susceptibility, severity, benefits, barriers, cues to action and self-
efficacy, only one study in this review used the HBM in its entirety (Bodurtha et al. 2009) and 
not all studies measured health beliefs as outcomes. Few trials reported changes in theoretical 
constructs and in those that did, results were inconsistent. There was also limited reporting of 
how constructs were operationalized as part of the intervention.  
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Perceived barriers was the most frequently (n=6) targeted construct. Hence, this review confirms 
that perceived barriers are the strongest constructs in predicting mammography behaviours, 
compared to other model constructs. However, the programme in Secginli and Nahcivan (2011) 
was not successful in decreasing perceived barriers to mammography and BSE. One reason for 
this effect of perceived barriers is that participants may have paid more attention to the barriers 
than to the benefits in performing screening behaviours. On the other hand, participants in the 
intervention group in Wang et al. (2012) reported significantly lower perceived screening 
barriers than that of the control group six months post-intervention and significantly greater risk 
perception. These reveal that following the intervention, participants were more aware of 
barriers that impeded them from performing the screening behaviours, and tried to resolve those 
barriers. When people consider that the benefits gained can outweigh barriers, then it is more 
likely that they perform the screening behaviour (Assari 2011).  
 
Perceived mammography benefits is indicative of one’s understanding of the benefits gained 
from screening compliance (Glanz et al. 2008). As for benefits to mammography and self-
efficacy, the mean scores were significantly higher in the intervention group in Secginli and 
Nahcivan (2011) but appeared not to be associated with positive behaviour change in Wu and 
Lin (2015). When the perceived seriousness of the disease is high, and the disease is perceived 
as incurable, it can produce reverse effects on BS behaviour (Eskandari-Torbaghan et al. 2014). 
Given the crossover between theoretical constructs and behaviour change techniques, the 
positive results in the latter may be a result of the individual behaviour change techniques 
employed, such as self-regulatory behaviours, rather than the theoretical constructs.  
 
5.5.2 The utility of CSM 
The lack of use of CSM in RCTs and in informing BS interventions, in itself, is an innovative 
finding and worth noting, considering that the CSM allows the testing of relations between 
patients’ reflections on their emotional responses to an illness and outcomes, such as quality of 
life and emotional coping (e.g., Evans and Norman 2009; Rozema et al. 2009). It seems that 
CSM has mainly been used to date for the prevention and management of other chronic illness 
threats (McAndrew et al. 2008) and to understand the illness perceptions of specific groups of 
patients (Figueiras and Alves 2007), or groups at risk from a particular illness (Hughner and 
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Kleine 2004). There is limited information on CSM’s impact among healthy individuals and 
their lay perceptions of serious illnesses, and whether the model has the same structure and 
pattern of inter-relationships (Figueiras and Alves 2007). Hence, examining the relationship 
between healthy individuals’ models of illness and their beliefs towards preventive health 
actions is the first step in the planning of appropriate strategies to increase BS uptake (Figueiras 
and Alves 2007).  
 
5.5.3 Outcome measures and tools used in measuring outcomes 
All six studies included valid outcome measures (i.e. self-reported receipt of mammograms, 
CBE and/or BSE). Besides recall bias, self-reports may be subject to other biases particularly in 
cases where cultural tendencies towards downplaying one’s own opinion and the desire to please 
others or to demonstrate ‘politeness’ may influence findings (Nakamura 2001). These cultural 
features might lead women in general to over report screening uptake. Verifying attendance to 
mammography through medical records is a reliable way of confirming data accuracy, though 
retrieving such records may prove difficult, particularly if women attend private clinics. 
Furthermore, the use of standardised, valid and reliable tools to measure outcomes can help to 
produce high quality data (Chan and So 2015). This review shows that Champion’s standardised 
and validated instrument (CHBMS) is commonly used to measure health beliefs. However, 
different measures were adopted by studies in this review to measure uptake rates, health beliefs 
and/or knowledge, making comparison and findings interpretation among studies difficult. 
Caution should be utilised in the interpretation of results as tool reliability and validity are not 
reported, and hence the quality of data is questionable. 
 
5.5.4 Intermediate outcomes 
Researchers have recognised the importance and relationships between health beliefs, 
knowledge of screening and cancer, intentions and final behavioural outcome (Zhang 2014). 
Any one or a combination of the latter mediates behavioural change, in order to enact positive 
health action (Orji et al. 2012). Hence, besides using screening uptake as an indicator of 
intervention effectiveness, major intermediate outcomes, such as health beliefs, knowledge and 
screening intentions, were added in this review. Limited supportive evidence emerged from this 
review on changes in knowledge of BC (n=1) (Secginli and Nahcivan 2011) and no evidence of 
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changes to intentions to having mammography emerged (Bodurtha et al. 2009), possibly 
attributed to the lack of standardised measures used across studies.   
 
5.5.5 Demographic factors 
Demographic factors, such as age, education level, household income and health insurance, have 
an impact on women's screening attendance other than the intervention itself (Sheppard et al. 
2008). By controlling these potential confounding factors during analyses, a more accurate 
estimate of the intervention effect on outcome measures can be achieved (Chan and So 2015). 
Four studies adjusted for these covariances during analysis in this review (Wu and Lin 2015; 
Wang et al. 2012; Sadler et al. 2011; Bodurtha et al. 2009). During sub-group analyses, older 
age, insurance coverage, and low acculturation were associated with greater screening intentions 
and uptake in the intervention group during sub-group analyses (Wu and Lin 2015; Wang et al. 
2012). None of the potential moderators were found to be significant in Sadler et al. (2011) and 
Bodurtha et al. (2009).  
 
The intervention effectiveness varied with ethnic groups, as the highest increase in BS uptake 
was in African Americans and Chinese-American women, while the difference in 
mammography rates were not statistically significant among Asian American women, 
Caucasian and Turkish women. This reflects the fact that participants’ demographic and cultural 
characteristics and beliefs may not be adequately addressed when designing intervention 
materials. Culture is a powerful and multifaceted construct that influences beliefs, attitudes and 
behaviour (Pasick et al. 2009) and plays an important role in explaining cancer screening 
disparities in racial and ethnic groups (Lee and Im 2013). Identification of the prevailing cultural 
factors associated with BS behaviour among women would be required to enhance population-
specific health promotion programs and strategies to increase cancer screening utilization. 
Additionally, exploring these factors helps to facilitate the design of adequate strategies in terms 
of age, literacy and income.  
 
5.5.6 Intervention design and effectiveness 
The review found that intervention studies varied greatly by study population and geographic 
area; hence it was not possible to arrive to a generalizable conclusion on the effectiveness of 
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any one particular intervention. First, there were differences in the delivery of intervention 
strategies e.g., interventions targeting Chinese American women (Wu and Lin 2015; Wang et 
al. 2012) adopted cultural sensitive ways to deliver these strategies (e.g. culturally-targeted 
video (Wang et al. 2012) and an interactive, individually tailored telephone counseling program 
(Wu and Lin 2015) respectively. Second, different patterns were found in relation to intervention 
design and effectiveness.  
 
Among the six intervention studies with valid outcome measures, only two used multiple 
intervention strategies (Wang et al. 2012; Secginli and Nahcivan 2011) to target Chinese 
American immigrants and Turkish women respectively. Evidence was found to support multiple 
strategies in increasing mammography uptake among certain Asian ethnic women: reminder 
letter and health education booklet delivered during a home visit (among Chinese, Malay, and 
Indian women in Singapore) (Seow et al. 1997). Further evidence from a Cochrane report 
favoured five BS intervention strategies: invitation letter; mailed educational material; invitation 
letter plus phone call; phone call; and training activities plus direct reminders for women 
(Bonfill et al. 2001). In another systematic review to evaluate interventions designed to increase 
the rate of breast, cervical, and colorectal cancer (CRC) screening (Brouwers et al. 2011), client 
reminders, small media, and provider audit and feedback appeared to be reasonable strategies 
to increase screening uptake, but one-on-one education in particular appeared to be an effective 
intervention to increase BS uptake at a population level. It is clear that intervention effectiveness 
appears to vary among diverse populations, methods of program delivery, and study setting. 
Hence, it cannot be concluded in this systematic review whether employing a combination of 
multiple strategies based on theory was more or less effective than single interventions in 
increasing mammography uptake among populations. This is inconsistent with other findings 
by Legler et al. (2002), where multiple interventions were most effective, leading to a 27% 
increase in mammography uptake rates, and in Gardner (2013) where multiple interventions 
showed the largest difference between intervention and control groups (20.7%). In the review 
by Bailey (2005), peer educators (‘face-to-face’), access-enhancing and multiple interventions 
were effective in increasing screening though no meta-analysis was carried out to determine 
effectiveness. Similarly, no meta-analysis was carried out in this systematic review and hence, 
the most effective strategy could not be determined. 
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There was weak evidence to suggest that the associations were stronger in studies with a shorter 
length of follow-up. There was also little evidence that the association between intervention and 
mammography uptake rates varied by source outcome (self-reports), location (urban or rural), 
whether control was usual care or not, whether mammography was free-of-charge or not, or by 
level of randomisation. In addition, five interventions were carried out in a community setting 
(Wu et al. 2015; Wang et al. 2012; Sadler et al. 2011; Secginli and Nahcivan 2011; Duan et al. 
2000). However, only three community-based intervention studies revealed significant effects: 
(i) the culturally-targeted video (Wang et al. 2012) significantly increased mammography 
screening among low-acculturated women over the fact sheet; (ii) the telephone counselling 
intervention reduced the non-adherence rate at one-year follow-up (Duan et al. 2000); (iii) the 
BC education sessions in beauty salons increased mammography rates significantly when 
compared to women who had received information about diabetes in the control group (Sadler 
et al. 2011). Evidence has shown that home visits, invitation letters, media campaigns, and 
mailed culturally sensitive print materials alone may be ineffective in increasing screening 
uptake (Lu et al. 2012) but the effectiveness of community-based or workplace-based group 
education programs increases when additional support, such as assistance in 
scheduling/attending screening and mobile screening services are provided (Lu et al. 2012).  
 
Training health professionals, or bilingual interviewers, or lay educators, proved to be effective 
in half of the studies to improve BS use. Cultural awareness training for health care professionals 
and outreach educators is likely to improve cancer screening uptake as it can help women 
overcome language and cultural barriers (Lu et al. 2012). On the other hand, cultural taboos, 
fatalistic views and attitudes towards cancer and screening may make it challenging to recruit 
women to participate in studies focused on breast or other cancer screening uptake (Ho et al. 
2005; Liang et al. 2004; Yi and Reyes-Gibby 2003). Although five studies reported statistical 
power to determine significance (Wu and Lin 2015; Wang et al. 2012; Sadler et al. 2011; 
Secginli and Nahcivan 2011; Bodurtha et al. 2009) and overall, the sample sizes were large, the 
validity of findings remains questionable due to uncertainty of selection bias (Table 5.6) and 
the incomparability between intervention and comparison groups.  
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Finally, no studies reported cost information and hence, economic evaluation of the cost-
effectiveness of most intervention studies is essentially infeasible. A meta-analysis on invitation 
letters and telephone calls to increase mammography undertook a cost-effectiveness analysis 
(Page et al. 2006) and found that when a phone number was available, a letter plus telephone 
call intervention was more cost-effective than a two letter intervention. Hence, further research 
is required to determine which interventions are most cost-effective. 
 
5.6 Limitations 
This review has several limitations that need to be acknowledged. Primarily, it includes studies 
published in the English language, omitting studies published in other languages. Secondly, the 
majority of the studies were conducted in the US, limiting the generalizability of findings since 
culture, accessibility of health care services and BS programmes, and cost affordability may be 
different to other countries. Further research is clearly warranted in other countries and other 
ethnic minority groups. Further systematic searches for articles have not been conducted since 
the searches carried out until 2016 due to resource constraints. However, PsycINFO, OVID 
EMBASE and OVID MEDLINE auto-alerts suggest that no additional studies have been 
published. The variation in research methods used in the identified studies is another limitation. 
Therefore, the findings are to be interpreted with caution due to the variation of tools for 
assessing outcomes, the varying validity of the translated instruments and the differences in 
random assignment. Due to its quantitative nature, this review did not allow for the exploration 
of women’s experiences with these interventions. Such experiences would be useful in 
highlighting important issues to researchers who are planning future interventions. Examples of 
these issues include the benefits to be gained from participation other than behaviour 
modification, and the challenges to implementing interventions.  
 
5.7 Conclusion 
This systematic review is the first of its kind to examine the effectiveness of interventions using 
HBM and/or CSM theory to increase mammography uptake. Overall, the findings suggest that 
interventions based on HBM carried out in a community setting involving culturally-targeted 
material, telephone counselling and BC education can improve BS rates. Although the present 
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review is consistent with previous findings supporting the notion that theory-based interventions 
are somewhat effective in promoting screening uptake (Han et al. 2011, 2009) (3 out of 6 
studies), more rigorous studies are required to increase the evidence-base due to the limited 
quality of the included studies. Interventions need to be described in their entirety to allow for 
the identification of effective components and replication.  
 
In some studies, intervention success appeared to be unrelated to the HBM constructs addressed, 
thereby challenging the utility of this model as the sole theoretical basis for BS interventions. 
Therefore, multiple health behaviour models seem to be more effective at increasing health 
behaviour and in meeting women’s complex needs (Byrd et al. 2013; Mishra et al. 2009), such 
as incorporating the use of CSM. The effect of interventions that draw on CSM constructs is 
unknown. Further research is required to evaluate intervention effectiveness and support the use 
of evidence-based theory, including the value of CSM. The combination of HBM and CSM may 
have a significant impact on how these interventions can be designed and implemented. This 
would help to link the identified common factors and mediators influencing screening outcomes, 
such as demographics, knowledge, beliefs and attitudes, as well as the cognitive and emotional 
representations of an illness in order to guide the design, implementation and evaluation of 
interventions and enhance their adaptation across cultures and populations. Notwithstanding the 
effectiveness of multiple health behaviour models, factors such as culture are often omitted. 
There is need for a comprehensive model that includes such characteristics as well as other 
factors and mediators altogether to improve health behaviours. As there are still many gaps in 
the literature with regards to what is required for an intervention to improve BS uptake, a 
qualitative enquiry is necessary to explore what may be needed for such an intervention. The 
following chapters present the rationale and methods for such qualitative studies. 
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Chapter 6 
 
Recommendations of Expert Steering 
Groups on Breast Cancer Screening in 
Malta – An Overview 
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6.1 Introduction 
As discussed in Chapter 3, Intervention Mapping (IM) was the chosen overarching framework 
for the intervention development process using a structured approach that moves from theory to 
practice (Kok 2009; Tortolero et al. 2005). In this research, Steps 2 and 3 of IM were supported 
through discussions held within two steering groups and included health experts located in 
Scotland and in Malta respectively. This chapter describes how the use of expert steering groups 
as part of IM helped to elicit expert input on core elements of the intervention and the most 
appropriate methods and strategies for implementing a future intervention. For ease of reference, 
the group held in Scotland is referred to as the Scottish steering group (SSG), while the group 
held in Malta is referred to as the Maltese steering group (MSG).  
 
6.2 Aims  
The purpose of this chapter was to identify potential theoretically informed intervention 
components, construct matrices of change objectives and create a logic model of change relating 
to changing BS behaviours in Malta. This chapter therefore comprises Step 2 of IM (see Table 
3.1). 
 
6.2.1 Objectives 
The objectives were: 
1. To develop a ‘logic model of the problem’ (i.e. this logic model is designed to better 
understand lower BS uptake rates in Malta relative to other European countries) based 
on: 
a) the literature review about BS determinants (Chapter 2) (Both steering groups); 
b) quantitative findings of Studies 2-5 (Chapter 4) (Both steering groups); 
c) feedback about organizational capacity in terms of:  
(i) whether the mission of the national cancer plan (2017-2021) (Ministry 
for Health 2017) coincides with the goals of the future intervention(s) to 
increase BS uptake in Malta, and  
(ii) the readiness of the local NHS for implementing a future proposed 
intervention(s) (MSG); 
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2. To develop a ‘logic model of change’ (i.e. what needs to change as a result of a potential 
intervention) (SSG); 
3. To judge basic fit to create a “short list” of potential future interventions to carry forward 
to Step 3 of IM (SSG) in terms of: 
i. Improving BS uptake, and  
ii. Priority population (MSG). 
 
6.3  Methods 
6.3.1 Key experts  
A qualitative study was undertaken with key experts using IM as a systematic approach (Scarinci 
et al. 2012). Two expert groups met to discuss the findings of the quantitative data (reported in 
Chapter 4) about factors that influence BS uptake in Malta, to identify specific preparatory 
behaviours (performance objectives, POs) and determinants (factors) related to BS, and to 
propose appropriate methods and practical strategies. The SSG included international academics 
with expertise in screening behaviour and intervention design and implementation (6 experts). 
The MSG included health practitioners, service managers and policy makers with expertise in 
health management (3 experts).  
 
6.3.2 Setting and recruitment 
The SSG met at Stirling University in Scotland in November 2016 and the MSG at Sir Anthony 
Mamo Oncology Centre in Malta in March 2017. The location was based on the participants’ 
preferences and travelling practicalities. Participant recruitment for the SSG occurred between 
August and September 2016, and between February and March 2017 for the MSG. Potential 
experts were identified through discussions with my primary supervisor (GH). Inclusion criteria 
for the SSG included researchers in screening behaviour and complex interventions. Inclusion 
criteria for the MSG included heads of departments or consultants with responsibility to make 
leadership decisions and policies regarding primary care, screening and cancer care processes. 
Identified experts were contacted by myself mainly through email to determine individual 
availabilities to schedule the meetings.  
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6.3.3 IM Step 2: Identification of outcomes, performance objectives and 
change objectives 
The first part of IM Step 2 involved discussions with key experts on the desired outcomes of the 
intervention. The overall desired outcome was to increase BS uptake. Second, POs in relation 
to the specified outcome were identified by the SSG i.e. a checklist of what needs to happen in 
order to increase BS attendance. Finally, the objectives of the intervention were specified in 
terms of what needs to change in the theoretical determinants of BS behaviour (i.e. change 
objectives, COs). Each PO was therefore scrutinised separately by the SSG, and specific 
determinants deemed useful in changing each PO were identified. A matrix of COs (change 
matrix) was then formulated (through discussion with SSG) as an output of this process, 
detailing what will be targeted in the intervention and to help in the identification of a list of 
feasible interventions (SSG) based on feedback about priority population and organizational 
capacity fit (MSG). Although this was a time-consuming process, the SSG was required to be 
precise about which behaviours should be targeted and what COs (actions) were required in 
order to achieve the POs, and thus improving BS uptake. 
 
6.3.4 IM Step 3: Selecting methods and practical strategies 
Following construction of change matrices, the next step was to discuss appropriate methods to 
change BS behaviour and translate these into practical strategies. First, each determinant (e.g. 
barriers) that was found to be significantly associated with non-attendance (Chapter 4, Studies 
2-5) was discussed by the SSG with a view to propose suitable change methods. The MSG took 
into account the given restraints in time and finances and characteristics of the target population 
and the abilities of local health educators delivering future interventions. This led to the choice 
of several ideas for practical intervention techniques derived from theory-based methods which 
were identified in the literature and translated into practical ideas, aided by the experience of 
the international experts.  
 
6.3.5 Data Collection 
Data collection was conducted using the same enrollment and qualitative data collection 
processes during both steering groups. All experts gave written informed consent (by email) 
prior to participation in the steering groups and written consent on the day of the group meetings 
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(Refer to Information Sheets (Appendix 6.1a, b) and Consent Form (Appendix 6.2)). Both 
steering groups were audio-recorded and transcribed verbatim by the researcher. No 
compensation was provided to the experts, except for one expert who travelled from Leeds to 
Stirling. I applied for a research post-graduate support fund of £250 to compensate for travel 
expenses of this SSG member.  
 
6.4  Results 
6.4.1 IM Step 1: Needs assessment and logic model of the problem 
First, a discussion with key experts focused on key determinants influencing mammography 
non-attendance in Malta. A summary and collation of findings was presented by myself to the 
experts (Table 6.1). To assist in data reporting, the SSG organized the data from the needs 
assessment into a logic model of the problem (Figure 6.1) based on the theoretical literature 
(Chapter 2) and quantitative findings (Table 6.1). There was a high level of consistency in 
personal and environmental factors identified through the literature and cross-sectional data. 
Hence, the discussion focused on low knowledge, fear of finding BC, fear and embarrassment 
concerning the procedure, negative attitudes toward BS, low perceived risk and other logistical 
barriers such as lack of time and transportation.  
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Table 6.1 - Synthesis and collation of findings for Studies 2-5  
Socio-
demographic 
factors 
Health status Knowledge 
of BS 
frequency 
(TI) 
 
HBM 
Predictors 
CSM 
Predictors 
Main Outcomes Conclusions 
FIRST BS INVITATION 
Family income - Non-
attendees 
were most 
unsure of TI  
Perceived 
Barriers 
(strongest) 
 
 
Cyclical 
Cancer 
Timeline 
 
Illness 
Coherence 
Reasons for non-attendance:  
1. Key reason was Fear (41.0%) (i.e. of 
result), pain, unknown procedure, 
radiation, and embarrassment).   
2. Private Mammography  
3. Never received an invitation  
4. Minor practical reasons i.e. ‘busy at 
work’ or ‘home’, ‘transport issues’, ‘on 
vacation’ and ‘being ill’. 
 
High awareness of BC signs and 
symptoms (>80% agreement for 7 out 
of 8 signs), but wide variation about 
causation (e.g., germ or virus: 38.6% 
‘agree’, 30.7% ‘disagree’). 
 
Strongest Predictors:  
HBM, particularly perceived barriers 
but illness perceptions improved 
model accuracy to predict non-
attendance when compared to HBM 
alone (65% vs 38.8%). 
Interventions should be 
based on theory including 
HBM and CSM 
constructs, and should 
target first BS uptake and 
specific barriers to reduce 
disparities and increase BS 
uptake in Malta. 
 
SECOND BS INVITATION 
- Breast condition 
/ disease 
Non-
attendees 
were most 
unsure of TI 
Perceived 
barriers 
(strongest) 
BC identity 
 
 
 
First BS uptake was the strongest sole 
significant predictor of subsequent 
uptake (OR = 0.102; 95% CI = 0.037, 
0.283; p = 0.000). 
Interventions to increase 
BS uptake should target 
first invitees since 
attending for the first time 
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The inclusion of illness perception 
items improved regression model 
accuracy in predicting non-attendance 
(84.6% vs 30.8%). 
is a strong predictor of 
attendance and non-
attendance for the second 
screening invitation. 
LIFETIME SCREENING 
Family income 
 
Status 
(lower number 
of widowers 
attend) 
 
Non-drivers 
(91.5% of 
drivers attended 
vs 81.9% of 
non-drivers) 
Breast condition 
/ disease 
(100% having 
breast condition 
vs 82.9% of 
women without  
breast condition) 
 
Relatives or 
close friends 
 
 
 
Non-
attendees 
were most 
unsure of TI 
Perceived 
Barriers 
(strongest) 
 
Cues to Action 
 
 
- Health beliefs were the strongest 
significant predictors to describe the 
variance between lifetime attendees and 
non-attendees. 
 
Non-attendees (n = 56) were women 
with a lower family income (χ2 = 13.1, 
p = 0.011) who were not encouraged by 
their GP (χ2 = 4.9, p = 0.027) and were 
more anxious (p = 0.040) and fearful (p 
= 0.039) than attendees.  
Women who do not attend 
the MBSP are not a 
homogenous group. 
Future research should 
target women’s health 
beliefs, and focus on 
women who were never 
screened as these require 
more targeted campaigns 
to reduce disparities.  
 
TIMELY SCREENING ADHERENCE 
- - Non-
attendees 
were most 
unsure of TI 
Perceived 
Barriers 
(strongest) 
 
Cues to Action 
- Health beliefs were the strongest 
significant predictors to describe the 
variance between adherent and non-
adherent attendees. 
 
There was significant association 
between adherent and non-adherent 
mammography attendees against 
organized and private screening (χ2 = 
24.6, p = 0.000). 
Future research should 
target women’s health 
beliefs, and focus on those 
who are non-compliant 
with recommended time 
intervals as these require 
more targeted campaigns 
to reduce disparities.  
 
Note. Variable names found in different cells represent the significant variables under each construct/category.  
- : no variable/s found to be significantly associated, TI = Time Interval 
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Figure 6.1 - Logic model of the problem 
Behaviour 
Problem 
Low BS rates 
 
 
 
 
 
Personal Determinants (women) 
Low level of knowledge (BC identity, causes, 
consequences; BS recommendations)  
Myths and misconceptions about BC/BS 
Low perceived risk from BC 
Attitudes (fatalism, procrastination) 
Perceived barriers (emotional 
representations: fear of result and/or 
procedure / pain, embarrassment)  
Logistical barriers (lack of time, 
transportation issues, cost) 
Low self-efficacy 
 
Socio-demographic factors/health status 
(women) 
Family income 
Breast condition/disease 
Environmental (interpersonal) 
factors (women) 
Low/no cues to action 
Lack of GP recommendations 
Lack of / low social support 
Health Problem 
Issues following BC 
diagnosis 
Quality of life 
Physical symptoms 
Absenteeism 
Loss of work 
Employee productivity 
losses 
Family life issues 
Social life issues 
Sexual issues / partner 
abandonment 
Lack of self-esteem / 
body image 
Rejection 
Psychosocial distress 
Shortened life span 
 
 
Personal Determinants 
(providers) 
Lack of knowledge about 
BC/BS by health care 
providers 
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6.4.2  IM Step 2: Performance Objectives and Matrices of change objectives 
Based on the needs assessment (Step 1), both steering groups considered whom to target prior to 
deciding on the delivery of an intervention. Both groups discussed whether the most important 
target group were attendees, non-attendees or those who attended privately. It was agreed that 
lifetime non-attendees were the most difficult to reach group and challenging to recruit for group 
discussions. Hence, the overall behavioural outcome was defined as "Non-attending women will 
attend for BS within 6 months of a missed appointment or after having received the intervention". 
It was agreed in both committees respectively that the ‘barriers’ construct in the HBM was the 
most significant component to target in a future intervention. 
 
Following the latter discussion, the following POs were developed for two groups (individuals and 
healthcare providers) i.e., what participants need to do to attend BS, and what healthcare providers 
need to do to aid women to attend (see Table 6.2). These POs address preparatory behaviour for 
BS use. 
 
Table 6.2 - Behavioural outcomes with associated performance objectives 
 
The next step was for the SSG to create a matrix of change objectives (COs) for each subgroup 
(Table 6.3, 6.4) by placing POs in the left column, and personal or external changeable 
determinants in the middle of the matrix. Then, for each determinant and the corresponding PO 
214 
 
the SSG asked: What has to change in relation to the determinant so that the Maltese population 
can achieve the desired PO? These COs were recorded in the right column cells of the matrix. 
During the discussion, changeable determinants of screening behaviour were identified by the SSG 
based on factors that were significant from the survey findings that were considered both important 
and changeable to the target group. Knowledge, barriers and benefits, self-efficacy, perceived 
social norms on screening and awareness of peer behaviour regarding mammography were 
selected as the most important determinants for women. Other important environmental 
determinants were the availability of screening and its accessibility. Socio-cultural determinants 
were considered not to be changeable in a short intervention, but were considered to tailor the 
interventions culturally. Attitude was also considered an important determinant to be incorporated 
in a future intervention and was added to the determinants. For healthcare providers, knowledge, 
barriers and benefits, attitude and standards of care were considered as the most important personal 
determinants to BS. 
215 
 
Table 6.3 - Matrix cells of change objectives for Maltese women 
Behaviour: Non-attending women will attend for BS within 6 months of a missed appointment or after having received the intervention. 
 
Performance 
Objectives 
(PO) 
Personal Determinants 
 
External Determinants 
 Knowledge (K) Perceived 
Barriers and 
Benefits (PBB) 
Attitude (A) Self-Efficacy (SE) Perceived 
Social Norms 
(PSN) 
Peer/Family 
Support (PFS) 
Availability / 
Accessibility 
(AA) 
PO1. 
Woman 
considers to 
have a 
mammogram 
K1a. Understands 
the meaning of 
BC and its related 
risks 
K1b. Understands 
that 
mammography 
screening can 
detect BC early 
K1c. Identifies 
herself at risk of 
developing BC 
K1d. Aware that 
the risks of 
developing BC 
will impact family 
and social life 
PBB1a.  
Considers that 
pain caused by 
undergoing 
mammography is 
tolerable 
PBB1b. Considers 
overcoming fear 
of BC and of 
screening test  
PBB1c. Considers 
other barriers to 
screening 
 
A1. Increases 
recognition of 
importance of 
screening 
SE1a. Expresses 
confidence in her 
ability  to 
overcome barriers  
SE1b. 
Demonstrates 
ability to manage 
competing 
demands 
 
PSN1. 
Believes that 
other women 
will consider 
to obtain a 
mammogram 
PFS1. 
Friends/family 
encourage her 
to consider 
attending for 
mammography 
AA1. Unit 
sends an 
invitation 
letter 
PO2. 
Woman sets 
an 
appointment 
or contacts 
the centre 
K2a. Describes 
where to call and 
where to go 
K2b. Identifies 
date of booked 
appointment 
 
PBB2a. Considers 
how to get to the 
centre 
PBB2b. Plans on 
how to overcome 
other barriers 
A2. Believes in 
her role to request 
a mammogram if 
her doctor has not 
recommended one 
SE2. Expresses 
confidence in her 
ability to call for 
an appointment 
PSN2. 
Believes that 
other women 
will contact 
the centre and 
ask their 
doctor for a 
referral 
PFS2. 
Friends/family 
encourage her 
to set an 
appointment 
AA2. Unit 
arranges 
convenient 
date and time 
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PO3. 
Woman 
arrives at the 
centre and  
experiences 
having a 
mammogram 
K3a. Describes 
the unit’s location  
K3b. Describes 
the procedure 
K3c. Describes 
BS 
recommendations 
PBB3. Expresses 
greater benefits 
than barriers to 
mammography 
A3a. Believes that 
BS can be cured 
through effective 
treatment 
A3b. Describes 
the 
embarrassment 
from the test as 
minimal 
A3c. Realizes that 
mammography 
pain is tolerable 
and waiting time 
is short 
SE3. Expresses 
confidence in 
obtaining 
mammography 
PSN3. 
Believes that 
other women 
obtain 
mammography 
PFS3a. 
Contacts 
relative or 
friend for 
support by 
accompanying 
her for the test 
PSF3b. 
Contacts 
relative or 
friend to 
facilitate 
transportation. 
 
AA3. Unit 
facilitates date 
and time 
PO4. Obtain 
results of the 
mammogram 
K4a. Describes 
how to obtain the 
results 
K4b. Describes 
what can be seen 
on a mammogram 
 
PBB4. Expresses 
benefits to being 
informed of the 
result 
A4a. Describes 
the relief of 
having a normal 
result 
A4b. Describes 
the positivity of 
being able to 
acquire treatment 
for BC if found 
SE4. Expresses 
confidence in 
being able to 
acquire the results 
and to understand 
them 
PSN4. 
Believes in 
other women’s 
ability to 
obtain the 
result 
PFS4a.  
Relative or 
friend ask her 
about the 
result 
PFS4b. 
Relative or 
friend provide 
support by 
accompanying 
her for follow-
up tests 
AA4. Unit 
informs her 
about how and 
when she shall 
receive the 
result 
PO5. 
Woman 
makes a 
reminder for 
next 
appointment 
K5. Describes a 
plan on where and 
when to go for the 
next mammogram 
 
PBB5. Expresses 
benefits in regular 
mammography 
A5. Believes that 
regular 
mammography 
can detect BC 
early 
SE5a. Expresses 
confidence in 
being able to call 
and schedule her 
next appointment.  
SE5b. Expresses 
confidence in her 
ability to obtain 
her next 
mammogram 
PSN5. 
Believes that 
other women 
like her can 
obtain their 
next 
mammogram 
PFS5. Relative 
or friend 
encourage her 
to schedule her 
next 
appointment 
 
AA5. Unit 
arranges 
convenient 
date and time 
for her next 
screening 
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Table 6.4 - Matrix cells of change objectives for healthcare providers 
 
Performance 
Objectives (PO) 
Personal Determinants 
 
 Knowledge (K) Perceived Barriers and 
Benefits (PBB) 
Attitude (A) Standards of Care 
(SOC)  
PO1. Unit directors 
will facilitate 
transportation to the 
centre. 
K1. Recognize transportation as 
a barrier to screening 
PBB1. Believe that 
providing this service 
will be of benefit to 
women 
A1. Believe that 
accessibility is part of 
the unit’s role 
SOC1. Recognize that 
other clinics facilitate 
transport to their unit. 
PO2. Healthcare 
providers will design 
and develop 
culturally and 
linguistically tailored 
intervention/s and 
related materials. 
K2a. Understand Maltese 
women’s cultural beliefs on 
health and screening 
maintenance.  
K2b. Realize that Maltese 
women lack BC/BS related 
knowledge. 
K2c. Recognize that uptake to 
the MBSP is lower among 
Maltese women than in other 
European countries.  
K2d. Recognize that Maltese 
women are more likely to be 
diagnosed with an advanced 
stage of BC if they do not 
attend for mammography 
PBB2. Recognize that 
women need to 
overcome barriers to 
BS. 
A2a. Believe in their 
role to help women 
obtain mammography. 
A2b. Believe that cues 
to action aid BS uptake. 
SOC2. Recognize that 
other providers deliver 
culturally sensitive 
interventions. 
PO3. Physicians will 
make a referral for 
mammography, 
when necessary. 
K3. Describe morbidity and 
mortality from BC for Maltese 
women  
PBB3. Believe that a 
recommendation will 
help women  overcome 
barriers 
A3. Believe that a 
recommendation will 
increase BS uptake 
SOC3. Recognize that 
guidelines for referral 
to mammography are 
met by other providers 
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6.4.3 IM Step 3: Intervention Design - Selecting Theoretical Methods and 
Strategies 
The systematic review findings (Chapter 5, Study 6) were discussed with both the SSG and the 
MSG to identify change methods based on the theoretical literature that would address the COs, 
and to determine which types of practical strategies could be most effective at changing BS 
behaviour in Malta. In this step, the SSG converted the logic model of the problem to a logic 
model of change to create the foundation for comparing interventions, methods and strategies 
that were found to be effective (Chapter 5, Study 6) to the needs of the Maltese population 
(Figure 6.2). To do this, the SSG brainstormed theoretical methods to change specific 
determinants identified in Step 2. These included modelling (Bandura 1986), information 
transmission (Fernandez et al. 2005), persuasion (McEachan et al. 2008), facilitation, skills 
training, and entertainment education (Bandura 1986; Singhal and Rogers 1999). The group 
mostly focused on knowledge, barriers, cues to action, self-efficacy and emotional 
representations based on the theoretical constructs of HBM and CSM. Proposed methods 
included culturally congruent role models and their stories, guided practice and counseling for 
problem-solving and overcoming barriers, and persuasion. On the other hand, the MSG 
considered the acceptability of a potential intervention to the Maltese population i.e. that the 
delivery would be suitable to the target population, the costs involved would be reasonable, the 
design of intervention materials and its essential elements would be effective with screening 
users, and that the intervention would be culturally congruent to Maltese women. Hence, the 
logic model of change was completed by adding theory- and evidence-based change methods 
that were suited to influencing the determinants. 
 
Further qualitative research was suggested in order to explore the perceptions of the target group 
(‘lifetime non-attendees’) in more depth, in terms of their perceived barriers and what they 
personally would consider as potential interventions to aid their attendance to BS (IM Step 3). 
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Figure 6.2 - Logic model of change 
 
Based on the evidence and organizational fit, the following were the recommendations of both 
steering groups: 
 HBM-based interventions show promise but more rigorous study designs that include all 
HBM constructs and use validated measures are required. 
 Theoretical interventions based on CSM in combination with HBM have not been 
developed or tested; these could be effective in increasing mammography uptake. 
 Community-based interventions involving linguistically appropriate material and 
cultural sensitive components (e.g., fatalistic views and attitudes towards BC and BS, 
respecting culturally or religiously constructed norms in conveying relevant 
information) show promise of improving uptake.  
 Community wide campaigns could encompass multiple components (e.g. containing 
many different activities), and including elements of social support, such as counselling, 
education, community events, group walks, role models and their stories. Since a wide 
range of interventions were contained within this grouping, common elements were the 
focus on building, strengthening and maintaining social networks through the use of 
strategies such as buddy systems and discussion groups. 
Theory- and evidence-based 
change methods 
Role modelling (women from 
the community as role models 
discussing how to cope with 
barriers) 
 
Problem-solving through 
counseling: cope with barriers 
with the help of a navigator 
(health worker) 
 
Information, dissemination and 
persuasion: providing correct 
information / persuasive 
messages by role models, GP 
and  navigator; decision 
prompts; rewards 
Determinants 
Knowledge (related to BC 
identity, causes, 
consequences, BS 
recommendations, myths 
and misconceptions) 
 
Skills, barriers and self-
efficacy (regarding 
problem-solving and 
planning logistics e.g., 
time-off work, 
transportation, child care) 
 
Modeling (related to how 
other women handle 
barriers) 
Behaviour 
Non-attendees 
attend BS 
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 Individually adapted interventions. The SSG focused on the strong evidence of the 
effectiveness of cues to action to suggest that interventions tailored to personal goals 
also appeared to be effective. Common elements of these interventions include: 
behavioural self-monitoring, prompting barrier identification and reinforcement through 
self-rewards. Problem-solving could occur through barrier-focused counseling (change 
method) delivered via a telephone call by a navigator (delivery) to cope with barriers.  
 Practical strategies identified to operationalize the method ‘entertainment education’ 
include testimonials and role-model stories of women who had BC and survived, as well 
as people talking with their physician about BS to overcome barriers. 
 Intervention content may include: 
o information messages individualized to address barriers; 
o addressing myths or misconceptions and providing facts on BC; 
o information on BC prevalence rates, risk assessment, the effectiveness and 
importance of screening and screening recommendations; 
 Intervention materials may include:  
o culturally-targeted materials incorporating cultural beliefs; 
o interactive, tailored telephone counselling programs involving individualized 
counseling messages specific to addressing perceived barriers and 
misconceptions about BC risks; 
o education sessions about the importance of BC early detection e.g., synthetic 
breast models to show how BC lumps might feel; 
o point of decision prompts e.g., having signs by lifts, escalators, billboards and 
shop windows to encourage people to make use of BS. 
 
6.5  Discussion and reflections 
The use of expert steering groups in this research sets an example in the field of screening and 
fills a number of important roles, such as providing expert insight on screening determinants, 
determining what POs need to be fulfilled, prioritizing goals, assessing potential risks to the 
success of an intervention, and advising on change methods and strategies. The use of steering 
committees also served to instil a framework of collaboration between experts on theory- and 
evidence-based development of health interventions (Wolfers et al. 2007). To the best of my 
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knowledge, it appeared that there were no examples in the literature on the use of steering 
committees for developing interventions to increase BS uptake. In the literature, the concept and 
responsibilities of a steering committee is neither clearly defined (Lechler and Cohen 2009) nor 
perceived in the context of screening programmes. The literature suggests that steering groups 
solely responsible for the implementation of projects do not widely exist (Lechler and Cohen 
2009). Committees are often set up by senior management teams of an organization to initiate 
and monitor projects by providing oversight into project budget, duration, risk, number of 
competencies (technologies), and visibility (Lechler and Cohen 2009). In this research, the SSG 
and MSG consisted of senior executives or researchers from different organizations to provide 
expert input in the field of screening and interventions. Hence, the use of steering groups as part 
of IM will add to the development of practice for the design of culturally sensitive interventions 
in the BS field. 
 
I experienced that using IM in research development and in practice requires flexible handling 
of a more compressed IM framework than that described in the literature, since the application 
of IM took more time than was available. The difficulties with the application of IM according 
to its protocol is also found in the literature (Wolfers et al. 2007; Kok et al. 2006; Perez-Rodrigo 
et al. 2005) and our experience of using IM was similar to other researchers (McEachan et al. 
2008; Kwak et al. 2007; Wolfers et al. 2007; Fernandez et al. 2005). Kwak and colleagues 
argued that the IM protocol is often applied to simple and uni-dimensional behaviours and can 
therefore be difficult to apply to multi-dimensional behaviours (Kwak et al. 2007). Despite the 
IM being time-consuming, it allowed us, as group members, to create a comprehensive, tightly 
focused and preparatory, theory-based intervention package. Although IM is a valuable guide 
to take the right steps in developing an intervention, it includes the risk of remaining in a lengthy 
endless process of doing further research on determinants, developing matrices for further 
specified POs, and moving iteratively between needs assessment, further exploratory research, 
intervention development and pre-testing. The knowledge of time and resources are unavailable 
in the day-to-day practice of public health services (Wolfers et al. 2007), and applying IM 
according to its full textbook instructions is therefore difficult in the practice of local screening 
programmes. 
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Although the role of steering groups is not clear-cut, I learnt to appreciate the great value that a 
team of experts brings to research. The collaboration between experts and myself was most 
helpful to combine the setting of specific practical objectives with theoretical insights of more 
general validity. My main tasks were to make sure that the targets of the IM steps were reached, 
and to organize and manage the consultation sessions with the experts. Therefore, I made every 
effort to ensure that the discussions were consistently in accordance with the theoretical 
strategies and fitted within the change objective matrices. Due to the experience of the experts 
in screening and implementation of interventions among diverse target groups, the SSG were 
best suited to create the logic model of change rather than the MSG. On the other hand, the 
preferences for the target group was best suited for MSG experts as they provided more detailed 
judgement of fit for potential interventions in terms of cultural fit, organizational capacity fit 
and cost-effectiveness. 
 
A variety of interventions were suggested by both steering groups to change behaviour by 
targeting knowledge, barriers, cues to action, self-efficacy and emotional representations as the 
key essential constructs. However, if the stepwise IM process has made one thing clear, it is that 
little is known about what specific intervention could be most suitable to change determinants 
and screening behaviour of Maltese women. Although the committees were valuable to provide 
expert advice based on change methods and practical strategies, more research in this field is 
warranted in order to develop evidence-based interventions. Further research with non-attendees 
can contribute to this goal. It was agreed that further in-depth research with the ‘lifetime non-
attendees’ is required through qualitative methods. This informed the next stages of this 
research.  
 
6.6  Strengths and Limitations 
The group discussions were held among a chosen group of experts. Their expertise contributed 
to further exploration of the evidence on behavioural determinants on BS uptake among women 
in Malta, a population that had not been researched before. The composition of the committees 
varied, consisting of Maltese experts and a broader international representation with varying 
contexts. This fed into the strengths of using IM as an overarching framework as it allowed a 
multi-disciplinary approach among experts, providing clear guidance on the application of 
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theoretical evidence, and producing a systematic approach into the overall design of a potential 
intervention. These strengths are possible since IM allows researchers to clearly describe the 
relationship between interventional goals, POs, COs, appropriate methods and practical 
strategies. Some IM weaknesses for the undertaken IM steps include the training required to 
address each IM step (Fernandez et al. 2005). Although the matrices inform the content of 
potential intervention strategies, IM does not provide sufficient guidance for the development 
of specific intervention materials, how to construct key messages and does not specify what 
essential elements they should incorporate. 
 
6.7  Chapter summary 
Overall, the findings suggest that a research study can be positively influenced by the 
involvement of steering groups. The use of steering groups has shown a direct effect on decision-
making through their proposed recommendations for this research, and an indirect effect on 
research performance by shaping and refining the context of IM processes. This affirms the 
importance of improving research effectiveness through the use of steering groups. From an 
organizational perspective, understanding their role will help form the integrative structural 
elements that need to be in place to gain full value from their investment in health management 
processes. Although time-consuming, steering groups agreed that using IM improved the overall 
planning of a future intervention which will greatly contribute to its success. Without this 
expertise, it is likely that the IM process would have been more difficult to accomplish. Further 
research is warranted to address the effective replication and dissemination of IM steps among 
other populations.  
 
This chapter also served to discover gaps in knowledge, the realisation for further research with 
non-attendees, and identifying potential methods (e.g., barrier-focused counselling, 
entertainment education) and practical strategies (e.g., telephone calls, testimonials, role-model 
stories) to be undertaken in a future intervention. It also allowed to create systematic and visual 
matrices, and logic models to share an understanding of the relationships among the activities 
required to carry out an intervention and the changes required, focusing particularly on barriers, 
cues to action, self-efficacy, knowledge and emotions. The next chapter presents findings 
gathered from the World Café event as a participatory method for community engagement. 
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Chapter 7 
 
 
Patient and Public Involvement:  
A World Café event - ‘Science 
Espresso’   
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7.1 Introduction 
The purpose of this chapter is to describe how members of the public i.e. women and men were 
engaged in a Patient and Public Involvement (PPI) event through the World Café method, to 
enhance the understanding of the quantitative findings of this research. PPI is emerging as a 
critical component in successful implementation of health research findings (Hoddinott et al. 
2018). The National Institute for Health Research advisory group supporting PPI in the UK 
(NIHR INVOLVE) has defined involvement as “research being carried out “with” or “by” 
members of the public (i.e. patients, potential patients, carers, people who use health and social 
services, people from organizations representing those who utilise services) (INVOLVE 2015) 
rather than “to,” “about” or “for” them” (Hayes et al. 2012). This implies that PPI involves the 
active contribution of patients and members of the public from informal discussions to decisions 
about the research itself from study conception to dissemination (Hoddinott et al. 2018). While 
PPI is recommended from the earliest research stages through to dissemination of findings 
(Boote et al. 2015), there is limited information on the reporting of PPI in terms of the context, 
process, and impact of public involvement (Crocker et al. 2016). PPI is still in its recognition 
stages (Brett et al. 2014) and further research on the impact of PPI is required.  
 
In view of the limited evidence for best practice (Kreis et al. 2013), frameworks such as the 
Public Involvement Impact Assessment Framework (PiiAF) (Popay et al. 2014) and Guidance 
for Reporting the Involvement of Patients and the Public (GRIPP) (Staniszewska et al. 2011) 
have been developed. The reporting checklists ‘Guidance for Reporting the Involvement of 
Patients and the Public’ (GRIPP2-LF i.e. long form and GRIPP2-SF i.e. short form) are the first 
international, evidence based, community consensus informed guidelines for the reporting of 
PPI in research. GRIPP2-SF, which includes five items on aims, methods, results, outcomes, 
and critical perspective of a PPI activity (Staniszewska et al. 2017), was used to report public 
involvement in this research.  
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7.2 Aim  
The aim of this PPI activity was to collaboratively involve and engage members of the public 
to enhance the understanding of the quantitative findings (studies 2-5) and the systematic review 
in this research and to inform the design of future BS interventions in Malta.  
 
7.2.1 Objectives 
The objectives of this PPI activity were two-fold:  
(1)  To gain an understanding of patient and public perceptions to health and screening practices;  
(2) To understand patient and public views on effective communication channels and 
interventions to increase mammography uptake in Malta. 
 
7.3 Methods 
7.3.1 Study design  
Two World Café type focus groups were conducted as a participatory, effective and flexible 
method for hosting a PPI event. The World Café event is also referred to as a ‘Science Espresso’ 
in this thesis. This method facilitates group dialogue and reflection in a relaxed and comfortable 
atmosphere (i.e. a café-style ambience) (Estacio and Karic 2016). World Cafés allowed for 
participant engagement through sharing individual and collective ideas (Sheridan et al. 2010) 
on BC and BS. Hence, this PPI event was informed by World Café and focus group literature in 
the following ways. 
 
Cafés have been named in different contexts to meet specific goals, for example ‘Knowledge 
Cafés’, ‘Creative Cafés’, ‘Strategy Cafés’, ‘Leaderships Cafés’, and ‘Community Cafés’. The 
World Café concept originated in California at the home of Juanita Brown and David Isaacs in 
1995 when a morning large-circle dialogue was disrupted by rain 
(http://www.theworldcafe.com/about-us/history/). The method is based on the realisation that 
best ideas emerge from informal processes, such as coffee breaks and dinners (Sheridan et al. 
2010). In World Cafés, all participants are regarded as experts of their own lived experience and 
experiential knowledge. In café conversations, participants are allowed to set their own direction 
in response to the main café question, therefore no perspective is privileged over others. Cafés 
thus build a collective network of authentic knowledge among the participant community 
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(Brown and Isaacs 2005), with the key principle being that local community knowledge is 
privileged as it sets the agenda (Sheridan et al. 2010) rather than allowing professional 
knowledge to take the lead. Moreover, there is no pressure to reach consensus among 
participants since diverse perspectives are encouraged and valued.  
 
Focus groups encourage peer-to-peer interactions by exploring areas of divergence and 
convergence (Hiratsuka et al. 2017). These interactions provide a setting for enabling discussion 
on multiple issues and exploring possible solutions (Duggleby 2005). World Café type focus 
groups have not been utilised in primary care or prevention (MacFarlane et al. 2017) nor in 
screening research. Hence, to the best of my knowledge, this piece of work is one of the first to 
report on World Cafés on BS. 
 
7.3.2 Setting 
With its official opening on 26th October 2016 and located in Kalkara (Malta), the Esplora 
Interactive Science Centre is Malta’s first visitor attraction seeking to cultivate a scientific 
culture of research among visitors. The renovated centre consists of several interconnected 
buildings and outdoor spaces, with main exhibition halls, landscaped gardens and activity 
centres for visitors to experience hands-on workshops and entertaining science shows. 
 
My proposal submitted to engage members of the public in research on BS was submitted to 
Esplora and was chosen from among numerous submissions as one of the final six ‘Science 
Espressos’ (Figure 7.1). Science Espressos formed part of SPARKS - a European project 
funded by the Horizon 2020 Framework Programme of the European Union (SPARKS Grant 
agreement No. 665825). SPARKS took place among 33 partners from 29 European countries 
between July 2015-2018, and was designed to awaken an interest and awareness among citizens 
about the concept and practice of responsible research and innovation (RRI). A creative 
exhibition touring in the 29 countries combined research with hands-on activities to engage 
patients and the public through Science Espressos. The scope of the experience gained through 
the project aimed to fuel policy recommendations at the EU, national, regional and local levels 
to facilitate the development of and enrich RRI processes in the fields of health and medicine. 
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Hence, the Science Espresso on BC and BS was chosen as an open community event organised 
at Esplora on the 30th August 2017 to engage the general public in local research.  
 
 
Figure 7.1 - The Six Science Espressos chosen from among numerous research submissions as part 
of the SPARKS European project 
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7.3.3 Recruitment 
An open invitation to the general public was made in preparation for this event but the public 
was encouraged to register for the Science Espresso in order to have an idea of the expected 
attendance prior to the event. Although World Cafés tend to have at least twelve participants, 
no upper limit is recommended (Dickson and Tholl 2014). For example, a World Café event 
hosted 1,000 tables in several cities on a single day in Israel as part of a series of social justice 
protests (Hartman 2011), while sixty people attended a Café event in Ohio in 2005 on hunger 
issues (Wheatley and Frieze 2011). Therefore, Esplora’s Programme Development Executive 
members (PDEM) provided online registration and contact numbers of the centre since it was 
acknowledged that a large number of attendees would be unmanageable, requiring considerable 
space. Members of the public were recruited primarily through word-of-mouth at cultural 
events, social media, TV and radio stations. I was invited on TV and radio programs to promote 
the event. Event advertising was also done through Facebook promotion among community 
organizations and female closed groups (Figure 7.2).  
 
7.3.4 Procedures  
The participatory activity was modelled after a café, with coffees and refreshments, allowing 
group members to establish a brief rapport with one another throughout the event. I conducted 
the Science Espresso on a late afternoon to accommodate participants with various work 
schedules. Husbands and wives were encouraged to attend the event together; this strategy 
helped recruitment dramatically, particularly that of men. Prior to the start of the session, all 
attending members of the public were provided with an information sheet (Appendix 7.1a, b) 
and were assured that all information would be reported in this thesis as collaborative feedback. 
Socio-demographic data were gathered prior to the start of the Science Espresso (Appendix 
7.2a, b). The attendees were then seated around two tables (females and males respectively) 
with coloured markers and large flipcharts provided to encourage participants to write, draw and 
capture key emerging ideas.  
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Figure 7.2 - Facebook promotion of the Science Espresso 
 
An executive member from Esplora introduced the Science Espresso by setting the context, 
sharing the Café etiquette rules, and putting participants at ease. The executive member then 
introduced the two table ‘hosts’ i.e. myself and a male research assistant from the local 
community who was formally paid and trained prior the event. I welcomed the participants, 
outlined the topic of the Café, together with the background and main findings of Studies 2-5 
(Table 6.1). What followed was the opening of the café discussion where I posed a single open-
ended question to the participants, ‘Based on the findings presented to you, what does BC mean 
to you?’ Such an open ended question allowed participants to break into two groups (males and 
females) around two tables respectively. Since all men and women were comfortable to 
communicate in both languages, the discussions were conducted in English and Maltese as they 
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pleased. Participants discussed the first question put forward by the host for 15 minutes and 
moved to the second table to discuss the second question ‘What do you know about BS 
practices?’ thus serving as travellers, carrying key ideas, themes and questions into the next 
conversation. This process carried on for another three questions: ‘Do you see a mammogram 
as important in your life / your partner’s / mother’s life?’, ‘What motivates you / makes it 
difficult for you / your partner / your mother to attend for screening?’ and ‘In what ways can 
we best encourage you to attend for a mammogram?’ The table hosts briefly shared the main 
ideas from the table’s previous conversation. The participants were encouraged to connect ideas 
from their previous table conversations and build on each other’s contributions, during which 
the table ‘hosts’ took notes. In the final round of the Science Espresso, participants were 
encouraged to synthesize key points. In conclusion, I summarised and discussed all the feedback 
received in a large group conversation, making the key points visible to all participants to share 
insights with everyone. The PPI event lasted around two hours in total. 
 
7.4. Results 
7.4.1 Members of the public 
Sixteen members of the public aged 18-69, residing in various localities in Malta, attended the 
Science Espresso. Hence, women and men sat at two tables of ten and six respectively. The ten 
female participants were 18 to 69 years of age. This age range happened to be well-suited to 
include women of screening age (i.e. 50 – 67 years currently being screened with the target to 
expand to 69 years), and younger women (<50 years) not yet invited to the MBSP. The sample 
included women with a level of education that varied between secondary level (n=4) and a 
tertiary education level (n=6). Of the 10 women, 4 were employed full-time. One of the latter 
women was a Director of a research company. Two women were retired, 3 were students and 1 
was unemployed. Seven females were married or cohabitating while 3 women were single. One 
female had BC and was a member of a BC support group in Malta. The other women had no 
cancer but suffered from other health conditions, e.g. a light stroke. Six women had a relative 
with cancer, while 7 women had a friend with cancer. Two women had undergone a 
mammogram within the past 12 months, 3 women had undergone a mammogram within the 
past 2-3 years, while 5 women had never experienced a mammogram.  
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The ages for males varied between 30 and 57 years. The sample included men with a level of 
education that varied between diploma level (n = 4) and degree level (n = 2). All males were 
employed full-time. Four males were married or cohabitating, 1 was divorced and 1 was single. 
None had cancer; however, 2 men had a friend with cancer while 3 men had a relative with BC.  
 
7.4.2 Addressing PPI objectives 1-2 
To address objective 1, members of the public sought to explore their own beliefs and 
perceptions in relation to the quantitative findings of this research. The discussions focused on 
barriers and facilitators to screening and reasons for the latter perceptions. Regarding objective 
2, the discussions sought to understand what communication channels and interventions would 
be effective to increase mammography uptake in Malta. The findings are divided into six 
categories as presented during the debriefing at the end of the café. Different sub-categories 
were outlined for each category by female members (FM) and male members of the public 
(MM) respectively and are tabulated in Table 7.1. 
 
7.4.3 Category 1: The mammography procedure 
7.4.3.1  Meaning 1: Prior experience of the examination 
Female members discussed how positive experiences encourage mammography attendance and 
re-attendance. This was dependent on their satisfaction with mammography, the environment 
and support staff at the facilities. Female members who had participated in screening 
commented on their personal experiences of the procedure, e.g. the relaxing atmosphere at the 
screening unit had helped them to relax while waiting for the procedure. Additionally, FM2 
spoke of the care received from radiographers, which was a motivating factor to re-attend for 
another mammogram. On the contrary, some female members spoke about how they “hated it” 
and that mammography “felt so cold”. 
 
7.4.3.2 Meaning 2: Perceptions of the examination 
Women’s perception of mammography was discussed in relation to fear of pain and the related 
anxiety. Women discussed the need for reassurance and a step-by-step explanation of the 
procedure. Men discussed how women may instigate fear between themselves by exaggerating 
the level of mammography pain. 
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Table 7.1 – Categories and sub-categories as expressed by female and male members of the public 
Category of 
findings 
Sub-categories  
(women 18-69 years) 
Sub-categories  
(men 30-57 years) 
Interpretation of findings 
(meaning) 
The 
mammography 
procedure 
Fear 
Pain or discomfort 
Expectations of the service 
Risk perception 
Touch 
Personal needs 
Fear 
Pain 
Prior experience of the 
examination 
Perceptions of the examination 
 
Supportive 
networks 
Lack of GP recommendation 
Experiences of friends and other women 
Daughter-initiated screening appeals to mothers 
Lack of GP recommendation 
Partner support 
Role of health providers 
The influence of family and 
friends 
Screening 
facilitators 
Family 
Convenience 
Accessibility 
Early detection beliefs 
Knowledge 
Early detection beliefs 
Knowledge 
Able to overcome barriers 
Screening 
barriers 
Fear of having BC 
Pain or discomfort 
Embarrassment 
Radiation 
Accessibility  
Negative health care experience 
Negative screening experience  
Long waiting time for result 
Fear of having BC 
Perception of pain or 
discomfort 
Cost, accessibility, and 
competing priorities (family 
and work) 
Emotional issues 
Personal risk of mortality 
Practical issues 
Lack of information and 
communication 
Lack of trust in the health 
system 
Negative screening experiences  
Communication 
channels 
 
Bulk emails 
Printed leaflets/brochures 
TV 
Radio 
Social media 
TV 
Internet 
Able to attend through effective 
communication materials 
Interventions to 
encourage BS 
and awareness 
Pharmacies 
Nail technicians 
Hair salons 
Beauty therapists 
GP recommendation 
Social media 
Partner encouragement and 
support 
Marketing through Billboards 
GP recommendation 
Able to attend through effective 
interventions 
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7.4.4 Category 2: Supportive networks 
7.4.4.1 Meaning 1: Role of health providers 
Although GP recommendations to undergo mammograms were identified as key facilitators 
to mammography attendance, members reported that, similarly, their own doctors do not 
recommend mammograms or screening tests and if they did, they would consider the 
recommendations. Women and men discussed how they look for information from health 
providers and are eager to learn about screening information and prevention practices from 
their doctors. Another table discussion focused on the inconsistency and/or lack of doctors’ 
recommendations on interval screening that act as screening barriers. 
 
7.4.4.2 Meaning 2: The influence of family and friends 
Female members discussed how women are eager to talk to other women regarding BC 
experiences to make decisions about screening and treatment. Men, on the other hand, 
discussed how they do not talk to other men regarding health-related decisions but consider 
their partner to be the key person to influence their decision-making. On the contrary, women 
discussed how their male partners are often not the key persons to trigger women’s health-
seeking action. Women tend to be influenced by health providers and view their partner’s 
recommendations as a means of support once they have triggered a health action or when 
they are concerned about their health. Women described men’s support as their main pillar 
of strength.  
 
The family was a major motivator for women to get screened for BC. Female members 
expressed the need to be there for their families and wanting to avoid having their family 
care for them. As a result, personal health was described as important to them. Younger 
female participants expressed how they would discuss breast issues with their mother and 
that they would encourage her to go every time screening is advertised on the media.  
 
Experiences of older women who had friends or relatives diagnosed with BC was a 
significant motivator for their participation in screening. FM4 described her personal 
experience, such that as soon as she found out a friend or relative was diagnosed with BC, 
this triggered her BS attendance on a regular basis.  
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7.4.5 Category 3: Screening facilitators 
7.4.5.1 Meaning 1: Able to overcome barriers 
Both female and male members discussed how BC can be adequately controlled so that 
treatment would be more effective, leading to improved survival. Men considered early 
detection to be the only way for “cure”. Both groups emphasised the importance of having 
correct and timely information from care providers in order to make informed choices. Other 
facilitators included family support such as providing transportation and receiving BS 
invitations and reminders. 
 
7.4.6 Category 4: Screening barriers 
7.4.6.1 Meaning 1: The impact of emotional issues 
When screening barriers were discussed, the emotion of fear was the most prominent 
expression regarding BC within both groups. Female and male members discussed how the 
word ‘cancer’ brings fear and that the thought of having cancer instils a sense of death. They 
also discussed that embarrassment and privacy are factors that inhibit women from getting 
mammograms. Women described how uncomfortable it would feel to have other persons 
touching a sexual body part such as the breast.  
 
7.4.6.2 Meaning 2: Personal risk of mortality 
Fear was linked to receiving a BC diagnosis and metastasis, such that the spread of cancer 
could lead to long-term physical pain and mortality. Perceptions by men focused specifically 
on mortality as a death sentence, such that BC “quickly kills you. It starts to eat you up.”  
 
7.4.6.3 Meaning 3: Practical issues 
Both groups mentioned accessibility and competing priorities as practical issues due to 
family and work commitments. Recommendations included easier access to the clinic, more 
available parking spaces and more flexibility in the appointment hours and dates. Men also 
spoke about the importance of family commitments and how this may at times take priority 
even over their own health.  
 
7.4.6.4 Meaning 4: Lack of information and communication 
Another barrier revolved around the lack of information that instigates fear. Young female 
members and men spoke of how the risk of getting BC and other diseases are not discussed 
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enough in the family and that family conversations can facilitate attendance to screening 
tests.  
 
7.4.6.5 Meaning 5: Lack of trust in the health system 
Members of the public went into detail to explain why they or their families did not trust 
medical professionals and spoke about the lack of trust in terms of a systems-level issue and 
lack of navigation through health care such that ‘a patient is lost in the system’. Some men 
also spoke about how their parents instilled this lack of trust in the medical team. Two 
younger women questioned the potential for unnecessary exposure to radiation during 
mammography and that this could be a result of professional incompetence.  
 
7.4.6.6 Meaning 6: Negative health experiences 
Common barriers to attending mammography were prior health experiences. Female 
members associated negative feelings with the mammography procedure experience, 
relating it to the pain experienced and the cool temperature of the “plates,” while men spoke 
of the rough treatment given during consultations and long waiting times to receive health 
results. Members reported pain as a factor that affected their willingness to go for routine 
mammograms. 
 
7.4.7 Category 5: Communication channels  
7.4.7.1 Meaning 1: Able to attend through effective communication materials 
Men agreed upon the internet and TV, but not the radio, to be ideal channels for 
disseminating information. Older women preferred bulk emails, printed leaflets or 
brochures, TV and radio sources. It was discussed how the internet is not considered an 
adequate communication channel for older women but appropriate for younger females as 
many do not have access to it and information provided online is generic.  
 
7.4.8 Category 6: Interventions to encourage breast screening and 
awareness 
7.4.8.1 Meaning 1: Able to attend through effective interventions 
Men’s comments reflected the effectiveness of partners’ encouragement, marketing through 
billboards and GP recommendations as effective interventions. The role of the GP was also 
considered by female members as one of the most effective strategies to raise BC awareness 
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and screening. On the contrary to women, male members considered phone calls to be a 
nuisance. While younger women suggested social media interventions, older women’s 
suggestions reflected a more focused array of activities, such as information dissemination  
primarily in pharmacies, followed by beauty salons, hair and nail salons. The role of 
pharmacists was considered important and was thoroughly discussed among all female 
members. 
 
7.5 Discussion 
There is a growing body of literature about the relevance of community-based participatory 
approaches to enable meaningful dialogue and engagement (INVOLVE 2015). Moreover, it 
has become increasingly imperative for patients, families and community members to be 
engaged in the design and development of tailored interventions (Hayes et al. 2012). To date, 
this unique Maltese study has used the World Café method to explore patient and public 
views on BC and BS. In addition, group dynamics enabled Maltese women and men feel 
more comfortable to discuss the topic (Lee-Lin et al. 2012; Fontana and Frey 1994). Six 
categories were discussed; the interpretation of findings have important implications for 
healthcare professionals and family members to assist and encourage BS uptake in the 
Maltese community. 
 
In this PPI event, both women and men alike emphasised the importance of the GP’s role 
towards effective health outcomes. An Irish study found that participants felt that the GP 
should be more pro-active in the prevention of cancer, primarily through the provision of 
both verbal and written information (Keeney et al. 2007). Nonetheless, GP’s possible issue 
of time constraints was examined in an American study, which sought to determine the 
amount of time required for a primary care physician to provide recommended preventive 
services to an average patient panel (Yarnall et al. 2003). The authors contended that the 
primary care physicians cannot achieve preventive service goals unassisted since the amount 
of time required is overwhelming. Nonetheless, presentation of patients with more advanced 
disease (Sant et al. 2009; Berrino et al. 2007) i.e. late presentation by patients are most likely 
explanations for late onward referral by general practitioners or lack of GP recommendations 
and adequate support. Such evidence highlights that family doctors could play a key role in 
cancer screening and prevention due to their frequent contact with the public and within the 
family unit (Ganry and Boche 2005).  
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Women discussed how they are often encouraged by other women’s experiences to attend 
for screening. In turn, once women decide to trigger a personal health action, they inevitably 
receive support and recommendations from their partner, which in turn might sustain 
women’s receptivity toward a screening invitation. Nonetheless, this is often and highly 
dependent on the relational aspects and strength of the interpersonal communication between 
the couple (Hsiung and Richard 2003). On the other hand, men saw their personal role as a 
supportive network to women’s screening decisions. This PPI provides an argument for 
training both partners and the primary health care practitioners in health promotion.  
 
The support of significant others such as daughters may also be fundamental to women’s 
participation in screening activities. The economic and cultural conditions have greatly 
influenced how families have evolved across the years (Haldeman 2012; Cherlin 2005), such 
as the boundaries of parent-child communication in the past (Glenwick and Mowrey 1986) 
and parenting styles (Pittman and Chase-Lansdale 2001) – as might be showcased by some 
older men and women in this PPI, who have never discussed health or breast issues with 
their parents or more specifically with their mothers. It is precisely the recognition of this 
general shift of communication boundaries between parent and child throughout recent years 
(Nixon et al. 2012) that provides the impetus for exploring the feasibility of a daughter-
initiated intervention. Early detection of breast and cervical cancers is known to be one 
preventive behaviour that may provide the adolescent daughter with a unique opportunity to 
provide encouragement to her mother or guardian to obtain screening (Mosavel and Wilson 
Genderson 2013; Browne and Chan 2012). The mother-daughter relationship in this PPI 
provides the primary context for exploring message design strategies for developing an 
adolescent-initiated screening appeal. 
 
While many of these barriers are shared with other populations, i.e. accessibility, competing 
priorities and fear (Fayanju et al. 2014; Filippi et al. 2014; Baron-Epel et al. 2009), some 
barriers may be more explicit to Maltese men and women. Men were familiar with many of 
the barriers that women experience when trying to access a mammogram, similar to other 
American Indian men’s perceptions of BS barriers for American Indian women (Filippi et 
al. 2014). It may be worth tackling barriers among Maltese men to encourage them to support 
their partner by facilitating women’s attendance and adherence to recommended screening 
guidelines. Some older Maltese women and men considered the BS topic to be of a private 
matter, similarly to the study among American Indian men in Kansas and Missouri (Filippi 
239 
 
et al. 2014). Embarrassment and privacy issues may need to be addressed through family-
based education.  
 
Cultural differences exist over pain in society, supporting the idea that minor discomfort 
perceived by men is considered much less severe than intense pain as experienced by some 
women (Markle et al. 2004). It was interesting to note in this PPI men’s perception of pain 
as compared to that of women. Men described the mammography procedure as an 
exaggeration of mammography pain, which is perceived to be continuously instigated by 
other female influences. Nonetheless, ignoring or disregarding women’s true feelings of pain 
may lead to their avoidance of screening tests. Studies have also found that the 
radiographers’ supportive care led women to have positive experiences of the screening 
procedure (Myklebust et al. 2009; Poulos and Llewellyn 2005) and that lack of 
communication during mammography increased pain (Davey 2007). Hence, the provision 
of a comfortable and supportive environment during the mammogram can positively 
influence women’s perceptions and motivation in screening participation.  
 
Members of the public seemed receptive to and supportive of enhancing BS among the 
general Maltese population. Recommendations from men were towards screening promotion 
on TV and the internet as their preferred communication channels. On the other hand, women 
opt for more culturally-tailored media that is simple and easily accessible. Men offered 
suggestions to improve BS uptake by incorporating partner or family-based support. This 
finding indicates that communication dynamics are changing within families and that gender 
relations in reference to BS awareness are an important topic for future research.  
 
On the other hand, women showed primary preference in pharmacist-led interventions as 
pharmacists encounter women on a weekly basis. Community pharmacies are increasingly 
recognised as an important setting to raise public awareness of cancer signs and symptoms 
as well as causes and risk factors of the disease. In Malta, community pharmacies are 
privately owned and are not subsidised by the state. On average, patients visit pharmacies 
more frequently than general practice and they are often more accessible than doctors 
(Department of Health 2008). Besides, pharmacies are found within every locality in Malta, 
are easily accessible on foot or by public transport and are open at more convenient times 
such as evenings and weekends. Moreover, a pharmacist is often a patient’s first port of call 
when symptoms occur. A clinical audit on bowel cancer conducted by the Royal 
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Pharmaceutical Society highlighted the potential of pharmacies to reach symptomatic 
individuals who may not otherwise visit their GP. The two-week audit found 70% of 
pharmacies saw at least one patient with symptoms of bowel cancer (Cancer Research UK 
2015). Moreover, the audit showed that men tended to present less frequently to general 
practice than women; hence pharmacies may represent an opportunity to engage men in 
health screening. These results were similar to those in a lung cancer audit (Cancer Research 
UK 2015). The audits showed that in the majority of cases, pharmacists took the most 
appropriate course of action, by either making a GP referral or over the counter medicines 
sale. The above audits highlight the key role that pharmacies can play in early cancer 
detection.  
 
7.6 Limitations 
This PPI event was strengthened by a widespread approach to recruitment (word-of-mouth 
at cultural events, social media, posters and TV/radio promotion). This piece of work 
contained two primary limitations. First, the number of members was small in comparison 
to the representation of men and women in the Maltese population. Hence, views of those 
who did not attend may differ to those who attended. Yet, this limitation is minimal since 
generalizability is not a goal of PPI. The objectives of PPI require multiple and diverse 
discussions, for which one World Café event can only provide a starting point. Second, the 
Science Espresso was conducted in the Southern area of Malta, which may have been a 
limited geographic location for easy access by women and men who live in the centre and 
northern regions of the island. However, the aim of this PPI event was to engage the public 
to enhance my understanding of BC and BS issues. Moreover, the representation of women 
and men as members of the public derives from different parts of the country. Another 
potential limitation may center around the fact that the café discussions were conducted on 
a culturally sensitive topic. This may have hindered participants’ willingness to openly show 
their true feelings, particularly from a male perspective. 
 
7.7 Conclusions  
The PPI groups contributed to the understanding of the quantitative findings and provided 
women and men’s views on health, screening practices and potential effective BS 
interventions. The cultural, social and healthcare-system factors as related to BS need to be 
addressed. Encouraging healthcare providers such as GPs to reinforce motivating factors and 
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address inhibiting factors during their clinical encounters can potentially improve BS 
utilization in Malta. In addition, researchers may better identify enhanced involvement of 
partners and daughters in health decision-making if researchers use study models that 
emphasize household dynamics. Creating or using models that stress gender and household 
dynamics may be better suited to capture the changing positions and nuances of Maltese 
men’s supportive roles in relation to decisions that pertain to women’s health, including BS. 
The receptivity on the part of the parent and daughter positions the daughter-mother 
relationship as an ideal conduit for sharing BS information, improving education and 
developing child-initiated health interventions.  
 
This PPI activity also identified potential interventions to encourage BS attendance in the 
Maltese community. Key strategies include tailoring health education messages and tackling 
fear on a personal level. A one-to-one intervention can be effectively delivered at suitable 
locations frequented regularly by women such as pharmacies to empower women with 
necessary resources and knowledge.  
 
7.8 Reflections  
PPI was found to be useful through the provision of meaningful input by members of the 
public. Based on the research’s relevance to user needs, members of the public felt engaged 
in interpreting the findings, identifying issues and proposing solutions. Creating a dialogue 
with members of the public helped to make this research more patient and client centred. The 
PPI contributed missing voices of women and men and their perspectives that are not often 
heard in quantitative or qualitative research. This also builds a case to involve members of 
the public at various phases in the planning, implementation, management and evaluation 
stages of research. The potential problems with regard to PPI may be similar to challenges 
of involving patients in quality improvement initiatives. PPI may not be optimised for a 
particular research field or target group, resulting in risks of superficial engagement and 
inefficient use of resources. Moreover, finding patients and members of the public was 
challenging for me as it was time-consuming to spread the word on digital and social 
media. It can be difficult to recruit people with ill health, caring responsibilities and hard-to-
reach groups such as those living in vulnerable social circumstances. Evidence shows that 
the most disadvantaged or marginalised in society are the hardest to access and engage 
(Bonevski et al. 2014). If more time was allocated to recruit a larger number of patients and 
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members of the public, it would have made this event more successful. However, the fact 
that I went out in the community rather than expecting members of the public to attend at a 
hospital, health centre or in an academic setting helped to facilitate trust and engagement. 
Further consideration is required on who, where and how to engage patients and members 
of the public, the provision of training for PPI representatives and the flexibility required to 
tailor PPI to the research topic, methods and resources available. The next chapter presents 
the findings of face-to-face interviews with non-attendees. 
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Chapter 8 
 
Non-attendance to Mammography 
Screening: A Qualitative Study among 
Non-attendees in Malta 
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8.1 Introduction 
Despite the availability of breast screening (BS), non-attendees still struggle to access or 
respond to screening invitations (Benoit et al. 2003; Benoit and Carroll 2001; Browne 2000). 
Study 4 (Chapter 4) found that perceived barriers and cues to action were the strongest 
predictors of lifetime non-attendance and that non-attendees were more likely to be women 
with a lower family income, widowers, non-drivers, without a breast condition, who had no 
relatives or close friends with cancer, who were less encouraged by a physician, unsure of 
the screening frequency, and who were more anxious and fearful. Furthermore, public 
perceptions and involvement were achieved through the PPI activity using the World Café 
method (Chapter 7). However, both pieces of work did not explore in depth the health beliefs, 
illness perceptions and other determinants among Maltese women of eligible screening age 
who never attended for mammography. Inadequate understanding of women’s 
underutilization of BS may constrain policy makers’ ability to develop effective 
interventions (Rosicki 2010). In order to understand these factors, it is essential to explore 
the broader contexts - such as psychosocial, economic and structural issues that affect health-
seeking behaviour among lifetime non-attendees who require a different and more targeted 
approach than those who have attended in the past but not routinely.  
 
Evidence suggests that the above factors are better examined through qualitative methods 
rather than through survey alone (Kue et al. 2013; Lamyian et al. 2007; Thierry 2004). 
Gaining a more detailed understanding of women’s beliefs and perceptions may help explain 
why mammography uptake does not appear to be sustained at a population level in Malta. In 
addition, determining women’s sources of information may help explain gaps in knowledge 
or misconceptions about BC and BS. The most influential key messages that help determine 
women’s health behaviours are those that women receive close to home, in their own ‘world’ 
(Kumar and Preetha 2012; Stoto et al. 1990). Hence, the recognition of these facilitating 
factors and barriers is the first step in persuading lifetime non-attendees to make better 
decisions about preventive and protective self-care (Lamyian et al. 2007). The data from this 
study (Study 7) will feed into the recommendations for potential interventions to increase 
BS uptake in Malta.  
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8.2 Aims 
The aim of study 7 was to gain a better understanding of factors that influence BS non-
attendance among lifetime non-attendees in Malta and to explore their knowledge and risk 
perceptions to guide the development of a future intervention to increase BS uptake. To 
address these aims, and to address RQ 4, Which factors influence non-attendance among 
lifetime non-attendees and which interventions are considered appropriate to increase BS 
uptake in Malta?, the following objectives were identified: 
(1) To gain a better understanding of beliefs, perceptions, attitudes, barriers and 
knowledge regarding BS among lifetime non-attendees; 
(2) To determine which interventions and channels are appropriate for communicating 
with women about BC and BS. 
 
8.3 Methods 
8.3.1 Design  
Study 7 employed qualitative methods and is reported in accordance with consolidated 
criteria for reporting qualitative research (COREQ) checklist (Tong et al. 2007) (Appendix 
8.1). A qualitative methodology was chosen for this study as it was well-suited to capture 
individual stories and can situate women’s experiences in larger social, economic and 
historical contexts.  
 
Face-to-face semi-structured interviews are the most commonly used technique in 
qualitative research (Eisenhardt and Graebner 2007; Press 2005). Although costly in time 
(Bowling 2009), face-to-face interviews provide the opportunity for probing and analysis of 
in-depth issues needing attention (Frankfort-Nachmias and Nachmias 1992). In the context 
of BS, this deeper exploration helps to elaborate the understanding of how and why women 
behave the way they do (Farooqui et al. 2013). Hence, the acquisition of a rich source of data 
about BS barriers, beliefs, perceptions and individual experiences enables an understanding 
of both individual (attitudinal, knowledge-based, skills-related, risk assessment) and 
organisational barriers (Farooqui et al. 2013; Gill et al. 2008). An advantage of semi-
structured interviews is that the researcher can adapt the questions as necessary, clarify doubt 
and ensure that the responses are properly understood, by repeating or rephrasing questions 
(Bowling 2009). Non-verbal cues can be detected through frowns, nervous tapping and other 
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body language, unconsciously exhibited by participants (Bowling 2009). Hence, the 
researcher is able to take note of the latter through field notes written during the interviews.  
 
8.3.2 Setting 
I conducted all face-to-face interviews (n=20) with female participants at their homes around 
Malta. The location was based on all participants’ preferences following a choice of 
locations. Interviews were carried out between December 2017 and February 2018. All 
interviews were conducted privately with only the researcher and the participant present for 
the interview. 
 
8.3.3 Participants  
From the larger quantitative study of 404 women, 13.9% of women (n=56) had never 
attended for mammography anywhere (‘lifetime non-attendees’). These participants had 
responded in the population-based survey (Study 2) that they were willing to be contacted 
further for research purposes. The same eligibility criteria (Section 4.2.2.3) also applied to 
this study. 
 
8.3.4 Sample and sampling strategy  
A purposeful sampling strategy was adopted by selecting a small number of cases that 
maximize the diversity of women (heterogeneous sample) relevant to the objectives (Section 
8.2). From 56 lifetime non-attendees, I selected at least three women per 
sociodemographic/health status group that had emerged as significant factors associated with 
lifetime mammography practices in Study 4. Hence, women were selected from, but not 
limited to, the following groups: ‘low family income’, ‘widowers’, ‘non-drivers’, ‘no breast 
condition/disease’, and ‘no relatives or close friends with cancer’.  
 
According to Guest et al. (2006), Green and Thorogood (2014) and Adler and Adler (1987), 
15 to 20 interviews are suitable to obtain sufficient data for analysis in qualitative studies. 
Although it initially appeared that data saturation was reached after 15 interviews, a further 
five interviews were conducted to confirm this, after which recruitment ceased. 
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8.3.5 Recruitment  
A research assistant (RA) i.e. a senior nurse and researcher in Malta, contacted potential 
participants by telephone to confirm that they had never been screened. During this 
telephone call, potential participants were given further information about the study 
objectives and to confirm whether they were willing to participate in a more in-depth 
interview. Potential participants were informed that they would receive honorarium of 
twenty euros upon interview completion. Although it is recognized that informed consent 
must be obtained under circumstances that minimize potential coercion or undue influence, 
the researcher was aware not to obscure women’s risk perception and not to expose subjects 
to risk of harm or to induce prospective subjects to consent to participate against their better 
judgement (undue inducement) (Bentley and Thacker 2004). The researcher only made use 
of the financial incentive to facilitate recruitment by helping make participation a revenue-
neutral experience, compensate women for their time and contribution (Halpern et al. 2015) 
and use it as an incentive for women to overcome barriers to participation in this study 
(Ulrich et al. 2005; Bentley and Thacker 2004).  
 
Those who were interested in taking part in this study were invited for a face-to-face 
interview with the researcher and were given a choice of locations. The interview was 
scheduled by RA between the researcher and the participant, according to the availability of 
the participant. RA confirmed the participant’s postal address and mailed the information 
sheet to the participant (Appendix 8.2a, b) in order to ensure that the information sheet was 
received at least 48 hours before signing the consent form during the interview (Appendix 
8.3a, b). RA used a socio-demographic questionnaire (Appendix 8.4a, b) to screen women 
for eligibility. Hence, participants’ sociodemographic data were primarily obtained from the 
previous cross-sectional data (Study 2) and further confirmed through this brief socio-
demographic questionnaire. A debrief was provided following completion of the interview 
to provide a summary about this study and information on the MBSP (Appendix 8.5a, b).  
 
8.3.6 Data collection 
Each participant took part in one audio-recorded interview by the researcher at the 
participant’s home using a topic guide (Appendix 8.6a, b) informed through existing 
literature. The questions during the interviews did not have a specific order and were asked 
in accordance to participants’ responses. During the interviews, I repeated and summarized 
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what the participants said to prevent misunderstandings and took field notes to facilitate the 
interview process. Interviews lasted between 55 and 77 minutes and were conducted in the 
Maltese language (as the preferred language by all participants). Participants signed 
informed consent forms (Appendix 8.3a, b) before the start of the interview. Consent was 
also sought from the participants for audio-recording. Figure 8.1 shows the flow of 
participants through the study. 
 
 
 
 
 
 
 
 
Figure 8.1 - Flow of participants through the study 
 
8.3.7 Measures 
8.3.7.1 Socio-demographic questionnaire 
Sociodemographic data were collected to describe the sample characteristics, women’s 
health status and health behaviours (Appendix 8.4a, b).  
 
8.3.7.2 Interview topic guide 
The interview guide was developed in light of this research’s conceptual framework (HBM 
and CSM). A semi-structured topic guide (Appendix 8.6a, b) was developed after an 
extensive literature search (Farooqui et al. 2013; Ferrat et al. 2013; Todd and Stuifbergen 
2011; Lasser et al. 2008; Lamyian et al. 2007; Fort and Ahmed 2005; Markovic et al. 2005; 
Mele et al. 2005). This guide consisted of a series of open-ended questions covering illness 
perceptions regarding BC, BC prevention and knowledge of screening, mammography 
beliefs, past health-related experiences, medical help seeking behaviour, interactions with 
healthcare providers, friends and relatives, BS facilitators and barriers, and effective 
interventions that would facilitate their attendance for mammography. Participants were 
given the opportunity to talk freely and at ease, but prompts were included in order to keep 
the discussion focused within the broad topic. The guide was piloted with two women 
Participants who were contacted by 
the research assistant (RA) 
N = 29 
Not eligible (N = 9): 
1 not interested in study; 
4 did not respond,  
4 had attended for 
mammography (2 attended at the 
MBSP and 2 attended private 
clinics). Took part in this study  
N = 20 
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(housewives of eligible screening age), but no changes were required. This pilot data was 
not included in the main analysis. 
 
8.3.8 Ethical considerations 
This study was approved by the NHS, Invasive or Clinical Research (NICR) Committee, 
(SREC14/15 – Paper No.18, Version 4) (Appendix 8.7) and by the Maltese HEC 
(HEC11/2014) (Appendix 8.8). Participants were mailed an information sheet (Appendix 
8.2a, b) containing information about the study, contact details of the Health Director 
General and that of an independent contact to report any concerns or complaints about the 
study. All respondents were informed of their right to refuse answering any question posed 
by the interviewer, how anonymity and confidentiality would be preserved and that they 
could withdraw from the study at any time. 
 
8.3.9 Data Analyses 
8.3.9.1 Socio-demographic questionnaire 
Descriptive statistics were produced. Specifically, the mean age of the sample was 
calculated, and percentages were produced to show the proportion of participants in each 
category.  
 
8.3.9.2 Thematic analysis of interviews  
Interviews were transcribed verbatim by myself and codes were assigned to each participant 
to protect the woman’s identity. Each interview was translated from Maltese to English by a 
qualified translator. Each interview was checked twice by a trained transcriptionist / 
translator (SD) and myself for accuracy of translations.  
 
The analysis followed the six phase guide to thematic analysis, a qualitative method outlined 
by Braun and Clarke in their paper on using thematic analysis in psychology: (i) 
familiarisation, (ii) generation of codes, (iii) searching for themes, (iv) reviewing themes, 
(v) defining the themes and (vi) writing the report (Braun and Clarke 2006). This qualitative 
method was chosen due to its flexibility and potential to provide a detailed and rich, yet 
complex account of the data (Braun and Clarke 2006). It is also a useful method for 
comparing similarities and differences between data and summarising key features of a large 
250 
 
body of data. I listened to the interview recordings as part of the familiarisation process, and 
read all of the transcripts several times to ensure I was fully immersed in the acquired data. 
 
8.3.9.3 Coding  
Following the familiarisation phase, I generated an initial list of codes. Through discussion 
with RA, I amended and refined the codes until a single list was agreed. Subsequent stages 
of the analysis were conducted manually by myself. Coding the transcripts involved 
selecting parts of the text and assigning codes to these sections, also ensuring that the context 
of the quote was also captured. More than one code was assigned to the same text passages, 
where relevant. This initial coding was very detailed in order to identify all of the relevant 
pieces of text. If new codes emerged during the coding of later interviews, these were added 
to the list and earlier interviews were recoded to ensure that no passages were left out. A 
selection of transcripts (n = 5) were then coded by RA to verify their consistency. There was 
high agreement on the coding; minor discrepancies were resolved following discussion 
between RA and myself. 
 
8.3.9.4 Themes and sub-themes 
Broad themes were pre-set and derived from the survey results and World Café type focus 
groups. These themes included: (i) attitudes, feelings, beliefs and perceptions, (ii) 
knowledge, (iii) social network experiences and (iv) perceived effective interventions. Sub-
themes emerged from this qualitative study and were strongly influenced by the interview 
topic guide and pre-set study objectives because the discussion was facilitated in this way. 
 
Once the coding was completed, I reviewed the coded transcripts to search for common sub-
themes that reflected the pre-set themes. This process was also conducted independently by 
RA. The list of sub-themes were then compared and discussed in detail between RA and 
myself with the scope of refining the list. Some sub-themes, although interesting, were not 
relevant to the specific area of interest and did not add further value to the understanding of 
BS factors. For example, some participants talked about the role of stress in their children’s 
lives. Hence, these were not included in this chapter. Once the final list of sub-themes was 
concluded, each sub-theme was named and given a written description. The sub-themes were 
then checked against all the transcripts to ensure that they were applicable to the majority of 
the sample.  
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8.3.9.5 Validity  
Credibility and conformability of data were established in three ways (Lamyian et al. 2007). 
First, the researcher revised the main outcomes of the discussion with participants before 
ending the interview in order to summarise what had been discussed, to add any further 
comments and for participants to provide any feedback on the data. Moreover, following 
data analyses, I contacted the participants by telephone and provided a summary of the 
emergent sub-themes to determine whether the codes and sub-themes were true from their 
point of view (member check). Second, the interviews enabled an in-depth prolonged 
engagement with participants, thereby allowing for a more detailed understanding of 
women’s beliefs and perceptions. Third, as a further validity check, RA checked half of all 
transcripts (peer check) to confirm the aptness of the results, to ensure their reliability and 
trustworthiness, and to refine the analysis and emergent sub-themes (Anderson 2010). RA 
interpreted the raw data of these transcripts independently by searching for emerging sub-
themes, which ultimately were congruent with that of the researcher. The results were also 
checked with two women (the same two women who participated in pilot-testing the topic 
guide) to confirm the aptness of the sub-themes and outcomes.  
 
8.4 Results 
8.4.1  Participants 
Socio-demographic and health characteristics of the female participants are shown in Table 
8.1. The mean age of the sample was 59.9 years (SD: 2.2 years). The majority were married, 
housewives and did not drive (85% respectively). Educational attainment varied between 
primary (25%) and secondary (75%) education level. Less than half of the participants (45%) 
had an income of less than €10,737 while 55% of women had an income between €10,737 
and €16,113. From the sample, 90% named a family doctor. Furthermore, the absolute 
majority had no breast condition or disease (90%). There were 70% of non-attendees who 
had a family history; 15% of these had close friends with cancer. Those who had no family 
history (30%) had no close friends with cancer. With regards to women’s perception of their 
current health status, 60% perceived the latter as ‘good’, 25% perceived this as ‘fair’, while 
10% considered it to be ‘poor’. Of our total sample, 75% had never had a clinical breast 
examination (CBE), 25% had never performed a breast self-examination (BSE), 45% had 
never undergone a smear test while 85% had never undergone a faecal occult blood test 
(FOBT). 
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Table 8.1 - Participant characteristics 
 
 
8.4.2 Key sub-themes 
Regarding objective 1, the analysis sought to explore women’s health beliefs, perceptions, 
attitudes and feelings of BC and BS. These findings are presented as sub-themes 1-5 below 
(Section 8.4.3). Knowledge was also investigated among non-attendees. These findings are 
presented as sub-theme 6 (Section 8.4.4). The analysis also sought to explore how non-
attendees perceived BS barriers as a result of their social networks and the reasons for the 
latter perceptions. These findings are presented as sub-theme 7 (Section 8.4.5). Regarding 
objective 2, the analysis sought to explore what interventions and communication channels 
would be effective to increase BS uptake in Malta. These findings are presented as sub-
theme 8 (Section 8.4.6). These eight sub-themes are sub-divided into identified elements, 
which were then compared to see whether they were related to the same idea or issue. When 
an identified element placed under one sub-theme was more related to another sub-theme, 
this was moved accordingly. All related elements were grouped together to form one or more 
categories (Table 8.2).  
 
 
 
Code Age 
(years)
Marital status Education Occupation Income Do you 
drive?
Do you have a family physician 
(GP) who provides medical 
care and advice to you?
Have you ever had any type 
of breast condition or 
disease?
Do you have a 
family history or 
close friends with 
NA1 58 Married Secondary Housewife Between €10,737 – €16,113 No Yes No No
NA2 64 Widowed Primary Pensioner Less than €10,737 No Yes No No
NA3 61 Married Primary Housewife Less than €10,737 No Yes No Yes
NA4 60 Married Secondary Housewife Between €10,737 – €16,113 No Yes No Yes
NA5 58 Married Secondary Housewife Less than €10,737 No Yes No Yes
NA6 62 Separated/Divorced Secondary Housewife Less than €10,737 No Yes No No
NA7 56 Married Primary Housewife Between €10,737 – €16,113 Yes Yes No No
NA8 58 Widowed Secondary Pensioner Less than €10,737 No Yes No Yes
NA9 61 Married Secondary Housewife Between €10,737 – €16,113 No Yes No Yes
NA10 59 Married Secondary Housewife Less than €10,737 No Yes No Yes
NA11 60 Married Secondary Housewife Between €10,737 – €16,113 Yes Yes Yes No
NA12 59 Married Secondary Housewife Between €10,737 – €16,113 No No No Yes
NA13 61 Married Primary Housewife Less than €10,737 No Yes No No
NA14 64 Married Primary Housewife Less than €10,737 No Yes No Yes
NA15 59 Married Secondary Private employee Between €10,737 – €16,113 No Yes No Yes
NA16 57 Married Secondary Housewife Between €10,737 – €16,113 No Yes No Yes
NA17 59 Married Secondary Housewife Between €10,737 – €16,113 No No No Yes
NA18 62 Married Secondary Housewife Less than €10,737 No Yes Yes Yes
NA19 62 Married Secondary Housewife Between €10,737 – €16,113 No Yes No Yes
NA20 58 Married Secondary Housewife Between €10,737 – €16,113 Yes Yes No Yes
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Table 8.2 - Classification of subthemes expressed by non-attendees 
 
Themes Subthemes  Detected Elements 
 
Categories 
Personal 
beliefs, 
perceptions, 
attitudes and 
feelings 
Perceived severity  
 
 
 
 
 
Fear 
 
 
 
 
 
 
 
 
 
 
 
 
Competing health 
priorities  
 
 
 
Emotional distress  
 
 
Negative health 
experiences 
Feeling well 
Lack of perceived 
severity 
Optimism 
Spiritual beliefs  
 
Fear of cancer diagnosis 
and its related treatment 
side effects 
Fatalism 
Mammography pain 
Radiation 
Mastectomy 
Embarrassment 
Experiences of relatives 
with cancer 
Not seeing children and 
grandchildren grow 
 
Other personal health 
problems 
Cancer in a family 
member 
 
Depression and Anxiety  
Low self-esteem 
 
Physical accidents 
Other surgical operations 
Late diagnoses 
Death of relatives/friends 
Perception of good 
health 
Absence of symptoms 
 
 
 
Fear of death 
Physical pain 
Altered body image 
Shame 
Not being there for the 
family 
 
 
 
 
 
 
 
Postponement 
 
 
 
 
Low self-confidence 
 
 
History of trauma 
Lack of trust in the 
health care system 
Knowledge 
and 
awareness 
Insufficient 
BC/BS 
information 
Misinformation Lack of knowledge 
Social 
network 
experiences 
Cultural factors Lack of physician-patient 
relationship 
Lack of family/partner 
support 
Loneliness and isolation 
Ineffective health 
communication 
Rejection 
Perceived 
effective 
interventions 
Able to attend 
through effective 
cues to action 
 
Lack of support 
Lack of cues to action 
One-to-one 
counselling 
GP and partner 
recommendations 
Sharing personal 
experiences  
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8.4.3 Theme 1: Personal beliefs, perceptions, attitudes and feelings 
Five sub-themes emerged from data analysis to reflect Theme 1. These sub-themes include: 
perceived severity, fear, competing health priorities, emotional distress, and negative health 
experiences. 
 
8.4.3.1 Sub-theme 1: Perceived severity  
Perceived severity was characterised as not needing the test because women perceive 
themselves as healthy and believe in God. This sub-theme was categorised as women’s 
perception of good health and absence of symptoms. 
 
Category 1: Perception of good health 
Various misconceptions of good health were evident in the participant’s lack of awareness 
of risk and perceived BC severity, hence perceiving themselves healthy and not needing the 
test:  
“There is no need to go and search for it (BC) because I am sure that I am healthy.” 
(NA15, 59 years) 
 
“I don’t need to go. I feel well overall.” (NA19, 62 years) 
 
Some non-attendees described the word ‘cancer’ as a disease that ‘brings negativity’ and 
wanted to view life in an optimistic manner, excluding the negativity around them: 
“I am a person that tries not to think negatively and I feel good about myself and 
positive. This disease (BC) brings sadness, so I just don’t think about it.” (NA10, 59 
years) 
 
While participants discussed how their faith in God helped alleviate fears about uncertainties 
in life, disease and death, four women abdicated their personal responsibilities in preventing 
BC by resorting to prayer and leaving everything in God’s hands: 
“I am determined that when I get to know I have cancer, I will live that remaining 
year of my life in peace. I will be leaving it in God’s hands. He will take me when he 
wants to. I could die tomorrow, we all have to die some day or other. We weren’t 
created to be here.” (NA8, 58 years) 
 
“I can prevent cancer through prayer. I cannot do much.” (NA1, 58 years) 
 
Category 2: Absence of symptoms 
According to some participants, absence of symptoms was one reason cited by women for 
not undergoing the test: 
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“I should feel something to go for a breast check-up” (NA16, 57 years) 
 
One participant stated that she would only visit her doctor if she detected any symptoms in 
her breasts, but was unwilling to visit a doctor otherwise.  
“I might do mammography only if I see BC, and if I see it, it means I can feel it. Only 
then will I go to my doctor.” (NA10, 59 years) 
 
8.4.3.2 Sub-theme 2: Fear 
Women considered fear as a critical factor to inhibiting mammography attendance. Five 
categories were identified related to fear: fear of death, of physical pain from the procedure 
or from treatment side-effects, altered body image, shame and not being there for the family. 
 
Category 1: Fear of death 
Fear of having to face a cancer diagnosis contributed to non-attendance among eighteen 
Maltese participants, particularly among women whose family and friends had died from the 
disease. Women spoke of how they had seen their relatives suffer and died from the disease:  
“I don’t want to have to face the possibility of having a positive result. I have seen 
my family suffer too much due to BC. My mother had intestinal cancer and died.” 
(NA5, 58 years) 
 
“People don’t get cured after getting BC. It is simply a death sentence.” (NA19, 62 
years) 
 
The majority of participants expressed how their perception of cancer is an unchangeable 
fate that cannot be prevented or cured: 
“If cancer forms in the breasts, you cannot do anything about it. It is nature and no 
one can control it. There’s no reason to stay beating around the bush. You die 
anyway. That’s your fate.” (NA7, 56 years) 
 
 
Category 2: Physical pain  
Women reported having fear of the mammography procedure itself, as they had heard other 
women talk of pain during the test: 
“It’s in my head…that idea of intense pain during mammography. My sister had 
done it once and she had felt pain. If my sister says it, then it is true.” (NA7, 56 years) 
 
“I do challenge ill health. I had a hysterectomy and went for it with courage but the 
fact that I know that I am going to feel pain, I can’t take it. That is what I was told 
by other women. They press the breasts between two plates and squash them. It isn’t 
for me.” (NA14, 64 years) 
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Women also spoke of how their relatives had suffered from physical intense pain due to the 
chemotherapy: 
“My mother (with intestinal cancer) died of intense pain. Chemotherapy kills you 
literally. She looked yellow with treatment and could hardly walk. Her veins were 
worn out.” (NA5, 58 years) 
 
“I saw my aunt who entered the oncology centre physically well. Then they gave her 
chemotherapy. She had a pipe in her neck and deteriorated. She then passed away.” 
(NA8, 58 years) 
 
Additional fears arose about the mammogram that were distinct from procedural pain or 
discomfort. Four women mentioned that they feared the effects of radiation exposure, which 
hindered their attendance and reflected misinformation that was never clarified by health 
professionals: 
“The exposure to radiation scares me. It can be harmful to our health and damages 
my breasts.” (NA11, 60 years) 
 
“My husband was fine but after being treated for brain cancer he got worse. It’s 
about those X-rays they gave him. The cancer spread even more.” (NA9, 61 years) 
 
Category 3: Altered body image 
Some women spoke of their fear of having a mastectomy. They associated surgical treatment 
with having physical pain post-surgery and a distorted body image, resulting in 
embarrassment and a loss of their femininity: 
“I fear having a mammogram because I cannot imagine losing my breasts and 
passing through that physical pain with drain pipes all over and long-term 
physiotherapy. This would mean not being a woman anymore, losing my role as a 
mother. Breasts are part of a woman’s beauty; it inflicts harm on something that 
symbolizes femininity and motherhood.” (NA11, 60 years) 
 
“I would feel embarrassed with no breast.” (NA3, 61 years) 
 
Category 4: Shame 
Some participants also mentioned how they felt shame in exposing themselves in front of 
others, particularly if the health professional was male: 
 
I already feel embarrassed about the thought of having to expose my breasts in front 
of them (radiographers) because they might find it awkward. I actually feel 
ashamed.” (NA11, 60 years) 
 
“I wouldn’t accept having a male professional checking me. It’s a woman thing.” 
(NA20, 58 years) 
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Category 5: Not being there for the family 
Five women spoke of how they feared not seeing their children or grandchildren grow and 
how this fear led them to refuse BS attendance to spare the family from suffering: 
“I want to see my children grow. It scares me not to see them get married and have 
their own children, because life is beautiful that way. But the fear is too big an 
obstacle for me. I don’t want my children to pass through suffering because of me.” 
(NA6, 62 years) 
 
8.4.3.3 Sub-theme 3: Competing health priorities 
The most important competing health priorities deterring women from screening included 
the presence of other personal health problems, and cancer in a family member. These were 
categorised as postponement. 
 
Category 1: Postponement 
Due to their current health condition, some women were determined to postpone 
mammography attendance to tackle their priorities: 
“Right now I am a diabetic patient and I have a CT scan booked to check upon 
some glands. I also have high blood pressure and my blood tests are being sent 
abroad for review. It isn’t the time for a mammogram.” (NA15, 59 years) 
 
“I have other health problems which are more important than having screening tests 
for something that may develop one day. The truth is I’ve lost some weight, so I am 
getting some tests done. This is my priority.” (NA1, 58 years) 
 
Many women reported that they were very busy with family obligations, because family 
members were experiencing or had experienced cancer. Women considered that taking care 
of their family needs during this difficult time was a priority over their own health: 
“My husband has been suffering from brain cancer for nine years. Abroad, they 
could not operate on it as it touches the nerves. Since we have a family, I need to take 
care of him and all at the moment.” (NA13, 61 years) 
 
“I cannot cope with my current issues, then if needs be it will have to be in the 
future.” (NA15, 59 years)  
 
 
8.4.3.4 Sub-theme 4: Emotional distress  
Category 1: Low self-confidence 
Three women reported having emotional distress, including symptoms of depression and 
anxiety, existential distress and loneliness. This led them to realise that they had low self-
esteem. 
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“Depression messes with your memory. I am on medication and feel very sluggish 
and nauseated every morning. Leaving the house is difficult and distressing. I’ve 
been very low to the point where I don’t even want to go out and I’m regularly 
missing health appointments. I worry that my legs will be amputated due to diabetes 
and no one will be there for me. It’s very depressing and it actually destroys my self-
esteem.” (NA20, 58 years) 
 
Losing one’s sense of control and fearing disease progression and disability were also 
common concerns: 
“I am always worrying about what’s coming next. Will I get cancer myself now after 
my husband? What will be my next limitations? Will I be disabled? I’m losing my 
focused frame of mind.” (NA9, 61 years) 
 
“I have always been one who likes taking control of things. Cancer could go to my 
brain, liver, anywhere really. My father’s lung cancer went to the liver.” (NA18, 62 
years) 
 
Low self-esteem causes women to feel weak and powerless, avoiding BS participation.  
“I have a low self-esteem and am not hopeful about the future, and so I do not pay 
much attention to my own health. I know this may be something wrong with me but 
that’s the way I feel about life. Weak, powerless, pointless.” (NA20, 58 years) 
 
Additionally, anticipation of results are likely to provoke anxiety in non-service users: 
“After experiencing a personal physical accident and passing through a lot, it is 
daunting for me to wait for a result. I get very anxious and so I don’t go for it 
(mammography).” (NA1, 58 years) 
 
8.4.3.5 Sub-theme 5: Negative health experiences  
Category 1: History of trauma 
Prior health care experiences for non-attendees were negative, life events related to prior 
physical accidents and previous traumatic operations: 
“I passed through a very bad car accident and spent 14 days in ITU with a torn liver 
and an internal haemorrhage, and had to undergo many surgical operations, a 
nightmare, and also ended up diabetic. I don’t want to experience all those tests 
again. Going to hospital again gives me the shivers. You don’t experience trauma 
then, the trauma comes out afterwards and you carry it for life.” (NA1, 58 years) 
 
Category 2: Lack of trust in the health care system 
Other dimensions of lifetime traumas arose from the experience of relatives who died of 
cancer. These experiences reflected issues of lack of trust in the health care system, due to 
concerns of ‘wrongful’ health care, physician incompetence, medical errors (unintentional 
harm) or unethical experimentation (intentional harm).  
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“That doctor killed my mum. It’s better if she hadn’t taken that treatment because 
she would still be alive. I blame it on them, on the hospital.” (NA20, 58 years) 
 
“My dad died at the age of 54. We took him to hospital and asked the doctors to 
arrange his cannula but instead they gave me a strong injection in his leg and died. 
We don’t even know what the injection was for and the doctor had just come from 
another ward. Now do you think these doctors wouldn’t do the same during 
mammography?” (NA4, 60 years) 
 
Women also related their friends’ experiences who reportedly had a screening mammogram 
and ultimately were diagnosed with late-stage cancer. As a result, women described negative 
associations between prevention and disease because they had experienced the loss of their 
own friends: 
“Many do mammography, but the doctors do not always find it (BC). My friend did 
her mammogram and had the all-clear result but in reality, she had it. Eventually, 
she lost her breast and then her existence.” (NA13, 61 years) 
 
 
8.4.4 Theme 2: Knowledge and awareness 
8.4.4.1 Sub-theme 6: Insufficient information 
All women identified the importance of receiving information about BC and BS. However, 
participants had misconceptions, and were occasionally misinformed.  
 
Category 1: Lack of knowledge 
One women stated that other tests or scans replace mammography, while another woman 
said that having breast-fed her children helped her avoid having BC. 
“I do not need the test. I did a CT (computed-tomography) scan and my breasts were 
checked during that scan.” (NA6, 62 years) 
 
“I’ve never thought about the possibility of having BC as I breast-fed my children. 
My sister had seven children and never went too. She died a normal death at 83 
years.” (NA19, 62 years) 
 
When asked about the possible causes of cancer, five women mentioned a familial BC 
history to be the main risk factor. However, these participants did not think that having 
various screening tests were necessary, except for having regular blood tests. Women 
considered lifestyle to be more important for general health and disease prevention: 
“Any woman can get BC, but people with a history of BC in their family, like myself, 
can get it even more, and those having unhealthy lifestyles too.” (NA2, 64 years) 
 
“We don’t have it (BC) in the family, so I don’t think I have a higher risk of getting 
it but it still scares me as I am not very healthy.” (NA20, 58 years) 
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None of the women gave correct information about screening time frequency and stated that 
they had no idea about how often one should be screened. One woman said that 
mammography should commence at menopause while another woman stated that 
mammography should commence after 30 years of age following professional advice.  
“I don’t know anything about how often one should attend. Perhaps during 
menopause?” (NA11, 60 years) 
 
“I once spoke to a health professional who told me I should have started 
mammograms in my thirties” (NA20, 58 years) 
 
Some women knew how to perform BSE through information provided on the media. They 
explained that they performed BSE while having a bath or whenever they remembered to do 
so. Three women were worried that they failed to detect breast lesions: 
“I know how to examine my breasts. They show this on TV.” (NA20, 58 years) 
 
“I do worry when I check my breasts … that I do not detect what is really in there.” 
(NA2, 64 years) 
 
8.4.5 Theme 3: Social network experiences 
Members of the public rely on BS information obtained from health care professionals, and 
through experiences dependent on the effect and impact of cultural factors. Detected 
elements included: lack of physician-patient relationship, lack of family/partner support, 
loneliness and isolation. Ineffective health communication and rejection were earmarked as 
important categories affecting women’s screening behaviour. 
 
8.4.5.1 Sub-theme 7: Cultural factors 
Category 1: Ineffective health communication 
Thirteen women reported that their GP had never encouraged them or did not provide 
adequate recommendations about screening benefits.  
“My doctor has not encouraged me to go for mammography.” (NA2, 64 years) 
 
“My doctor used to tell me that if I wasn’t up for it (mammography), I would be 
doing well not to go because he used to tell me… ‘I showed you how to check your 
breasts, so that’s enough’. And when I received the letter, he told me that I don’t 
need to go.” (NA8, 58 years) 
 
Some women recognised the powerful role that physicians play in encouraging screening 
compliance and that an ineffective physician–patient relationship may lead to women’s non-
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attendance to BS. Four women said they would have a mammogram if their physicians 
recommended it. 
“I don’t speak to my doctor about breast tests. I don’t have that close relationship 
with him. And since I don’t ask, he hasn’t ever mentioned it (mammography). I would 
need to be really pushed to go for one. I would prefer if my GP spoke to me about 
it.” (NA2, 64 years) 
 
“It’s not like we have a solid relationship except for the occasional visit.” (NA15, 59 
years) 
 
Category 2: Rejection 
Women’s major concern was that having a mastectomy or further treatment would 
precipitate rejection and abandonment by their partner. Lack of family support and family 
rejection were also common concerns in women’s daily lives. 
“I had a friend whose husband rejected her when she had her breast removed. If I 
had to have (a breast) removed, I’d think that he’d seek another woman and that I’m 
no longer attractive to him.” (NA10, 59 years) 
 
“I’ve got four children, all married but none of them take me to health appointments 
or anywhere really. I feel rejected and alone. Let alone how much I will be able to 
cope if I found out that something was wrong.” (NA20, 58 years) 
 
“I’d really want that extra push from my family. My husband doesn’t encourage me 
to go for a mammogram.” (NA5, 58 years) 
 
8.4.6 Theme 4: Perceived effective interventions 
All non-attendees reported that national BC campaigns held in Malta do not trigger them to 
go for mammography. They felt that the ongoing media coverage in October was too long 
which would make them change the television channel if they came across screening 
discussions. Instead, non-attendees preferred one-to-one counselling, partner and GP 
recommendations, and sharing personal experiences on the media as more effective cues to 
action. 
 
8.4.6.1 Sub-theme 8: Able to attend through effective cues to action 
Category 1: One-to-one counselling  
Several women reported that being contacted and counselled over the phone were facilitating 
factors: 
“A one-to-one telephone conversation would encourage me although deep down I 
would be scared.” (NA15, 59 years) 
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“Speaking to you really helped me think it through.” (NA7, 56 years) 
 
 
Category 2: GP and partner recommendations 
Four women said they would have a mammogram if their physicians recommended it: 
“I would prefer if my doctor spoke to me about mammography. I would consider his 
recommendations seriously.” (NA2, 64 years) 
 
Furthermore, recommendations from a woman’s partner would encourage three women to 
attend BS: 
“My husband is my closest link to health care. If he says so, I would consider his 
advice.” (NA5, 58 years) 
 
Category 3: Sharing personal experiences  
More than half of non-attendees reported that the most frequent source of BC and BS 
knowledge was through listening to others who shared their personal experiences of the 
disease. The experiences of relatives or friends or experiences shared on the media i.e. 
through television and radio, would motivate them to attend.  
“If you chat with a friend or relative about their cancer experience, you get 
encouraging first hand information.” (NA2, 64 years) 
 
“Women who experience cancer often speak their hearts out. That’s very 
encouraging.” (NA18, 62 years) 
 
Non-attendees were reluctant to receive brochures, pamphlets and listen to educational talks 
as the latter did not seem to increase knowledge and awareness of BC and BS among non-
attendees or to motivate them to attend. Non-attendees would discard brochures, pamphlets 
or booklets if received at home: 
“Once I receive them (brochures, pamphlets, booklets), they’re immediately 
discarded.” (NA7, 56 years) 
 
 
8.5 Discussion 
Building on the findings of quantitative data (Studies 2, 4), this study used thematic analyses 
to explore for the first time and in further depth women’s reasons for non-attending BS in 
Malta, as well as their beliefs, perceptions, attitudes and knowledge of BC and BS. This 
qualitative study also provides valuable insight regarding potential interventions in Malta. 
While the current study confirmed the findings of the cross-sectional data such that there are 
263 
 
a number of psychosocial factors impeding attendance, it provided new knowledge by 
informing the understanding of these factors.  
 
This study delineated that although all women had heard about mammography, non-
attendees were unable to take an adequately informed decision about BS and could not share 
in the decision-making process due to a number of barriers. According to the participants in 
this study, fear was a primary barrier to BS attendance. Maltese women’s fear surrounding 
BC and BS seems to encompass many factors but certainly includes fear of a cancer 
diagnosis, fear of pain, fear of death, fear of radiation, fear of embarrassment and of the 
medical establishment. The belief that “it is better not to know” has been reported as a barrier 
to screening in studies focusing on Hispanic women (Austin et al. 2002) and among Turkish 
women (Kissal and Beşer 2011). Such fears also inhibit or delay women’s visit to a physician 
until they feel pain or experience a symptom (Lamyian et al. 2007). As one participant put 
it in this study: “I have to feel pain due to a lump or due to cancer itself to take care and do 
something about it, perhaps go to the doctor then.” Fear is the most extensively studied 
emotional variable in the literature (Lamyian et al. 2007; Gbenga et al. 2005) and includes 
fear of mastectomy, fear of death and fear of an altered body image, among others (Borrayo 
et al. 2005; Ogedegbe et al. 2005; Young and Severson 2005). The role of participants’ fear 
emerges either as a facilitator or as a barrier in the context of screening behaviour (Kissal 
and Beşer 2011).  
 
The absence of symptoms suggests that the benefits of screening programmes are either 
poorly understood or that screening is rejected as a premature intervention or because women 
did not have a strong belief in preventive care. In a qualitative study among 187 low-income, 
minority women in New York, this preventive care paradigm has been reported to be 
positively correlated with women’s health outcomes when faced with other chronic diseases 
(Gbenga et al. 2005; Cohen et al. 1994). Women often consider non-attendance as 
‘carelessness’ which leads to neglect, reluctance and postponement as part of their actions 
(Kissal and Beşer 2011). Women in our study described using neglect and postponement as 
coping strategies for tackling their fears that resulted in cultural norms to delay care or not 
seek BS. Similarly, according to a study by Montazeri and colleagues, around 25% of 
patients with breast symptoms had delayed seeking medical help for more than 3 months 
(Montazeri et al. 2003).  
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Another main finding in this study is that women were not motivated to perform BS due to 
fear of not seeing their children grow and due to the lack of emotional support from family 
and friends. Women’s perceived main role in life seems to be attending to the family and 
children (Khazaee-pool et al. 2014; Taha et al. 2012). This literature provides significant 
evidence to support the notion that women’s fear of not being present within the family if 
BC occurred superceeds women’s consideration of screening benefits. Our findings are 
consistent with previous studies, whereby social and emotional support from women’s 
immediate networks such as family members, specifically husbands/partner, and siblings 
advocacy, could motivate women to improve their BS practices (Khazaee-pool et al. 2014; 
Kalsta et al. 2013; Kawar 2013; Torres et al. 2013).  
 
Furthermore, this study showed that a lack of support from family members often causes 
existential rejection, distress, depression, isolation, neglect and loneliness. The concept 
of loneliness includes both the objective dimension of being alone and the subjective 
dimension of feeling lonely (Dahlberg 2007). Loneliness has been described extensively in 
relation to death (Sundström et al. 2018) but not in relation to BS practices. Hence, this study 
provides innovative qualitative data regarding existential loneliness in the BS context, and 
how non-attendees related aspects of existential loneliness when considering aspects in the 
health care context. Additionally, women’s low self-confidence in this study was similar to 
the effect of women’s low self-efficacy in cancer prevention practices in studies by Miller 
(2005) and Otero-Sabogal et al. (2003). The present study found that social network 
experiences are important to build self-confidence because they serve as a source of 
advocacy to increase the effectiveness of health information and aid the understanding of 
cultural factors.  
 
In this study, women spoke about how they felt embarrassed to expose their breasts in front 
of others. The reason for this fear of embarrassment is mostly related to privacy matters of 
sexual organs and is considered not a topic of discussion by women (Khazaee-pool et al. 
2014). Literature suggests that women tend to cover their breasts, and consider not to be 
touched by others (Suh 2008; Lee 2000) or only by female professionals (Marmarà et al. 
2015). Iranian women believe that their breasts are sexualized for male satisfaction and 
hence, almost all women in an Iranian study did not visit male doctors due to modesty 
(Khazaee-pool et al. 2014). This is consistent with previous qualitative studies, which 
reported that physicians’ gender can affect whether women decides to attend or not for 
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screening tests, such as Pap smears, mammography and CBE (Kwon 2013; Taha 2012; 
Kwok 2011). This implies that the concept and meaning of ‘shame’ for women can be 
avoided through tailored cultural information (Wang et al. 2012).  
 
Other competing priorities such as having relatives with cancer or other personal health 
concerns e.g., other examinations such as surgical interventions, were observed as inhibiting 
factors for participants in this study. The finding that women fail to prioritise their own health 
also replicates other findings (Trigoni et al. 2008; Payne 2006). In their in-depth interviews 
with 30 women aged 45-65 in Crete, Trigoni et al. (2008) found that women’s family 
obligations were one of the reasons for their delayed BS behaviour. Taking time to care for 
the family was also a BS barrier among 31 Iranian women (Lamyian et al. 2007). 
 
Screening non-attendance can also be attributed to underlying spiritual beliefs such that faith 
in God attenuates women’s fear and reduces the perceived BC threat. Bener et al. (2002) 
confirmed this assertion in their qualitative study on screening behaviour among women in 
the United Arab Emirates. Cancer-related fatalism has been defined as the perception that 
individuals have limited influence to change the course of the disease, to detect it early or to 
prevent it (Lamyian et al. 2007). As shown in this study, fatalism may lead to BS non-
attendance as some Maltese women equated mammography with an impending BC 
diagnosis, contributing to increased fears of the health care system. The role of spirituality 
and its impact on health behaviours can be found in a significant body of literature within 
the African-American community (Guidry et al. 2003; Mansfield et al. 2002; Phillips et al. 
1999; Jennings 1996). The belief that God or a higher power controls both positive and 
negative outcomes i.e. divine control, is often conceptualized as a component of fatalism 
(Umezawa et al. 2012; Morgan et al. 2008; Peek 2008; Schieman et al. 2006). Fatalistic 
beliefs in this study, such as "having cancer is like getting a death sentence" or that 
"screening tests would ultimately lead to death", "cancer is in God’s hands" and that "there 
is very little one can do to prevent getting cancer", were barriers for Maltese women from 
seeking BS. Literature suggests religious, cultural and spiritual beliefs can be facilitating 
factors to overcome this propensity in women (Islam et al. 2017), such that empowering 
messages can be tailored to appeal to Maltese women to take responsibility for themselves 
and will contribute to ameliorating health disparities.  
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Women’s negative health care experiences were often the result of poor patient-provider 
communication in this study. It was clear that the health care team failed to adequately 
communicate with the patient in several instances about what was happening to their 
relatives’ health and why. This lack of information left women feeling vulnerable and had a 
negative overall impact on how they experienced and interpreted their health care encounter. 
Similarly, findings by Partin and Slater (2003) found negative experiences associated with 
health care services. This study found that barriers to non-attendance particularly included 
history of trauma due to relatives’ experiences with cancer and lack of trust in clinicians and 
mammography due to prior traumatic health experiences. It is known that fear of the health 
care system and subsequent denial/repression is one mechanism (of many) by which 
negative health care experiences may facilitate delays in seeking health care (Lamyian et al. 
2007), resulting in worse health outcomes such as late-stage diagnoses and higher mortality 
rates. Literature shows that traumatic exposure is common among low-income uninsured 
primary care patients (Medrano et al. 2004; McCauley et al. 1997). Traumas are often related 
to domestic violence, rape or childhood abuse (Green et al. 2006; Miranda et al. 2006) but 
none have been found in relation to BS literature. Trauma exposure have been associated 
with decreased routine or preventive health care (Rheingold et al. 2004; Farley et al. 2001; 
Robohm and Buttenheim 1996) and are tied to substantial health care system costs (Walker 
et al. 2003, 1999) due to negative mental health effects, including anxiety, depression, and 
interpersonal problems (Consedine 2004; Roth et al. 1997; Weaver and Clum 1995; Green 
1994), as well as negative physical health effects (Green and Kimerling 2004; Schnurr and 
Green 2004; Friedman and Schnurr 1995) and disability (Seng et al. 2006).  
 
In the extant literature, effective health communication has been found to be a very important 
motivating factor to BS behaviour (Lamyian et al. 2007; Bener et al. 2002). In this regard, 
this research found that women would consider a recommendation by the GP to attend for 
screening and to improve their knowledge on BC and BS. However, most participants in this 
study had not received any advice from their physician while some had received negative 
advice towards screening. Insufficient information about screening may partly explain the 
discordance between women’s beliefs and scientific evidence, and could result in women 
absorbing incorrect information. This may be adding to women’s confusion about BS 
guidelines.  
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A large number of participants in this study reported that they followed information on the 
media, particularly television programmes and radio stations. Information obtained from the 
latter platforms or social media may be unreliable as certain health claims may not be 
supported by sufficient evidence (Marx et al. 2008; Chew et al. 2002). Moreover, several 
studies have raised concerns about the completeness and quality of reporting health 
information (Korownyk et al. 2014; Bala et al. 2013). These findings further highlight a need 
for women to be directed to appropriate information about cancer screening, possibly by 
health professionals, and the need to disseminate accurate information through appropriate 
platforms to target hard-to-reach patient populations. Non-attendees suggested various 
communication channels as facilitators to BS, such as one-to-one counselling, GP/partner 
recommendations and support, and listening to other women’s personal health experiences. 
Hence, effective interventions should focus on supporting personal strategies that build upon 
individual coping styles and preferences, for example counselling women to develop 
personalised care plans. 
 
8.6 Strengths and limitations 
There are strengths and limitations of having conducted this qualitative enquiry. First, 
conducting a qualitative study is important prior to developing an intervention for BS uptake 
that has been under-researched in Malta. It allows for the tailoring of an intervention through 
the identification of new knowledge on key factors to be targeted and of interventions 
required to change these factors. Intervention design can be improved through users’ input 
that is captured through qualitative enquiry (Craig et al. 2008). 
 
Another strength of this study is that it used a qualitative exploration to investigate 
knowledge and risk perception of BC and BS. Other studies have used questionnaires to 
assess such factors (Sobani et al. 2012; Anagnostopoulos et al. 2012; Okobia et al. 2006) 
which limit the understanding of the extent to which participants understand the disease. 
This study was not limited in this regard and importantly, it allowed for any misconceptions 
and misinterpretations to be identified, which strengthens the case for providing BS 
education to non-attendees. A qualitative approach also allowed the researcher to observe 
how non-attendees received and processed information about BC and BS, which indicates 
that all aspects of an intervention should be communicated simply and in a ‘language’ that 
women can understand (Mohan 2017).  
268 
 
The thematic framework was an independent and iterative process. To ensure rigour and 
project fidelity, the same researcher conducted all of the interviews. I documented the steps 
and the decisions made to save the auditability for other researchers to perform these steps 
in future studies. This enabled the data to be explored in depth while simultaneously 
maintaining an effective and transparent audit trail, which enhances the rigour of the 
analytical processes and the credibility of findings (Ritchie and Lewis 2003). Through this 
analytical framework, I was able to systematically and explicitly apply the principles of 
undertaking qualitative analysis to a series of interconnected stages that guided the process, 
enabling me to move back and forth across the data until a coherent account emerged. This 
resulted in constant sub-theme refinement (Smith and Firth 2011). 
  
This study has some limitations. First, the risk perceptions for non-attendees were not 
objectively measured. Instead, non-attendees self-assessed their BC risk. It has been 
highlighted in the literature that many women either underestimate or overestimate their 
actual BC risk (Fehniger et al. 2014; Apicella et al. 2009). It would therefore have been 
useful to see how women’s perceptions of their personal BC risk compared to their actual 
risk. 
 
Second, while there is an indication that non-attendees had limited knowledge of BC and BS 
(Section 8.4.4), their actual knowledge and health literacy levels were not measured. The 
knowledge and health literacy levels of non-attendees are important as evidence revealed 
that inadequate health literacy was strongly associated with lower mammography 
performance (Rakhshkhorshid et al. 2018; Pagán et al. 2012). Therefore, it would have been 
useful to compare non-attendees’ knowledge level and health literacy to see how this may 
have impacted on their responses regarding BC and BS knowledge and their risk perception.  
 
Third, variation in relation to cancer-related health education (Livingston 2012), beliefs, 
attitudes and behaviours (Azubuike and Okwuokei 2013) is likely to exist between countries 
and regions, limiting generalizability of findings. 
 
8.7 Conclusions 
For the first time, this study provides valuable, in-depth qualitative insights into women's 
beliefs, perceptions, knowledge and attitudes for women’s lack of BS use in Malta. The 
study builds upon previous research in the Maltese context and other settings but uniquely, 
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provides health care providers and policy makers in Malta with qualitative evidence specific 
to their local population for the future development of effective interventions to increasing 
BS uptake.  
 
This in-depth data suggests that there is a growing understanding of the importance of 
tackling fear of BS and reducing fear of preventive health care more generally. Fear of BS 
among Maltese women is multi-faceted, and reflects shared experiences within the health 
care setting as well as the psychosocial context in which women live. This study identifies a 
prominent role for primary care physicians, the family, particularly husbands, and the health 
care system in general to address barriers to mammography utilization within the Maltese 
population. The majority of participants in this study had not received professional advice 
from physicians, which may in part explain why they were not fully informed about 
screening benefits. This had led several participants to opt out from seeking screening 
information relying only on symptoms. In order to ensure that women are properly informed 
about the role of screening, it is important that they receive sufficient advice from their 
physician, are supported through their immediate networks such as their partner/spouse, and 
are directed to appropriate sources of information.  
 
Despite a cancer diagnosis in the family prompted some lifestyle changes in women, it was 
not the primary motivator to attend BS. Participants seemed to be overcome by fear of death 
and traumatic histories from experiences of relatives with cancer or personal traumas. 
Factors related to practical and emotional support throughout a woman’s life are important 
to non-attendees, and approaches assisting individuals to express these at an early stage 
should be assimilated into health care practices to increase women’s self-confidence. It is 
vital that healthcare professionals refer to the patient’s wider support networks and make the 
necessary referrals to appropriate services, while policy makers should ensure that services 
providing psychological, social and emotional support are accessible to women in general. 
The impact of physical and psychosocial variables on levels of personal resilience and self-
confidence should inform the planning and delivery of future screening interventions. In 
addition, health care organisations should provide appropriate support to women who have 
experienced any personal traumas as this may be the first point of call for women seeking 
help. 
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9.1 Introduction 
The purpose of this chapter is to summarise and discuss the synthesis of findings in relation 
to the research questions and current literature regarding BC and BS. This is followed by a 
discussion of the implications of the research’s findings for theory, methods and practice 
and to conclude what interventions are likely to be effective in Malta. Finally, it outlines the 
strengths and limitations of this research and provides recommendations for future work and 
an overall conclusion to this research. 
 
The overall aim of this research was to explore the barriers and facilitators to BS uptake 
through an understanding of Maltese women’s health beliefs, illness perceptions and other 
determinants of BC prevention and BS practices, with the aim of developing a future 
intervention to increase BS uptake among Maltese women. A mixed methods approach was 
utilised in this thesis to ensure the most appropriate methods were selected to address the 4 
RQs (Section 1.8). The contribution of this thesis will be discussed in terms of its mixed 
design to collect and analyse data, synthesize results and inform a future intervention, in 
relation to health psychology theory and the application of the overarching Intervention 
Mapping framework (Bartholomew et al. 1998) to guide the mixed methods approach.  
 
9.2 Summary and synthesis of findings  
9.2.1 Is the adapted tool i.e. Maltese Breast Screening Questionnaire 
(MBSQ) valid and reliable?  
Study 1 aimed to translate, adapt and pilot-test the quantitative tool used for this research. 
The innovative part of this study is the combination, adaptation and translation of the two 
scales, CHBMS-MS and IPQ-R, to develop the Maltese Breast Screening Questionnaire 
(MBSQ) for the Maltese scenario. Having high validity showed how accurately the study 
measurements assessed the explored constructs, while high reliability implies that 
measurements can be reproduced with accuracy by producing identical results if measured 
repeatedly (Heale and Twycross 2015). The preliminary evidence of the psychometric 
properties assessment of the MBSQ showed promise of being a valid and reliable instrument 
that could be used among Maltese women to assess their health beliefs and illness 
perceptions towards BC and BS practices.  
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9.2.2 Which significant factors are associated with breast screening 
uptake to a first invitation at the MBSP, re-attendance, lifetime 
mammography use and timely adherence in Malta?  
The level of knowledge was found to be significantly associated with attendance to a first 
and second screening invitation, lifetime mammography use and adherence to recommended 
time intervals. In quantitative study 2, which aimed to understand the determinants and 
psychosocial factors associated with a first MBSP invitation, participants held high 
awareness of BC signs and symptoms, but wide variation in knowledge about BC causes and 
its related risk factors. Moreover, non-attendees were the most unsure of BS recommended 
practices and had higher emotional barriers. Overall, the knowledge of BC prevention and 
BS practices appears comparable to the published literature. Studies have shown that most 
people have limited or basic knowledge of BC and BS practices (Liu et al. 2014; Charkazi 
et al. 2013; Guvenc et al. 2012; Dandash and Mohaimeed 2007), such as among Arab 
women (Elobaid et al. 2014; Bener et al. 2001). This calls for urgent renewed health 
education and tailored information on the importance of screening while addressing 
misunderstandings, debunking screening myths and improving knowledge gaps. Advice in 
the BS context may be particularly influential given that healthcare professionals play a 
central role in health promotion and lifestyle information towards patients and the general 
population (Jonsdottir et al. 2011), such that discussions initiated by a health professional 
have been associated with healthier behaviours among cancer survivors (Jones and Courneya 
2002). This raises the need for appropriate training among health care professionals (as part 
of their Continued Professional Development) on how to provide information and advice 
about BC symptoms, lifestyle factors and screening recommendations. This also presents a 
perfect opportunity for GPs to raise the topic of BC and screening during consultations and 
may involve a discussion between the GP and the patient to address any queries and assess 
the patient’s needs. 
 
Studies 2-5 showed that HBM constructs, primarily perceived barriers, were the strongest 
predictors of non-attendance to a first and second invitation to the MBSP and to lifetime 
attendance and timely adherence, followed by cues to action. These findings suggest that 
interventions to increase BS uptake in Malta should address health beliefs, in particular 
perceived barriers such as fear, since these emerged as the strongest predictors of uptake 
throughout the analyses. The combination of both HBM and CSM constructs provided 
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improved prediction of BS non-attendance, when compared to HBM alone, which is an 
innovative finding in BS research. These results imply that interventions should be based on 
theory including both HBM and CSM constructs, since those interventions that also address 
illness perceptions, such as BC causes and consequences, may increase their effectiveness. 
 
In all the quantitative analysis, attendees were more likely to perceive their susceptibility to 
BC, believed BC to be life-changing and considered cues to action to aid attendance to 
mammography. Evidence shows that those who attend for routine mammography may 
already understand screening benefits, have come to terms with barriers to undergo 
mammography (Farhadifar et al. 2016), and have confidence in their abilities to get screened 
(Anagnostopoulos et al. 2012). On the other hand, nonadherent women were in stronger 
agreement about the painful procedure and were less likely to consider cues to action as 
beneficial. This is consistent with other studies where women describe mammography as 
painful (Marmarà et al. 2015; Carney et al. 2002) and consider cues to action, such as GP 
recommendations, to increase uptake (Keeney et al. 2007). Moreover, the findings of study 
3 showed that attending for the first time is a strong predictor of uptake to the second cycle. 
These results further support the evidence that those who obtain at least one mammogram 
are more likely to sustain screening practices (Anagnostopoulos et al. 2012; Allen et al. 
2008; Moodi et al. 2012). Therefore, if non-attendees can be persuaded to attend once, they 
are likely to re-attend, unless their screening experience has been a negative one. Hence, 
interventions should target first time invitees to increase mammography uptake.  
 
Non-attendees consisted of a heterogeneous group of women with diverse reasons for non-
attendance. Study 4 found that 86.1% of the study sample were lifetime attendees, some of 
whom had attended for mammography at private clinics rather than at the MBSP, while 
13.9% were lifetime non-attendees. Non-attendees were more likely to be anxious and 
fearful women without a breast condition, who had no relatives or close friends with cancer, 
and who were less encouraged by a GP, and had limited knowledge of BS practices. These 
are also some of the reported reasons in the literature (Anagnostopoulos et al. 2012; Aro et 
al. 2001; Lagerlund et al. 2000). It was not known to date which significant predictors 
describe the variance between lifetime attendees and non-attendees. Study 4 found that the 
most significant variables to describe the differences between lifetime attendees and non-
attendees were perceived benefits, barriers, cues to action, self-efficacy and emotional 
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representations. Hence, the health beliefs of women who have never attended for 
mammography during their lifetime should be targeted, particularly perceived barriers and 
cues to action, since these emerged as the strongest predictors to lifetime non-attendance. 
Although it is acknowledged that lifetime non-attendees are an extremely difficult group to 
target (Cockburn et al. 1997), this research recommends to target women who have never 
participated in BS primarily and those who are invited for the first time by the MBSP. 
 
Whether these beliefs and other factors are predictive of adherence with recommended time 
intervals for mammography at organized or private screening in Malta was unknown and 
hence was explored in this research. It is, however, known that in order to achieve health 
benefits, women must attend BS regularly at recommended time intervals (Coyle et al. 2014; 
Ritvo et al. 2012). Maltese women have been routinely invited to undergo mammography at 
three-year intervals at an organized programme (MBSP) or could opt to attend privately. 
Study 5 explored the predictors for Maltese women screened within or exceeding the 
recommended three-year frequency in organized or private screening in Malta. No 
significant associations were found between adherent or non-adherent women in relation to 
sociodemographic or health status variables. A plausible explanation for the disappearance 
of an effect of socio-demographic factors in subgroup analyses on adherence in this study is 
that they represent ‘carriers’ of already established health-related behaviours 
(Anagnostopoulos et al. 2012;  Moodi et al. 2012). This is consistent in all of the quantitative 
studies (Studies 2-5), where different socio-demographic and health status variables were 
non-significant predictors of BS uptake (Table 6.1). The findings of Study 5 suggest that to 
increase routine and timely mammography practices, women who are non-adherent to 
recommended time frequency guidelines should be targeted, together with their health 
beliefs, predominantly perceived barriers and cues to action, which emerged as the most 
important predictors to timely attendance. Women who attend at longer intervals may also 
need to overcome barriers to seeking mammography and follow tailored cues to action in 
order to attend at recommended intervals (Ritvo et al. 2012; Edwards et al. 2009; Rakowski 
et al. 2006). Women should therefore receive further information on the recommended 
screening frequency and the benefits of being part of an organised programme in order to 
reach greater adherence to recommended time intervals (WHO 2014; Ferrat et al. 2013).  
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9.2.3 What types of interventions are effective at increasing 
mammography uptake within populations?  
9.2.3.1 Findings of the systematic review 
The findings of the systematic review are novel since interventions to increase 
mammography uptake through the use of HBM and/or CSM theory has not been previously 
explored, and therefore adds to the literature on interventions in the BS field. The use and 
combination of HBM and CSM may help to link factors and mediators influencing screening 
outcomes, and the cognitive and emotional illness representations to guide the design, 
implementation and evaluation of interventions across diverse cultures and populations. The 
findings of this review showed that only one study used the HBM as a whole and not all 
studies measured health beliefs as outcomes. Perceived barriers were most frequently 
targeted when designing interventions, a finding that reiterates the quantitative findings in 
this research. The findings of the review also showed that interventions based on the HBM 
carried out in a community setting involving culturally-targeted material, telephone 
counselling and BC education were more likely to be successful than face-to-face risk 
tailored information messages or a nurse-delivered breast health promotion program to 
improve mammography uptake. However, further research is required to prove the 
effectiveness of any one particular intervention or multiple strategies based on theory to 
improve BS uptake that could be adopted for the Maltese population because of 
discrepancies in the findings.  
 
No RCTs were found using the CSM as a theoretical framework and the effect of 
interventions that draw on CSM constructs is yet unknown. The reason may be attributed to 
the fact that it has generally been used for the prevention and management of other chronic 
illness threats (McAndrew et al. 2008) and to understand the illness perceptions of groups at 
risk from a particular illness (Hughner and Kleine 2004). Therefore, there is limited 
information on the impact of CSM among healthy individuals and their lay perceptions of 
BC (Figueiras and Alves 2007). Hence, the lack of use of CSM in RCTs and in informing 
BS interventions, in itself, is an innovative finding and this research primarily showed how 
incorporating CSM constructs in BS research aids the prediction of BS non-attendees. 
Further research is required to evaluate intervention effectiveness and support the value of 
CSM by examining whether the model has the same pattern of interrelationships between 
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healthy individuals’ models of illness and their beliefs and perceptions towards preventive 
health actions.  
 
The findings of this review have considerable implications for the development of BS 
interventions to help improve screening behaviours among Maltese women. Although 
several theory-based behaviour change interventions have shown promise with regard to 
improving mammography uptake rates, they are not necessarily appropriate for 
implementing on a large scale, as they are resource intensive. For example, although the BC 
education program in the study by Sadler et al. (2011) was successful to increase 
mammography rates, it relied on training cosmetologists, while the culturally-targeted DVD 
materials were mailed to participants in the RCT by Wang et al. (2012). There is thus a need 
for the design and development of effective, yet inexpensive interventions, which can be 
rolled out on a large scale. 
 
9.2.3.2 Expert steering groups  
Steps 2 of Intervention Mapping (IM) were supported through the setting up of two steering 
groups by the researcher, involving key health experts who met up in Scotland and in Malta 
respectively to identify potential theoretically informed intervention components, construct 
matrices of change objectives and create a logic model of change relating to changing BS 
behaviours in Malta. This included discussions between experts to identify specific 
preparatory behaviours related to BS (performance objectives, POs) and determinants 
(factors) to BS uptake. The expert groups also discussed appropriate methods that could be 
used among the Maltese population in order to identify change methods that would address 
the change objectives (COs). Practical strategies, that could be most effective at changing 
BS behaviour in Malta, were discussed based on feedback about priority population and 
organizational capacity fit. POs were developed for two groups (individuals and healthcare 
providers) (Table 6.2). These POs addressed preparatory behaviour by women for BS use, 
and what health providers need to do to aid women to attend. Intervention developers can 
thus identify exactly what needs to change in order to accomplish the PO, and ultimately the 
intervention outcome (McEachan et al. 2008). Women’s limited knowledge, attitudes, low 
perceived risk, personal and logistical barriers, emotional concerns, low self-efficacy and 
the lack of cues to action were selected as the most important determinants for women. For 
healthcare providers, knowledge, barriers and benefits, attitude and standards of care were 
considered as the most important personal determinants to BS. Socio-cultural determinants 
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were considered not to be changeable in a short intervention, but were considered to tailor 
the interventions culturally. 
 
Both groups concluded that the ‘barriers’ construct was the most significant component to 
target in a future intervention and that the non-attendees were difficult to reach but the most 
important target group. Hence, the need for further qualitative work was suggested by both 
committees in order to explore in more depth the health beliefs and illness perceptions of 
lifetime non-attendees. Similarly, this need is highlighted in the literature since participation 
in BS is a complex phenomenon that has many dimensions (Sterlingova and Lunden 2018). 
Notwithstanding, there are a limited number of qualitative studies that have investigated the 
phenomenon of non-participation within organized BS programmes from the perspective of 
non-attending women (Sterlingova and Lunden 2018; Manjer et al. 2015; Johansson and 
Bertero 2003).  
 
No single method was identified by both steering groups as being more effective than others 
to change behaviour, increase knowledge or measure an intention to change. Theoretical 
change methods that were considered to possibly be applicable to the POs were skills 
training, peer education, group discussions and individual counselling, focusing on barriers 
to change, social aspects of screening use, and disseminating information. Two further 
methods were discussed: entertainment education (Serra et al. 2017; Singhal and Rogers 
2004; Bandura 1986) i.e. employs formats based on entertainment to promote educational 
messages (Serra et al. 2017) and role modelling i.e. real-life role models identified as peers 
of the target population who communicate key messages (having same language, similar 
cultural and social norms) (Serra et al. 2017; Alegria et al. 2009; Kok et al. 2004). These 
overarching methods also include other change methods such as consciousness raising and 
providing women with cues to action (HBM theory).  
 
In this research, eliciting expert opinion was very useful to aid and influence the decision-
making process. For example, following upon their proposed suggestions, I thoroughly 
considered carrying out qualitative research among non-attendees. The use of steering 
committees also had an indirect effect on research performance, as the expert members 
helped to shape and refine the context of research processes. Since there is a general lack of 
research on the role of committees to guide research studies and their implementation 
processes, the use of steering groups in the field of cancer screening can be considered as a 
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first step in reducing this gap. However, there is the need to better understand their role in 
realizing value as a structural element of research and intervention management. From an 
organizational perspective, further understanding of their role will help form the integrative 
structural elements that need to be in place to gain full value from their investment in health 
management pathways.  
 
9.2.3.3 Patient and Public Involvement 
Chapter 7 aimed to understand the use of the World Café process as a PPI event to engage 
collective community perspectives on BC and BS and effective interventions to increase BS 
uptake in Malta. It can be concluded that combining PPI with mixed methods research 
benefitted the quality and rigour of this research, gaining wider perspectives of the Maltese 
population. PPI groups provided perspectives that were different from those heard from 
research participants who participated in the national survey or qualitative interviews. 
Mutual trust between researchers and members of the public whose voices are less often 
heard was established in this PPI.  
 
Since the Maltese population tend to be community-centered (Ciappara 2015), families 
within the community are key to providing social support to women (Filippi et al. 2014; 
English et al. 2008). The community is, therefore, an ideal setting for health promotion 
(Merzel and D’Afflitti 2003) and in particular, to improve BS uptake (Engelman et al. 2011). 
The lack of social support in community settings emerged as an interpersonal factor to BS 
uptake when formulating the logic model of the problem (Figure 6.1). Hence, the notion of 
patient and public involvement (PPI) is integral to the understanding of community 
perspectives on BC and screening, and may enhance understanding of social roles in BS 
decisions of Maltese women. Given the importance of community engagement, obtaining 
scientifically based evidence of the most effective ways of stimulating community change is 
essential for planning future interventions in Malta. 
 
This PPI activity found that partners/husbands and daughters can be potential conduits to 
health decision-making including BS. In the literature, men’s perceptions, knowledge, 
attitudes and beliefs about BC and BS are widely ignored (Thomas 2010; Flores and Mata 
1995), possibly because BC in men is uncommon (accounting for less than 1% of all BCs 
and less than 1% of all carcinomas in men) (Giordano et al. 2006) or because people often 
assume that men cannot acquire the disease (Thomas 2010; Flores and Mata 1995). Limited 
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evidence suggests that women rely on male family members for support and protection 
(Donnelly et al. 2017). Men saw their personal role as a supportive network to women’s 
health decisions. Hence, men can influence women to accept an invitation to attend BS 
programmes (Donnelly et al. 2017; Chamot and Perneger 2002). Moreover, relevant 
information available to men about BC is scarce (Robinson et al. 2008; Peate 2001). 
Therefore, understanding Maltese men’s perspectives and knowledge of BC and BS through 
PPI enhanced the understanding of men’s social roles in health decisions, particularly when 
it comes to BS among Maltese women.  
 
On the other hand, this PPI activity has shown that the mother-daughter relationship and 
communication norms within the family provide the primary context for exploring message 
design strategies for developing an adolescent-initiated screening intervention. Research 
suggests that mothers are receptive to BS appeals (Mosavel and Wilson Genderson 2016; 
Browne and Chan 2012), particularly those of their adolescent daughters (Mosavel 2009). 
Children can be appropriate channels for health messaging and education, positively 
impacting their own health and that of their families (Onyango-Ouma et al. 2005), as 
children or youths can persuade their mother to improve health-related behaviours (Mosavel 
and Wilson Genderson 2016; Ayi et al. 2010; Mwanga et al. 2008; Onyango-Ouma et al. 
2005). In an Australian study exploring the potential for adult daughters (18-39 years) to 
deliver mammography promotion messages to their screening-eligible mothers (Browne and 
Chan 2012), both mothers and daughters were amenable to a two-way conversation on the 
topic when prompted, although the mammogram communication that occurred was 
primarily in the downward direction (from mother to daughter). Similarly, in a survey among 
American college women that examined the types of BC prevention information-seeking 
information given to mothers (Kratzke et al. 2014), screening information was found to be 
the most frequent type of information that daughters provided to their mothers. Therefore, 
young females could potentially serve as opinion leaders for their mothers regarding cancer 
screening. For this reason, effective interventions promoting BS should consider both 
younger and older female generations as well as men’s beliefs and perceptions related to, 
and their respective engagement in, BS to further increase BS uptake.  
 
Men do not seem to chat with other men regarding health-related issues but consider their 
female partner to be key in influencing their health decision-making. Previous studies have 
shown that men are less knowledgeable about health-related issues than women and are less 
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likely to assume health responsibilities for others (Norcross et al. 1996; Flores and Mata 
1995; Umberson 1992). Nonetheless, in Geneva, men seemed at least as likely as women to 
support initiatives promoting BS (Chamot and Perneger 2002). This PPI activity also found 
that women tend to be influenced more by their health care provider and once women decide 
to trigger a personal health action, they inevitably receive support and recommendations 
from their partner, which in turn might sustain women’s receptivity toward a screening 
appeal. This finding challenges the assumption that men take critical decisions and women 
simply comply; rather, the findings paint a picture of a more iterative pathway and dynamic 
relationship in the health decision-making processes of families. Hence, men may contribute 
to shaping the social norm on BS and support initiatives related to mammography utilisation 
and their partner’s health decision-making.  
 
Fear of BC emerged as the main BS barrier among members of the public. For those who 
had not attended for mammography or were too young for the procedure, mammography 
instilled fear and their perception of the procedure was one of pain.  The literature shows 
that painful mammography experiences stop women from attending subsequent 
mammograms (Askhar and Zaki 2017) and that women have ready formed expectations 
about BS before receiving information from the screening programme, which also 
compromise the perception of balance between screening benefits and harm (Henriksen et 
al. 2015). The perception of pain varied between men and women in this PPI, such that minor 
discomfort perceived by men was considered much less severe than intense pain as 
experienced by some women. Men described the mammography procedure as an 
exaggeration of mammography pain continuously instigated by other women. Literature that 
deals with men’s knowledge of BS practices is not available to compare with the results of 
this study. Men’s perspective may have an indirect impact on women’s screening decision 
as women may perceive their partner’s perspective as a lack of understanding of their fears 
and worries and a lack of emotional receptivity and compassionate care. The challenge of 
minimizing the gap between men’s perceptions and actual experiences seems to be not just 
a matter of limited opinion but a consensus between men. The perception of men should be 
further investigated, together with the effect of how facts are framed for men and illuminate 
the context in which men base their interpretations of experiences and information. 
 
Men offered recommendations that incorporate men or family-based support to promote BS. 
The preferred communication channels for men were TV, internet, billboard advertisements 
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and GP recommendations, while women preferred culturally-tailored media through bulk 
emails, printed leaflets and brochures, TV and radio channels. Women gave higher 
preference to one-to-one interventions that can be effectively delivered at suitable locations 
frequented routinely by women such as community pharmacies, followed by nail, hair and 
beauty salons. Both women and men emphasised the importance of the GP’s role towards 
effective health outcomes, a finding reiterated in the quantitative findings of this research 
(Chapter 4) and in the literature review (Chapter 2). 
 
9.2.4 Which factors influence non-attendance among lifetime non-
attendees and which interventions are considered appropriate to increase 
mammography screening uptake in Malta?  
Study 7 aimed to understand the factors that influence non-attendance in more depth. 
Qualitative data analysis revealed eight sub-themes relating to personal beliefs, perceptions, 
attitudes and feelings, knowledge, social networks and perceived interventions. This study 
confirmed the findings of the survey data and that there are numerous factors influencing 
attendance but provided new knowledge by informing a better understanding of these 
factors.  
 
This study revealed a number of unmet needs that continue to require additional support and 
resources, particularly in the domains of psychosocial health. Fear was reiterated as a main 
barrier impeding BS attendance and included fear of mastectomy, fear of death, fear of pain, 
fear of an altered body image, and fear of not being with the family. Research suggests that 
such emotional factors (Remennick 2006) such as fear of losing femininity and sexuality 
(Ferrat et al. 2013) and fear of social stigma may be reasons for not seeking immediate 
medical help or screening (Khazaee-pool et al. 2014; Filippi 2013; Engelman 2012). 
Although a cancer diagnosis in the family appeared to have prompted lifestyle changes, it 
was not a motivator to attending mammography in this study. Rather, participants seemed to 
be overcome by fear of a personal cancer diagnosis, its related death, traumatic histories and 
personal traumas. Some participants described negative associations between prevention and 
disease because they had experienced  past personal traumas, family/friends’ experiences of 
the disease or negative health care experiences. These concerns were often related to their 
trust in practitioners and the health service, such that some doubted whether the care pathway 
was truly effective and as a result reverted to other means for cancer prevention. This is 
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consistent with other populations, such as the Chinese community (Zhang 2014) who often 
revert to Western medicine as an alternative treatment (Rochelle and Marks 2011). These 
findings imply that healthcare providers should be aware of the diversity and alternative 
healthcare seeking behaviour among populations. In addition, these findings highlight an 
area for improved support and education to ensure that women are fully supported and 
informed about BS benefits. Interventions that are specific to trauma-related experiences in 
the health care setting are less developed (Mealer et al. 2009) and to the best of my 
knowledge, there is no literature related to lifetime traumatic experiences or more 
specifically, prior traumatic health experiences in relation to BS uptake. 
 
Other barriers to BS reported in the literature are lack of social support from family, spouses 
and friends (Lamyian et al. 2007; Nahcivan and Secginli 2007; Kearney 2006). This study 
similarly showed that women lacked support from family members. However, this study 
found that lack of social support led women to experience existential rejection, distress, 
depression, isolation, neglect and loneliness. These emotional factors have not been 
thoroughly investigated in the BS field. Factors related to practical and emotional support 
throughout a woman’s life are important to women, and that approaches assisting individuals 
to express these at an early stage should be assimilated into health care practices. Moreover, 
the majority of participants in this study had not received professional advice from 
physicians, which may in part explain why they were not fully supported and informed about 
mammography benefits. This had led several participants to opt out from seeking screening 
information relying only on symptoms or pain. Evidence has shown that an estimated 20%–
30% of women will wait at least 3 months before seeking help for BC symptoms (Richards 
et al. 2000). In order to ensure that women are properly supported and informed about 
screening benefits, it is important that they receive sufficient advice from their physician, 
are supported by their partner/spouse and family members, and are directed to appropriate 
sources of information. 
 
The findings of this study suggest that healthcare professionals should refer to the patient’s 
wider support networks and make the necessary referrals to appropriate services, while 
policy makers should ensure that services providing psychological, social and emotional 
support are accessible to women in general. Futhermore, health care organisations should 
provide appropriate support to women who have experienced any personal traumas as this 
may be the first point of call for women seeking help. Such factors may influence each other, 
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and targeting one factor may help to bring positive change in another (Mohan 2017). If left 
untackled, women may experience mental health issues such as depression, anxiety and 
stress. Women could be taught how to accomplish self-care activities, and perform behaviour 
change techniques. Action planning, goal-setting and positive social interactions can aid to 
reinforce a woman’s self-esteem and perceived self-efficacy (Michie et al. 2011; Mohan 2017).  
 
9.3 Contributions towards health psychology theory 
Theoretical models aid the understanding of mechanisms involved at increasing BS uptake 
among Maltese women. The theoretical contribution of this study was that the factors related 
to mammography screening use among Maltese women were explored in relation to the 
HBM (Becker et al. 1977) and CSM (Leventhal et al. 1984). Despite the prevalence of using 
HBM and CSM to understand the beliefs and perceptions related to behaviour change among 
diverse populations, there was no knowledge on their application to the Maltese population 
prior to this study. The HBM is useful in explaining and predicting health behaviours by 
focusing on the attitudes and beliefs of individuals (Jahanlou et al. 2013; Janz and Becker 
1984). On the other hand, the key CSM construct is the concept of illness representations or 
‘lay’ beliefs about illness (Hale et al. 2007) through the understanding of cognitions (the 
perceived reality of the health threat) and associated emotional responses (such as fear, 
anxiety or worry) (Leventhal et al. 1998). The findings provide further support for models 
containing the CSM constructs to account for a larger proportion of the overall variance in 
BS utilisation and cancer control prevention. The findings also support the evidence that 
illness representations are individualised based on personal experiences and culturally 
available knowledge (Wyke et al. 2013).  
 
The findings of the thematic analysis showed that Maltese women’s screening-decision 
process regarding BS non-utilisation covered all HBM and CSM variables. The findings of 
the quantitative data also indicated the fact that HBM constructs, in conjunction with CSM 
constructs, improved the accuracy to predict non-attendance. There are also other factors 
influencing BS uptake among women from the Maltese community in addition to the 
constructs of HBM and CSM. For example, it was evident from the PPI event and qualitative 
interviews that social network experiences and prior personal traumatic histories were 
important factors that influenced BS behaviour among Maltese women. Previous research 
has documented that social network experiences (DiMatteo et al. 2000), prior trauma and 
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poor post-trauma social support (Cordova et al. 2017) may act as barriers to taking health 
actions in general. Hence, BS interventions should also consider these factors when targeting 
the Maltese population in order to target psychosocial factors that are likely to act as barriers 
to BS utilisation. 
 
9.4 Contributions to the use of mixed methods 
The benefits of using a mixed methods approach has been described in this thesis in order to 
explore health beliefs, illness perceptions and other determinants to BS uptake in Malta. In 
this research, quantitative data were employed by way of generating numerical data or data 
that could be transformed into usable statistics through statistical techniques. In practice, this 
method is used to quantify beliefs, attitudes, behaviours and other defined variables and 
generalizing it across a group of individuals to explain a particular phenomenon (Carson et 
al. 2001). Since limitations in quantitative research include being unable to understand 
complex factors and to predict human behaviours in-depth (Kura 2012), the use of qualitative 
methods are employed to gain further insights to the underlying reasons, beliefs, motivations 
and behaviours (Bowling 2009). Thematic analysis was used in the analysis of qualitative 
data obtained to identify all salient themes due to its flexible approach in specifying the 
similarities of a group of participants and individual experiences (Braun and Clarke 2006). 
In addition, thematic analysis provided a rich and detailed, yet complex account of data for 
examining the perspectives of different research participants (King 2004), generating 
unanticipated research insights. 
 
In the context of the World Café event, six categories were discussed related to health 
attitudes, knowledge, role of health providers, family and friends, experience and 
perceptions of the mammography procedure, screening facilitators, screening barriers, the 
effectiveness of communication channels and effective interventions to encourage screening 
and awareness. However, some of the categories were somewhat influenced by the 
researcher’s theoretical orientation on the topic. On the other hand, the qualitative face-to-
face data analysis among lifetime non-attendees revealed eight sub-themes which were 
strongly influenced by the interview topic guide and pre-set objectives of the study. 
Although thematic analysis provides the empirical evidence for the development of a future 
intervention, it fails to take into account the influence of researchers’ role during analysis 
(Taylor and Ussher 2001). The identification of themes are affected by the researcher’s own 
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theoretical position and values (Taylor and Ussher 2001). Hence, this requires reflexivity 
from among researchers to reflect upon and clearly articulate their position and subjectivities 
(i.e. world view, perspectives, biases) (Sutton and Austin 2015). Additionally, this thesis has 
demonstrated how both empirical evidence and theory can be used to guide the selection of 
appropriate intervention methods that best fit the future design of BS interventions and 
practical strategies in Malta. 
 
9.5 Contributions to the use of Intervention Mapping 
Intervention Mapping (IM) (Bartholomew et al. 2006) has been used successfully to plan, 
implement and evaluate interventions to increase uptake of disease prevention programmes 
(Garba and Gadanya 2017). This current study has provided a good understanding of the role 
of IM to explore the determinants to mammography utilisation in Malta and to plan and 
propose recommendations for the development of future interventions. The use of mixed 
methods was based on the stepwise IM framework to bridge the gap between theory and 
practice, and to guide, identify, measure and synthesize findings on the determinants, 
barriers and facilitators to BS uptake with the aim of developing a future, theory-based 
intervention among Maltese women. Hence, IM served as a framework for this study that 
described the iterative path from the identification of gaps to problem solving and proposing 
recommendations. While many studies only describe the development of disease prevention 
interventions using IM (Garba and Gadanya 2017), this study took into account and provided 
all possible details of the processes involved in that development (e.g. sampling techniques, 
methods of data collection and analysis, study design), thereby improving the 
methodological quality and validity of the studies. 
 
The studies carried out in this thesis covered the following steps. IM Step 1 (needs 
assessment) was accomplished through a literature review of barriers and facilitators, 
systematic review of theoretical interventions as well as quantitative and qualitative studies. 
The systematic review showed that culturally tailored interventions in a community setting 
are more effective in terms of increasing BS uptake. Because the target population was 
Maltese women in this study, the needs assessment also included a cross-sectional survey, a 
PPI event involving females and males, as well as qualitative interviews with non-attendees 
so that the psycho-social factors related to non-attendance to mammography, could be better 
understood.  
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IM Step 2 (the development of matrices of change objectives) formed the foundation for the 
development of a future intervention by specifying the detailed information about who and 
what will change due to the intervention (Bartholomew et al. 2006). On the basis of the needs 
assessment, the POs, which are the more specific and detailed behavioural objectives, were 
developed for two groups (individuals and healthcare providers) with the scope of future 
intervention development (Tables 6.3 - 6.4). The developed matrices of COs provided a 
guide for the discussion on the selection of methods and strategies towards mammography 
behavioural change.  
 
The aim of IM Step 3 was to provide recommendations for potential interventions and 
practical strategies based on the evidence and organizational fit to achieve the change 
objectives defined in Step 2. To do this, the following question was considered: ‘How can 
the change objectives be achieved?’ The interventions and strategies were proposed based 
on: (1) the findings from the systematic review of theoretical interventions (Chapter 5), (2) 
the findings of the quantitative and qualitative studies in this thesis (Chapters 4, 8), (3) the 
feedback from the expert steering groups (Chapter 6) and PPI event (Chapter 7), and (4) the 
resources available in Malta (which were discussed with the MSG).  
 
This study set out to use IM as a way of identifying and articulating the essential elements 
of a potential intervention. However, the challenges in practice included the identification of 
other evidence-based interventions and deciding whether and how they could be adapted for 
a new setting and new population such as the Maltese community. Planners need to assure 
that interventions match the new setting’s capacity, health problem, context, and the at-risk 
population (Mihalic et al. 2008). However, intervention evaluations rarely report on which 
features of an intervention constitute the essential elements to make the intervention 
successful (Elliott and Mihalic 2004). Step 4 (intervention design), Step 5 (specification of 
adoption and implementation) and Step 6 (creation of programme evaluation) were not 
within the scope of the current research but will be considered in future work. 
 
9.6 Implications for practice and dissemination of findings 
Opportunities exist to enhance awareness and support for women and men’s role in BC 
education and screening decisions. This research provides valuable information to healthcare 
providers, researchers, screening leads and public health educators as the findings can aid to 
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design culturally sensitive interventions to improve screening behaviours. Overall, the 
implications of the research results were two-fold. I began an extensive community 
dissemination process, including dissemination to the scientific and lay communities. 
Dissemination to the scientific community has included scientific articles and oral 
conference presentations, as well as public talks and television/radio recordings during Pink 
October in Malta, as well as international publications and conference presentations. By 
exploring in further depth the views of participants in this research, I was in a better position 
to better influence and inspire the 2017 and 2018 BS campaigns, aiding the national 
development of culturally-tailored BC information and educational materials that promote 
awareness, screening and resources designed specifically for the local community. 
 
October is the month where worldwide annual campaigns are organised to highlight the 
importance of breast awareness, education and research. In 2017 and 2018, ‘Pink October’ 
campaigns in Malta were led by the Maltese Prime Minister’s wife, who also founded the 
Marigold Foundation (http://marigold.org.mt/) to raise public awareness and funds for BC 
research and other rare diseases. For the first time in Malta, more focused campaigns were 
conducted based on the quantitative findings of this research (Appendix 9). The main 
objective of both campaigns were set to encourage women to face their fear of BC and BS. 
An eye catching key message was displayed on social media, local television and radio 
stations, public locations and billboard promotions for the duration of the month of October. 
The main key message was drawn up as ‘Face Your Fear’ – Would you rather sit in the dark 
or turn on the light? (Figure 9.1). The campaigns also included raising awareness among 
young adults in schools, as well as in public and private organisations. 
 
Figure 9.1 - Key message for Pink October campaign held in Malta in 2017 
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A systematic review of interventions (Austoker et al. 2009) found good evidence that the 
BC Awareness Month in the US promotes diagnosis of BC at an early stage and some 
evidence that educational interventions by community health advocates and public education 
campaigns downstage BC. Media awareness campaigns are often a person’s natural option 
to stay in synchronization with the global perspective and should be seen as the cornerstone 
for health communication interventions because of the myriad of communication techniques 
and channels that could be used to increase awareness and knowledge of health problems 
and interventions (DeJong 2010; Kreps and Sivaram 2008). It is also believed that mass 
media channels have the power to reach and inform large audiences, while interpersonal 
channels are more influential in motivating attitudinal change. Television, for instance, has 
the power to shape how we think and relate to each other (Lee 2010). However, in health 
communication studies, scholars have found that educated women prefer to access 
newspapers, magazines and medical journals than watch television health programmes. They 
have argued that women rely on the print media as one of its major sources of information 
on cancer, and women read magazines for BC information (Kreps and Sivaram 2008; Leask 
et al. 2010). This represents an opportunity to engage with the harder-to-reach group. Similar 
results were found in a study by Nelson and Salawu (2016) whereby it was concluded that 
mass media messages should be considered as the main mechanism to improving breast care 
among women in South-West Nigeria.  
 
Some health campaigns are designed simply to raise general awareness of a particular health 
threat, while other campaigns have more specific goals, such as convincing individuals to 
reduce risky behaviours (Jacobsen and Jacobsen 2011). The aim of a breast campaign is for 
women to take the most appropriate course of action to detect cancer early, by either making 
a GP referral or attending a screening mammogram (Robb et al. 2009). Catalano et al. (2003) 
examined the relationship between early BC awareness efforts and diagnoses, using 
quarterly diagnosis data from 1975 to 1997 in three metropolitan areas that sponsored 
awareness month activities during the early years of locally-sponsored BC awareness 
months. They found that BC diagnosis rates increased in each of these cities in the last 
quarter of the calendar year after the first community-based awareness months were started 
in 1985. Since the beginning of the BC awareness movement in the US, both screening rates 
and diagnosis rates have increased markedly. Breen (2007) reports that the proportion of 
women who reported having had a mammogram in the previous two years increased 
significantly from 29% in 1987 to about 70% in 1999. Along the years, an additional 
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contributing factor may be that the increased use of computer-generated annual reminders 
and automatic scheduling have increased the number of women who undergo routine 
screening (Kaczorowski et al. 2009).  
 
The impact and success of the local multimedia national campaigns and reported levels of 
cancer awareness and mammography uptake amongst the Maltese population are yet to be 
evaluated. Nonetheless, the findings of this thesis have informed the development of the 
Maltese campaign in a number of ways, not only by aiming to target fear but also through 
the potential of developing interventions aimed at increasing mammography uptake based 
on theory and evidence-based findings. Following the 2017 and 2018 local campaigns, there 
are plans to incorporate further findings of this study in subsequent campaigns. Broader 
engagement regarding what is most important to citizens could further support the 
development of a tailored intervention to increase BS uptake in Malta. 
 
9.7 Strengths and limitations of the current research  
There are strengths and limitations that need to be considered in the interpretation of results. 
This section outlines some of the common strengths and limitations, which are applicable 
across several of the studies in this thesis. The strengths and limitations of each study have 
been outlined in the relevant chapters. 
 
9.7.1  Strengths  
There are advantages of having conducted quantitative and qualitative studies. First, 
conducting quantitative and qualitative research before designing an intervention for a topic 
that has been under-researched is vital, as it allows for the idenfication of key factors to be 
targeted and change mechanisms and the subsequent tailoring of the intervention. It also 
enables the input of participants to be captured and incorporated into the intervention design 
(Craig et al. 2008). Exploring women’s views is in line with recommendations on how to 
drive health promotion in the health setting (Springer et al. 2017). IM provided helpful 
guidance in exploring the factors that influence BS behaviour. 
 
The quantitative part of this research produced a rich dataset, which allowed the analyses of 
diverse subgroups. This facilitated data in relation to a first and second MBSP invitation, 
lifetime screening practices and timely screening adherence. No research could be found that 
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had similarly and simultaneously assessed sociodemographic and psychological variables as 
predictors of BS behaviours. 
 
A qualitative enquiry also allowed the researcher to explore health beliefs, illness 
perceptions and knowledge levels of women in further depth. Other studies have used 
questionnaires to assess health beliefs (Anagnostopoulos et al. 2012; Huaman et al. 2011; 
Champion et al. 2008), illness perceptions (Petrak et al. 2015; Anagnostopoulos et al. 2012) 
and knowledge of BS behaviour (Dundar et al. 2006). These questionnaires limit 
understanding of how well people understand the disease as they provide a list of potential 
variables for participants to choose, thereby prompting women to select the associated risk 
factors. These limitations were overcome through qualitative research, allowing for any 
misconceptions and misinterpretations to be identified, which strengthens the case for 
improving knowledge among the Maltese community.  
 
9.7.1.1 The role of a Maltese researcher 
I played a vital role in aiming to reduce any potential bias such as ‘response bias’ and 
‘measurement error’ in this research, by using my research and interviewing experience 
throughout the data collection process. Racial differences between the researcher and 
participants may have a substantial impact on the ‘genuineness’ and ‘accuracy’ of how 
participants respond to research questions (Rhodes 1994). Sharing the same ethnicity and 
gender between the researcher and participants may have allowed participants to feel more 
comfortable to discuss their beliefs and experiences with BS and prevention. 
Notwithstanding that I, ‘the researcher’, and participants had no racial or ethnic differences 
in the entire research, data collected might be affected by social-desirability response bias as 
participants may still be more likely to respond in a more positive way to reach the 
expectations of ‘the researcher’ (Anagnostopoulos et al. 2012; Gunaratnam 2003).  
 
BC is a sensitive and private topic for the Maltese community, and women feel embarrassed 
when talking about their breasts and exposing them infront of others (Marmarà et al. 2015). 
The literature review (Chapter 2) indicated that BS compliance may be influenced by culture 
and health beliefs. This research was conducted by a Maltese, bilingual female researcher 
with fluency in both Maltese and English languages. Maltese participants in this research 
stated that they had no difficulties in understanding and speaking Maltese as it is Malta’s 
national language. However, English is also our official language, though not all Maltese 
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individuals can converse in English. Hence, using a Maltese researcher can eliminate the 
language barrier. Participants may also express some beliefs, perceptions and characteristics 
of the Maltese culture, which are difficult to express in English. Therefore, sharing the same 
cultural background and language between ‘the researcher’ and participants can definitely 
facilitate quantitative and qualitative research and aid ‘the researcher’ to obtain rich and in-
depth information from participants. 
 
9.7.2 Limitations 
9.7.2.1 Self-reported data 
The use of self-reported data throughout this thesis is a significant limitation and subject to 
bias. There are no national data records from private practices currently available to date in 
Malta. Therefore, it was not possible to capture data of repeat mammograms at another 
facility as this is not recorded on the screening database. Hence, self-reports for private 
mammography was used to measure lifetime mammography and adherence to timely 
mammography rather than having objective measures from private clinics. Self-reported data 
could also have affected the observed difference between women attending private screening 
and the MBSP. Since data collection was dependent on women’s memory about recalling 
past mammography events, this may have caused recall bias effects (Hassan 2005). However 
such a recall bias is more likely to be minimal as women tend to recall health events 
(Rheingold et al. 2004) that threaten their stability in life. 
 
9.7.2.2 Cross-sectional data  
With the exception of Chapter 4, Study 3 (which included a prospective design) and Chapter 
8, Study 7 (which was qualitative in nature), all survey data in this thesis (Chapter 4, Studies 
2-5) were cross-sectional. Therefore, although associations between variables were 
examined, a temporal relationship between exposure and outcome cannot be established and 
hence, it is not possible to infer causation. For example, in Study 5, those not meeting the 
screening interval guidelines were more likely to want advice on some topics. The researcher 
inferred from this that individuals with less healthy behaviours were aware that they needed 
to be screened for BC, and therefore wanted advice to help them make this change in 
screening behaviour. However, it is equally possible that those who were meeting screening 
recommendations were knowledgeable about screening and had already sought out 
information which had helped them to attend, and were therefore less interested in receiving 
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further screening advice. Evidence has shown that some psychosocial factors, including 
illness perceptions maintain relative stability over time (Rutter and Rutter 2007). However, 
further prospective longitudinal research is warranted to confirm these findings and to 
validate the direction of causal associations with a strict amount of control to explore how 
certain variables (such as perceived control over BC) at time 1 change at time 2 and how the 
latter relates to mammography utilisation (Petrak 2013). Furthermore, the strength of the 
statistical association between variables and the theoretical plausibility of the presumed 
causal relationships should be assessed (Taris and Kompier 2003). 
 
9.7.2.3 Qualitative data  
Although the findings of face-to-face interviews (Chapter 8, Study 7) have limitations in 
generalization, the aim of qualitative research is to explore the interaction between variables 
within a certain context rather than to generalize the findings to the whole population 
(Yardley 2008). Thereby, the results of these studies fulfilled the purpose of the 
methodology. It is recognised that women in different organisations and with different 
societal values may express different views (Parker et al. 2015). However, since the MBSP 
shares much in terms of rationale, purpose and implementation with its counterparts in the 
UK and many European countries, it is likely that the findings of this current research will 
be at least partially transferable to these contexts.  
 
Finally, it is possible that experts who participated in the steering groups were somehow 
different from those who did not; the researcher, however, sought to minimise such potential 
bias by ensuring that experts from a range of backgrounds and professed opinions about 
screening were involved.  
 
9.8 Future research  
While the studies in this thesis have provided interesting results on BS determinants and 
potential interventions, there are still a number of gaps in the literature warranting further 
investigation. First, the researcher plans to complete steps 4, 5 and 6 of IM in further work. 
The future intervention to improve BS among non-attendees could be revised according to 
feedback received from the intended participants and health service providers to ensure that 
the designed intervention materials are culturally relevant and the intervention could be 
adequately implemented. The final intervention could be assessed in practice to explore 
293 
 
whether the intervention could decrease non-attendance and hence determine actual 
behaviour change as the primary outcome, followed by changes in cancer-related 
knowledge, health beliefs, illness perceptions and intention to go for BS. A RCT would be 
required to establish the evidence for intervention efficacy (Akobeng 2005). A further 
intervention could be developed to target non-adherent women, together with their health 
beliefs, predominantly perceived barriers and cues to action, to increase routine and timely 
mammography practices. Further research is warranted to prove the effectiveness of any one 
particular intervention or multiple strategies based on theory to improve BS uptake that could 
be adopted for the Maltese population.  
 
The findings of this study can be used by health professionals as a guide to develop culturally 
and linguistically appropriate educational materials to promote breast health and screening 
among Maltese women. In addition, the results can help to evaluate whether the existing 
educational materials are suitable. Additionally, it would be worth exploring the causal 
relationships between psychosocial factors related to BS generated by this research and 
mammography uptake.  
 
Study 1 provided preliminary evidence of the psychometric properties assessment of the 
scales. As these were preliminary findings, further psychometric testing of the scales is 
recommended to obtain further evidence of the instrument’s reliability and validity among 
women with varied backgrounds and diverse perspectives. Study 3 in this thesis was 
conducted among a small sample, so it is not possible to generalise the findings. More 
research is required among a larger representative sample to investigate whether uptake to a 
first screening invitation is a significant predictor of subsequent screening in Malta. It would 
also be interesting to measure health beliefs and illness perceptions before and after 
screening. Further qualitative research is required to understand in more depth why women 
choose opportunistic screening over an organised programme.  
 
Since the findings suggest scope for community family physicians to be more proactive, a 
focus group study among local GPs could be conducted to explore the association between 
their attitudes towards BS and women’s participation in screening programmes. The barriers 
reported by Maltese participants together with the perspectives from healthcare providers 
would provide richer data on the development of training programmes targeted for 
healthcare providers to provide effective healthcare services among the Maltese community. 
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Future in-depth research could also target the health beliefs, illness perceptions and assess 
the risk factors for BC among young women and those at high-risk as these groups of women 
may hold different understandings and beliefs of health and prevention from older women 
or low-risk women. This was evidenced in the PPI event among the younger female 
generation.  
 
This research found two levels of influence: individual (intrapersonal) factors such as 
knowledge, attitudes and behaviour, and social (interpersonal) factors such as social 
networks and support systems. Other multiple influences exist such as organizational 
(institutional) factors for social institutions with organizational characteristics and 
regulations for operation; community factors for relationships among organizations, 
institutions and networks; and policy factors for local, state and national laws and policies 
(Sallis et al. 2008; McLeroy et al. 1988). Further qualitative exploration of organizational, 
community and policy barriers will serve to design multi-level frameworks with 
incorporated theoretical elements, together with concepts that have been shown consistently 
to increase BS uptake. 
 
9.9 Conclusion  
This was the first research to explore women’s health beliefs and illness perceptions as well 
as barriers and facilitators to BS uptake in Malta. This research utilised a mixed methods 
approach and involved a wide selection of participants, and international and local key 
players in healthcare services, and could therefore provide a comprehensive picture of the 
BS topic. Besides aiding intervention developers to provide culturally and linguistically 
appropriate health interventions in Malta, the findings of this thesis will enable healthcare 
providers and policy makers to be cognizant of the real issues that act as barriers among the 
Maltese community to improve mammography screening uptake. This research 
encompassed various studies but integrated the work and findings through an overarching 
framework, Intervention Mapping, to inform a future theory-based BS intervention.  
 
The innovative part in Study 1 is the combination, adaptation and translation of two scales 
for the Maltese scenario. The preliminary evidence of the psychometric properties 
assessment of the MBSQ showed promise of being a valid and reliable instrument to be used 
among Maltese women. The findings of Study 2 indicate that it was the combination of both 
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HBM and CSM contructs that provided improved prediction of non-attendance, when 
compared to HBM alone, which is an innovative finding in BS research. No studies prior to 
Study 3 existed on women’s reattendance at the MBSP or on screening predictors to the 
second MBSP round. Study 3 found that interventions should particularly target non-
attendance to first screening invitations. Study 4 found that fear is a key factor in relation to 
lifetime non-attendance and that cues to action aid lifetime attendance. Study 5 found that 
women who attend private screening were less likely to be regulated in their attendance when 
compared to MBSP attendees. Furthermore, women’s knowledge level, and their beliefs and 
perceptions were found to be significantly associated with timely mammography adherence.  
Studies 2-5 showed that HBM constructs, primarily perceived barriers, were the strongest 
predictors of non-attendance to a first and second invitation to the MBSP and to lifetime 
attendance and timely adherence, followed by cues to action. The systematic review (Study 
6) is the first of its kind to explore interventions that used HBM and/or CSM theory to 
increase mammography uptake. Study 6 found no interventions that used CSM in the design 
of BS interventions, which is also an innovative finding. Perceived barriers were most 
frequently targeted when designing interventions, a finding that reiterates the quantitative 
findings in this research. Reviewed interventions based on the HBM carried out in a 
community setting involving culturally-targeted material, telephone counselling and BC 
education were more likely to be successful to improve mammography uptake.  
 
The steering groups provided a more holistic approach towards understanding BS uptake 
from the expert perspectives. Both groups concluded that perceived barriers are the most 
important construct to target in future interventions. Experts supported multiple 
interventions, including physician recommendations, education and counselling. The PPI 
event was the first to report on World Cafés in BS research and included both Maltese 
women and men for their contribution to this topic. Members of the public identified the 
involvement of partners and daughters in health decision-making. Moreover, for the first 
time, Study 7 provided valuable, in-depth qualitative insights into Maltese women’s beliefs, 
perceptions, knowledge and attitudes for the lack of mammography use. Qualitative findings 
found that health-related knowledge was low, fear was the key barrier to non-attendance, 
and that socio-cultural factors, particularly support networks, household dynamics, traumatic 
histories and mental health approaches, impeded attendance. Women’s lifetime traumatic 
experiences is novel in the BS field.  
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In conclusion, this research recommends to target women who have never participated in BS 
primarily and those who are invited for the first time by the MBSP. The findings from this 
research show that, due to the interplay of several individual, social and cultural influences 
on women’s health beliefs, illness perceptions and knowledge levels, a multi-factorial, 
systematic approach is required including multiple, theoretical interventions to increase BS 
uptake in Malta. Interventions should include BC and BS education, telephone counselling 
and physician recommendations, and incorporate support networks and household dynamics 
to improve the psychosocial well-being of women on levels of personal resilience and self-
confidence. A potential intervention should target health beliefs, particularly overcoming 
perceived barriers to a first BS invitation while providing cues to action to motivate and 
encourage women to attend. The inclusion of illness perceptions shall improve the accuracy 
with which non-attendance rates are predicted. Fear was the strongest predictor to non-
attendance across all the studies. Hence, since emotional factors strongly influence Maltese 
women’s screening behaviours, fear should be addressed in future intervention development, 
together with women’s social network experiences, prior traumatic experiences, poor post-
traumatic social support and approaches to mental health. The intervention would be more 
effective within a community setting, such as in local community pharmacies, and the 
application of theory including elements of both HBM and CSM, is advocated as an integral 
and innovative step in intervention design, implementation and evaluation.  
 
This thesis has presented, for the first time, a combination of novel sources of information 
to understand the barriers and facilitators to BS uptake. It is hoped that the above findings 
shall be useful to policy makers and intervention developers to design screening 
interventions both at a local and international level. 
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Appendix 4.1.4 – Permission to use Champion’s scale 
 
 
April 11, 2013 
 
Danika Attard, BSc, MSc, MLJ 
ALCM, ATCL, LLCM, Dip. ABRSM, LRSM 
Senior Radiographer 
National Breast Screening Programme 
Postgraduate Researcher 
Scotland 
 
Dear Ms. Attard, 
 
Thank you for your interest in my work.  You have permission to modify and use the Champion 
Health Belief Model instrument as long as you cite my work and send me an abstract of your 
completed project. You also have permission to translate the scale into Maltese language.  
Sincerely, 
Victoria Champion, Ph.D., R.N., F.A.A.N. 
Distinguished Professor 
Edward W. and Sarah Stam Cullipher Endowed Chair 
Associate Director Cancer Prevention and Control/Population Sciences 
Indiana University Simon Cancer Center 
VC:dd 
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Appendix 4.1.5 – Permission to use the IPQ-R scale 
 
 
Hi Danika 
That’s fine.  I advise you to do some pilot work on the IPQ-R with your population so that 
you can make some appropriate amendments.  You may want to consider including some 
form of identity questionnaire as experiencing symptoms is often what encourages people to 
attend screening even though there are none. 
Best wishes 
Rona 
  
Rona Moss-Morris 
Professor of Psychology as Applied to Medicine 
Health Psychology Section, Psychology Dept., 
Institute of Psychiatry, KCL, 
5th floor Bermondsey Wing 
Guy's Hospital Campus 
London Bridge 
London SE1 9RT 
 
Phone:   0207 188 0180 
Fax:     0207 188 0184 
Email:   rona.moss-morris@kcl.ac.uk 
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Appendix 4.1.6a - Covering Letter (English version) 
Title: Health Beliefs, Illness Perceptions and Determinants to Breast Screening Uptake 
in Malta: A Cross-Sectional Survey 
 
Dear Participant, 
I am a postgraduate researcher, currently conducting a local study that aims to identify the 
key barriers and facilitators to Breast Cancer Screening uptake in Malta and to address the 
barriers through the development of a theory and evidence-based intervention. You are 
invited to take part in this study, where structured telephone interviews will evaluate your 
health beliefs, illness perceptions and determinants associated with breast screening uptake. 
In addition, we will be looking at certain background factors to assess their impact on the 
knowledge and attitudes about breast cancer screening behaviours. By helping us to gather 
this information, we may be able to improve beliefs, attitudes and screening behaviours for 
breast cancer. 
 
Consequently, this telephone survey shall be conducted with a random sample of Maltese 
and Gozitan women who were invited to the Breast Screening programme and attended or 
did not attend the service. Questions regarding factors related to breast screening and breast 
cancer shall be explored with you and these questions should only take approximately 20 
minutes of your time.  
 
Confidentiality, Anonymity and Voluntary Participation 
All the information collected will be treated in strict confidence by preserving your 
confidentiality and anonymity at all times. At no time will your identity be revealed. Your 
participation is entirely voluntary and you are therefore under no obligation to participate. 
You may withdraw from the study at any time, without the need to give any reason. If you 
refuse to take part, care, medical treatment and your right for further examinations will not 
be affected. It is important to understand that you will not be paid for participating in this 
study. 
 
Benefits and Risks 
As a participant in this study, you may gain insight into your decision making process. The 
risks involved are minimal. Since a few items deal with breast cancer and breast screening 
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behaviours, you may experience some anxiety while answering these questions. It is not the 
intent of the researcher to offend or embarrass you. If, for any reason, you experience distress 
during the questions being asked, please feel free to notify the researcher. If, for any reason, 
you experience distress during the questions being asked, please feel free to notify the 
researcher so that the researcher can direct you to a lead radiographer [Ms. _________] 
and/or a practice nurse [Ms. _________] at [17, Lascaris Wharf, Valletta] who are trained 
and have experience to deal with regular arising women's issues at the screening programmes 
and you may discuss further any issue or distress on a one-to-one basis with these 
professionals.  
Results of the Study 
The results of this study will be shared with the members of the principal investigator’s 
expert working group members. The study findings shall be of great value to the Screening 
Management and shall assist policy makers and the Ministry of Health to plan and implement 
the appropriate interventions required to increase uptake as well as develop strategies for 
future age extensions and subsequent screening cycles. This study is in line with the strategy 
for cancer care for the Maltese Islands (National Cancer Plan 2011-2015) by assessing local 
population needs. Moreover, the data gathered shall assist health authorities when 
formulating national policies in order to reduce social inequalities for health service delivery.  
 
Questions, Queries or Complaints 
I, the researcher of this study, will be very happy to answer any of your questions or queries 
about the study or your rights as a participant in the study.  If you do have further questions 
or any queries that might arise during the study, do not hesitate to may contact me on [+356 
79005111] or email me on [danika.marmara@gov.mt]. 
 
If you have any concern and/or grounds for complaints, please do not hesitate to contact the 
screening coordinators at the National Breast Screening Programme in writing to the 
following address [17, Lascaris Wharf, Valletta VLT 1921] or by email on 
[mbsp.mhec@gov.mt] or by phone if you so wish on [21227470 or 21227471]. Such 
complaints will be followed up specifically by the Head/Delegate of the Screening 
Programme and/or the Chief Executive Officer of the Primary Health Care Department. 
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Informed Consent 
If you agree to participate in the study, I will take that as evidence of your informed consent 
to participate in this study. If you also agree to be contacted further for more in-depth 
discussions, you are providing your consent to participate in further research. Your data 
could also be used for further analysis of subsequent screening cycles. I look forward to your 
feedback. I thank you in advance for your co-operation. 
 
 
Danika Marmarà 
Director (Cancer Care Pathways) 
Postgraduate Researcher, University of Stirling 
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Appendix 4.1.6b - Covering Letter (Maltese version) 
 
Ittra ta' Akkumpanjament 
Titolu: Konvinzjonijiet dwar is-Saħħa, Perċezzjonijiet ta' Mard u Determinanti għat-
Teħid ta' Skrining tas-Sider f'Malta: Stħarrig Trażversali 
 
Għażiża Parteċipanta, 
Jiena riċerkatriċi postgradwatorja, bħalissa qed nagħmel studju lokali bil-għan li nidentifika 
l-ostakli u l-faċilitaturi ewlenin għall-Iskrining kontra l-Kanċer fis-Sider f'Malta u nindirizza 
l-ostakli permezz ta' żvilupp ta' intervent ibbażat fuq it-teorija u fuq l-evidenza. Int mistiedna 
tipparteċipa f'dan l-istudju, fejn se ssir evalwazzjoni permezz ta' intervisti strutturati bit-
telefown tal-konvinzjonijiet dwar is-saħħa, perċezzjonijiet ta' mard u determinanti marbutin 
mal-iskrining tas-sider. Barra minn hekk, se nkunu qed inħarsu lejn ċerti fatturi fl-isfond 
biex nivvalutaw l-impatt tagħhom fuq l-għarfien u l-attitudnijiet dwar l-approċċ lejn l-
iskrining kontra l-kanċer fis-sider. Billi tgħinna niġbru din l-informazzjoni, aħna nkunu 
nistgħu ntejbu l-konvinzjonijiet, l-attitudnijiet u l-approċċ lejn l-iskrining kontra l-kanċer 
fis-sider. 
Konsegwentement, dan l-istħarriġ bit-telefown għandu jsir permezz ta' kampjun aleatorju ta' 
nisa Maltin u Għawdxin li ġew mistiedna għall-programm tal-Iskrining tas-Sider u li jkunu 
rrikorrew għas-servizz jew le. Il-mistoqsijiet li se jsirulek huma dwar il-fatturi marbuta mal-
iskrining tas-sider u l-kanċer fis-sider u dawn il-mistoqsijiet għandhom jieħdu madwar 20 
minuta mill-ħin tiegħek. 
 
Kunfidenzjalità, Anonimità u Parteċipazzjoni Volontarja 
L-informazzjoni kollha miġbura se tiġi trattata strettament kunfidenzjali billi nħarsu l-
kunfidenzjalità u l-anonimità tiegħek il-ħin kollu. Fl-ebda ħin m'aħna se niżvelaw l-identità 
tiegħek. Il-parteċipazzjoni tiegħek hija għalkollox volontarja u għalhekk m'għandek l-ebda 
obbligu li tipparteċipa. Tista' tirtira fi kwalunwe ħin minn dan l-istudju, mingħajr il-ħtieġa li 
tagħti raġunijiet. Jekk tirrifjuta milli tipparteċipa, dan mhux se jaffettwa l-kura, it-trattament 
mediku jew id-dritt tiegħek li jsirulek xi testijiet oħra. Hu importanti li tifhem li mintix se 
titħallas talli tipparteċipa f'dan l-istudju. 
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Benefiċċji u Riskji 
Bħala parteċipanta f'dan l-istudju, tista' tikseb xi forma ta' għarfien fil-proċess tat-teħid tad-
deċiżjonijiet tiegħek. Ir-riskji involuti huma minimi. Minħabba li ċerti entrati jittrattaw il-
kanċer fis-sider u l-approċċ lejn l-iskrining tas-sider, jista' jkun li tħossok nervuża int u 
twieġeb dawn il-mistoqsijiet. Mhuwiex il-ħsieb tar-riċerkatriċi li tpoġġik f'sitwazzjoni 
antipatka jew li timbarazzak. Jekk, għal kwalunkwe raġuni, tħossok skomda meta tkun qed 
tiġi mistoqsija, tiddejjaqx tgħid lir-riċerkatriċi. Barra minn hekk, inti ser tkun diretta wkoll 
lejn professjonisti speċjalizzati bhal radjografa [Ms. _________] u infermiera [Ms 
_________] fi [17, Lascaris Wharf, Valletta] li huma mħarrġa u ghandhom esperjenza biex 
jittrattaw kwistjonijiet tan-nisa li jattendu fil-programmi tal-Iskrining u inti tista' tiddiskuti 
aktar magħhom kwalunkwe kwistjoni fuq bażi individwali ma' dawn il-professjonisti. 
Riżultati tal-istudju 
Ir-riżultati ta' dan l-istudju se jitqassmu lill-membri tal-grupp ta' ħidma ta' esperti tal-
investigatur prinċipali. Is-sejbiet tal-istudju għandhom ikunu ta' valur kbir għall-
Amministrazzjoni tal-Iskrining u għandhom jgħinu lill-fassala tal-politika u lill-Ministeru 
tas-Saħħa biex jippjanaw u jimplimentaw interventi xierqa meħtieġa biex jiżdied l-għadd ta' 
nies li jirrikorru għas-servizz kif ukoll biex jiżviluppaw strateġiji għal estensjonijiet tal-età 
fil-ġejjieni u ċikli ta' skrining sussegwenti. Dan l-istudju hu konformi mal-istrateġija għall-
kura tal-kanċer għall-Gżejjer Maltin (Pjan Nazzjonali tal-Kanċer 2011-2015) billi jivvaluta 
l-ħtiġijiet tal-popolazzjoni lokali. Barra minn hekk, id-data miġbura għandha tgħin lill-
awtoritajiet tas-saħħa huma u jifformulaw il-politiki nazzjonali sabiex inaqqsu d-differenzi 
soċjali fl-għoti ta' servizzi tas-saħħa.  
 
Mistoqsijiet, Dubji jew Ilmenti 
Jiena, ir-riċerkatriċi ta' dan l-istudju, lesta nwieġeb kwalunkwe mistoqsija jew niċċara 
kwalunkwe dubju li jista' jkollok dwar l-istudju jew id-drittijiet tiegħek bħala parteċipanta 
f'dan l-istudju. Jekk ikollok xi mistoqsija jew dubju li jistgħu jqumu matul l-istudju, 
toqgħodx lura milli tikkuntattjani fuq [+356 79005111] jew ibgħatli email fuq 
[danika.marmara@gov.mt]. 
 
Jekk għandek xi tħassib u/jew lok għal ilment, jekk jogħġbok ikkuntattja lill-koordinaturi 
tal-iskrining tal-Programm Nazzjonali tal-Iskrining tas-Sider billi tikteb f'dan l-indirizz [17, 
Lascaris Wharf, Valletta VLT 1921] jew tibgħat email [mbsp.mhec@gov.mt] jew jekk trid 
384 
 
tista' ċċempel fuq [21227470 jew 21227471]. Tali lmenti jiġu segwiti speċifikament mill-
Kap/Deputat Kap tal-Programm tal-Iskrining u/jew mill-Kap Eżekuttiv tad-Dipartiment tal-
Kura tas-Saħħa Primarja. 
 
Kunsens Infurmat 
Jekk taqbel li tipparteċipa fl-istudju, nieħu dak bħala evidenza tal-kunsens infurmat tiegħek 
biex tipparteċipa f'dan l-istudju. Jekk inti taqbel ukoll li tiġi kkuntatjata għal aktar 
diskussjonijiet fil-fond, inti qegħda tagħti l-kunsens tiegħek biex tipparteċipa f’aktar riċerka. 
Id-data tiegħek tista’ ukoll tiġi użata għal aktar analiżi ta’ ċikli oħra sussegwenti għall-
Iskrining tas-Sider. Nistenna b'interess ir-rispons tiegħek. Nirringrazzjak bil-quddiem tal-
kooperazzjoni. 
 
Danika Marmarà 
Direttriċi (Cancer Care Pathways) 
Riċerkatriċi postgradwatorja, l-Università ta' Stirling 
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Appendix 4.1.7a - Consent Form (English version) 
Client Identification Number for this study:  _____________ 
 
In participating in this study, I am giving my consent to participate in the research study 
entitled ‘Health Beliefs, Illness Perceptions and Determinants to Breast Screening Uptake 
in Malta: A Cross-Sectional Survey’. The researcher has explained to me the purpose and 
detail of the study and any difficulties which I raised about the study have been adequately 
answered.   
 
I understand that the results obtained for this study in which I am participating may be 
reported or published or used for medical or scientific purposes. However, I shall not be 
personally identified in any way without my express written permission as I have been 
assured that my answers will be treated with the utmost confidentiality and that my identity 
will not be made public. 
 
I have been informed that participation is entirely voluntary and I am therefore under no 
obligation to participate in this study. I may withdraw from the study at any time, without 
the need to give any reason. If I refuse to take part in this study, any medical treatment, care 
and my right for further examinations will not be affected. I am not receiving any 
remuneration for participating in this study. I have also been informed that my data could be 
used for further analysis of subsequent screening cycles. 
I hereby give consent to participate in this research study          
I hereby withhold consent to participate in this research study    
 
I have been well-informed that the researcher [Danika Marmara'] is the contact person to 
answer any queries that I may have regarding the study or regarding my rights as a participant 
in this study. If, for any reason, I experience distress during the questions being asked, I shall 
notify the researcher so that the researcher can direct me to a lead radiographer [Ms. 
_________] and/or a practice nurse [Ms. _________] at [17, Lascaris Wharf, Valletta] who 
are trained and have experience to deal with regular arising women's issues at the screening 
programmes and I may discuss further any issue or distress on a one-to-one basis with these 
professionals.  
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If I have any concern and/or grounds for complaints, I can contact the screening coordinators 
at the National Breast Screening Programme in writing to the following address [17, Lascaris 
Wharf, Valletta VLT 1921] or by email on [mbsp.mhec@gov.mt] or by phone if I so wish 
on [21227470 or 21227471]. Such complaints will be followed up specifically by the 
Head/Delegate of the Screening Programme and/or the Chief Executive Officer of the 
Primary Health Care Department. 
 
I would also like to be contacted again for more in-depth interviews on barriers and effective 
interventions to help increase breast screening uptake in Malta.  
      Yes              No  
I agree to my data being used for further analysis of subsequent screening cycles. 
        Yes                      No  
 
The Participant: _____________________ Date:  ________________ 
 
The Researcher:  ______________________ Date:   ________________ 
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Appendix 4.1.7b - Consent Form (Maltese version) 
Formola tal-Kunsens 
 
Nurmu ta' Identifikazzjoni tal-Klijent għal dan l-istudju:  _____________ 
 
Billi nipparteċipa f'dan l-istudju, jien nagħti l-kunsens tiegħi biex nipparteċipa fl-istudju ta' 
riċerka intitolat ‘Health Beliefs, Illness Perceptions and Determinants to Breast Screening 
Uptake in Malta: A Cross-Sectional Survey’ (Konvinzjonijiet dwar is-Saħħa, 
Perċezzjonijiet ta' Mard u Determinanti għat-Teħid ta' Skrining tas-Sider f'Malta: 
Stħarrig Trażversali). Ir-riċerkatriċi spjegatli l-għan u d-dettal tal-istudju u wieġbet b'mod 
xieraq kwalunkwe diffikultà li kelli dwar l-istudju.   
 
Nifhem li jista' jsir rapport tar-riżultati miksuba minn dan l-istudju li pparteċipajt fih jew li 
jiġu ppubblikati jew użati għal finijiet mediċi jew xjentifiċi. Madankollu, ma nista' bl-ebda 
mod niġi identifikata personalment mingħajr il-permess tiegħi espress bil-miktub peress li 
ġejt żgurata li t-tweġibiet tiegħi se jiġu trattati strettament kunfidenzjali u li l-identità tiegħi 
mhijiex se tiġi pubblikata. 
 
Ġejt infurmata li l-parteċipazzjoni tiegħi hija għalkollox volontarja u għalhekk m'għandi l-
ebda obbligu li nipparteċipa f'dan l-istudju. Nista' nirtira fi kwalunkwe ħin mingħajr il-ħtieġa 
li nagħti raġunijiet. Jekk nirrifjuta milli nipparteċipa, dan mhux se jaffettwa l-kura, it-
trattament mediku jew id-dritt tiegħi li jsiruli xi testijiet oħra. Minix se nirċievi xi 
remunerazzjoni talli nipparteċipa f'dan l-istudju. Ġejt infurmata ukoll li d-data tiegħi tista’ 
tiġi użata għal aktar analiżi ta’ ċikli oħra sussegwenti għall-Iskrining tas-Sider. 
 
B'dan nagħti l-kunsens tiegħi li nipparteċipa f'dan l-istudju ta' riċerka       
B'dan nirtira l-kunsens tiegħi milli nipparteċipa f'dan l-istudju ta' riċerka   
 
Ġejt infurmata sew li r-riċerkatriċi [Danika Marmara'] hija l-persuna ta' kuntatt biex twieġeb 
kwalunkwe dubju li jista' jkolli rigward l-istudju jew id-drittijiet tiegħi bħala parteċipanta 
f'dan l-istudju. Barra minn hekk, nista nkun diretta wkoll lejn professjonisti speċjalizzati bhal 
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radjografa [Ms. _________] u infermiera [Ms. _________] fi [17, Lascaris Wharf, Valletta] 
li huma mħarrġa u ghandhom esperjenza biex jittrattaw kwistjonijiet tan-nisa li jattendu fil-
programmi tal-Iskrining u jiena nista' niddiskuti aktar magħhom kwalunkwe kwistjoni fuq 
bażi individwali ma' dawn il-professjonisti. 
 
Jekk ikolli xi tħassib u/jew lok għal ilment, nista' nikkuntattja lill-koordinaturi tal-iskrining 
tal-Programm Nazzjonali tal-Iskrining tas-Sider billi nikteb f'dan l-indirizz [17, Lascaris 
Wharf, Valletta VLT 1921] jew nibgħat email [mbsp.mhec@gov.mt]  jew nista' nċempel fuq 
[21227470 jew 21227471]. Tali lmenti jiġu segwiti speċifikament mill-Kap/Deputat Kap tal-
Programm tal-Iskrining u/jew mill-Kap Eżekuttiv tad-Dipartiment tal-Kura tas-Saħħa 
Primarja. 
 
Nixtieq ukoll li nerġa niġi kkuntatjata għal aktar intervisti fil-fond fuq ostakli u interventi 
effettivi li jistgħu jgħinu biex iżidu l-attendenza għall-iskrining tas-sider f’Malta.   
   Iva              Le  
Naqbel li d-data tiegħi tista tiġi użata għal aktar analiżi ta’ ċikli oħra sussegwenti għall-
Iskrining tas-Sider.      Iva              Le  
 
Il-Parteċipanta: _____________________ Data:  ________________ 
 
Ir-Riċerkatriċi:  ______________________ Data:   ________________ 
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Appendix 4.2.1 - Version of Study 2 published in the BMC Public Health 
Journal 
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Appendix 4.2.2 - STROBE 2007 (v4) Statement—Checklist of items that should be included in reports of cross-
sectional studies 
Section/Topic Item 
# Recommendation 
Reported on page # (of 
published Study 2)  
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 1 
(b) Provide in the abstract an informative and balanced summary of what was done and what was found 1-2 
Introduction  
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 3-5 
Objectives 3 State specific objectives, including any prespecified hypotheses 5-6 
Methods  
Study design 4 Present key elements of study design early in the paper 6 
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and 
data collection 
6-9 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of participants 6-8 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give 
diagnostic criteria, if applicable 
12 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of assessment (measurement). 
Describe comparability of assessment methods if there is more than one group 
12 
Bias 9 Describe any efforts to address potential sources of bias 13 
Study size 10 Explain how the study size was arrived at 7-8 
Quantitative 
variables 
11 Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were 
chosen and why 
12 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 12 
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(b) Describe any methods used to examine subgroups and interactions 12 
(c) Explain how missing data were addressed 12 
(d) If applicable, describe analytical methods taking account of sampling strategy  
(e) Describe any sensitivity analyses  
Results  
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for 
eligibility, confirmed eligible, included in the study, completing follow-up, and analysed 
7-8, Refer to Fig. 1 
(b) Give reasons for non-participation at each stage 7-8, Refer to Fig. 1 
(c) Consider use of a flow diagram Fig. 1 
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures 
and potential confounders 
13-15 
(b) Indicate number of participants with missing data for each variable of interest 15 
Outcome data 15* Report numbers of outcome events or summary measures 18-21 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% 
confidence interval). Make clear which confounders were adjusted for and why they were included 
 
(b) Report category boundaries when continuous variables were categorized  
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period  
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses 15-24 
Discussion  
Key results 18 Summarise key results with reference to study objectives 24-31 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both 
direction and magnitude of any potential bias 
31-32 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, 
results from similar studies, and other relevant evidence 
32-33 
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Generalisability 21 Discuss the generalisability (external validity) of the study results 31 
Other information  
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the original 
study on which the present article is based 
33 
 
*Give information separately for exposed and unexposed groups. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The 
STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal 
Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org. 
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Appendix 4.2.3a - Telephone Interview: Verbal Consent (English version)  
 
Madam, 
My name is Danika Marmarà and I am a researcher who is conducting a research study 
regarding Breast Cancer Screening in Malta. With reference to the previous phone call you 
received from my research assistant in which you consented to participate in this study, I 
would like to ask you some questions over the phone about your health beliefs, illness 
perceptions and factors associated with breast screening uptake. Your participation is 
voluntary and should take approximately 20 minutes of your time.  
 
Do you wish to participate?   YES   NO  
   
Appendix 4.2.3b - Telephone Interview: Verbal Consent (Maltese version)  
 
Dokument ta' Informazzjoni u Kunsens għall-Intervisti bit-Telefown (verżjoni bil-
Malti)  
 
Sinjura, 
Jiena jisimni Danika Marmara', riċerkatriċi li bħalissa qed nagħmel studju lokali fuq l-
Iskrining kontra l-Kanċer fis-Sider f'Malta. B’referenza ghat-telefonata li rċevejt minghand 
l-assistenta tiegħi fuq din ir-riċerka li fiha inti aċċettajt li tipparteċipa, nixtieq nistaqsik xi 
mistoqsijiet fuq it-telefown dwar saħħtek, kif thares lejn il-mard u dak li jinfluwenzak biex 
tattendi ghall-iskrining tas-sider. Il-parteċipazzjoni tiegħek hija volontarja. L-istħarriġ 
għandu jieħu madwar 20 minuta mill-ħin tiegħek. 
 
Tixtieq tipparteċipa?   IVA   LE  
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Appendix 4.2.4a – Research tool (English version)  
Health Beliefs, Illness Perceptions and Determinants of Breast Screening Uptake in 
Malta: A Cross-Sectional Survey 
Client Unique Identifier Number: __________ 
Sociodemographic Variables 
Q1. How old are you?     ____________________ 
 
Q2. Where do you live?  ____________________ 
 
Q3. What is your level of education? 
 
(1) No schooling   
(2) Primary level   
(3) Secondary level    
(4) Tertiary level (Diploma)   
(5) Tertiary level (Degree)   
(6) Tertiary Level (Masters or above)  
 
Q4a) What is your occupation:  
________________  Unemployed    Pensioner   Housewife → continue to Q5  
 
b)Are you employed with the Goverment or private sector?   
(1) Government  
(2) Private    
 
Q5. What is your status? 
 
(1) Single      (2) Married     (3) Separated/Divorced    (4) Widowed   
 
Q6. What is your family income level? 
(1) Less than €10,737  
(2) €10,737 – €16,113   
(3) €16,114 – €23,563  
(4) €23,564 – €33,966  
(5) Greater than €33,966  
(6) Prefer not to say  
 
Q7. a) Do you own a car?  Yes    No  
 b) Do you drive?  Yes    No  
 
Q8. Do you have an illness, disability or condition of any kind? 
   Yes  No →continue toQ9 
  ↓ 
What is it? ________________________ 
 
Q9 (a) Do you have a family physician (GP) who provides medical care and advice?   
  Yes    No  
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(b) How often do you visit your GP?  
1. Only when I have a problem   
2. Once a month  
3. More than once a year  
4.   Once a year   
5.   Once every two years  
 
Q10. Have you ever had any type of breast condition or disease? 
(i) Yes  (continue to Q10a) No   (continue to Q11) 
 
a) What type of breast condition or disease? 
(i)  Fibrocystic “Lumpy Breasts”  
(ii)  Cysts  
(iii) Cancer in one breast  
(iv) Cancer in both breasts  
(v)  Other  (please specify) ____________________ 
 
Q11. Have your relatives or close friends had cancer?    
  Yes  No  Prefer not to say  
   ↓ 
If YES, which of the following? 
Family member or friend Breast Cancer Other Cancer 
First degree relative with breast 
cancer 
 
 Mum  
 Sister  
 Daughter  
Mum___________________ 
Sister___________________ 
Daughter________________ 
Other family member 
 
 Dad  
 Brother  
 Grandmother 
 Grandfather  
 Aunt  
 Uncle  
 Cousin (M)  
 Cousin (F)  
Dad  ___________________ 
Brother _________________ 
Grandmother_____________ 
Grandfather  _____________ 
Aunt   __________________ 
Uncle __________________ 
Cousin (M)______________ 
Cousin (F)_______________ 
 
Close friend   ________________________ 
 
Husband  ________________________ 
 
 
SECTION A: LIFETIME BREAST SCREENING 
PRACTICES 
1 (A) LIFETIME MAMMOGRAPHY USE 
 
(i) Have you ever done a mammogram in your lifetime?  
YES  (Go to (ii))  NO  (Go to (iii))  
 
 
IF YES: 
(ii) How many times during your lifetime have you had a mammogram?      
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1. One mammogram only (‘EVER’)    
2. Two or more mammograms (‘REPEAT’)   
 
(iii) Have you had a mammogram within the past 3 years (‘RECENT’)?  
YES        NO  
  
  (iiia) If ‘YES’, when, where and why? _________________  
1.  Breast Screening Unit    
2.  Governmental Hospital (Mater Dei)    
3.  Private Clinic    
  
(B) ATTENDANCE and NON-ATTENDANCE TO FIRST INVITATION AT THE MBSP 
(i) When you received your first invite to the Breast Screening programme, did you attend?  
 (a)Yes   (b) No  
 
 
If YES:  If NO:  
(ai) Would you have 
attended for a 
mammogram if: 
 (bi) Why not?  
1. You were not 
invited or sent for? 
Yes   
 No    
1. Lack of Knowledge or 
information about screening 
Yes   
No    
  2. Practical Issues (e.g. lack of 
free time and family 
obligations, lack of access to 
child-care, difficulty getting 
time off work, transportation 
issues, other) 
Yes   
No    
  3. Fear (of pain, radiation, 
embarrassment, of unknown 
procedure, of result) 
Yes  
 No   
  4. Other  Please specify: 
_____________
_____________
_____________ 
 
(ii) Did your family physician (GP) encourage you to attend for a mammogram?  
 Yes  No  
(C) RE-ATTENDANCE TO THE SECOND SCREENING INVITATION AT THE MBSP 
(i) If you receive a second invite, would you attend? (INTENTION) 
 Yes         No         Unsure  
 
(ii) If YES, why? (Reason) _____________________________________________ 
 
(iii) If NO why? (Reason) ______________________________________________ 
(iv) If UNSURE, why? (Reason) ________________________________________ 
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(D) KNOWLEDGE ABOUT RECOMMENDED SCREENING FREQUENCY 
(i) How often do you think a woman your age should have a mammogram? 
1. Every year   
2. Every 1.5 years  
3. Every 2-3 years  
4. Every 4-5 years  
5. Unsure  
 
SECTION B: HEALTH BELIEFS 
We are interested in your own personal views of how you see Breast Screening and Breast Cancer. 
Please indicate how much you agree or disagree with the following statements about Breast 
Screening and Breast Cancer.  
Champion’s Health Belief Model Scale for Mammography Screening 
B1.   PERCEIVED SUSCEPTIBILITY (RISK PERCEPTION) 
Scale 
ITEM 
NO. 
PERCEIVED 
SUSCEPTIBILITY  
ITEMS 
Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree  
(5) 
1. There is no possibility of 
getting breast cancer. 
     
2. Your chances of getting 
breast cancer are high. 
     
3. There may be the 
possibility of developing 
breast cancer in your 
lifetime. 
     
 
B2.   PERCEIVED BENEFITS OF MAMMOGRAPHY SCREENING 
SCALE 
ITEM 
NO. 
PERCEIVED BENEFITS 
ITEMS 
Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree  
(5) 
1. When you get a 
mammogram, you feel 
good about yourself. 
     
2. When you get a 
mammogram, you do not 
worry as much about 
breast cancer. 
     
3. Having a mammogram 
will help you find lumps 
early in your breasts. 
     
4. If you find a lump 
through a mammogram, 
the treatment for breast 
cancer may not be as bad. 
     
5. Having a mammogram 
will decrease your 
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chances of dying from 
breast cancer. 
6. Having a mammogram 
will help you find a lump 
before it can be felt by 
yourself or a health 
professional. 
     
 
B3.  PERCEIVED BARRIERS TO MAMMOGRAPHY SCREENING  
SCALE 
ITEM 
No. 
PERCEIVED BARRIERS 
ITEMS 
Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree  
(5) 
1. Having a routine 
mammogram would 
make you anxious about 
breast cancer. 
     
2. Having a routine 
mammogram would 
make you worry. 
     
3. You fear having a 
mammogram because 
you might find out that 
something is wrong. 
     
4. You fear having a 
mammogram because 
you do not know the 
procedure or what to 
expect. 
     
5. You fear having a 
mammogram because 
you know someone 
(family or friend) with 
breast cancer. 
     
6. It is embarrassing for you 
to have a mammogram. 
     
7. Undergoing 
mammography will be 
painful or uncomfortable. 
     
8. Having a mammogram is 
time consuming. 
     
9. If you attended for Breast 
Screening:  
You are discontent with 
Breast Screening 
personnel as they have 
been rude to you. 
     
10. You have fear or distrust 
in the medical team. 
     
11. Having a mammogram 
would expose you to 
unnecessary radiation. 
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12. You have too many other 
problems in your life than 
to get a mammogram 
done. 
     
13. You are not old enough 
to have a mammogram 
periodically. 
     
 
B4. CUES TO ACTION  
SCALE 
Item  
No. 
CUES TO ACTION  
ITEMS 
Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree  
(5) 
1. If your GP advises you to 
attend for a mammogram, 
you will attend. 
     
2. If your relatives or friends 
advise you to attend for a 
mammogram, you will 
attend. 
     
3. If someone close to you 
has been diagnosed with 
breast cancer, you will 
attend for a mammogram. 
     
4. Hearing about breast 
cancer and breast 
screening in the media or 
news makes you think 
about getting a 
mammogram. 
     
5. Reminder letters would 
help you to get a 
mammogram. 
     
6. Reminder phone calls or 
text messages would help 
you to get a mammogram. 
     
7. Routine educational talks 
regarding breast cancer 
awareness would help you 
to get a mammogram. 
     
B5. SELF-EFFICACY (confidence in obtaining a mammogram)  
Scale 
Item 
No. 
SELF- EFFICACY  
ITEMS 
Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree  
(5) 
1. You feel confident that if 
you had a mammogram 
done, any abnormalities in 
your breasts will be 
detected. 
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2. You can arrange other 
things in your life to get a 
mammogram.  
     
3. In case you need a 
mammogram, you will find 
a place to get it done. 
     
4. You can make an 
appointment for a 
mammogram. 
     
5. You can arrange 
transportation to get a 
mammogram. 
     
6. If you attended for Breast 
Screening:  
You can talk to people at the 
breast screening centre 
about your concerns. 
     
7. You can find a way to pay 
for a mammogram if you 
need to. 
     
 
SECTION C: ILLNESS PERCEPTIONS 
Please indicate how much you agree or disagree with the following statements specifically about 
Breast Cancer. 
The Revised Illness Perception Questionnaire (IPQ-R) 
C1.  BREAST CANCER IDENTITY (Core symptoms list) 
SCALE 
Item  
No. 
IDENTITY ITEMS Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree 
(5) 
1. The presence of a lump or 
thickening in the breast 
     
2. Nipple discharge 
 
     
3. Sudden nipple retraction 
 
     
4. Change in shape or 
appearance of the nipple 
     
5. Breast swelling, dimpling, 
redness or soreness of the 
skin 
     
6. Skin changes of the breast      
7. A sudden change in breast 
size  
     
8. Aching breasts  
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C2. CAUSES OF BREAST CANCER (personal ideas about aetiology) 
SCALE 
Item  
No. 
Psychological Attributions Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree 
(5) 
1. Stress or worry 
 
     
2. Your mental attitude (e.g. 
thinking about life 
negatively)  
 
     
3. Family problems or worries 
 
     
4. Overwork 
 
     
5.  Your emotional state (e.g. 
feeling down, lonely, 
anxious, empty) 
     
6. Your personality 
 
     
RISK FACTORS /  
LIFESTYLE FACTORS 
 
 
1. Hereditary – it runs in the 
family 
     
2. Diet or eating habits 
 
     
3. Poor medical care in the 
past 
     
4. Your own behaviour 
 
     
5. Ageing 
 
     
6. Smoking 
 
     
7.  Alcohol 
 
     
IMMUNITY 
 
 
1. 
 
A germ or virus      
2. Pollution in the 
environment 
     
3. Altered immunity 
 
     
ACCIDENT OR CHANCE 
 
 
1. 
 
Chance or bad luck      
2. Accident or injury 
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C3a. CANCER TIMELINE: ACUTE/CHRONIC (the perceived duration of Breast Cancer) 
SCALE 
Item  
No. 
TIMELINE ITEMS Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree 
(5) 
1. Breast cancer will last a 
short time. 
     
2. Breast cancer is likely to 
be permanent rather than 
temporary. 
     
 
C3b. CANCER TIMELINE: CYCLICAL  
SCALE 
Item  
No. 
TIMELINE ITEMS Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree 
(5) 
1. A patient with breast 
cancer goes through cycles 
in which her illness gets 
better and worse. 
     
 
C4. CONSEQUENCES (expected effects and outcome) 
SCALE 
Item  
No. 
CONSEQUENCES ITEMS Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree 
(5) 
1. Breast cancer has major 
consequences on a patient’s 
life. 
     
2. Breast cancer will not have 
much effect on your life. 
     
3.  Breast cancer would strongly 
affect the way others see you. 
     
4. Breast cancer has serious 
economic and financial 
consequences. 
     
5.  Breast cancer would strongly 
affect the way you see yourself 
as a person. 
     
6. Breast cancer would threaten a 
relationship with your husband 
or partner. 
     
7. If you had breast cancer, your 
whole life would change. 
     
8. If you developed breast cancer, 
the chances of living a long 
life would decrease. 
     
 
 
 
421 
 
C5.  CURABILITY/CONTROLLABILITY 
C5a. PERSONAL CONTROL (how one controls or recovers from Breast Cancer) 
SCALE 
Item  
No. 
PERSONAL CONTROL ITEMS Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree 
(5) 
1. There is a lot which you can 
do to control the symptoms if 
Breast Cancer occurs. 
 
 
    
2. The course of Breast Cancer 
will depend on your actions. 
     
3. Your actions will have an 
effect on the outcome of 
Breast Cancer. 
 
 
    
 
C5b. TREATMENT CONTROL  
SCALE 
Item  
No. 
TREATMENT CONTROL 
ITEMS 
Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree 
(5) 
1. There is no treatment that will 
help to improve Breast Cancer. 
     
2. The treatment provided will be 
effective in controlling or 
curing Breast Cancer. 
 
 
    
3. The negative effects of Breast 
Cancer can be prevented or 
avoided by the treatment 
given. 
     
C6. ILLNESS COHERENCE 
SCALE 
Item  
No. 
ILLNESS COHERENCE ITEMS Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree 
(5) 
1. You have a clear picture and 
understanding of Breast 
Cancer. 
     
2. Breast Cancer is a mystery to 
you. 
 
 
    
 
C7. EMOTIONAL REPRESENTATIONS 
SCALE 
Item  
No. 
EMOTIONAL 
REPRESENTATIONS ITEMS 
Strongly 
Disagree  
(1) 
Disagree  
 
(2) 
Undecided  
 
(3) 
Agree  
 
(4) 
Strongly 
Agree 
(5) 
1. You get anxious when you 
think about Breast Cancer. 
     
2. Breast Cancer makes you feel 
afraid. 
     
3. You get worried when you 
think about Breast Cancer. 
 
 
    
THANK YOU for taking the time to answer the survey. 
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Appendix 4.2.4b – Research tool (Maltese version) 
GĦODDA TAR-RIĊERKA 
 
Numru ta' Identifikazzjoni tal-Klijent: _________________ 
Mistoqsijiet Demografiċi 
 
M1. Kemm għandek żmien? ________________ 
 
M2. Fejn toqgħod?  _______________________  
 
M3. X'inhu l-livell ta' edukazzjoni tiegħek? 
 
(1) Ma mortx skola    
(2) Livell primarju     
(3) Livell sekondarju     
(4) Livell terzjarju (Diploma)   
(5) Livell terzjarju (Lawrja)    
(6) Livell terzjarju (Masters jew ogħla)  
 
M4a) X'taħdem: 
_____________   Ma taħdimx  Pensjonanta   Mara tad-dar  → Mur għall-M5 
 
b) Int impjegata mal-Gvern jew fis-settur privat?   
 
(1) Mal-Gvern      
(2) Fil-privat      
 
M5. X'inhu l-istat tiegħek? 
 
1)  Xebba      (2) Miżżewġa     (3) Separata/Divorzjata    (4) Armla    
 
M6. X'inhu l-livell ta' dħul tal-familja tiegħek? 
 
(1) Inqas minn €10,737  
(2) €10,737 – €16,113   
(3) €16,114 – €23,563  
(4) €23,564 – €33,966  
(5) Iktar minn €33,966  
(6) Nippreferi ma ngħidx  
 
M7. a) Għandek karozza?  Iva    Le  
 b) Issuq?   Iva    Le  
 
M8. Għandek xi marda, diżabilità jew kundizzjoni ta' kwalunkwe tip? 
   Iva     Le  → Mur għall-M9 
  ↓ 
X'inhi? ______________________ 
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 M9 (a) Għandek tabib tal-familja (GP) li tirrikorri għalih għal kura u pariri mediċi?   
   Iva    Le  
 
(b) Kemm-il darba tmur għand il-GP tiegħek?  
 1. Meta jkolli problema biss  
 2. Darba fix-xahar  
 3. Iktar minn darba f'sena   
 4. Darba f'sena   
 5. Darba kull sentejn  
 
M10. Qatt kellek xi tip ta' kundizzjoni jew marda f'sidrek? 
(i) Iva    (Mur għall-M10a)  Le     (Mur għall-M11) 
 
(a) X'tip ta' kundizzjoni jew marda tas-sider? 
(i) “Boċoċ” f’sidrek       
(ii) Ċesti       
(iii) Kanċer f'sider minnhom       
(iv) Kanċer fiż-żewġ sider      
(v) Kundizzjoni jew marda oħra  (jekk jogħġbok speċifika)     
 
M11. Qatt kellek xi ħadd mill-qraba jew ħbieb tal-qalb tiegħek li kellu kanċer?    
  Iva     Le   Nippreferi ma ngħidx  
  ↓ 
Jekk IVA, liema milli ġejjin? 
Membru tal-familja jew 
ħabib/a 
Kancer fis-sider Kancer iehor 
Qariba fl-ewwel grad   Ommok           
 Oħtok             
 Bintek            
Ommok_____________________ 
Oħtok______________________ 
Bintek______________________ 
Membru ieħor tal-familja   Missierek        
 Ħuk                
 Nanntek          
 Nannuk           
 Zijtek              
 Zijuk               
 Kuġinuk          
 Kuġintek         
Missierek___________________ 
Ħuk _______________________ 
Nanntek____________________ 
Nannuk     __________________ 
Zijtek  _____________________ 
Zijuk ______________________ 
Kuġinuk____________________ 
Kuġintek____________________ 
Ħabiba tal-qalb    
_________________________ 
Ir-raġel  _________________________ 
 
TAQSIMA A:  L-ISKRINING TAS-SIDER MATUL ĦAJTEK 
1(A) UŻU TAL-MAMMOGRAFIJA MATUL ĦAJTEK 
 
(i) Qatt għamilt mammogram f'ħajtek?   
Iva   (Mur għal (ii))  Le  (Mur għal (iii))  
 
Jekk ‘IVA’: 
(ii) Kemm-il darba għamilt mammogram f'ħajtek? 
1. Mammogram wieħed f'ħajti (‘BISS’)       
2. Żewġ mammograms oħra jew iktar f'ħajti (‘RIPETIZZJONI’)    
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(iii) Qatt kont għamilt mammogram f’dawn l-aħħar 3 snin (‘RIĊENTI’)?    
 Iva     Le   
 
(iiia) Jekk ‘IVA’, meta, fejn kont għamiltu u għala? ______________________ 
1.  Iċ-Ċentru tal-Iskrining tas-Sider   
2.  Sptar tal-Gvern   
3.  Fi klinika privata   
  
(B) ATTENDENZA GĦALL-EWWEL STEDINA GĦALL-PROGRAMM TA’ SKRINING 
TAS-SIDER 
 
(i) Meta rċevejt l-ewwel stedina biex tmur għall-Programm ta' Skrining tas-Sider, mort?  
 (a) Iva      (b) Le   
 
 
Jekk IVA:  Jekk LE:  
(ai) Kont tmur kieku:  (bi) Għalfejn Le?  
Ma kontx mistiedna 
jew ma bagħtux 
għalik biex tmur? 
Iva    
 Le    
Nuqqas ta' għarfien jew nuqqas ta’ 
informazzjoni dwar l-iskrining 
Iva  
Le    
  Kwistjonijiet prattiċi (eż. nuqqas ta' 
ħin liberu u obbligi tal-familja, ma 
kellix min jeħodli ħsieb it-tfal, 
diffikultà biex nieħu l-liv mix-xogħol, 
trasport, oħrajn) 
Iva   
Le   
  Biża' (li nweġġa', mir-raġġi, li 
nimbarazza ruħi, minn xi proċedura li 
ma nafx biha, mir-riżultat) 
Iva   
 Le   
  Raġuni oħra  Jekk jogħġbok 
speċifika: 
 
 
 
 
 
(ii) It-tabib tal-familja tiegħek (GP) ħeġġek biex tmur għal mammogram?  
 Iva     Le  
 
 
(C) ATTENDENZA MILL-ĠDID GĦAT-TIENI STEDINA GĦALL-PROGRAMM TA’ 
SKRINING TAS-SIDER 
(i)  Jekk tirċievi t-tieni stedina, tmur? (INTENZJONI) 
 
Iva       Le      Ma nafx  
 
(ii) Jekk ‘IVA’, għala? (raġuni) _________________________________________ 
 
(iii) Jekk ‘LE’, għala? (raġuni) _____________________________________ 
 
(iv) Jekk ‘Ma Tafx’, għala? (għati raġuni) ____________________________ 
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(D) GĦARFIEN DWAR KEMM-IL DARBA HU RAKKOMANDAT LI TMUR GĦAL 
SKRINING 
(i) Kemm-il darba taħseb li għandha tmur mara tal-età tiegħek għal mammogram? 
1. Darba fis-sena    
2. Kull sena u nofs   
3. Kull 2 sa 3 snin   
4. Kull 4 sa 5 snin   
5. Ma nafx    
 
TAQSIMA B: KONVINZJONIJIET DWAR IS-SAĦĦA 
Nixtiequ nkunu nafu x'taħseb dwar kif tħares lejn l-Iskrining tas-Sider u l-Kanċer fis-Sider. Jekk 
jogħġbok indika kemm taqbel jew ma taqbilx mad-dikjarazzjonijiet li ġejjin dwar l-Iskrining tas-
Sider u l-Kanċer fis-Sider. 
L-iskala tal-Mudell ta' Champion dwar il-Konvinzjonijiet għall-Iskrining 
tas-Sider 
B1.   SUXXETTIBBILTÀ PERĊEPITA (PERĊEZZJONI TAR-RISKJI) 
NRU 
TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' 
SUXXETTIBBILTÀ 
PERĊEPITA  
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. M'hemmx ċans li 
joħroġlok kanċer fis-
sider. 
     
2. Iċ-ċansijiet li 
joħroġlok kanċer fis-
sider huma kbar. 
     
3. Jista' jkun hemm ċans 
li f'ħajtek tiżviluppalek 
kanċer fis-sider. 
     
 
B2.   BENEFIĊĊJI PERĊEPITI TAL-ISKRINING BIL-MAMMOGRAFIJA 
NRU TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' 
BENEFIĊĊJI 
PERĊEPITI  
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Meta tagħmel 
mammogram, tħossok 
tajba dwarek nnifsek. 
     
2. Meta tagħmel 
mammogram, ma 
tinkwetax daqshekk 
dwar il-kanċer fis-
sider. 
     
3. Li tagħmel 
mammogram tgħinek 
ssir taf kmieni jekk 
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għandekx boċoċ 
f'sidrek. 
4. Jekk issir taf b'boċċa 
permezz ta' 
mammogram, it-
trattament għall-kanċer 
f’sidrek jista' ma jkunx 
daqshekk kiefer. 
     
5. Li tagħmel 
mammogram 
inaqqaslek ċ-ċans li 
tmut b'kanċer fis-sider. 
     
6. Li tagħmel 
mammogram jgħinek 
ssir taf dwar boċoċ 
f'sidrek qabel tkun 
tista' tħosshom inti 
stess jew professjonist 
mediku. 
     
 
B3.  OSTAKLI PERĊEPITI GĦALL-ISKRINING BIL-MAMMOGRAFIJA  
NRU TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' 
OSTAKLI PERĊEPITI 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Li tagħmel 
mammogram regolari 
tagħmlek nervuża 
dwar il-kanċer fis-
sider. 
     
2. Tinkwieta li kieku 
jkollok tagħmel 
mammogram regolari. 
     
3. Tibża' tagħmel 
mammogram għax 
tibża' li jsibulek xi 
ħaġa ħażina. 
     
4. Tibża' tagħmel 
mammogram għax ma 
tafx il-proċedura jew 
x'għandek tistenna. 
     
5. Tibża' tagħmel 
mammogram għax taf 
lil xiħadd (fil-familja 
jew ħabiba) li għandu 
kanċer fis-sider. 
     
6. Timbarazza ruħek biex 
tagħmel mammogram. 
     
7. Tweġġa' jew tħossok 
skomda biex tagħmel 
mammogram. 
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8. Il-proċess tal-
mammogram huwa ħin 
mitluf. 
     
9. Jekk attendejt għall-
Iskrining tas-Sider: 
Ma ħriġtx sodisfatta 
mill-attitudni tal-istaff 
fl-Iskrining tas-Sider 
għax ma kinux edukati 
miegħek. 
     
10. Tibża' mit-tim mediku 
jew m'għandekx 
fiduċja fih. 
     
11. Mammogram jesponik 
għal radjazzjoni bla 
bżonn. 
     
12. Għandek ħafna 
affarijiet oħra fuq 
rasek milli tara li 
tagħmel mammogram. 
     
13. M'għandekx biżżejjed 
età biex tagħmel 
mammogram kull tant 
żmien. 
     
 
B4. SINJALI BIEX TITTIEĦED AZZJONI   
NRU TAL-
ENTRATA 
FUQ L-
ISKALA 
SINJALI BIEX 
TITTIEĦED 
AZZJONI 
 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Jekk il-GP tiegħek 
jagħtik parir biex 
tmur tagħmel 
mammogram, tmur. 
     
2. Jekk il-qraba tiegħek 
jtuk parir biex tmur 
tagħmel 
mammogram, tmur. 
     
3. Jekk xiħadd qrib 
tiegħek ħariġlu 
kanċer fis-sider, tmur 
tagħmel 
mammogram. 
     
4. Li tisma' dwar il-
kanċer fis-sider fil-
midja jew fuq l-
aħbarijiet, iġegħluk 
taħseb biex tmur 
tagħmel 
mammogram. 
     
5. Ittri biex ifakkruk, 
jgħinuk biex tmur 
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tagħmel 
mammogram. 
6. Telefonati jew SMS 
biex ifakkruk, 
jgħinuk biex tmur 
tagħmel 
mammogram. 
     
7. Taħditiet edukattivi 
regolari dwar il-
kanċer fis-sider 
jgħinuk biex tmur 
tagħmel 
mammogram. 
     
 
B5. KEMM TEMMEN FIK INNIFSEK (fiduċja li tagħmel mammogram)  
NRU TAL-
ENTRATA 
ENTRATI TA' KEMM 
TEMMEN FIK 
INNIFSEK 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Tħossok fiduċjuża li 
kieku kellek tagħmel 
mammogram, isibu 
kwalunkwe problema 
li jista' jkun hemm 
f'sidrek. 
     
2. Tista' tirranġa 
affarijiet oħra f'ħajtek 
biex tkun tista' 
tagħmel 
mammogram. 
     
3. F’kas li jkollok bżonn 
mammogram, ssib 
post fejn tagħmlu. 
     
4. Tista' tagħmel 
appuntament għal 
mammogram. 
     
5. Tista' tirranġa dwar it-
trasport biex tagħmel 
mammogram. 
     
6. Jekk attendejt għall-
Iskrining tas-Sider: 
Tista' titkellem fiċ-
ċentru tal-iskrining 
tas-sider dwar 
x'jinkwetak. 
     
7. Tista' ssib mod kif 
tħallas għal 
mammogram jekk 
għandek bżonn 
tagħmlu. 
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TAQSIMA C: PERĊEZZJONIJIET TA' MARD 
Jekk jogħġbok indika kemm taqbel jew ma taqbilx mad-dikjarazzjonijiet li ġejjin speċifikament 
dwar il-Kanċer fis-Sider. 
Il-Kwestjonarju Rivedut dwar il-Perċezzjoni ta' Mard (IPQ-R) 
C1.  IDENTITÀ TAL-KANĊER FIS-SIDER (Lista tas-sintomi ewlenin) 
NRU 
TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' 
IDENTITÀ 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix ċerta  
 
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Il-preżenza ta' boċċa 
jew ħxuna fit-tessut tas-
sider  
     
2. Tnixxija tan-nipil 
 
     
3. Ġbid lura f'daqqa tan-
nipil  
 
     
4. Bdil fil-forma jew id-
dehra tan-nipil 
 
     
5. Nefħa, tikmix, ħmura 
jew sensazzjoni tenera 
fis-sider  
 
     
6. Bdil fil-ġilda tas-sider 
 
     
7. Bdil f'daqqa fid-daqs 
tas-sider  
 
     
8. Uġigħ fis-sider  
 
     
 
C2. KAĠUN TAL-KANĊER FIS-SIDER (ideat personali dwar l-etjoloġija) 
NRU TAL-
ENTRATA 
FUQ L-
ISKALA 
ATTRIBWIZZJONIJI
ET PSIKOLOĠIĊI 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Stress jew inkwiet 
 
     
2. L-attitudni mentali 
tiegħek (eż. taħseb 
b'mod negattiv dwar 
il-ħajja)  
     
3. Problemi jew inkwiet 
familjari 
 
     
4. Xogħol żejjed 
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5.  L-istat emozzjonali 
tiegħek (eż. tħossok 
mdejqa, waħdek, 
nervuża, bla skop) 
     
6. Il-personalità tiegħek 
 
     
FATTURI TA' RISKJU /  
FATTURI TA' STIL TAL-ĦAJJA 
 
 
1. Marda ereditarja – 
għandek fil-familja 
     
2. Dietà jew drawwiet 
ta' ikel 
     
3. Kura ħażina tas-
saħħa fil-passat 
     
4. Imġiba tiegħek stess 
 
     
5. Tixjiħ 
 
     
6. Tipjip 
 
     
7.  Alkoħol 
 
     
IMMUNITÀ 
 
 
1. 
 
Mikrobu jew vajrus      
2. Tniġġis tal-ambjent 
 
     
3. Tibdil fir-reżistensa 
tal-ġisem għal mard 
(sistema immunitarja) 
     
INĊIDENT JEW 
B'KUMBINAZZJONI 
 
1. 
 
B'destin jew xorti 
ħażina 
     
2. Inċident jew 
korriment 
     
 
C3a. SKEDA TA' ŻMIEN: AKUTA/KRONIKA (it-tul ta' żmien perċepit tal-Kanċer fis-Sider) 
NRU 
TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' SKEDA 
TA' ŻMIEN 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix ċerta  
 
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Kanċer fis-sider ma 
jdumx wisq. 
     
2. Kanċer fis-sider jista 
ikun għal dejjem 
(permanenti) iktar milli 
xi ħaġa għal ftit żmien 
(temporanja). 
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C3b. SKEDA TA' ŻMIEN: ĊIKLIKA 
NRU TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' SKEDA 
TA' ŻMIEN 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Pazjenta b'kanċer fis-
sider tgħaddi minn 
fażijiet li matulhom 
saħħitha tmur għall- 
aħjar u għall-agħar. 
     
 
C4. KONSEGWENZI (effetti u riżultati mistennija) 
NRU TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' 
KONSEGWENZI 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Kanċer fis-sider 
għandu konsegwenzi 
maġġuri fuq ħajjet il-
pazjenta. 
     
2. Kanċer fis-sider ma 
jkollux wisq effett fuq 
ħajtek. 
     
3.  Kanċer fis-sider 
jaffettwa ħafna l-mod 
kif ħaddieħor iħares 
lejja. 
     
4. Kanċer fis-sider  
għandu konsegwenzi 
ekonomiċi u finanzjarji 
serji. 
     
5.  Kanċer fis-sider 
jaffettwa ħafna l-mod 
kif tħares lejk nnifsek 
bħala persuna. 
     
6. Kanċer fis-sider 
jhedded ir-relazzjoni 
tiegħek ma' żewġek 
jew is-sieħeb. 
     
7. Kieku jkollok kanċer 
fis-sider, ibiddillek 
ħajtek ta' taħt fuq. 
     
8. Kieku jkollok kanċer 
fis-sider, jista 
jonqoslok ċ-ċans li 
jkollok ħajja twila. 
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C5. KURA/KONTROLL  
C5a. KONTROLL PERSONALI (kif wieħed jikkontrolla jew jirkupra minn Kanċer fis-Sider) 
NRU TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' KONTROLL 
PERSONALI 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Hemm ħafna x'tista' 
nagħmel biex tikkontrolla 
s-sintomi jekk toħroġlok 
Kanċer fis-Sider. 
 
 
    
2. L-esperjenza tal-Kanċer 
fis-Sider jiddependi skont 
l-azzjonijiet li tieħu. 
     
3. L-azzjonijiet tiegħek  
jħallu effett fuq l-impatt 
tal-Kanċer fis-Sider 
f’ħajtek. 
 
 
    
 
C5b. KONTROLL TAT-TRATTAMENT  
NRU TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' KONTROLL 
TAT-TRATTAMENT 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. M'hemmx trattament li 
jgħin biex tittejjeb is-
sitwazzjoni ta' pazjenta tal-
Kanċer fis-Sider. 
     
2. It-trattament li jingħata 
jkun effettiv biex 
jikkontrolla jew ifejjaq 
Kanċer fis-Sider. 
 
 
    
3. L-effetti negattivi tal-
Kanċer fis-Sider jistgħu 
jkunu limitati jew jiġu 
evitati bit-trattament li 
jingħata. 
     
 
C6. KOERENZA TAL-MARDA 
NRU TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' 
KOERENZA TAL-
MARDA 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Għandek stampa ċara u 
għarfien tajjeb tal-
Kanċer fis-Sider. 
     
2. Il-Kanċer fis-Sider hu 
misteru għalik. 
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C7. RAPPREŻENTAZZJONIJIET EMOZZJONALI 
NRU TAL-
ENTRATA 
FUQ L-
ISKALA 
ENTRATI TA' 
RAPPREŻENTAZZJONI
JIET EMOZZJONALI 
Ma naqbilx 
assolutament  
 
(1) 
Ma 
naqbilx  
 
(2) 
Minix 
ċerta  
 
(3) 
Naqbel 
 
 
(4) 
Naqbel 
assolutament 
 
(5) 
1. Tħossok anzjuża meta 
taħseb dwar il-marda tal-
Kanċer fis-Sider. 
     
2. Il-Kanċer fis-Sider 
ibeżżgħak. 
     
3. Tħossok inkwetata meta 
taħseb dwar il-Kanċer 
fis-Sider. 
 
 
    
 
GRAZZI tal-ħin li ħadt biex weġibt dan l-istħarriġ. 
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Appendix 4.3.1- Version of Study 4 published in the BMC Public Health 
Journal
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Appendix 4.3.2 - STROBE 2007 (v4) Statement—Checklist of items that should be included in reports of cross-
sectional studies 
Section/Topic Item 
# Recommendation 
Reported on page # (of 
published Study 4) 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 1 
(b) Provide in the abstract an informative and balanced summary of what was done and what was found 1-2 
Introduction  
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 3-5 
Objectives 3 State specific objectives, including any prespecified hypotheses 5-6 
Methods  
Study design 4 Present key elements of study design early in the paper 6-7 
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and 
data collection 
6-7 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of participants 6-7 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give 
diagnostic criteria, if applicable 
8 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of assessment (measurement). 
Describe comparability of assessment methods if there is more than one group 
8-9 
Bias 9 Describe any efforts to address potential sources of bias 26 
Study size 10 Explain how the study size was arrived at 6 
Quantitative 
variables 
11 Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were 
chosen and why 
8-9 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 9 
(b) Describe any methods used to examine subgroups and interactions 9 
(c) Explain how missing data were addressed 9 
(d) If applicable, describe analytical methods taking account of sampling strategy  
(e) Describe any sensitivity analyses  
Results  
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for 
eligibility, confirmed eligible, included in the study, completing follow-up, and analysed 
10 
(b) Give reasons for non-participation at each stage 10 
(c) Consider use of a flow diagram 10 
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Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures 
and potential confounders 
10 
(b) Indicate number of participants with missing data for each variable of interest 9 
Outcome data 15* Report numbers of outcome events or summary measures 10 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% 
confidence interval). Make clear which confounders were adjusted for and why they were included 
10-20 
(b) Report category boundaries when continuous variables were categorized  
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period  
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses 10-20 
Discussion  
Key results 18 Summarise key results with reference to study objectives 20-25 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both 
direction and magnitude of any potential bias 
26 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, 
results from similar studies, and other relevant evidence 
27 
Generalisability 21 Discuss the generalisability (external validity) of the study results 26 
Other information  
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the original 
study on which the present article is based 
27 
 
*Give information separately for exposed and unexposed groups. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The 
STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal 
Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org. 
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Appendix 4.4.2 - STROBE 2007 (v4) Statement—Checklist of items that should be included in reports of cross-
sectional studies 
Section/Topic Item 
# Recommendation 
Reported on page # (of 
published Study 5) 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 1 
(b) Provide in the abstract an informative and balanced summary of what was done and what was found 2-3 
Introduction  
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 4-6 
Objectives 3 State specific objectives, including any prespecified hypotheses 6 
Methods  
Study design 4 Present key elements of study design early in the paper 9 
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and 
data collection 
9 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of participants 9 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give 
diagnostic criteria, if applicable 
10 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of assessment (measurement). 
Describe comparability of assessment methods if there is more than one group 
10 
Bias 9 Describe any efforts to address potential sources of bias 19-20 
Study size 10 Explain how the study size was arrived at 9 
Quantitative 
variables 
11 Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were 
chosen and why 
10 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 10 
(b) Describe any methods used to examine subgroups and interactions 10 
(c) Explain how missing data were addressed 10 
(d) If applicable, describe analytical methods taking account of sampling strategy  
(e) Describe any sensitivity analyses  
Results  
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for 
eligibility, confirmed eligible, included in the study, completing follow-up, and analysed 
11 
(b) Give reasons for non-participation at each stage 11 
(c) Consider use of a flow diagram 11 
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures 
and potential confounders 
11 
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(b) Indicate number of participants with missing data for each variable of interest 11 
Outcome data 15* Report numbers of outcome events or summary measures 12-14 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% 
confidence interval). Make clear which confounders were adjusted for and why they were included 
 
(b) Report category boundaries when continuous variables were categorized  
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period  
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses 12-14 
Discussion  
Key results 18 Summarise key results with reference to study objectives 15-19 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both 
direction and magnitude of any potential bias 
19-20 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, 
results from similar studies, and other relevant evidence 
20-21 
Generalisability 21 Discuss the generalisability (external validity) of the study results 19 
Other information  
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the original 
study on which the present article is based 
21 
 
*Give information separately for exposed and unexposed groups. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The 
STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal 
Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org. 
 
 
 
464 
 
Appendix 5.1 – Primary searches across electronic databases 
Ovid MEDLINE(R)  
# Searches Results Type 
1 exp Breast Neoplasms/  264303  Advanced    
2 exp Mammography/  27798  Advanced    
3 (breast screen* or mammog*).af.  38816  Advanced    
4 (breast cancer* or breast tum?r* or breast neoplasm*).af.  334972  Advanced    
5 1 or 2 or 3 or 4  343970  Advanced    
6 exp Mass Screening/  116495  Advanced    
7 (health screen* or mass screen* or cancer screen*).af.  115973  Advanced    
8 6 or 7  137995  Advanced    
9 5 and 8  15115  Advanced    
10 
(campaign* or educat* or interven* or program* or promot* or 
outreach* or navigat*).af.  
3694287  Advanced    
11 9 and 10  7450  Advanced    
12 (attitud* to health or health* attitud*).af.  263632  Advanced    
13 exp Attitude to Health/  371943  Advanced    
14 exp health promotion/ or exp health educattion/  68934  Advanced    
15 
(patient ed* or health ed* or health promot* or health navigat* 
or patient navigat*).af.  
280271  Advanced    
16 (audiovisual* or audio-visual*).af.  11868  Advanced    
17 12 or 13 or 14 or 15 or 16  692104  Advanced    
18 11 and 17  2974  Advanced    
19 limit 18 to (english language and yr="2000 - 2015")  1802  Advanced    
20 (1 or 2 or 3) and 4  266776  Advanced    
21 8 and 20  13191  Advanced    
22 10 and 21  6355  Advanced    
23 17 and 22  2548  Advanced    
24 limit 23 to (english language and yr="2000 - 2015")  1556  Advanced    
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PUBMED  
 
WEB of Science  
Search History: All Databases  
 
Set 
 
Results 
 
  
Combine Sets 
 AND   OR 
 
Delete Sets 
  
 
 
# 12 548 #9 AND #6 
Refined by: PUBLICATION YEARS: ( 2011 OR 2007 OR 2002 OR 2008 OR 2012 OR 2006 OR 2013 OR 2003 OR 
2005 OR 2004 OR 2001 OR 2014 OR 2010 OR 2009 OR 2000 OR 2015 ) AND LANGUAGES: ( ENGLISH ) 
Timespan=2000-2015 
Search language=Auto   
Select to combine sets.
 
Select to delete this set.
 
 
# 11 586 #9 AND #6 
Refined by: PUBLICATION YEARS: ( 2011 OR 2007 OR 2002 OR 2008 OR 2012 OR 2006 OR 2013 OR 2003 OR 
2005 OR 2004 OR 2001 OR 2014 OR 2010 OR 2009 OR 2000 OR 2015 ) 
Timespan=2000-2015 
Search language=Auto   
Select to combine sets.
 
Select to delete this set.
 
 
# 10 586 #9 AND #6 
Timespan=2000-2015 
Search language=English   
Select to combine sets.
 
Select to delete this set.
 
 
# 9 Approximately 
241,513 
#8 OR #7 
Timespan=2000-2015 
Search language=English   
Select to combine sets.
 
Select to delete this set.
 
 
# 8 Approximately 
203,946 
TOPIC: (("patient ed*" or "health ed*" or "health promot*")) 
Timespan=2000-2015 
Search language=English   
Select to combine sets.
 
Select to delete this set.
 
 
# 7 Approximately 
45,449 
TOPIC: (("attitud* to health" or "health* attitud*")) 
Timespan=2000-2015 
Search language=English   
Select to combine sets.
 
Select to delete this set.
 
 
# 6 Approximately 
6,287 
#5 AND #4 
Timespan=2000-2015 
Search language=English   
Select to combine sets.
 
Select to delete this set.
 
 
# 5 Approximately 
8,302,550 
TOPIC: (campaign* or educat* or intervent* or program* or promot* or outreach* or navig*) 
Timespan=2000-2015 
Search language=English   
Select to combine sets.
 
Select to delete this set.
 
 
# 4 Approximately 
10,926 
#3 AND #2 AND #1 
Timespan=2000-2015 
Search language=English   
Select to combine sets.
 
Select to delete this set.
 
 
# 3 Approximately 
107,324 
TOPIC: (("health screen*" or "mass screen*" or "cancer screen*")) 
Timespan=2000-2015 
Search language=English   
Select to combine sets.
 
Select to delete this set.
 
 
# 2 Approximately 
829,112 
TOPIC: (("breast cancer*" or "breast tum?r*" or "breast neoplasm*")) 
Timespan=2000-2015 
Search language=English   
Select to combine sets.
 
Select to delete this set.
 
 
# 1 Approximately 
72,421 
TOPIC: ("breast screen*" or mammog*) 
Timespan=2000-2015 
Search language=English   
Select to combine sets.
 
Select to delete this set.
 
 
 
466 
 
PsycINFO  
S5  S3 AND S4  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Research Databases  
Search Screen - 
Basic Search  
Database - 
PsycINFO 
221   
S4  
audio-visual 
aid* or 
audiovisual 
aid* or health 
educat* or 
patient educat* 
or attitud* to 
health  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Research Databases  
Search Screen - 
Basic Search  
Database - 
PsycINFO 
27,517   
S3  S1 AND S2  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Research Databases  
Search Screen - 
Basic Search  
Database - 
PsycINFO 
1,461   
S2  
campaign* or 
educat* or 
interven* or 
program* or 
promot* or 
outreach*  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Research Databases  
Search Screen - 
Basic Search  
Database - 
PsycINFO 
1,167,204   
S1  
breast screen* 
or mammog*  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Research Databases  
Search Screen - 
Basic Search  
Database - 
PsycINFO 
1,850   
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Scopus  
 10 
History Search Terms( ( ( TITLE-ABS-KEY ( "breast screen*"  OR  mammogra* ) )  OR  ( TITLE-ABS-
KEY ( ( "breast cancer*"  OR "breast tum?r*"  OR  "breast neoplasm*" )  AND  screen* ) ) )  AND  ( TITLE-
ABS-KEY ( uptak*  OR  up-
tak*  OR  increas*  OR  facilitat*  OR  comply  OR  complianc*  OR  attend*  OR  adher*  OR  predict*  OR det
ermin*  OR  understand* ) )  AND  ( TITLE-ABS-KEY ( metaanal*  OR  meta-
anal* ) ) )  AND ( TITLE ( metaanal*  OR  meta-anal* ) )  AND  ( LIMIT-TO ( PUBYEAR ,  2014 )  OR  LIMIT-
TO ( PUBYEAR , 2013 )  OR  LIMIT-TO ( PUBYEAR ,  2012 )  OR  LIMIT-TO ( PUBYEAR ,  2011 )  OR  LIMIT-
TO ( PUBYEAR , 2010 )  OR  LIMIT-TO ( PUBYEAR ,  2009 )  OR  LIMIT-TO ( PUBYEAR ,  2008 )  OR  LIMIT-
TO ( PUBYEAR , 2007 )  OR  LIMIT-TO ( PUBYEAR ,  2006 )  OR  LIMIT-TO ( PUBYEAR ,  2005 )  OR  LIMIT-
TO ( PUBYEAR , 2014 )  OR  LIMIT-TO ( PUBYEAR ,  2013 )  OR  LIMIT-TO ( PUBYEAR ,  2012 )  OR  LIMIT-
TO ( PUBYEAR , 2011 )  OR  LIMIT-TO ( PUBYEAR ,  2010 )  OR  LIMIT-TO ( PUBYEAR ,  2009 )  OR  LIMIT-
TO ( PUBYEAR , 2008 )  OR  LIMIT-TO ( PUBYEAR ,  2007 )  OR  LIMIT-TO ( PUBYEAR ,  2006 )  OR  LIMIT-
TO ( PUBYEAR , 2005 )  OR  LIMIT-TO ( PUBYEAR ,  2004 )  OR  LIMIT-TO ( PUBYEAR ,  2003 )  OR  LIMIT-
TO ( PUBYEAR , 2002 )  OR  LIMIT-TO ( PUBYEAR ,  2001 )  OR  LIMIT-TO ( PUBYEAR ,  2000 ) )  AND  ( LIMIT-
TO ( LANGUAGE ,  "English" ) )  
78 document results  
 History Search Identifier9 
History Search TermsTITLE ( metaanal*  OR  meta-anal* )  
45,288 document results  
 History Search Identifier8 
History Search Terms( ( ( TITLE-ABS-KEY ( "breast screen*"  OR  mammogra* ) )  OR  ( TITLE-ABS-
KEY ( ( "breast cancer*"  OR "breast tum?r*"  OR  "breast neoplasm*" )  AND  screen* ) ) )  AND  ( TITLE-
ABS-KEY ( uptak*  OR  up-
tak*  OR  increas*  OR  facilitat*  OR  comply  OR  complianc*  OR  attend*  OR  adher*  OR  predict*  OR det
ermin*  OR  understand* ) )  AND  ( TITLE-ABS-KEY ( metaanal*  OR  meta-
anal* ) ) )  AND ( TITLE ( metaanal*  OR  meta-anal* ) )  AND  ( LIMIT-TO ( PUBYEAR ,  2014 )  OR  LIMIT-
TO ( PUBYEAR , 2013 )  OR  LIMIT-TO ( PUBYEAR ,  2012 )  OR  LIMIT-TO ( PUBYEAR ,  2011 )  OR  LIMIT-
TO ( PUBYEAR , 2010 )  OR  LIMIT-TO ( PUBYEAR ,  2009 )  OR  LIMIT-TO ( PUBYEAR ,  2008 )  OR  LIMIT-
TO ( PUBYEAR , 2007 )  OR  LIMIT-TO ( PUBYEAR ,  2006 )  OR  LIMIT-TO ( PUBYEAR ,  2005 )  OR  LIMIT-
TO ( PUBYEAR , 2014 )  OR  LIMIT-TO ( PUBYEAR ,  2013 )  OR  LIMIT-TO ( PUBYEAR ,  2012 )  OR  LIMIT-
TO ( PUBYEAR , 2011 )  OR  LIMIT-TO ( PUBYEAR ,  2010 )  OR  LIMIT-TO ( PUBYEAR ,  2009 )  OR  LIMIT-
TO ( PUBYEAR , 2008 )  OR  LIMIT-TO ( PUBYEAR ,  2007 )  OR  LIMIT-TO ( PUBYEAR ,  2006 )  OR  LIMIT-
TO ( PUBYEAR , 2005 )  OR  LIMIT-TO ( PUBYEAR ,  2004 )  OR  LIMIT-TO ( PUBYEAR ,  2003 )  OR  LIMIT-
TO ( PUBYEAR , 2002 )  OR  LIMIT-TO ( PUBYEAR ,  2001 )  OR  LIMIT-TO ( PUBYEAR ,  2000 ) )  AND  ( LIMIT-
TO ( LANGUAGE ,  "English" ) )  
326 document results  
 History Search Identifier7 
History Search Terms( ( ( TITLE-ABS-KEY ( "breast screen*"  OR  mammogra* ) )  OR  ( TITLE-ABS-
KEY ( ( "breast cancer*"  OR "breast tum?r*"  OR  "breast neoplasm*" )  AND  screen* ) ) )  AND  ( TITLE-
ABS-KEY ( uptak*  OR  up-
tak*  OR  increas*  OR  facilitat*  OR  comply  OR  complianc*  OR  attend*  OR  adher*  OR  predict*  OR det
ermin*  OR  understand* ) )  AND  ( TITLE-ABS-KEY ( metaanal*  OR  meta-
anal* ) ) )  AND ( TITLE ( metaanal*  OR  meta-anal* ) )  AND  ( LIMIT-TO ( PUBYEAR ,  2014 )  OR  LIMIT-
TO ( PUBYEAR , 2013 )  OR  LIMIT-TO ( PUBYEAR ,  2012 )  OR  LIMIT-TO ( PUBYEAR ,  2011 )  OR  LIMIT-
TO ( PUBYEAR , 2010 )  OR  LIMIT-TO ( PUBYEAR ,  2009 )  OR  LIMIT-TO ( PUBYEAR ,  2008 )  OR  LIMIT-
TO ( PUBYEAR , 2007 )  OR  LIMIT-TO ( PUBYEAR ,  2006 )  OR  LIMIT-TO ( PUBYEAR ,  2005 )  OR  LIMIT-
TO ( PUBYEAR , 2014 )  OR  LIMIT-TO ( PUBYEAR ,  2013 )  OR  LIMIT-TO ( PUBYEAR ,  2012 )  OR  LIMIT-
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TO ( PUBYEAR , 2011 )  OR  LIMIT-TO ( PUBYEAR ,  2010 )  OR  LIMIT-TO ( PUBYEAR ,  2009 )  OR  LIMIT-
TO ( PUBYEAR , 2008 )  OR  LIMIT-TO ( PUBYEAR ,  2007 )  OR  LIMIT-TO ( PUBYEAR ,  2006 )  OR  LIMIT-
TO ( PUBYEAR , 2005 )  OR  LIMIT-TO ( PUBYEAR ,  2004 )  OR  LIMIT-TO ( PUBYEAR ,  2003 )  OR  LIMIT-
TO ( PUBYEAR , 2002 )  OR  LIMIT-TO ( PUBYEAR ,  2001 )  OR  LIMIT-TO ( PUBYEAR ,  2000 ) )  
354 document results  
 History Search Identifier6 
History Search Terms( ( ( TITLE-ABS-KEY ( "breast screen*"  OR  mammogra* ) )  OR  ( TITLE-ABS-
KEY ( ( "breast cancer*"  OR "breast tum?r*"  OR  "breast neoplasm*" )  AND  screen* ) ) )  AND  ( TITLE-
ABS-KEY ( uptak*  OR  up-
tak*  OR  increas*  OR  facilitat*  OR  comply  OR  complianc*  OR  attend*  OR  adher*  OR  predict*  OR det
ermin*  OR  understand* ) )  AND  ( TITLE-ABS-KEY ( metaanal*  OR  meta-
anal* ) ) )  AND ( TITLE ( metaanal*  OR  meta-anal* ) )  
406 document results  
 5 
TITLE-ABS-KEY(metaanal* or meta-anal*) 
130,986 document results 
 4 
TITLE-ABS-KEY(uptak* or up-tak* or increas* or facilitat* or comply or complianc* or attend* or adher* or 
predict* or determin* or understand*) 
16,182,422 document results 
 3 
(((TITLE-ABS-KEY("breast screen*" or mammogra*)) or (TITLE-ABS-KEY(("breast cancer*" or "breast 
tum?r*" or "breast neoplasm*") and screen*))) and (TITLE-ABS-KEY(uptak* or up-tak* or increas* or facilitat* 
or comply or complianc* or attend* or adher* or predict* or determin* or understand*)) and (TITLE-ABS-
KEY(metaanal* or meta-anal*))) and (TITLE(metaanal* or meta-anal*)) 
74,305 document results 
      
 2 
TITLE-ABS-KEY(("breast cancer*" or "breast tum?r*" or "breast neoplasm*") and screen*) 
40,461 document results 
 1 
TITLE-ABS-KEY("breast screen*" or mammogra*) 
51,523 document results 
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EMBASE 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     exp Breast Neoplasms/ (374237) 
2     exp Mammography/ (42361) 
3     (breast screen* or mammog*).af. (46072) 
4     (breast cancer* or breast tum?r* or breast neoplasm*).af. (369330) 
5     1 or 2 or 3 or 4 (414880) 
6     exp Mass Screening/ (163736) 
7     (health screen* or mass screen* or cancer screen*).af. (108549) 
8     6 or 7 (173530) 
9     5 and 8 (24283) 
10     (campaign* or educat* or interven* or program* or promot* or outreach* or navigat*).af. 
(3641264) 
11     9 and 10 (9999) 
12     (attitud* to health or health* attitud*).af. (135535) 
13     exp Attitude to Health/ (81358) 
14     exp health promotion/ or exp health educattion/ (71434) 
15     (patient ed* or health ed* or health promot* or health navigat* or patient navigat*).af. (284138) 
16     (audiovisual* or audio-visual*).af. (31708) 
17     12 or 13 or 14 or 15 or 16 (428295) 
18     11 and 17 (2526) 
19     limit 18 to (english language and yr="2000 - 2015") (1829) 
 
COCHRANE  
Date Run: 14/01/15 10:14:40.787 
ID Search Hits 
#1 "breast neoplasm*" or "breast cancer*"  18491 
#2 mammogra* or "breast screen*"  1839 
#3 #1 and #2  1426 
#4 campaign* or educat* or intervent* or program* or promot* or outreach* or navig* 
 180948 
#5 #3 and #4  816 
#6 "attitud* to health" or "health* attitud*"  3088 
#7 "patient ed*" or "health ed*" or "health promot*"  19266 
#8 #6 or #7  21194 
#9 #5 and #8  224 
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JOANNA BRIGGS INSTITUTE 
Search Strategy: 
1     breast screening or mammography {Including Limited Related Terms} (13) 
2     limit 1 to yr="2000 - 2015" (13) 
 
PROSPERO 
 
Search strategy: breast screen* OR mammogram* (all fields) 
Review Status: Published 
Date registered: 01/01/2000 – 31/12/2015 
 
Search Results (1 records) 
Registration no.   
 
 
 
Title   
 
 
 
Status   
 
 
 
CRD42012002247 Shift work and the development of breast cancer: protocol for a systematic review Published 
Centre for Reviews and Dissemination | Legal statements 
 
 
York databases  
 
Search strategy: (breast and (mammog* or screen*)) AND (campaign* or educat* or 
interven* or program* or promot* or outreach* or navigat*) OR (audiovisual* or audio-
visual* or patient ed* or health ed* or health promot* or health navigat* or patient 
navigat* or attitud* or ed* or promot*) FROM 2000 TO 2015 
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Appendix 5.2 – Supplementary searches for HBM and/or CSM  
CINAHL  
 
 
Medline search  
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Embase search  
 
 
 
 
Scopus and Web of Science (same strategy used in each database) 
 ( TITLE-ABS-KEY ( ( breast*  AND  screen* )  OR  mammog* ) )  AND  ( TITLE-ABS-KEY ( "champion* health 
belief"  OR  "health belief model"  OR  "common sense model"  OR  "self regul* model"  OR  "illness 
perception*" ) ) )  AND  ( TITLE-ABS-KEY ( "random* control* trial*" ) )  AND  ( LIMIT-
TO ( LANGUAGE ,  "English" ) )  
 
 
Web of Science 
 
# 5 
  
23 
  
#2 AND #1 
Refined by: LANGUAGES: ( ENGLISH ) AND PUBLICATION YEARS: ( 2014 OR 2006 OR 1999 OR 2013 OR 
2003 OR 1998 OR 2016 OR 2012 OR 2000 OR 1995 OR 2015 OR 2011 ) 
Databases= WOS, BCI, CCC, DRCI, DIIDW, KJD, MEDLINE, RSCI, SCIELO, ZOOREC Timespan=All years 
Search language=Auto   
  
  
# 4 
  
30 
  
#2 AND #1 
Refined by: LANGUAGES: ( ENGLISH ) 
Databases= WOS, BCI, CCC, DRCI, DIIDW, KJD, MEDLINE, RSCI, SCIELO, ZOOREC Timespan=All years 
Search language=Auto   
  
  
# 3 
  
30 
  
#2 AND #1 
Databases= WOS, BCI, CCC, DRCI, DIIDW, KJD, MEDLINE, RSCI, SCIELO, ZOOREC Timespan=All years 
Search language=Auto   
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# 2 
  
117,596 
  
TOPIC: ((( breast* AND screen* ) OR mammog* )) 
Databases= WOS, BCI, CCC, DRCI, DIIDW, KJD, MEDLINE, RSCI, SCIELO, ZOOREC Timespan=All years 
Search language=Auto   
   
# 1 
  
557 
  
TOPIC: (( ("champion* health belief" OR "health belief model" OR "common sense model" OR "self regul* 
model" OR "illness perception*" ) AND ( "random* control* trial*" ) )) 
Databases= WOS, BCI, CCC, DRCI, DIIDW, KJD, MEDLINE, RSCI, SCIELO, ZOOREC Timespan=All years 
Search language=Auto    
 
 
SCOPUS 
( TITLE-ABS-KEY ( ( ( ( "champion* health belief"  OR  "health belief model"  OR  "common sense model"  OR  
"self regul* model"  OR  "illness perception*" )  AND  ( "random* control* trial*" ) ) ) ) )  AND  ( TITLE-ABS-KEY 
( ( ( ( breast*  AND  screen* )  OR  mammog* ) ) ) )  AND  ( LIMIT-TO ( PUBYEAR ,  2016 )  OR  LIMIT-TO ( 
PUBYEAR ,  2015 )  OR  LIMIT-TO ( PUBYEAR ,  2014 )  OR  LIMIT-TO ( PUBYEAR ,  2012 )  OR  LIMIT-TO 
( PUBYEAR ,  2011 )  OR  LIMIT-TO ( PUBYEAR ,  2006 )  OR  LIMIT-TO ( PUBYEAR ,  2003 )  OR  LIMIT-
TO ( PUBYEAR ,  2002 )  OR  LIMIT-TO ( PUBYEAR ,  1999 )  OR  LIMIT-TO ( PUBYEAR ,  1994 )  OR  
LIMIT-TO ( PUBYEAR ,  1993 ) )  
 17 document results   
3   
( TITLE-ABS-KEY ( ( ( ( "champion* health belief"  OR  "health belief model"  OR  "common sense model"  OR  
"self regul* model"  OR  "illness perception*" )  AND  ( "random* control* trial*" ) ) ) ) )  AND  ( TITLE-ABS-KEY 
( ( ( ( breast*  AND  screen* )  OR  mammog* ) ) ) )  
 18 document results   
2   
TITLE-ABS-KEY ( ( ( ( breast*  AND  screen* )  OR  mammog* ) ) )  
 103,003 document results   
1   
TITLE-ABS-KEY ( ( ( ( "champion* health belief"  OR  "health belief model"  OR  "common sense model"  OR  
"self regul* model"  OR  "illness perception*" )  AND  ( "random* control* trial*" ) ) ) )  
 370 document results   
 
 
University of York CDR/PROPERO databases (same strategy used in each database) 
("champion* health belief" or "health belief model" or "common sense model" or "self 
regul* model" or "illness perception*") AND breast* 
 
 
Cochrane 
Date Run: 19/08/16 14:46:55.281 
ID Search Hits 
#1 MeSH descriptor: (Breast Neoplasms) explode all trees 9715 
#2 MeSH descriptor: (Mass Screening) explode all trees 5450 
#3 MeSH descriptor: (Mammography) explode all trees 1006 
#4 #1 and #2  500 
#5 #3 or #4  1158 
#6 "champion* health belief" or "health belief model" or "common sense model" or 
"self regul* model" or "illness perception*"  380 
#7 #5 and #6  16 
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Appendix 6.1a – Information sheet for Scottish expert steering group  
 
 
 
 
 
School of Health Sciences 
University of Stirling 
 
Mob: + 356 7777 3313 
Email: attard.danika@gmail.com 
 
04 September 2016 
 
Health Beliefs, Illness Perceptions and Determinants of Breast Screening Uptake in 
Malta 
 
 
Dear Colleagues, 
 
During the past year, I have carried out a Nation-wide survey entitled “Health beliefs, illness 
perceptions and the determinants to breast screening uptake in Malta” as part of my 
doctoral research work at the University of Stirling. The aim of the study was to determine 
if health beliefs, illness representations, socio-demographic and medical factors are 
associated with uptake to attend the Malta Breast Screening Programme (MBSP). The 
findings of this study are of particular importance to the National Breast Screening 
Programme, to policy makers and other relevant key stakeholders in Malta.   
 
Following the completion of this survey, expert steering groups are being set up in Malta 
and in Scotland to bring together local and international expertise in the field of research, 
screening and intervention development. These steering groups shall provide an opportunity 
to discuss with experts the appropriate strategies in developing an intervention for the 
Maltese population. 
 
The objectives of this steering group are: 
1. To discuss the findings of the literature review on non-attendance for mammography 
screening, as well as women’s health beliefs, illness perceptions and other 
determinants to breast screening uptake in Malta; 
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2. To conceptualise key theoretical components of an intervention that could be used to 
overcome modifiable barriers to breast screening and that has the potential to 
increase uptake in Malta; 
3. To develop a logic model of change; and 
4. To create a “short list” of potential interventions. 
 
Once the above objectives are fulfilled, another future phase of this project will be conducted 
to develop the intervention material.  
 
You have been nominated as a member of this Expert group as you are considered to be of 
great value to this steering group. Your contribution shall be acknowledged in future 
publications. I would appreciate if you could save the following date: 10th November 
 
The steering group meeting will take place at the University of Stirling, Pathfoot building, 
conference room E26. I shall be circulating details of a confirmed date and time in due 
course. 
 
Meanwhile, I thank you for your interest and for taking the time to collaborate in this project. 
I look forward to see you all. 
 
Best regards, 
 
 
Danika Marmarà 
Doctoral Researcher 
University of Stirling  
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Appendix 6.1b - Information Sheet for Maltese Expert Steering Group 
 
 
 
 
 
School of Health Sciences 
University of Stirling 
 
Mob: + 356 7777 3313 
E: d.m.attard@stir.ac.uk 
E: attard.danika@gmail.com 
 
07 March 2017 
Health Beliefs, Illness Perceptions and Determinants of Breast Screening Uptake in 
Malta 
 
 
Dear Colleagues, 
During the past two years, I have carried out a Nation-wide survey entitled “Health beliefs, 
illness perceptions and the determinants to breast screening uptake in Malta” as part 
of my doctoral research work at the University of Stirling. The aim of the study was to 
determine if health beliefs, illness representations, socio-demographic and medical factors 
are associated with uptake to attend the Malta Breast Screening Programme (MBSP). The 
findings of this study are of particular importance to the Chief Executive Officer heading the 
Primary Health Care Department, the National Breast Screening Programme, policy makers 
and other relevant key stakeholders in Malta.   
 
Following the completion of this survey, expert steering groups are being set up in Malta 
and in Scotland to bring together local and international expertise in the field of research, 
screening and intervention development. These steering groups shall provide an opportunity 
to discuss the results with academic experts in the field, experts heading the local healthcare 
community and policy makers in order to explore the way forward in developing appropriate 
strategies and culturally-appropriate interventions for the Maltese population. 
 
The objectives of this steering group are: 
1. To discuss the findings of the literature review on non-attendance for mammography 
screening, as well as women’s health beliefs, illness perceptions and other 
determinants to breast screening uptake in Malta; 
2. To develop a logic model of the problem. 
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3. To judge basic fit based on priority population and organizational capacity. 
 
Once the above objectives are fulfilled, another future phase of this project will be conducted 
to carry out further research work.  
 
You have been nominated as a member of this Expert steering group as you bring great value 
to this steering group. Your contribution shall be acknowledged in future publications.  
 
The steering group meeting will take place at the Office of the Cancer Care Pathways 
Directorate on 23rd March 2017 at 08:30 – 10:30.  
 
Meanwhile, I thank you for your interest and for taking the time to collaborate in this project. 
I look forward to see you all. 
 
Best regards, 
 
 
Danika Marmarà 
Doctoral Researcher 
University of Stirling, UK  
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Appendix 6.2 - Consent Form 
                          
 
 
 
 
School of Health Sciences 
University of Stirling 
 
Mob: + 356 7777 3313 
E: d.m.attard@stir.ac.uk 
E: attard.danika@gmail.com 
 
Consent for Use of Audio Recording 
 
In participating in this study, I have given my consent to participate as an expert member of 
this Expert steering group as part of Ms. Danika Marmarà’s doctoral research study. The 
researcher has explained to me the purpose and objectives of the steering group and has 
provided further detail through an information letter. I understand that the results obtained 
for this study in which I am participating may be used or published for scientific research 
purposes.  
 
Please read the following and, if you are in agreement, sign where indicated. 
 
1. I consent to the audio-recordings being made of the session/s and to these tapes being 
used to aid the work.      
 
Signed.....................................................  Dated.............................................. 
 
2. I consent to the excerpts from these recordings, or descriptions of them, being used 
by Danika Marmarà (the researcher) for the purposes of her PhD research study. 
 
Signed.....................................................  Dated.............................................. 
 
3. I understand that every effort will be made to ensure professional confidentiality and 
anonymity and that any use of audio tapes will be used for research purposes only. 
 
 
Signed.....................................................  Dated.............................................. 
 
 
 
 
 
Name.............................................  
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Appendix 7.1a: Information Sheet (English version) 
 
 
 
 
 
 
School of Health Sciences 
University of Stirling 
Work contact: + 356 79005111 
E: d.m.attard@stir.ac.uk 
E: attard.danika@gmail.com 
30th August 2017 
Health Beliefs, Illness Perceptions and Determinants of Breast Screening Uptake in Malta 
 
I am a female researcher at the University of Stirling with experience in mammography 
screening and cancer care, and trained in performing similar research in Malta. During the 
past two years, I have carried out a Nation-wide survey entitled “Health beliefs, illness 
perceptions and the determinants to breast screening uptake in Malta” as part of my 
doctoral research work at the University of Stirling. The aim of the study was to determine 
if health beliefs, illness representations, knowledge, socio-demographic and health status are 
associated with uptake of the first invitation to attend the Maltese Breast Screening 
Programme (MBSP). This study was followed by further analyses of the main predictors for 
re-attendance, the exploration of women being screened within or in excess of the 
recommended time intervals, and examining the determinants for lifetime mammography 
utilization and non-use in Malta. The findings are of particular importance to the Ministry 
for Health and policy makers and other key stakeholders in Malta.   
 
Today’s Science Espresso shall provide an opportunity to understand and discuss breast 
cancer and screening beliefs, attitudes and behaviours among the general public and explore 
your perceptions, knowledge, barriers and motivators to mammography screening. This will 
aid the development of appropriate strategies and culturally-appropriate interventions to 
increase mammography utilization among Maltese women. 
 
As a member of the general public, you bring great value to this research work as your 
contribution shall form the basis of intervention development in the Maltese context. All 
information shall be reported as collaborative feedback. Meanwhile, I thank you for your 
interest and for taking the time to participate in this project.  
 
 
Danika Marmarà, M.Sc., B.Sc. (Hons.) 
Doctoral Researcher 
University of Stirling (UK)  
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Appendix 7.1b: Information Sheet (Maltese version) 
 
 
 
 
Skola tax-Xjenzi tas-
Saħħa 
L-Università ta’ Stirling 
Nru tat-telefown: + 356 25452467/8 
Posta elettroknika: d.m.attard@stir.ac.uk 
Posta elettronika: attard.danika@gmail.com 
30 ta’ Awwissu 2017 
Il-Konvinzjonijiet dwar is-Saħħa, il-Perċezzjonijiet ta’ Mard u Determinanti għat-Teħid ta' 
Skrining tas-Sider f'Malta 
 
Jiena riċerkatriċi fl-Università ta’ Stirling b’esperjenza fl-Iskrining tas-Sider u l-kura tal-
kanċer, u b’taħriġ fit-twettiq ta’ ricerki simili. Matul dawn l-aħħar sentejn, għamilt stħarriġ 
fuq livell nazzjonali intitolat “Il-Konvinzjonijiet dwar is-Saħħa, il-Perċezzjonijiet ta’ 
Mard u Determinanti għat-Teħid ta' Skrining tas-Sider f'Malta” bħala parti mir-riċerka 
tiegħi fil-livell ta’ dottorat mal-Università ta’ Stirling. L-għan tal-istudju kien li jiddetermina 
jekk il-konvinzjonijiet dwar is-saħħa, ir-rappreżentazzjonijiet tal-mard, l-għarfien, l-istat 
soċjodemografiku u tas-saħħa humiex marbutin mal-attendenza tal-Programm Nazzzjonali 
tal-Iskrining tas-Sider f’Malta (MBSP) mal-ewwel stedina. Dan l-istudju kien segwit b’iktar 
analiżi f’Malta tal-fatturi ewlenin li jwasslu għal attendenza mill-ġdid, studju dwar nisa li 
qed jiġu skrinjati f’intervalli ta’ żmien kif rakkommandat, u eżaminazzjoni tad-determinanti 
li jwasslu lil dak li jkun li jirrikorri għall-mammografija matul il-ħajja jew li ma jmur qatt. 
Is-sejbiet jinteressaw b’mod partikolari lill-Ministeru tas-Saħħa u lil dawk li jfasslu l-politika 
u msieħba interessati oħra f’Malta.  
 
Il-preżentazzjoni fis-Science Espresso tal-lum joffru l-opportunità lil dak li jkun li jifhem u 
jiddiskuti l-kanċer tas-sider u l-konvinzjonijiet u l-attitudnjiiet dwar l-iskrining fost il-
pubbliku ġenerali u jesplora l-perċezzjonijiet, l-għarfien, l-ostakoli u dak li jħeġġeġ lill-mara 
tmur tagħmel skrining tas-sider. Dan jgħin fl-iżvilupp ta’ strateġija xierqa u interventi li 
jkunu adattati skont il-kultura biex tiżdied l-attendenza tan-nisa Maltin li jagħmlu 
mammogram. 
 
Bħala membru tal-pubbliku ġenerali, il-kontribut tiegħek hu siewi ħafna f’din il-ħidma ta’ 
riċerka minħabba li jservi bħala l-bażi biex jiġu żviluppati azzjonijiet fil-kuntest Malti. L-
informazzjoni ser tiġi rrapurtata bħala rispons kollaborattiv. Għaldaqstant, nirringrazzjakom 
tal-interess li wrejtu u għall-ħin li tajtu biex tieħdu sehem f’dan il-proġett.  
 
Danika Marmarà M.Sc., B.Sc. (Hons.) 
Riċerkatriċi fil-livell ta’ dottorat,  
L-Università ta’ Stirling (ir-Renju Unit)  
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Appendix 7.2a: Baseline recruitment screener (English version) 
 
Sociodemographics and health status (English version) 
 
Unique Identifier Number: __________     30th August 2017 
 
Q1. Female      Male  
Q2. How old are you?     ____________________ 
Q3. Where do you live?  ____________________ 
Q4. What is the highest level of education you have completed? 
(1) No schooling    
(2) Primary level    
(3) Secondary level     
(4) Diploma    
(5) Bachelor Degree    
(6) Post-Graduate Degree (Masters or above) 
(7) Other (Specify) ____________________  
Q5. What is your current employment status? Are you.. 
a. Employed full-time     
b. Employed part-time     
c. Unemployed     
d. Retired or on a pension     
e. Full-time student     
f. Engaged in home duties     
g. Other (Specify) __________________  
Q6. What best describes your current marital status? 
 
a. Single/Never been married    
b. Married          
c. Cohabitating     
d. Separated/Divorced        
e. Widowed      
Q7. What is your annual household income? 
 
(1) Less than €10,737    
(2) €10,737 – €16,113     
(3) €16,114 – €23,563    
(4) €23,564 – €33,966    
(5) Greater than €33,966    
(6) Don’t know/Prefer not to say    
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Q8. a) Do you own a car?  Yes    No  
 b) Do you drive?  Yes    No  
 
Q9. (a) Have you had a breast cancer diagnosis in the last 5 years? 
 Yes   No    
 
        (b) Have you had any other cancer diagnosis in the last 5 years? 
 Yes   Which cancer? ___________________ No     
 
Q10. Have your relatives had cancer?    
  Yes      Who? __________________ Define which cancer ______________ 
  No     
 
Q11. Has a close friend been diagnosed with cancer?  
  Yes     Define which cancer ________________________ 
  No      
 
Q12. Which best describes the last time you had any of the following? (circle number 
below) 
Health services utilization Within the 
past 12 
months 
1 to 2 years 
ago 
More than 2 
years ago 
Never 
Visit to a primary care 
physician / GP 
1 2 3 4 
Pap smear for Cervical 
cancer screening 
1 2 3 4 
Faecal Occult Blood test 
(FOBT) (through a stool 
sample) for Colorectal 
cancer screening 
1 2 3 4 
Blood pressure check for 
high blood pressure 
1 2 3 4 
Bone density screening for 
Osteoporosis 
1 2 3 4 
Mammogram for Breast 
cancer 
1 2 3 4 
Clinical Breast 
Examination by a 
specialist 
1 2 3 4 
Blood test for diabetes 1 2 3 4 
 
Q13. Religion 
a. Catholic affiliation  
b. Christian affiliation  
c. Other religion (specify)  ________________________ 
d. Somewhat religious (rate on 1-10 scale) 1      2       3      4      5     6      7      8      9      10 
e. Atheist (non-believer in the existence of God or gods)  
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Appendix 7.2b: Baseline recruitment screener (Maltese version) 
 
Numru tal-identifikatur uniku: __________    30 ta’ Awwissu 2017 
Q1. Mara      Raġel   
Q2. Kemm għandek żmien?     ____________________ 
Q3. Fejn toqgħod?  ____________________ 
Q4. X’inhu l-ogħla livell ta’ edukazzjoni li temmejt? 
(1) Qatt ma mort skola      
(2) Livell primarju      
(3) Livell sekondarju       
(4) Diploma      
(5) Grad ta’ Baċellerat      
(6) Grad post Gradwatorju (Masters jew iktar)   
(7) Ieħor (Speċifika) ____________________   
 
Q5. X’taħdem? Int... 
a. Impjegat/a full-time       
b. Impjegat/a part-time       
c. Bla xogħol       
d. Irtirat/a jew pensjonat/a       
e. Student/a full-time       
f. Tagħmel xogħol fid-dar       
g. Taghmel Ħaġ’oħra (Speċifika) _______________  
 
Q6. Kif l-aqwa tiddeskrivi l-istat ċivili tiegħek bħalissa? 
a. Xebba/Ġuvni      
b. Miżżeweġ/Miżżewġa          
c. Nikkoabita       
d. Separat/a/Divorzjat/a          
e. Armel/Armla       
 
Q7. X’inhu d-dħul tal-familja tiegħek? 
(1) Inqas minn €10,737      
(2) €10,737 – €16,113       
(3) €16,114 – €23,563      
(4) €23,564 – €33,966      
(5) Iktar minn €33,966      
(6) Ma nafx/Nippreferi ma ngħidx     
Q8. a) Għandek karozza?  Iva   Le  
 b) Issuq?    Iva   Le  
 
Q9. (a) Fl-aħħar 5 snin kellek dijanjożi ta’ kanċer tas-sider? 
 Iva    Le    
 
        (b) Kellek xi dijanjożi ta’ xi kanċer ieħor fl-aħħar 5 snin? 
 Iva   X’kanċer? ___________________ Le     
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Q10. Kellek xi qraba li ħarġilhom kanċer?    
  Iva      Min? __________________ X’kanċer? __________________ 
  Le     
 
Q11. Kellek xi ħabib/a tal-qalb bil-kanċer?  
  Iva     X’kanċer? ________________________ 
  Le      
 
Q12. Liema minn dawn jiddeskrivu bl-aqwa mod l-aħħar darba li għamilt xi użu minn xi 
wieħed mis-servizzi tas-saħħa li ġejjin? (agħmel ċirku man-numru t’hawn taħt) 
Użu minn servizz tas-
saħħa 
Fl-aħħar 12-il 
xahar 
Minn sena 
sa sentejn 
ilu 
Iktar minn 
sentejn ilu 
Qatt 
Vista għand it-tabib 
tiegħek 
1 2 3 4 
Skrining għall-kanċer tal-
għonq tal-utru (Pap smear) 
1 2 3 4 
Skrining għall-kanċer tal-
musrana permezz ta’ test 
guaiac tad-demm okkult 
fir-rawt (FOBT) (permezz 
ta’ kampjun tal-ippurgar)  
1 2 3 4 
Test tad-demm għall-
pressjoni għolja  
1 2 3 4 
Skrining tad-densità tal-
għadam għall-Osteoporożi 
1 2 3 4 
Mammogram għall-kanċer 
tas-sider 
1 2 3 4 
Eżami kliniku tas-sider 
minn speċjalista 
1 2 3 4 
Test tad-demm għad-
dijabete 
1 2 3 4 
 
Q13. Reliġjon 
a. Affiljazzjoni kattolika  
b. Affiljazzjoni kristjana  
c. Reliġjon ieħor (speċifika)  ________________________ 
d. Reliġjuż/a b’mod moderat (minn grad 1 sa 10) 1      2       3      4      5     6      7      8      9   10   
e. Ateist/a (ma nemminx fl-eżistenza ta’ Alla jew tal-allat)  
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Appendix 8.1: Consolidated criteria for reporting qualitative research 
(COREQ): a 32-item checklist for interviews 
 
No.  Item  
 
Guide questions/description Reported on 
Page / Section # 
Domain 1: Research team 
and reﬂexivity  
  
Personal Characteristics    
1. Interviewer/facilitator Which author/s conducted the 
interview or focus group?  
Section 8.3.2 
 
2. Credentials What were the researcher’s 
credentials? E.g. PhD, MD  
Appendix, 
Participant 
Information 
Sheet 
3. Occupation What was their occupation at the time 
of the study?  
n/a 
4. Gender Was the researcher male or female?  Appendix, 
Participant 
Information 
Sheet 
5. Experience and training What experience or training did the 
researcher have?  
Appendix, 
Participant 
Information 
Sheet 
Relationship with 
participants  
  
6. Relationship established Was a relationship established prior to 
study commencement?  
Study 2 
.   
7. Participant knowledge of 
the interviewer  
What did the participants know about 
the researcher? e.g. personal goals, 
reasons for doing the research  
Appendix, 
Participant 
Information 
Sheet 
8. Interviewer characteristics What characteristics were reported 
about the interviewer/facilitator? e.g. 
Bias, assumptions, reasons and 
interests in the research topic  
Appendix, 
Participant 
Information 
Sheet, reasons 
and interests in 
the research 
topic 
Domain 2: study design    
 
Theoretical framework    
 
9. Methodological orientation 
and Theory  
What methodological orientation was 
stated to underpin the study? e.g. 
grounded theory, discourse analysis, 
ethnography, phenomenology, content 
analysis  
Section 8.3 
Participant selection    
 
10. Sampling How were participants selected? e.g. 
purposive, convenience, consecutive, 
snowball  
Section 8.3.4 
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11. Method of approach How were participants approached? 
e.g. face-to-face, telephone, mail, email  
Section 8.3.5 
 
 
12. Sample size How many participants were in the 
study?  
Section 8.3.4 
 
13. Non-participation How many people refused to 
participate or dropped out? Reasons?  
Figure 8.1 
 
 
Setting   
 
14. Setting of data collection Where was the data collected? e.g. 
home, clinic, workplace  
Section 8.3.2 
. 
15. Presence of non-
participants 
Was anyone else present besides the 
participants and researchers?  
Section 8.3.2 
Inferred as one-
to-one 
interviews 
 
16. Description of sample What are the important characteristics 
of the sample? e.g. demographic data, 
date  
Section 8.3.3 – 
8.3.4 
 
Data collection    
 
17. Interview guide Were questions, prompts, guides 
provided by the authors? Was it pilot 
tested?  
Appendix and 
Section 8.3.7.2 
 
18. Repeat interviews Were repeat interviews carried out? If 
yes, how many?  
No 
 
19. Audio/visual recording Did the research use audio or visual 
recording to collect the data?  
Yes, Section 
8.3.6 
20. Field notes Were ﬁeld notes made during and/or 
after the interview or focus group? 
Section 8.3.6 
21. Duration What was the duration of the 
interviews or focus group?  
Section 8.3.6  
 
 
22. Data saturation Was data saturation discussed?  Sections 8.3.4 
 
23. Transcripts returned Were transcripts returned to 
participants for comment and/or 
correction?  
Section 8.3.9.5 
  
Domain 3: analysis and 
ﬁndings  
  
Data analysis   
 
 
24. Number of data coders How many data coders coded the data?  Section 8.3.9.3 
 
25. Description of the coding 
tree 
Did authors provide a description of 
the coding tree?  
Section 8.3.9.3 
 
26. Derivation of themes Were themes identiﬁed in advance or 
derived from the data?  
 
In advance, 
Section 8.3.9.4 
 
27. Software What software, if applicable, was used 
to manage the data?  
Manually, 
Section 8.3.9.3 
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28. Participant checking Did participants provide feedback on 
the ﬁndings?  
Yes, Section 
8.3.9.5 
Reporting   
 
 
29. Quotations presented Were participant quotations presented 
to illustrate the themes/ﬁndings? Was 
each quotation identiﬁed? e.g. 
participant number  
Yes, Sections 
8.4.3 – 8.4.6 
 
30. Data and ﬁndings 
consistent 
Was there consistency between the 
data presented and the ﬁndings?  
Yes, there was. 
Section 8.4, 
Results 
31. Clarity of major themes Were major themes clearly presented 
in the ﬁndings?  
Yes, Sections 
8.4.3 – 8.4.6 
32. Clarity of minor themes Is there a description of diverse cases 
or discussion of minor themes?       
Discussion of 
major and minor 
sub-themes in 
Section 8.5 
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Appendix 8.2a: Participant information sheet for Maltese women (English 
version) 
 
Study Title: Non-attendance to mammography screening: a Qualitative Study among 
non-screeners in Malta 
 
You are invited to take part in this study. 
 
This sheet is to provide you with the information you need to see if you would like to take 
part in the study. 
 
Please ask if you have more questions or need more information. 
 
What is the purpose of the Study?  
I am a female researcher at the University of Stirling with experience in mammography 
screening and cancer care, and trained in performing similar research in Malta. I am 
interested in understanding why women do not undergo mammography. This will help 
to develop a future intervention to promote breast cancer prevention and screening 
among Maltese women living in Malta. Therefore, we need to collect some data to 
understand the Maltese women’s knowledge and beliefs about breast cancer, barriers to 
mammography, and motivating and inhibiting factors related to the uptake of 
mammography.  
Why you? 
You have been asked to join the study as you have never attended for mammography 
screening. This study is an extension to the previous telephone survey where we had 
explored your health beliefs, illness perceptions and determinants of Breast Screening 
Uptake in Malta, and you had agreed to be contacted further. 
What will it involve? 
You will be interviewed by the main researcher of this study at a convenient location 
and time for you. At first, you will be asked to complete a questionnaire regarding some 
demographic information such as your age. After that, you will be encouraged to discuss 
your views and experiences about breast cancer prevention and other life experiences. 
This conversation will be audio recorded for the purpose of data analyses. A debrief 
will be provided once the conversation has finished. In this, you will get detailed 
information about this study and the breast cancer screening programme.  
How long will participation take?  
This conversation will last approximately one to one and a half hours.  
Will I encounter any risk or discomfort? 
Usually, you will have no risks or discomfort in participation in this study. In rare cases, 
the questions could be distressing. You will be given details of counselling services that 
are available to help you.  
What are the benefits in taking part in this study? 
By taking part in this study, you can help us to understand factors associated with 
screening decisions among Maltese women, thus to design and implement effective 
services to improve breast health among Maltese women. In addition, you will be 
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provided some useful information about breast cancer and the effective ways to prevent 
it. You will be awarded 20 euros at the end of the interview as a token of thanks for 
participation in this study.  
What will happen to the results of the study? 
The results will be used to better understand the beliefs, perceptions, attitudes and 
knowledge about breast screening among women who do not attend for mammography, 
to better understand potential barriers to participation and to determine which 
interventions, cues to actions, key messages and channels are most appropriate for 
communicating with women about breast cancer screening. Research papers may be 
published and presented at conferences. In this way, more people are aware of the 
factors related to non-attendance to mammography screening. These results will aid the 
future development of interventions to increase breast screening uptake in Malta. 
What about Confidentiality?  
All information will be confidential and anonymous. You will NOT be named in any 
results or reports written on the study. Data will be kept in a locked filing cabinet and 
in password protected folders on computers at the School of Health Sciences and Sport, 
University of Stirling. The audio recording will not be destroyed for at least five years. 
 Ethical Approval 
The NHS, Invasive or Clinical Research (NICR) Committee at the University of Stirling 
and the Maltese Health Ethics Committee has reviewed the study. There will be 
monitoring from the University of Stirling that this research project is being properly 
conducted. 
What happens next? 
A research assistant shall contact you by telephone to confirm that they have NEVER 
been screened, to explain the research objectives and to confirm if you are willing and 
able to participate. If you agree to take part in this research study, you shall receive the 
information sheet by post and a suitable time and location for the interview shall be 
arranged according to your preferences and availability. The interview shall be 
conducted face-to-face between yourself and the researcher, based on your preferences. 
You will be asked by the researcher to complete a consent form to confirm your 
willingness to participate in the study. The interview will be conducted in the Maltese 
or English language (as preferred by yourself) and is envisaged to last between 60 - 90 
minutes. The researcher shall take field notes during the interview to facilitate the 
interview process.  
What about Voluntary Participation and Withdrawal?  
You have the right to withdraw at any stage without having to give an explanation and 
without loss of payment. If you do stop you may wish to give a reason as this may help 
plan future studies. You are free to ask any questions at any time.  
Where will the study take place? 
This study will be carried out at a convenient location and time as defined by yourself. 
Please keep a copy of this information sheet.  
What if I wish to complain about the study? 
You can submit a written complaint about any part of the study to:  
Ministry for Health 
Director General (Health Care Services) 
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Office of the Director General, 
15, Palazzo Castellania,  
Merchants Street,  
Valletta, Malta. 
 
Who do I contact for further information about the study? 
If you have any questions about this research project or concerns about your rights as a 
research participant in this study, please call the Principal Investigator (researcher) for 
this study. Details of the researcher can be found hereunder. 
 
Researcher        
Danika Marmarà, M.Sc., B.Sc. (Hons.)       
School of Health Sciences and Sport,    
University of Stirling       
Stirling         
FK9 4LA         
Tel: +356 77773313       
Email:  d.m.attard@stir.ac.uk           
attard.danika@gmail.com     
 
 
Independent contact 
Should you have any concerns, or wish to speak to someone independent of the study, please 
contact ________________, Faculty of Health Sciences and Sports at: 
__________@stir.ac.uk 
 
 
Thank you for taking the time to read this and to consider taking part in the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participant information sheet V2 16.09.17 
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Appendix 8.2b: Participant information sheet for Maltese women (Maltese 
version) 
 
Nota ta’ informazzjoni għall-parteċipanti Maltin (verżjoni bil-Malti) 
Titlu tal-Istudju: Nuqqas ta’ attendenza għall-iskrining tas-sider: Studju Kwalitattiv 
fost dawk li ma jmorrux għall-iskrining f’Malta 
 
Int mistiedna tieħu sehem f’dan l-istudju. 
 
L-għan ta’ din in-nota hu li tagħtik l-informazzjoni li teħtieġ jekk tixtieq tieħu sehem fl-
istudju. 
 
F’każ li għandek iktar mistoqsijiet jew tixtieq iktar informazzjoni, staqsi. 
 
X’inhu l-għan tal-Istudju? 
Jiena riċerkatriċi fl-Università ta’ Stirling b’esperjenza fl-Iskrining tas-Sider u l-kura 
tal-kanċer, u b’taħriġ fit-twettiq ta’ ricerki simili. Qiegħda nistħarreġ għalfejn in-nisa 
jiddeċiedu li ma jmorrux għall-mammogram. Dan jgħin sabiex tiġi żviluppata strateġija  
li tippromwovi l-prevenzjoni tal-kanċer tas-sider u l-iskrining fost in-nisa Maltin li 
jgħixu Malta. Għaldaqstant, irridu niġbru xi data biex nifhmu l-għarfien tan-nisa Maltin 
u l-konvinzjonijiet dwar il-kanċer tas-sider, l-ostakoli għall-mammografija, u l-fatturi li 
jħeġġu u li jwaqqfu lil dak li jkun milli jmur għal skrining tas-sider. 
Għalfejn qed nikkuntattjaw lilek? 
Qed tintalab tieħu sehem fl-istudju minħabba li qatt ma mort tagħmel skrining tas-sider. 
Dan l-istudju hu estensjoni tal-istħarriġ li kien sar bit-telefown fejn konna stħarriġna il-
konvinzjonijiet tiegħek dwar is-saħħa, il-perċezzjonijiet ta’ mard u determinanti għat-
Teħid ta' Skrining tas-Sider f'Malta, u kont qbilt li terġa’ tiġi kkuntattjata. 
X’jinvolvi? 
Se tiġi intervistata mir-riċerkatriċi ewlenija ta’ dan l-istudju f’post u ħin konvenjenti 
għalik. Fil-bidu, se tintalab timla kwestjonarju li fih tagħti informazzjoni demografika 
dwarek, pereżempju l-età. Wara, se tiddiskuti l-ideat u l-esperjenzi tiegħek dwar il-
prevenzjoni tal-kanċer tas-sider u xi esperjenzi oħra li kellek tul ħajtek. Il-vuċi tul il-
konverżazzjoni se tiġi rrekordjata sabiex tkun tista’ tiġi analizzata d-data li tinġabar. Fi 
tmiem il-konverżazzjoni, jingħata rendikont ġenerali. Hawn, tingħata informazzjoni 
dettaljata dwar dan l-istudju u l-programm ta’ skrining għall-kanċer tas-sider. 
Kemm idum dan il-proċess?  
Din il-konverżazzjoni mistennija ddum bejn siegħa u siegħa u nofs. 
Hemm xi riskju jew ċans li nħossni skomda? 
Normalment, ma jkunx hemm lok għal riskji jew li tħossok skomda meta tipparteċipa 
f’dan l-istudju. F’każijiet rari, il-mistoqsijiet jistgħu jqanqlu ansjetà. F’dak il-każ 
tingħata dettalji ta’ min jista’ jgħinek. 
X’inhuma l-benefiċċji li tieħu sehem f’dan l-istudju? 
Is-sehem tiegħek f’dan l-istudju jista’ jgħinna nifhmu l-fatturi assoċjati mad-deċiżjoni 
li jieħdu n-nisa f’Malta biex imorru għall-iskrining jew le, biex infasslu u nattwaw 
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servizzi effettivi li jtejbu s-saħħa tas-sider fost in-nisa f’Malta. Barra minn hekk, 
tingħata informazzjoni utli dwar il-kanċer tas-sider u modi effettivi ta’ prevenzjoni. 
Tingħata 20 ewro fl-aħħar tal-intervista bħala turija ta’ ringrazzjament talli tkun ħadt 
sehem f’dan l-istudju. 
Xi jsir mir-riżultati tal-istudju? 
Ir-riżultati jintużaw biex nifhmu aħjar il-konvinzjonijiet, perċezzjonijiet, attitudnijiet u 
għarfien dwar l-iskrining tas-sider fost in-nisa li ma jmorrux għall-mammogram, 
nifhmu x’inhuma l-ostakoli li jista’ jkun qed jiffaċċjaw biex jipparteċipaw u 
niddeterminaw x’tip ta’ azzjonijiet u messaġġi ewlenin imissna nużaw biex 
nikkomunikaw man-nisa dwar l-iskrining għall-kanċer tas-sider. Jista’ jkun li riċerka 
abbinata ma’ dan tiġi ppubblikata u ppreżentata f’konferenzi. B’dan il-mod, iktar nies 
isiru konxji tal-fatturi relatati man-nuqqas ta’ attendenza għall-iskrining tas-sider. Dawn 
ir-riżultati jgħinu biex ikun hemm żvilupp fil-ġejjieni ta’ azzjonijiet biex tiżdied l-
attendenza ta’ dawk li jmorru għall-iskrining f’Malta. 
L-informazzjoni li tinġabar tinżamm kunfidenzjali?  
L-informazzjoni kollha tinżamm kunfidenzjali u anonima. Ismek mhu se jitniżżel fl-
ebda riżultat jew rapport li jinħareġ ta’ dan l-istudju. Id-data tinżamm f’armarju msakkar 
u f’folders protetti b’password fuq kompjuters tal-Iskola tax-Xjenzi tas-Saħħa u l-
Isport, l-Università ta’ Stirling. Ir-rekording tal-vuċi tinżamm għallanqas ħames snin. 
 Approvazzjoni etika 
Il-Kumitat tal-Iskola tar-Riċerka (NICR) fl-Università ta’ Stirling u l-Kumitat ta’ Etika 
dwar is-Saħħa ta’ Malta analizzaw l-istudju. L-Università ta’ Stirling se timmonitorja 
dan il-proġett ta’ riċerka biex tiżgura li jitwettaq sew. 
X’inhuma l-passi li jmiss? 
L-assistenta tar-riċerkatrici għandha tikkuntattjak bit-telefown biex tikkonferma li int 
QATT ma mort għal skrining, tispjegalek l-għanijiet tar-riċerka u tikkonferma miegħek 
li tixtieq tieħu sehem. Jekk taqbel li tieħu sehem f’dan l-istudju ta’ riċerka, tirċievi n-
nota ta’ informazzjoni bil-posta u jiġi miftiehem ħin u post tajjeb għalik biex issir l-
intervista skont il-preferenzi u d-disponibbiltà tiegħek. L-intervista ssir wiċċ’imb wiċċ 
bejnek u r-riċerkatriċi, abbażi tal-preferenzi tiegħek rigward il-ħin. Ir-riċerkatriċi 
titolbok timla formola tal-kunsens biex tikkonferma li int tixtieq tieħu sehem f’dan l-
istudju. L-intervista ssir bil-Malti jew bl-Ingliż (skont kif tippreferi) u mistenni li ddum 
minn 60 sa 90 minuta. Ir-riċerkatriċi tieħu n-noti waqt l-intervista biex tiffaċilita l-
proċess tal-intervista. 
Is-sehem tiegħi hu voluntarju u nista’ nirtira mill-proċess?  
Għandek dritt tirtira fi kwalunkwe stadju tal-proċess mingħajr ma tagħti spjegazzjoni u 
mingħajr ma titlef il-ħlas. Jekk tiddeċiedi li tieqaf ikun apprezzat jekk tagħti raġuni 
għalfejn għamilt dan peress li hekk tkun qed tgħin lil min se jkun qed jippjana studji 
simili fil-futur. Tista’ tistaqsi kwalunkwe mistoqsija fi kwalunkwe mument. 
Fejn isir l-istudju? 
Dan l-istudju se jsir f’post u ħin konvenjenti skont kif indikat minnek. 
Jekk jogħġbok żomm kopja ta’ din in-nota ta’ informazzjoni.  
X’jiġri jekk inkun irrid inressaq ilment dwar l-istudju? 
Tista’ tibgħat l-ilment bil-miktub dwar kwalunkwe parti ta’ dan l-istudju f’dan l-indirizz: 
Il-Ministeru tas-Saħħa 
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Id-Direttur Ġenerali (Servizzi għall-Kura tas-Saħħa) 
Uffiċċju tad-Direttur Ġenerali, 
15, Palazzo Castellania,  
Triq il-Merkanti,  
Il-Belt Valletta, Malta. 
 
Lil min nikkuntattja għal iktar informazzjoni dwar l-istudju? 
Jekk għandek xi mistoqsijiet dwar dan il-proġett ta’ riċerka jew xi tħassib dwar id-
drittijiet tiegħek bħala parteċipanta f’dan l-istudju, tista’ ċċempel lill-Investigatur 
Prinċipali (ir-riċerkatriċi) ta’ dan l-istudju. Id-dettalji tar-riċerkatriċi jinsabu hawn taħt. 
 
Ir-Riċerkatriċi       
Danika Marmarà M.Sc., B.Sc. (Hons.)        
L-Iskola tax-Xjenzi tas-Saħħa u l-Isport,    
L-Università ta’ Stirling       
Stirling, Ir-Renju Unit        
FK9 4LA         
Nru tat-telefown: +356 77773313       
Posta elettronika:  d.m.attard@stir.ac.uk         
attard.danika@gmail.com     
 
Kuntatt indipendenti 
F’każ li għandek xi problema, jew tixtieq titkellem ma’ xi ħadd indipendenti dwar dan l-
istudju, tista’ tikkuntattja lill-_____________, il-Fakultà tax-Xjenzi tas-Saħħa u l-Isport 
permezz tal-posta elettronika: ____________@stir.ac.uk 
 
 
Nirringrazzjak tal-ħin li sibt biex taqra din in-nota u talli kkunsidrajt tieħu sehem fl-
istudju. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nota ta’ informazzjoni għall-Parteċipanti V2 16.09.17 
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Appendix 8.3a - Informed consent form (English version) 
 
  PLEASE 
INITIAL 
BOX IF 
YOU 
AGREE 
1. I confirm that I have read and understand the information sheet 
(version 2 160917) for this study and have had the opportunity to 
ask questions 
 
2. I understand that if I participate in an interview it may be audio-
recorded 
 
3. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason 
 
4. I understand that the research team will hold the information I give 
confidentially and my name will not be mentioned in any reports 
 
5. I understand that all information from this study will be kept in a 
locked filing cabinet at the University of Stirling and stored in a 
password protected folder on the University computer hard drive 
 
6. I understand that if consent to participate in the study is declined 
or terminated at any stage, I will enter normal follow up care  
 
7. I agree to participate in this study 
 
 
 
 
Name of participant_____________________________  
 
Signature _____________________________________ 
Date_________________________________________ 
 
Name of witness (Researcher)_____________________ 
 
Signature _____________________________________ 
Date__________________________________________ 
 
 
 
 
 
 
 
 
 
Participant consent form V2 16.09.17 
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Appendix 8.3b - Informed consent form (Maltese version) 
 
 
Formola tal-kunsens infurmat 
 
Titlu tal-Istudju: Nuqqas ta’ attendenza għall-iskrining tas-sider: Studju Kwalitattiv 
fost dawk li ma jmorrux għall-iskrining f’Malta 
 
  JEKK 
JOGĦĠBOK 
DAĦĦAL L-
INIZJALI 
TIEGĦEK 
JEKK 
TAQBEL  
1. Nikkonferma li qrajt u fhimt in-nota ta' informazzjoni (verżjoni 
2 160917) għal dan l-istudju u kelli ċ-ċans insaqsi l-mistoqsijiet  
 
2. Nifhem li jekk nieħu sehem, l-intervista se tiġi rekordjata   
3. Nifhem li l-parteċipazzjoni tiegħi hija volontarja u li nista’ 
nirtira fi kwalunkwe stadju, mingħajr ma nagħti raġuni 
 
4. Nifhem li t-tim ta' riċerka se jżomm l-informazzjoni li nagħti 
b'mod kunfidenzjali u ismi mhu se jidher fl-ebda rapport  
 
5. Nifhem li l-informazzjoni kollha minn dan l-istudju se tinżamm 
imsakkra f’armarju fl-Università ta’ Stirling u f'folders protetti 
b'password fuq il-hard drive tal-kompjuters tal-Università  
 
6. Nifhem li jekk inwaqqa' jew nittermina l-kunsens biex nieħu 
sehem fi kwalunkwe stadju tal-istudju, jien inkun nista’ 
nirrikorri għall-kura tas-saħħa mingħajr xkiel 
 
7. Naqbel li nieħu sehem f’dan l-istudju 
 
 
 
 
Isem il-parteċipanta ___________________________ 
 
Firma ______________________________________ 
Data_______________________________________ 
 
Isem ix-xhud (Ir-Riċerkatriċi)____________________ 
 
 
Firma ______________________________________ 
Data________________________________________ 
 
 
 
 
 
Formola tal-kunsens għall-parteċipanti V2 16.09.17 
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Appendix 8.4a – Socio-demographic questionnaire (English version) 
 
Code Number:               ______________________ 
Date of Interview (MM/DD/YY): ______________________ 
Location of Interview:  ______________________ 
Start time of Interview:  ______________________ 
Has participant signed the Informed Consent? Yes   No  
End time of Interview:  ______________________ 
 
Table 1: Individual characteristics  
Sociodemographic and Health 
Status variables 
 
Age (years) 
 
______________________ 
 
District 
 
______________________ 
Marital status 
      
      
      
Married  
Single    
Separated / Divorced  
Widowed  
Education 
     
     
         
Primary school  
Secondary school  
Tertiary level (Diploma)  
Tertiary level (Degree)  
Tertiary level (Masters or above)  
Occupation 
      
      
 
Government employee  
Private employee  
Housewife  
Unemployed  
Pensioner  
Income 
      
      
      
Less than €10,737  
Between €10,737 – €16,113  
Between €16,114 – €23,563  
Between €23,564 – €33,966  
Greater than €33,966  
Unable/unwilling to say  
Do you own a car? 
Do you drive? 
Yes    No   
Yes    No  
Illness or Disability 
     If Yes, what is it? 
Yes    No  
_______________________________ 
 
Do you have a family physician (GP) 
who provides medical care and advice 
to you? 
Yes    No  
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Have you ever had any type of breast 
condition or disease? 
What type of breast condition or 
disease? 
Yes    No  
 
Fibrocystic ‘Lumpy Breasts’  
Cysts  
Other  __________________ 
 
Have you ever been diagnosed with 
cancer? 
Do you have a family history or close 
friends with cancer? 
     If Yes, who? 
Yes    No  
 
Yes    No  
  
____________________ 
 
Perceived health status 
     
     
 
Excellent  
Very good  
Good  
Fair  
Poor  
Cancer Screening behaviours 
Ever had a clinical breast exam? 
Ever performed breast self-
examination? 
Ever had a mammogram? 
Ever had a Pap-smear test (cervical 
Papanicolaou’s smear)? 
Ever had a faecal occult blood test 
(FOBT)? 
 
Yes    No  
 
Yes    No  
Yes    No  
Yes    No  
 
Yes    No  
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Appendix 8.4b – Socio-demographic questionnaire (Maltese version) 
 
Numru tal-kodiċi:   ______________________ 
Data tal-Intervista (XX/DD/SS): ______________________ 
Post fejn saret l-Intervista:  ______________________ 
X’ħin bdiet l-Intervista:  ______________________ 
Il-parteċipanta ffirmat il-Formola tal-Kunsens Infurmat? Iva   Le  
X’ħin spiċċat l-Intervista:  ______________________ 
Tabella 1: Karatteristiċi individwali  
Varjabbli soċjodemografiċi u Stat ta’ 
Saħħa  
 
Età (fi snin) 
 
______________________ 
 
Distrett 
 
______________________ 
Stat 
      
      
      
Miżżewġa  
Xebba    
Separata / Divorzjata  
Armla  
Edukazzjoni 
     
     
         
Skola primarja  
Skola sekondarja  
Livell terzjarju (Diploma)  
Livell terzjarju (Lawrja)  
Livell terzjarju (Masters jew iktar)  
Impjieg 
      
      
 
Impjegata mal-Gvern  
Impjegata mal-Privat  
Mara tad-dar  
Qiegħda  
Pensjonanta  
Dħul 
      
      
      
Inqas minn €10,737  
Bejn €10,737 – €16,113  
Bejn €16,114 – €23,563  
Bejn €23,564 – €33,966  
Iktar minn €33,966  
Ma nistax jew nippreferi ma ngħidx  
Għandek karozza? 
Issuq? 
Iva    Le   
Iva    Le  
Mard jew diżabbiltà 
     Jekk iva, speċifika? 
Iva    Le  
_______________________________ 
 
Għandek tabib tal-familja (GP) li 
jipprovdilek saħħa medika u jtik pariri? 
Iva    Le  
 
Qatt kellek xi tip ta’ kundizzjoni jew 
marda f’sidrek? 
X’tip ta’ kundizzjoni jew marda? 
Iva    Le  
 
“Boċoċ fis-Sider”(fibrocystic)   
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 Ċesti  
Ħaġ’oħra  _______________ 
 
Qatt kellek xi tip ta’ kanċer? 
Għandek lil xiħadd fil-familja jew ħbieb 
qrib li ntlaqtu mill-kanċer? 
     Jekk iva, min? 
Iva    Le  
Iva    Le  
 
____________________ 
 
Perċezzjoni tal-istat ta’ saħħa  
     
     
 
Eċċellenti  
Tajba ħafna  
Tajba  
Passabbli  
Ħażina  
Skrining għal kanċer  
Qatt għamilt eżami kliniku ta’ sidrek? 
Qatt eżaminajt sidrek int stess? 
Qatt għamilt mammogram? 
Qatt għamilt test tal-għonq tal-utru? 
(cervical Papanicolaou’s smear) 
Qatt għamilt test tad-demm kontra l-
kanċer tal-musrana (magħruf bħala 
FOBT - test guaiac tad-demm okkult 
fir-rawt)? 
 
 
Iva    Le  
Iva    Le  
Iva    Le  
Iva    Le  
 
 
Iva    Le  
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Appendix 8.5a - Debrief (English version) 
Thank you very much for taking part in the study. The aim of this study is to understand 
factors related to mammographic decisions among Maltese women in order to design 
and implement effective services to improve your participant rates.  
 
Breast cancer accounts for 28.8% of all female cancer incidences in Europe with 425,000 
new cases diagnosed yearly. In Malta, BC accounts for 21% of all female cancer 
incidences with an average of 280 women diagnosed each year, over the last decade. 
Breast cancer is more common in women who are over 50 years of age and in post-
menopausal women and the risk continues to increase with age. Therefore, it is 
necessary to uptake of mammography in order to detect the early cancer.  
 
Mammography can detect breast cancer early and women who take part in breast screening 
reduce their personal risk of dying from breast cancer. The mammography procedure is 
a low dose x-ray and during the procedure, each breast is placed in turn on the x-ray 
machine and gently but firmly compressed with a clear plate. Compression is needed to 
keep the breast still and to get the clearest picture with the lowest amount of radiation 
possible. Most women find this uncomfortable and some feel short-lived pain. Most 
women find it slightly uncomfortable and some may find it painful. All women will 
have two views of the breast taken at every screen - one from above (cranio-caudal) and 
one into the armpit diagonally across the breast (medio-lateral oblique). 
 
In this study, you will not be identified at any time in the write up. Information given by you 
will not be disclosed to any third parties. No records will be kept which could identify 
any individual as being linked to any information disclosed in this study. The 
information you have provided will be only used to design and implement effective 
services to improve the prevention of breast cancer among Maltese women.  
 
For more information about breast screening programme, please call on 21227470/1. A 
video of the mammography procedure is available at 
http://www.nhs.uk/video/Pages/Breastcancerscreening.aspx 
 
If you have any queries or concerns regarding the study please contact the researcher, Danika 
Marmarà, at d.m.attard@stir.ac.uk or 77773313. If you feel that you have experienced 
any feelings of distress as a result of this study and want to discuss these feelings please 
contact the nursing team at the National Breast Screening Programme on 21227470/1 
for counselling. 
 
 
 
 
 
 
Participant debrief V2 16.09.17 
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Appendix 8.5b - Debrief (Maltese version) 
Rendikont ġenerali  
Grazzi talli ħadt sehem fl-istudju. L-għan ta’ dan l-istudju hu li nifhmu il-fatturi marbutin 
mad-deċiżjonijiet li jieħdu nisa Maltin dwar jekk imorrux jagħmlu mammogram jew le 
sabiex inkunu nistgħu nfasslu u nattwaw servizzi effettivi biex intejbu l-attendenza. 
 
Il-kanċer tas-sider jammonta għal 28.8% tal-każijiet kollha ta’ kanċer fost in-nisa madwar l-
Ewropa b’425,000 każ ġdid fis-sena. F’Malta, il-kanċer tas-sider jammonta għal 21% 
tal-każijiet kollha ta’ kanċer fis-sena, b’medja ta’ 280 każ ġdid fis-sena, fuq l-aħħar 
medda ta’ għaxar snin. Il-kanċer tas-sider hu iktar komuni fin-nisa ‘il fuq minn 50 sena 
u li jkunu fil-fażi ta’ wara l-menopawsa u r-riskju jkompli jiżdied mal-età. Għalhekk, 
hu neċessarju li jsir mammogram sabiex il-kanċer ikun jista’ jinqabad fi stadju bikri. 
 
Il-mammografija tista’ taqbad kanċer tas-sider fi stadju bikri u n-nisa li jmorru għall-
iskrining tas-sider inaqqsu r-riskju li jmutu bil-kanċer tas-sider. Il-proċedura tal-
mammografija hija doża baxxa ta’ raġġi X u matul il-proċedura, is-sider jitpoġġa fuq il-
magna li titfa’ r-raġġi X u tiġi kompressata bil-galbu biex ma jiċċaqlax. Il-kompressjoni 
hi meħtieġa sabiex is-sider ma jiċċaqlaqx u jkun jista’ jittieħed l-iktar ritratt ċar bl-inqas 
ammont possibbli ta’ radjazzjoni. Bosta jħossuhom skomdi u wħud iħossu uġigħ li ma 
jdumx. Oħrajn iħossuhom ftit skomdi u wħud iweġġagħhom sew il-proċess. Kull mara 
jitteħdulha żewġ ritratti ta’ kull sider – wieħed minn fuq (cranio-caudal) u ieħor b’mod 
dijagonali minn taħt l-abt san-naħa l-oħra tas-sider (medio-lateral oblique). 
 
F’dan l-istudju, fl-ebda ħin ma int se tiġi identifikata fil-ktiba li ssir wara. L-informazzjoni 
li tagħti mhux se tiġi żvelata ma’ terzi persuni. Mhu se jinżamm l-ebda reġistru li b’xi 
mod jista’ jidentifika l-individwu li jkun abbinat ma’ kwalunkwe informazzjoni li tkun 
ġiet żvelata matul l-istudju. L-informazzjoni li tagħti tista’ tintuża biss biex jiġu mfassla 
u attwati servizzi effettivi biex titjieb il-prevenzjoni kontra l-kanċer tas-sider fost in-
nisa Maltin. 
 
Għal iktar informazzjoni dwar il-programm ta’ skrining tas-sider, ċempel fuq 21227470/1. 
Wieħed jista’ jara vidjo dwar il-proċedura tal-mammografija fuq 
http://www.nhs.uk/video/Pages/Breastcancerscreening.aspx 
 
Jekk għandek xi mistoqsijiet jew tħassib dwar l-istudju, jekk jogħġbok ikkuntattja lir-
riċerkatriċi, Danika Marmara’ permezz tal-posta elettronika d.m.attard@stir.ac.uk jew 
fuq 77773313. Jekk tħoss li kien hemm xi mumenti li kkawżawlek l-ansjetà minħabba 
dan l-istudju u tixtieq tiddiskuti ma’ xiħadd, ikkuntattja lit-tim ta’ infermiera tal-
Programm Nazzjonali tal-Iskrining tas-Sider fuq  21227470/1 għal għajnuna 
psikoloġika. 
 
 
 
Rendikont ġenerali għall-parteċipanti V2 16.09.17 
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Appendix 8.6a: Interview guide with Maltese women (English version) 
 
 How do you take care of your health in general?  
 How do you remember to schedule your health appointments? 
 What is the meaning of ‘cancer’ in your view? 
 And the words ‘breast cancer’? 
 Have you ever thought about the possibility of developing breast cancer? What are 
your related fears? 
 Do you think breast cancer can be prevented? What effective ways do you think 
about preventing breast cancer? 
 Do you have any intentions to prevent breast cancer? What do you usually do? 
 What do you know about breast health practices? 
 What can you tell me about breast screening in Malta? 
 What is your perception about a Breast Screening mammogram at the National 
Breast Screening Programme as opposed to a private mammogram? Do you think 
that the quality of the mammogram differs?  
 Why did you not attend to a mammogram in your life? Are there any 
environmental barrier, social barriers or intrapersonal barriers you would like to 
mention that really discourage you from having a mammogram? 
 Did any earlier experience in your life influence your decision to reject the screening 
invitation? Explain some of your experiences in which you have made decisions 
which you think were risky. 
 In your opinion, what set of circumstances would encourage you to go for a 
mammogram?  
 Where and how do you get health-related information? What sources of advice or 
information do you look to?  
 Which kind of educational modality would you prefer to get information about breast 
health?  
 We are trying to figure out how we can encourage women like you to get checked 
for breast cancer. What things would encourage you to screen regularly? What can 
we do from our end to help you attend?  
 Is there anything else you would like to share? 
 
 
Interview guide V2 16.09.17 
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Appendix 8.6b: Interview guide with Maltese women (Maltese version) 
 
Gwida għall-Intervista: Sett ta’ mistoqsijiet għal waqt l-Intervista ma’ nisa 
Maltin 
 Kif tieħu ħsieb saħħtek b’mod ġenerali?  
 Kif tagħmel biex tiftakar tagħmel l-appuntamenti mediċi? 
 Fil-fehma tiegħek, x’inhi t-tifsira ta’ “kanċer”? 
 U l-kliem “kanċer tas-sider”? 
 Qatt ħsibt dwar il-possibbiltà li joħroġlek kanċer tas-sider? X’inhuma l-biżgħat 
tiegħek? 
 Taħseb li l-kanċer tas-sider jista’ jiġi evitat? X’taħseb li huma l-modi effettivi biex 
tevita l-kanċer tas-sider? 
 Għandek intenzjonijiet biex tevita milli joħroġlok kanċer tas-sider? X’tagħmel 
normalment? 
 X’taf dwar il-prattiki għas-saħħa tas-sider? 
 X’taf tgħidli dwar l-iskrining tas-sider f’Malta? 
 X’inhi l-perċezzjoni tiegħek tal-Iskrining tas-Sider bil-mammogram li jsir fil-
Programm Nazzjonali tal-Iskrining tas-Sider li mhux bħall-mammogram li jsir 
privat? Taħseb li l-kwalità tal-mammograms tvarja? 
 Għalfejn qatt ma mort tagħmel mammogram? Hemm xi ostakolu ambjentali, soċjali 
jew intrapersonali li tixtieq tindika li qed iwaqqfek milli tagħmel mammogram?  
 Għaddejt minn xi esperjenza fil-ħajja li jista’ jkun li qed tinfluwenzalek id-deċiżjoni 
li tirrifjuta li tilqa’ l-istedina għall-iskrining? Spjegali xi esperjenzi li minħabba 
fihom ħadt deċiżjonijiet li taħseb li setgħu kienu ta’ riskju. 
 Fl-opinjoni tiegħek, x’inhuma ċ-ċirkostanzi li jistgħu jħeġġuk tmur tagħmel 
mammogram? 
 Minn fejn u kif iġġib l-informazzjoni dwar is-saħħa? Minn fejn tieħu l-pariri tiegħek 
u x’sorsi ta’ informazzjoni tfittex? 
 B’liema mezz tippreferi teduka lilek innifsek biex iġġib informazzjoni dwar is-saħħa 
tas-sider? 
 Qed nippruvaw nistħarrġu kif nistgħu nħeġġu nisa bhalek biex jagħmlu testijiet 
għall-kanċer tas-sider. X’taħseb li jħeġġek biex tagħmel skrining regolari? X’nistghu 
naghmlu iktar biex nhegguk tmur ghal breast screening?  
 Hemm xiħaġa oħra li tixtieq taqsam miegħi? 
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Appendix 8.7 – NICR Approval 
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Appendix 8.8 – HEC Approval 
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Appendix 9 – A recognition note from the Maltese Prime Minister’s wife  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
